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Through time, we as a society have been tested with infectious disease outbreaks of different 
magnitude, which often pose major public health challenges. To mitigate the challenges, 
research endeavors have been focused on early detection mechanisms through identifying 
potential data sources, mode of data collection and transmission, case and outbreak detection 
methods, and further characterization techniques. Driven by the ubiquitous nature of 
smartphones and wearables equipped with a variety of physiological sensors, the current 
endeavor is targeted towards individualizing the surveillance effort, where case detection is 
realized by exploiting self-collected physiological data from wearables and smartphones. A 
personalized health model, which could be realized with the individual’s self-generated data, 
plays a vital role in the feasibility of the individualized surveillance system. In this regard, the 
quest is to devise a model that can continuously monitor and screen the individual’s health 
status and be able to detect when the individual becomes ill. However, despite the research 
effort and promises the data present, still there doesn’t exist any implemented system with such 
capability.  
 
This dissertation aims to demonstrate the concept of a personalized health model as a case 
detector for outbreak detection purposes by utilizing self-recorded data from people with type 
1 diabetes. To realize the stated goal, the dissertation starts by defining a framework for the 
proposed personalized health model-based digital infectious disease detection system, i.e. 
Electronic disease surveillance and monitoring network (EDMON). Then, assess the predictive 
potential of different self-recorded parameters and optimal parameters indicative of infection 
onset are identified. A personalized health model (case detector) is devised using the identified 
optimal parameters and its detection capability is assessed. Finally, the dissertation closes by 
assessing user concerns, expectations, and willingness towards sharing self-collected health-
related data to the proposed EDMON system.  
 
The results have shown that infection onset triggers substantial deviations and results in 
prolonged hyperglycemia regardless of higher insulin injections and fewer carbohydrate 
consumptions. Per the findings, key parameters such as blood glucose level, amount of insulin 
injection, amount of carbohydrate consumption, and the ratio of insulin-to-carbohydrate are 
found to carry high discriminative power. A personalized health model designed based on a 
one-class classifier and unsupervised methods using some selected input parameters achieved 
promising detection performance. Experimental results show the superior performance of the 
one-class classifier and, particular models such as one-class support vector machine, k-nearest 
neighbor, and, k-means achieved relatively better performance from their respective groups. 
Besides, the result also revealed the effect of input parameters, data granularity, and sample 
sizes on model detection performances. On the other hand, people with diabetes have shown 
willingness to share most parameters, and, however, are reserved for certain parameters, i.e. 
geographical location (GPS), and signs of infection. In return to data sharing, this patient group 
expects some kind of incentives like tailored and personalized services, integrated view, and 




security and confidentiality (trust), ownership related to who owns the data, and storage related 
to where the data is stored. 
 
The results presented have practical significance for understanding the effect of infection 
episodes amongst people with type 1 diabetes, and the nature of infection triggered deviations 
incurred on blood glucose dynamics. Further, it also has practical significance for 
understanding the potential of personalized health model in outbreak detection settings. The 
added benefit of the personalized health model concept introduced in this dissertation lies in its 
usefulness beyond the surveillance purpose. In this regard, for example, the presented 
personalized health model can also be used for other purposes such as to devise decision support 
tools and learning platforms for the patient to properly manage infection-induced crises. 
Generally, developing a personalized health model-based digital infectious disease detection 
system like EDMON, which aims for early detection, i.e. during the incubation period, requires 
considering various aspects, and the results presented in this dissertation construct evidence 
that supports the efforts towards building the next generation personalized health model-based-
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Both in the past and present, we as a society have experienced infectious disease outbreaks of 
different magnitude often resulting in mass fatalities and causalities. These incidences are either 
naturally occurring or man-made, e.g. bio-weapons, phenomenon, and known to inflict major 
public health challenges [52; 237]. In this regard, there have been continuous endeavors to 
contain and reduce the burden through early and timely detection of the incidences and 
implementing proper infection control measures to mitigate the infection rate [46]. These efforts 
are mainly targeted in identifying potential data sources, mode of data collection and 
transmission, case definitions and detection methods, outbreak detection methods, and other 
outbreak characterization techniques [46; 52; 236; 237]. The transition from the traditional 
surveillance system, which mainly exploits high diagnostic precision data from the laboratory, 
to the state-of-the-art syndromic surveillance system, which relies on pre-diagnostic data has 
created opportunities to improve the timeliness of detection [55; 102; 170]. The state-of-the-art 
systems exploit data aggregated at the population level including clinical data, e.g. chief 
compliant data [227], and other surrogate data such as different search engines, social media, 
absenteeism, pharmacy drug sells,  and other various internet sources [79; 138; 143; 166; 170]. 
Furthermore, its capability to collect and transmit data in near real-time coupled with the 
availability of outbreak detection algorithms that can operate in real-time has further 
strengthened its significance in this regard [46; 227; 262]. However, as compared to the 
traditional surveillance system, outbreak characterization resulting from the syndromic 
surveillance system remain a significant challenge since it mainly operates with low-diagnostic 
precision (pre-diagnostic) data aggregated at the population level [236; 237]. In other words, a 
syndromic surveillance system lacks a look-back capability, which is a vital mechanism to 
trace-back to the sick individual for further clarification of the pathogens involved. Actually, it 
is worth mentioning that look-back capability is challenging by itself given the privacy and 
confidentiality issues posed. 
Currently, the endeavor is targeted towards individualizing the surveillance effort [194], where 
the case detection is realized by exploiting self-collected physiological data from different 
wearables and sensors [157; 181]. In this regard, the main drivers are the rapid progress in 
information and communication technology, and the widespread availability of different 
smartphones and wearables equipped with a variety of physiological sensors, which created a 
suitable platform to easily self-track health data [106; 181; 185; 202; 205]. These technologies 
are increasingly been integrated into our daily life for a variety of reasons ranging from fitness 
tracking to managing diseases [20; 74; 85; 95; 106; 154; 203; 243]. As a result, a huge amount 
of data are being recorded on a daily basis that grows at an unprecedented rate [71; 214; 231]. 
The existence of these data is the cornerstone in the individualization effort that created 
unbounded possibilities for improving the state-of-the-art disease surveillance systems [44; 
194]. Accordingly, the transition in granularity from population-level surveillance into 
individualized surveillance are becoming feasible and converging at a faster rate. In this regard, 
for instance, recent studies have shown the feasibility of smartwatches and wearable technology 
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in monitoring, detecting, and predicting illness [25; 157; 180; 181; 202; 223]. As compared to 
the existing syndromic surveillance system, individualization of the surveillance has a double 
benefit, it can be geared to monitor and notify changes in individual health status and 
simultaneously monitor the status of infectious disease outbreaks among the public [181; 194]. 
This is a great leap forward because previous systems, e.g. Google Flu Trends [86; 138] and 
HealthMap [45; 79], consider only detecting health threats at population levels and don’t 
possess a mechanism to trace back to the sick individual. The potential and promises of the 
individualization effort lie in the fact that it operates with a secondary source of information 
mainly data generated for other purposes outside of the healthcare service settings. However, 
as described earlier, it faces significant challenges concerning user privacy and confidentiality, 
and ethical issues as it directly deal with individual health-related data [82; 128; 131; 157; 214]. 
Moreover, another prominent challenge in such a system is the availability of quality user-
generated health-related data, and how to motivate and buy user trust to get the required data is 
a topic that needs to be carefully addressed [91; 126; 172].  
A personalized health algorithm, which could be modeled with the individual’s self-generated 
data, plays a vital role in the feasibility of the individualized surveillance system [157; 181]. In 
this regard, the quest is to devise a model that can continuously monitor and screen the 
individual’s health status and be able to detect when the individual becomes ill in either real-
time or near real-time using the individual’s self-generated data. After having a successful case 
detector at an individual level, it becomes straightforward to realize a method for detecting a 
cluster of infected individuals on a Spatio-temporal basis [181; 237; 262]. As described above, 
apart from its use in detecting infectious disease outbreak, this type of early warning system 
can also address the need of having real-time health status information for different groups in 
the population, including chronic patients, aging populations, people using ambient assisted 
living, and healthy individuals [5; 12; 13; 72; 94; 114; 155; 193; 196; 243; 268]. However, 
despite the research effort and promise the data presents, still there doesn’t exist any 
implemented system with such capability [181; 237]. This dissertation aims to demonstrate the 
concept of a personalized health model as a case detector for outbreak detection purposes by 
utilizing self-recorded data from people with type 1 diabetes. It further examines users’ 
concerns, expectations, and willingness towards sharing self-collected health-related data for 
the proposed EDMON system. The dissertation starts by defining a framework for the proposed 
personalized health model-based digital infectious disease detection system. Then, it quantifies 
the extent of infection triggered deviations on the key parameters of blood glucose dynamics 
amongst people with type 1 diabetes. Next, it explores the state-of-the-art approaches for 
classifying blood glucose patterns and detecting anomalies in blood glucose dynamics amongst 
people with type 1 diabetes giving due emphasis to the cause and effect relationship between 
parameters used in modeling. Further, it devises a personalized health model (case detector) for 
continuous monitoring of an individual’s health status and automatic detection of infection 
onset. Finally, the dissertation closes by assessing user concerns, expectations, and willingness 




The current tragic event due to the corona-virus (SARS-CoV-2) outbreak, also known as 
COVID-19, has resulted in mass panic among the society and loss of many lives around the 
globe [21; 186]. The incident has thought us that we as a society stand far from prepared for 
such kinds of outbreaks. The first step to reducing the impact of any infectious disease 
outbreaks is to devise an early detection system, which requires a well-equipped digital 
infectious disease detection system. As has been tested frequently through time, the existing 
disease surveillance systems have several shortcomings, which calls for revolutionizing the 
system by integrating with novel data sources and aberration detection mechanism [54; 157; 
170; 181; 199; 237]. The availability of different physiological sensors coupled with a huge 
amount of data generated daily creates enormous opportunities to advance the state-of-the-art 
system by driving a lot more research to be conducted to improve the time delay in the existing 
systems, given the profound implication of time criticality for disease surveillance design. In 
this regard, the timeliness requirement calls for the integration of new data sources, and novel 
aberration detection methods with a system that can collect and analyses data in real-time or 
near real-time [108; 237].  
Self-recorded health-related data from people with type 1 diabetes could be one potential 
choice, which is becoming rich in both quality and quantity as a result of advancement in 
diabetes technologies [11; 19; 23]. Type 1 diabetes is a chronic disease that results in a lack of 
blood glucose control as a result of insulin deficiency within the body [56; 64]. This group of 
patients is expected to follow complex treatment regimens to control their blood glucose levels 
within the recommended targets including tracking blood glucose levels throughout the day, 
administrating balanced insulin while considering factors like blood glucose levels, meal 
intake, physical activity, and other possible factors. This group of patients are estimated to 
account for more than five percent of all the people diagnosed with diabetes and is expected to 
grow [161]. Infection onset is known to induce hyperglycemia (elevated blood glucose levels) 
among people with diabetes [38; 47; 62; 115; 133]. In this regard, there is previous evidence in 
the literature that shed some light on the possibility of harnessing self-recorded data from 
people with type 1 diabetes as a potential data source to detect infectious disease outbreaks [17; 
30; 31; 34; 36; 38; 90].  
In this dissertation, the predictive potential of different self-recorded parameters is investigated 
and optimal parameters that are indicative of infection onset are identified. A personalized 
health model is devised using the identified optimal parameters and its detection capability is 
assessed. It is apparent that blood glucose dynamics are affected by various factors apart from 
infection incidences, and hence, these optimal features are an important building block for 
realizing a personalized health model with a minimum and acceptable false alarm rate. Based 
on these findings, it remains straightforward to realize the proposed EDMON system for 
assisting in detecting infectious disease outbreaks among the public. In this regard, the main 
idea here is to exploit self-recorded health-related data from people with type 1 diabetes to 
assist detection of infectious disease outbreaks among the public.   
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 Research context  
This dissertation is part of the “EDMON-Electronic Disease Surveillance and Monitoring 
Network” project, which is a personalized health model-based-digital infectious disease 
detection system. EDMON aims to exploit self-generated data from various population groups, 
e.g. healthy and chronic patients, to assist in detecting infectious disease outbreaks among the 
public. In this regard, this dissertation presents a case study using self-recorded data from 
people with type 1 diabetes. The proposed EDMON system incorporates five units; patient unit, 
data repository unit, infection detection unit, clustering unit (decision making), and information 
dissemination unit (visualization), as shown in Figure 1. The patient unit includes a user mobile 
devices terminal used for collecting and transmitting data to a central server. The data repository 
unit stores the incoming user data. The infection detection unit tracks the individual health 
status by analyzing the data in real-time based on a personalized health model. The clustering 
unit identifies any possible cluster of infected individuals based on a Spatio-temporal analysis. 
The information dissemination unit provides real-time information regarding the current status 
of the area under surveillance for the concerned bodies, i.e. ordinary citizens, patients, and 
public health officials. This dissertation focuses on topics related to the patient unit and 




Figure 1: EDMON system overview, adapted from [259], Figure 14. 
 Research problem and questions 
The main research problem the dissertation addresses is: MP - What is the effect of infection 
incidence on key parameters of blood glucose dynamics amongst people with type 1 diabetes, 
and how can self-recorded data from this patient group assist in detecting an infectious 
disease outbreak? To effectively answer the main research problem, different sub-questions 
were derived that address part of the main research problem as follows:  
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 Q1 – How is a personalized digital infectious disease detection system that collects 
self-recorded data from participants, analyzes the data, detects deviations on an 
individual basis, identifies a cluster of individuals, and notifies the status of an 
outbreak to be designed and implemented?  
Description: Pursue to develop a general framework for realizing a personalized health model-
based digital infectious disease detection system based on self-collected data from people with 
type 1 diabetes. It gives an overview of the EDMON system components and the interaction 
between them. Furthermore, the framework address factors and challengs that need to be 
addressed during implementation both from the technology and user perspectives.  
 Q2 – What is the effect of infection incidence on key parameters of blood glucose 
dynamics among people with type 1 diabetes, and which parameters can effectively 
be used for detecting infection incidences in people with type 1 diabetes? 
Description: Pursue to uncover the effect of infection onset on key parameters of blood glucose 
dynamics. Blood glucose dynamics are affected by numerous factors and it is very important 
to identify if there exist any other possible confounding parameters, which could perhaps have 
a similar effect as infection and thereby resulting in a false alarm. This helps me to pinpoint 
and select potential event indicator parameters from the diabetes profile that can be effectively 
used in detecting health changes or deviation from normality, i.e. infection onset while reducing 
false alarms. 
 Q3 –What is the status regarding an infection detection system using self-recorded 
data from people with type 1 diabetes and to what extent do the existing personalized 
decision support systems, and blood glucose alarm events applications consider 
infection incidence and its effect while developing blood glucose anomalies detection 
algorithms?  
Description: Pursue to identify if there is any previously developed and implemented infection 
detection system using self-recorded data from people with type 1 diabetes and also to 
understand the extent to which the existing literature incorporates the effect of infection 
incidences in people with type 1 while modeling personalized blood glucose anomalies, i.e. 
hyper/hypoglycemia and glycaemic variability, detection algorithms. Further, it is also used to 
assess and analyses the success of machine learning models in these algorithms for achieving 
the required task in a real-time, and free-living condition considering different types of input 
variables, data collection procedures, and devices used. This helps me to figure out the direction 
of the dissertation in terms of approaching the infection detection tasks.  
 Q4 – How to design and develop a personalized health model that can continuously 
monitor individual health status and automatically detect infection onset using self-
recorded data from people with type 1 diabetes? 
Description: Pursue to develop a personalized health model to effectively monitor the 
individual’s health status continually and automatically detect infection onset. The idea behind 
this is to realize a model that is capable of detecting infection-triggered deviation while leaving 
changes due to other confounding parameters undetected; thereby reducing false alarms. This 
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is central to the proposed EDMON system performing as a case detector to screen the 
individual’s health.    
 Q5 – What are the user concerns and expectations towards sharing self-collected 
health-related data with the proposed system? and what type of data are they willing 
to anonymously share? 
Description: Pursue to assess and examine user concerns, expectations, and willingness 
towards sharing self-collected health-related data to the proposed EDMON system. Different 
factors could affect the user's willingness to share their health-related data unless they perceive 
that the system could meet their expectations and also address their concerns. These findings 
are expected to guide on factors that need to be addressed during the design and developments 
of the patient unit as well as the proposed EDMON system in general.  
 Significance of the study 
The dissertation is multidisciplinary in its nature and draws facts, concepts, tools, and methods 
from different fields of study. A personalized health model that can effectively monitor the 
individual’s health status and automatically detect infection onset among people with type 1 
diabetes is developed, which can be geared towards both individual and public health benefits. 
The concept behind the personalized approach can also be generalized towards infection 
detection in other types of diabetes and also among different population groups. These findings 
have practical significance in different fields; informatics, public health, medicine, and 
healthcare.   
Informatics 
The significance of this dissertation to informatics is based on the models, data analysis and 
knowledge produced. The approach can be easily extended to people with other types of 
diabetes, not only type 1 diabetes. 
Public health  
The significance of this dissertation to public health is related to the approach presented, which 
can be used to detect the incidence of infection at an individual level and thereby detecting 
infectious disease outbreaks at the population level. The EDMON system presented in the 
dissertation can be integrated with existing syndromic surveillance and assist in detecting 
infectious disease outbreaks and thereby alarming possible outbreaks that could endanger 
public health.  
Healthcare  
The significance of the dissertation to healthcare is related to the personalized health model 
presented since it can be geared towards realizing an application for tailored personalized 
decision support and learning platform. In this regard, the presented analysis and models can 
be used to realize a tailored platform to educate individuals on how to respond to infection-





The findings, i.e. analysis and models, presented in this dissertation can also be informative to 
an individual with type 1 diabetes. Among people with type 1 diabetes, infection occurrence is 
known to induce significant challenge to self-manage their blood glucose levels. Therefore, 
information regarding blood glucose evolution, and change in insulin resistance, i.e. insulin to 
carbohydrate ratio, during infection incidences can be quite helpful for this group of patients. 
 Claimed contribution and included papers 
 Contribution of the dissertation 
This dissertation mainly contributes towards the development of a personalized health model-
based - digital infectious disease detection system, also known as Electronic Disease 
Surveillance and Monitoring Network (EDMON), that relied on the detection of infection onset 
on an individual basis to predict infectious disease outbreaks on the population level using self-
recorded data from people with type 1 diabetes, which makes the system the first of its kind. 
EDMON incorporates a patient unit, data repository unit, infection detection unit, clustering 
unit, and information dissemination unit. This dissertation presents the following contributions:  
1) A framework of personalized health model-based digital infectious disease detection 
system, i.e. EDMON system, for realizing a system that can collect, analyze, detect, and 
notify the concerned bodies about the ongoing outbreak (C1),  
2) An infection detection unit that can effectively monitor the individual’s health status 
continually and automatically detect infection onset (C2, C3, C4), and 
 A proof of concept towards using key parameters of blood glucose dynamics for 
detecting infection onset (C2). This contribution characterizes the effect of infection 
onset on key parameters of blood glucose dynamics and put forward optimal 
parameters for realizing the proposed personalized health model. 
 A personalized health model for detecting infection onset in people with type 1 
diabetes using blood glucose, insulin, and carbohydrate information (C3). These 
models require all the three key parameters of blood glucose dynamics. 
 An alternative personalized health model for detecting infection onset in people with 
type 1 diabetes using only insulin and carbohydrate information (C4). The point is to 
provide alternative models when there is a challenge in getting blood glucose 
measurements for various reasons. In this regard, the underlying reason could be 
linked to fear associated with information leakage or data usage by 3rd parties. For 
example, blood glucose information containing experiences of repeated lows blood 
glucose level (hypoglycemia), if discovered by a licensing authority, might end up 
suspending one’s driving license. 
3) Finally presents a list of factors related to user concerns, expectations, and willingness for 
the successful mass sharing of self-collected health-related data to the proposed EDMON 
system (C5).  
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The presented system addresses the dissertation research problem and the stated contributions 
along with the associated research questions are presented in Table 1. The third research 
question (Q3) is linked with the background of the dissertation.  
Table 1:Contributions and research questions addressed in the dissertation. 
Contribution Description  Publication  
C1 Q1 A general framework of a personalized health model-
based digital infectious disease detection system for 
realizing a system that collects, analyses, detects, and 
notifies the concerned bodies about ongoing outbreaks. 
 Paper 1 
   
C2 Q2 A proof of concept towards using key parameters of 
blood glucose dynamics for detecting infection onset.  
Paper 1 
BKGND Q3 Literature review of data-driven blood glucose pattern 
classification and anomaly detection mechanisms among 
people with type 1 diabetes.  
Paper 2 
C3 Q4 A personalized health model for detecting infection onset 
in people with type 1 diabetes using blood glucose, 
insulin, and carbohydrate information. 
  Paper 3 
  
C4 Q4 An alternative personalized health model for detecting 
infection onset in people with type 1 diabetes using only 
insulin and carbohydrate information. 
Paper 4 
C5 Q5 Assessments of user concerns, expectations, and 
willingness towards sharing self-collected health-related 
data. 
 Paper 5 
 
 
 Other contributions  
Apart from the main contributions, there are other relevant contributions I produced during the 
work on my Ph.D. project, which is not included in the dissertations. 
Paper 7 Coucheron, S., Woldaregay, A. Z., Årsand, E., Botsis, T., & Hartvigsen, G. 
(2019). EDMON - A System Architecture for Real-Time Infection Monitoring and 
Outbreak Detection Based on Self-Recorded Data from People with Type 1 Diabetes: 
System Design and Prototype Implementation. Paper presented at the SHI 2019. 
Proceedings of the 17th Scandinavian Conference on Health Informatics, November 12-
13, 2019, Oslo, Norway.  
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Paper 8 Woldaregay, A. Z., Issom, D., Henriksen, A., Marttila, H., Mikalsen, M., Pfuhl, 
G., Sato, K., Lovis, C., & Hartvigsen, G. (2018). Motivational Factors for User 
Engagement with mHealth Apps. Studies in Health Technology and Informatics, 249, 
151.  
Paper 9 Yeng, P. K., Woldaregay, A. Z., Solvoll, T., & Hartvigsen, G. (2020). Cluster 
Detection Mechanisms for Syndromic Surveillance Systems: Systematic Review and 
Framework Development. JMIR Public Health Surveill, 6(2), e11512. 
doi:10.2196/11512. 
Paper 10 Woldaregay, A. Z., Arsand, E., Walderhaug, S., Albers, D., Mamykina, L., 
Botsis, T., & Hartvigsen, G. (2019). Data-driven modeling and prediction of blood 
glucose dynamics: Machine learning applications in type 1 diabetes. Artif Intell Med, 
98, 109-134. doi:10.1016/j.artmed.2019.07.007 
Paper 11  Woldaregay, A. Z., Årsand, E., Botsis, T. & Hartvigsen, G. 2017. An Early 
Infectious Disease Outbreak Detection Mechanism Based on Self-Recorded Data from 
People with Diabetes. Studies in health technology and informatics, 245, 619-623. 
Paper 12 Yeng, P. K., Woldaregay, A. Z., & Hartvigsen, G. (2019, November). K-
CUSUM: Cluster Detection Mechanism in EDMON. In SHI 2019. Proceedings of the 
17th Scandinavian Conference on Health Informatics, November 12-13, 2019, Oslo, 
Norway (No. 161, pp. 141-147). Linköping University Electronic Press. 
Paper 13 Tejedor, M., Woldaregay, A. Z., & Godtliebsen, F. (2020). Reinforcement 
learning application in diabetes blood glucose control: A systematic review. Artificial 
Intelligence in Medicine, 104, 101836. 
doi:https://doi.org/10.1016/j.artmed.2020.101836.  
Paper 14 Giordanengo, A., Årsand, E., Woldaregay, A. Z., Bradway, M., Grottland, A., 
Hartvigsen, G., Granja, C., Torsvik, T., & Hansen, A. H. (2019). Design and Prestudy 
Assessment of a Dashboard for Presenting Self-Collected Health Data of Patients With 
Diabetes to Clinicians: Iterative Approach and Qualitative Case Study. JMIR Diabetes, 
4(3), e14002. doi:10.2196/14002.  
 Statements of originality 
This section puts forward the statement of originality, by stating the relevance of each article 
to the dissertation along with my contribution.  
Paper 1 Woldaregay, A. Z., Launonen, I. K., Årsand, E., Albers, D., Holubová, A., & 
Hartvigsen, G. (2020). Toward Detecting Infection Incidence in People With Type 1 
Diabetes Using Self-Recorded Data (Part 1): A Novel Framework for a Personalized 




Relevance: The study provides the basis for the development of the proposed personalized 
digital infectious disease detection system in general and the personalized health model in 
particular. A proof of concept regarding infection onset and its degree of effect on key 
parameters of blood glucose dynamics is presented. Thus, it provides information about optimal 
parameters of blood glucose dynamics to effectively support the strategies need for designing 
and developing the proposed personalized health model. Moreover, it presents a general 
framework to effectively guide the development of the proposed personalized health model-
based digital infectious disease detection system, i.e. EDMON system. The framework provides 
a detailed description of the EDMON system components and challenges that needs to be 
addressed during system implementation. To the best of my knowledge, this is the first study 
that empirically and numerically quantifies the effect of infection episodes on key parameters 
of the blood glucose dynamics among people with type 1 diabetes exploiting self-recorded data. 
My Contribution: I proposed the study, defined the problem, collected the data from the study 
participants, designed and carried out the experiments, and wrote the manuscript. G. 
Hartvigsen, I. Launonen, E. Årsand, A. Holubová, and D. Albers provide successive expert 
input to improve the study, presented some alternative approaches to shape the study, and 
reviewed the manuscript.   
Paper 2 Woldaregay, A. Z., Arsand, E., Botsis, T., Albers, D., Mamykina, L., & 
Hartvigsen, G. (2019).  Data-Driven Blood Glucose Pattern Classification and 
Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes. J Med 
Internet Res, 21(5), e11030. doi:10.2196/11030 
Relevance: The study presented an overview of the state-of-the-art approaches used for 
classifying blood glucose patterns and detection of anomalies within the framework of 
personalized decision support and alarm applications for blood glucose control. The review 
sheds some light on the applicability of different models, challenges that need to be addressed, 
success and limitations of different input features and diabetes self-management technologies, 
cause-effect reasoning ability of the implemented system, and the extent of integrating 
information regarding infection incidence within the implemented systems.  
My Contribution: I conceived the idea, proposed the study, defined the problem, designed the 
method, and carried out the search and analysis. G. Hartvigsen, E. Årsand, T. Botsis, D. Albers, 
and L. Mamykina provide successive expert input in shaping the method design and analysis. I 
wrote the manuscript based on successive reviews and discussions with co-authors.   
Paper 3 Woldaregay, A. Z., Launonen, I. K., Albers, D., Igual, J., Årsand, E., & 
Hartvigsen, G. (2020). A Novel Approach for Continuous Health Status Monitoring and 
Automatic Detection of Infection Incidences in People With Type 1 Diabetes Using 
Machine Learning Algorithms (Part 2): A Personalized Digital Infectious Disease 
Detection Mechanism. J Med Internet Res, 22(8), e18912. doi:10.2196/18912 
Relevance: The study provides an approach for detecting infection onset in an individual with 
type 1 diabetes exploiting self-recorded blood glucose level, insulin, and carbohydrate 
information. A personalized health model is presented, which can track an individual’s health 
 
11 
status in a continuous manner and automatically detects infection onset. The aim of the study 
was to thoroughly evaluate the performance, necessary sample sizes, and computational time 
of different machine learning algorithms. To the best of my knowledge, this is the first attempt 
towards realizing a personalized health model to capture infection episodes among people with 
type 1 diabetes using self-recorded data. 
My Contribution: I conceived the idea and proposed the study, designed and performed the 
experiments. G. Hartvigsen, I. Launonen, E. Årsand, and D. Albers provides successive expert 
input during the designing of the experiment and proposed some alternative solutions. I wrote 
the manuscript based on a thorough discussion with co-authors. Further, the co-authors 
reviewed the manuscript and provide successive comments and suggestions to improve the 
manuscript. 
Paper 4 Woldaregay, A. Z. Woldaregay, A. Z. Automatic Detection of Infection State in 
Individuals with Type 1 Diabetes Under Free-Living Conditions Using Using Self-
Recorded Insulin and Carbohydrate Information (Part 3). EARLY DRAFT 
MANUSCRIPT. This Manuscript contains overlapping texts and results from the 
dissertation. 
Relevance: As an alternative solution, this study presents a personalized health model that 
exploits self-recorded insulin and carbohydrate information. This alternative provides a greater 
advantage when there is a lack of information about blood glucose levels. Hence, the study 
compares with the performance achieved in Paper 3. The result demonstrates the potential of 
the proposed approach. 
My Contribution: I conceived the study, designed and performed the experiments, and wrote 
the manuscripts. In this study, the ideal was to further strengthen the result presented in Paper 
3 and to provide alternative ways of achieving the same objective.  
Paper 5 Woldaregay, A. Z., Henriksen, A., Issom, D. Z., Pfuhl, G., Sato, K., Richard, 
A., Lovis, C., Arsand, E., Rochat, J., & Hartvigsen, G. (2020). User Expectations and 
Willingness to Share Self-Collected Health Data. Stud Health Technol Inform, 270, 
894-898. doi:10.3233/SHTI200290 
Relevance: The study presented a list of findings related to user concerns, expectations, and 
willingness towards sharing one’s self-collected health-related data to the proposed 
personalized health model-based digital infectious disease detection system, i.e. EDMON 
system. Given the sensitivity of health data, prior understanding of user concerns and 
expectations are very important especially when it comes to the sharing of health-related data. 
To facilitate mass data sharing, it is necessary to properly address user concerns and meet user 
expectations throughout the EDNON system design and development. In this regard, the study 
puts forward factors that need to be addressed during system design and implementation so as 
to buy the user's willingness to engage in sharing data to the proposed system. A survey 
questionnaire was developed based on the results from a qualitative interview [252] to further 
understand factors related to user concerns, expectations, and willingness. A survey 
questionnaire assessing different factors related to user concerns, willingness, and expectations 
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was distributed to participants and the response was analyzed using statistical techniques. These 
findings will act as guidelines during the realization of the proposed EDMON system. 
My Contribution: I, together with the co-authors, has conceived the idea, proposed the study 
and formulated the problem. Further, contributed through the development of the survey 
questioners, and posted the survey questionnaire related to diabetes in an appropriate channel 
in collaboration with E. Årsand. G. Pfuhl conducted the statistical analysis. A. Henriksen and I 
wrote the manuscript based on a thorough discussion with the co-authors.  
 Defining the red thread 
This section describes each stage of the dissertation and the connection between them.  
The Initial Phase (Q1) - Development of a general framework of a personalized health 
model-based digital infectious disease detection system.  
As an initial work, the general framework defines the main components of the proposed 
personalized health model-based digital infectious disease detection system, i.e. EDMON 
system, along with the challenge that needs to be addressed during system design and 
implementation Paper 1 [259]. The presented framework shapes the dissertation by pinpointing 
the crucial part of the EDMON system. All the rest of the dissertation topics emanates from the 
proposed framework.  
The First Phase (Q2) – Nature, extent, and degree of effect of infection incidences on key 
parameters of blood glucose dynamics amongst people with type 1 diabetes.  
There is evidence in the literature describing the effect of infection incidences in people with 
type 1 diabetes. Some literature clearly described the potential of blood glucose levels and other 
diabetes profile parameters as an indicator of infection onset in this patient group. However, 
there is a knowledge gap when it comes to empirical and numerical evidence depicting the 
degree of deviation as a result of infection with respect to each diabetes profile. This work 
uncovers the nature and extent of infection-induced deviations on each key parameter of blood 
glucose dynamics and puts forward optimal parameters for realizing a personalized health 
model Paper 1 [259]. As a result, this piece of work layout the foundation for the development 
of a personalized health model for detecting infection incidences.   
The Second Phase (Q3) – Personalized decision support systems, blood glucose alarm events 
applications, and anomalies detection algorithms. 
As a roadmap to the development of a personalized health model, the systematic review is 
aimed at assessing and analyzing the state-of-the-art approaches used for classifying blood 
glucose patterns and detecting anomalies within the framework of personalized decision 
support and alarm applications for blood glucose control. It also tries to assess and understand 
if there is any literature, which incorporates information related to infection onset and how these 
algorithms tried to include such information in their process Paper 2 [253]. This wide piece of 
work helps me to choose the right modeling approach towards realizing the proposed 
personalized health model for detecting infection incidences on an individual basis. 
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The Third Phase (Q4) – Modelling a personalized infection detection algorithm. 
After understanding the state-of-the-art approaches and the associated knowledge gap, this 
work realizes a personalized health model that can monitor the individual health status in a 
continuous manner and automatically detects infection onset using the individual’s diabetes 
profile. This piece of work is the core for realizing the proposed personalized health model-
based digital infectious disease detection system, i.e. EDMON system.  
To begin with, modeling of a personalized health model was carried out using blood glucose 
levels, insulin, and carbohydrate information as input features to the algorithm Paper 3 [258]. 
Furthermore, the possibility of using insulin and carbohydrate information as input features for 
realizing a personalized health model was explored in Paper 4.  
The Fourth Phase (Q5) – Assessments of user concerns, expectations, and willingness 
towards sharing self-collected health-related data.  
As the last stage, this piece of work tries to pinpoint user concerns, expectations, and 
willingness towards sharing self-collected health-related data to the proposed EDMON system. 
A system that relies on self-collected data typically requires the timely sharing of these data for 
further processing to produce precise results. Fulfilling patient expectations, and properly 
addressing their concerns has a great impact on the successful mass sharing of health-related 
data to the proposed EDMON system Paper 5 [257].  
 Organization of the dissertation 
The entire dissertation is organized as follows; Chapter two provides the background of the 
dissertation; Chapter three presents the methods and materials used in the studies; Chapter four 
introduces the proposed framework of the personalized health model-based digital infectious 
disease detection system along with the associated challenge that needs to be addressed during 
system design and implementation; Chapter five gives a detailed analysis depicting the nature 
and extent of infection-induced deviations on each key parameter of blood glucose dynamics 
among people with type 1 diabetes; Chapter six presents solutions for a personalized health 
model that can monitor the individual’s health status in a continuous manner and automatically 
detect infection onset in people with type 1 diabetes; Chapter seven puts forward list of findings 
related to user concerns, expectations, and willingness for long-term and successful sharing of 
self-collected health-related data. The final chapter, Chapter Eight, gives a concluding remark 
of the dissertation and future works. 
This dissertation has a content reuse, and specifically from Paper 1, 2, 3, and 5 and are allowed 
by the publishers under the Creative Commons Attribution license. In this regard, given the 
absence of written guidelines from UiT – The Arctic University of Norway, a guideline from 
the Technical University of Denmark are used, and can be found from https://www.dtu.dk/english/-
/media/DTUdk/Uddannelse/PhD-Udannelse/Dokumenter/DTU-Guidelines-for-avoiding-plagiarism-and-self-plagiarism-
in-PhD-thesis-writing.ashx?la=da&hash=3D7503AB200968C246A901BD90C4E0C9A04E3940. Based on this, a 


































2 Theoretical Background 
Synopsis: This chapter puts forward detailed descriptions of the theoretical background of 
the dissertation. Even if each article has a detailed and broader background section, this part 
will complement and highlight some theoretical background necessary to understand the work 
presented in this dissertation. The first half of the chapter provides insight into blood glucose 
homeostasis and infection incidences, and then proceed to describe existing literature 
suggesting diabetes profile parameters as infection indicator. 
 Blood glucose dynamics   
Blood glucose homeostasis is the process by which the body maintains normal blood glucose 
levels [184]. The pancreas' alpha and beta cells play a vital role in blood glucose homeostasis 
by secreting insulin and glucagon, which are necessary to regulate blood glucose levels. As 
shown in Figure 2 [190], the occurrence of either elevated or lowered blood glucose 
concentration stimulates the pancreas beta and alpha cells to release insulin and glucagon 
respectively. For instance, let us consider that there is elevated blood glucose concentration 
after a meal, and this scenario directly stimulates pancreatic beta cells to release insulin, thereby 
activating the liver to take up glucose, convert and store it as glycogen through a process known 
as glycogenesis. In addition, at the same time, the body will be activated to take up and use 
more glucose. As a result, glucose concentration in the blood lowers to the normal range, and 
stimulus for insulin release also diminishes, as shown in Figure 2. By the same token, let us 
assume that an individual has skipped a meal and his/her blood glucose levels begin to drop 
below a certain threshold, and this scenario stimulates pancreatic alpha cells to release glucagon 
into the blood. Hence, glucagon activates the liver to break down glycogen into glucose through 
the process called glycogenolysis and release it into the blood. As a result, blood glucose levels 
rise to the normal range and thereby diminishing the stimulus for glucagon production, as 
shown in Figure 2. 
Regarding people with type 1 diabetes, there is a lack of insulin secretion from pancreatic beta 
cells. This patient group needs to inject a proper amount of exogenous insulin as medication to 
compensate for the lack of insulin secretion. Mostly, the key diabetes parameter such as the 
current blood glucose levels, amount of carbohydrate consumption, and physical activity 
session or exercise load are taken into account to determine the necessary amount of insulin 
injection. Insulin injection is administered based on either multiple daily injections, which 
involves several small injections at different times of the day, or continuous subcutaneous 
insulin infusion, which relies on insulin pump therapy. People with type 1 diabetes usually rely 
on carbohydrate counting, which involves estimating insulin-to-carbohydrate ratios [210], to 
accurately determine the necessary amount of insulin during mealtime [84; 167; 210; 228]. The 
estimated insulin-to-carbohydrate ratio is a function of an individual’s insulin sensitivity and 
factors that affect insulin sensitivity directly or indirectly also affect the ratio. These factors 
include the time of the day [167], weight, age, menstruation, physical activity, stress, illness, 
infection, and so many others [48]. During normal situations, the estimated value of the insulin-
to-carbohydrate ratio in most cases is normally distributed within the usual range of 0.02, 
equivalent to 1 unit of insulin to every 50 grams of carbohydrate, to 0.2, equivalent to 1 unit of 
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insulin to every 5 grams of carbohydrate [158; 167]. However, it should be noted that this 




Figure 2: Blood glucose homeostasis (regulation) [10; 208], source Campbell, Figure 25.10. 
 
Blood glucose concentration is affected by different factors, which are often designated as 





 Some list of factors that affect blood glucose levels, source – diaTribe1 [43]
b) Grouping of factors affecting blood glucose levels [22]. 
Figure 3: Factors affecting blood glucose dynamics. Figure (a) depicts some of the factors that 
affect blood glucose levels and Figure (b) depicts a grouping of these factors amongst the 
individuals.  
                                                     
1
https://diatribe.org/42factors 
Factors affecting blood glucose dynamics
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These factors are also grouped into either patient controllable or patient uncontrollable 
parameters depending on the degree of direct control the patient has to limit the effect of these 
factors on blood glucose dynamics [253]. From the patient perspective, the patient controllable 
parameter is known to induce reasonable deviation on blood glucose dynamics. For instance, 
blood glucose deviation due to meal intake can be approximated and known in advance. 
However, the effect of patient uncontrollable parameters is difficult to estimate in advance and 
known to induce unreasonable deviations that usually differs from the typical norm of blood 
glucose dynamics. For example, blood glucose deviations as a result of infection onset are 
difficult to manage and often could end up in prolonged hyperglycemia. However, from a blood 
glucose fluctuations perspective, any incurring blood glucose deviations can be defined as 
either normal or special cause variations [253]. In this regard, normal cause variations are those 
induced by common and individual factors. Yet, special cause variations are those induced by 
unpredictable factors, and patients usually struggle to manage and understand the underlying 
cause during the incidences. A particular example of special cause variation is depicted during 
an infection episode, where the individual patient struggles to control the blood glucose levels 
through frequent administration of insulin [37]. 
 Infections incidences in people with diabetes 
 Acute illness and glucose metabolism  
During infection episodes, several hormonal changes occur within the body often known as 
counter-regulatory, which affects blood glucose metabolism. The counter-regulatory hormones, 
e.g. epinephrine and cortisol, mainly stimulate the production of hepatic glucose, glucose 
utilization, and lipolysis and thereby elevating the plasma blood glucose concentrations 
(hyperglycemia) [133; 147; 264].  
 Blood glucose control during infection incidences 
During infection incidences, self-management of diabetes can become very problematic, given 
the interference of the counter-regulatory hormones, which affects the individual’s blood 
glucose levels and insulin sensitivity. Excess glucose productions and the influence of insulin 
resistance (less insulin sensitivity) on the blood glucose dynamics are believed to be responsible 
for creating a shift in the operating point mainly in terms of the insulin-to-carbohydrate ratio 
[30; 38; 141; 142; 158; 179; 248; 264]. As a result, it is common to observe an abnormal rise 
in blood glucose levels and different reactions to insulin injection and meal intake. Managing 
hyperglycemia is critical during infections, where poor self-management can lead to 
complications including diabetic ketoacidosis and other similar incidences [145]. Generally, it 
is recommended to frequently measure blood glucose levels, and inject more insulin despite 
experiencing a feeding problem (loss of appetite) [121; 142; 144; 145]. The optimal 
management of hyperglycemia episodes during infection incidences needs to balance the 
amount of insulin and carbohydrate intake, considering a 10 - 40 % raise in the total daily 
insulin and reduction in the amount of carbohydrate consumption (light foods are 
recommended)  [121; 141; 142; 144; 145]. A typical example of patients discussing the 









a) People with type 2 diabetes discussing the effect of infection on blood glucose 
dynamics. 





b) People with type 1 diabetes discussing the effect of infection episode on blood glucose 
dynamics. 
Figure 4: Depicts what patients discuss on online forums about infection and blood glucose 
levels, source [78; 141; 142]. Figure (a) depicts type 2 diabetes and Figure (b) depicts type 1 
diabetes. User's identifiers are removed for privacy purposes. 
 The literature on using diabetes profile for infection detection  
As a roadmap to better understand the project, I tried to pinpoint the state-of-the-art studies. In 
this regard, using parameters from diabetes profile as an indicator of infection incidences have 
been studied in the literature, as shown in Table 2 below. The literature ranges from proof of 
concept study to system description. From the diabetes profile, almost all of the literature 
considers blood glucose levels as indicators of infection episodes. Some other studies also 
suggested hba1c and white blood cell count as an alternative indicator of infection episodes, 
but these parameters have significant availability and feasibility issues given the fact that these 
parameters are difficult to get the records on a daily basis with the least possible cost. As 
described above, there are already efforts to prove the relationship between elevated blood 
glucose levels and infection episodes. However, there is a lack of empirical and numerical 
evidence describing the nature, extent, and duration of infection-induced deviations on each 











Table 2: Using diabetes profile for detecting infection incidences among people with diabetes. 
Reference Type Data Type Method Findings 
[29; 38] Proof of concept 
Infection evidence and daily 





Elevated blood glucose 
levels during the 
infection episodes 
[31; 33; 34; 
36] 
Analysis and system 
specification 
Diabetes Control and 
Complications Trial (type-1 
diabetes) 
Informatics for Diabetes 




After infection, HBA1c 
values were elevated 
despite tight blood 
glucose  control 
[17] System description 
User ID, blood glucose level, 
and geographical location 
---- ---- 
[90] System prototype Blood glucose level ---- ---- 
[135] System description 
Blood glucose levels, illness, 
and symptom report 
---- ---- 
[30] System Specification 
Blood glucose, white blood 
cell count, and other sources 
---- ---- 
 
 Chapter summary 
This chapter put forward and discussed four important topics; blood glucose homeostasis, the 
effect of infection on blood glucose dynamics, blood glucose control during infection 
incidences, and available evidence suggesting the feasibility of using blood glucose levels and 
other diabetes profiles as an indicator of infection episode. The connection between prolonged 
elevated blood glucose levels (hyperglycemia) and infection episode has been known for a long 
time, however, there are few previous proofs of concept studies that verify the potential of 
diabetes profile for detecting infection episode. Moreover, there is little effort to capitalize this 
information towards detecting infection incidences on an individual basis; thereby detecting 






3 Materials and Methods 
 
Synopsis: This chapter puts forward detailed descriptions of the materials and methods used 
in different sub-phases of the dissertation. It describes the type of data source exploited, 
approaches used to exploit and clean the dataset, methods used to analyze the effect of infection 
episode on blood glucose dynamics, approaches used to design a personalized health model, 
and finally approaches used to identify major factors that can enhance user motivation towards 
successful engagement and sharing of health-related data. Finer elements of the methodology 
are also presented in each associated chapters.  
 A general overview of research approaches 
This dissertation is multidisciplinary in nature and draws diverse concepts, tools, and methods 
from various disciplines including informatics, public health, and medical research. A 
multidisciplinary approach has been proved to be effective in addressing complex topics [65; 
162; 191; 195]. In this regard, the dissertation uses concepts, tools, and methods from the 
aforementioned disciplines to develop new methods and approaches that account for a better 
understanding of infection incidences and their effect on blood glucose levels amongst people 
with type 1 diabetes and also for realizing a novel personalized health model-based digital 
infectious disease detection system, which could provide benefits to both individual and the 
general population.  
 Overview of approaches used in different phases of the study   
In this dissertation, four different methods were used, which are in agreement with the standard 
scientific practice of attaining new knowledge.  
a) Systematic Review  
b) Retrospective, Numerical and Empirical Data Analysis 
c) Controlled Experiments 
d) Qualitative interview, Quantitative Survey, and Statistical Analysis 
The first method, systematic review, is very essential to identify the existing body of knowledge 
and associated knowledge gaps in the existing literature. The second method, numerical and 
empirical data analysis, is extremely valuable to assess, analyze, and interpret information from 
real-world data to draw a valid conclusion. The third method, controlled experiment, is useful 
to design experiments for the development of machine learning models. The fourth method, 
qualitative interview, and quantitative survey is used to study and assess factors related to user 
concerns, expectations, and willingness towards sharing self-collected health-related data to the 
proposed EDNON system and further explain it through collection and analysis of data.  
 Overview of the dissertation stage 
This dissertation, as shown in Figure 5, is consisted of five sub-phases each dealing with a 
specific sub-question of the original research problem. It should be noted that each sub-phase 
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is a continuation of the previous sub-phase, and however, some of these sub-phases were 
conducted in a concurrent manner.   
 
 
Figure 5: Progressive stage of the dissertation. 
 
The Initial Phase (Q1) - Development of a general framework of a personalized health 
model-based digital infectious disease detection system  
Attached with Paper 1 
As an initial phase, the formulation of a general framework was carried out to identify and 
pinpoint the main components of the proposed personalized health model-based digital 
infectious disease detection system, i.e. EDMON system. The framework presents and 
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describes the system architecture, requirements, necessary equipment, communication 
platform, and other various system components along with the challenge that needs to be 
addressed during system design and implementation. The proposed framework plays a crucial 
role as a roadmap to shape the dissertation by pinpointing the crucial part of the system. All the 
rest of the dissertation topics emanates from the proposed framework.     
The First Phase (Q2) – Nature, extent, and degree of effect of infection incidences on key 
parameters of blood glucose dynamics amongst people with type 1 diabetes  
Attached with Paper 1 
After formulating the general framework, the first phase of the dissertation tries to uncover the 
degree of effect of infection episode on blood glucose dynamics amongst people with type 1 
diabetes. Among other things, the study also identifies optimal key parameters of blood glucose 
dynamics that can successfully be used as input features for the realization of the proposed 
personalized health model. The study retrospectively analyzed empirical data, i.e. self-collected 
health data, containing self-reported states of infection episodes. As a result, this piece of work 
layout the foundation for the development of a personalized health model for detecting infection 
onset.   
The Second Phase (Q3) – Personalized decision support systems, BG alarm applications, 
and anomalies detection algorithms 
Attached with Paper 2 
As a roadmap to the development of a personalized health model, the second phases of the 
dissertation involves performing a systematic review to assess and analyses the state-of-the-art 
methods and approaches that focused on realizing an algorithm that performs classification of 
blood glucose pattern and detection of anomalies within the framework of personalized decision 
support systems, and blood glucose alarm applications. Among other things, the review also 
looked at two things; 1) do there exist any previously developed infection detection systems for 
people with type 1 diabetes? and 2) to what extent do the existing prediction and anomalies 
detection algorithm incorporates information on infection episode as one of their input 
parameters? This wide piece of work provides an overview to carefully select the right 
modeling approach towards realizing the proposed personalized health model. 
The Third Phase (Q4) – Modeling a personalized infection detection algorithm 
Attached with Paper 3 & 4 
After understanding the state-of-the-art approaches and the associated knowledge gap, the third 
phase of the dissertation realizes a personalized health model using an individual’s self-
recorded data (diabetes profile). The model is capable of monitoring an individual’s health 
status in a continuous manner and also can detect infection episodes (health deviation) 
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automatically. This piece of work is the core for realizing the proposed personalized health 
model-based digital infectious disease detection system, i.e. EDMON system.  
There are two associated papers with this phase; Paper 3 and Paper 4. Paper 3 presents a 
personalized health model using bivariate input - blood glucose levels, and the ratio of insulin 
-carbohydrate information as input features to the machine learning algorithm. Paper 4 
provides an alternative implementation but using only one input (univariate) – the ratio of 
insulin to carbohydrate information as an input feature to the algorithm.   
The Fourth Phase (Q5) – Assessments of user concerns, expectations, and willingness 
towards sharing self-collected health-related data.  
Attached with Paper 5  
As the last stage, this piece of work tries to pinpoint user concerns, expectations, and 
willingness towards sharing self-collected health-related data to the proposed EDMON system. 
A real-time system like EDMON that relies on self-collected data typically requires the timely 
sharing of these data for further processing to produce precise results. In this regard, the study 
assesses and identifies a list of factors related to user concerns, expectations, and willingness 
that could impact successful mass sharing of self-collected health-related data to the proposed 
EDMON system. It is obvious that people face challenges to join a new system for various 
reasons including individual views and attitudes towards data sharing and perceived benefits, 
and risks of data sharing, trust issues, fear of privacy, and data breaches, motivations, and a lot 
of other factors. Hence, fulfilling users' expectations, and properly addressing their concerns 
can have a great impact on the successful mass sharing of health-related data to the EDMON 
system. 
 Empirical data analysis and modeling 
The objective of the empirical data analysis was to study and uncover the effect of infection 
triggered deviations on the individual’s blood glucose dynamics, and, in particular, to identify 
and select optimal parameters indicative of infection onset to be used for the design and 
development of the proposed personalized health model. The objective of the modeling part is 
to devise a personalized computational health model using those previously identified optimal 
parameters for tracking the individual’s health status and automatically detect when the 
individual becomes sick.   
 Definition of key terms 
The description of terms used throughout the empirical data analysis and modeling are given in 
Table 3. These terms are crucial in understanding the whole design and development of the 
personalized health model. These terms are described in detail in the theoretical background 





Table 3: Key terms used in empirical data analysis and modeling. 
Key term Definition 
Blood glucose dynamics 
Describes the complex relationship depicting the effect of patient controllable and 
uncontrollable parameters on blood glucose levels.  
Patient controllable 
parameters 
Describes the category of parameters that incorporates factors on which the patient 
has direct control and can roughly understand their immediate effect on the BG 




Describes the category of parameters that incorporates factors on which the patient 
doesn’t have direct control and face challenge to understand their immediate effect 
on the blood glucose levels. For instance, parameters such as emotional stress and 
illness are categorized under this.  
Normal cause deviation 
Deviation incurred due to patient controllable factors such as meal-induced 
hyperglycemia. 
Special cause deviation Deviation incurred due to patient uncontrollable factors including infection episode. 
Operating point of blood 
glucose dynamics 
Describes the state of blood glucose level at any time t in response to patient 
controllable and uncontrollable parameters.  
 
 Datasets and data sources 
The empirical data analysis and modeling were carried out using self-collected health-related 
data from people with type 1 diabetes. These phases of the dissertation typically require an 
accurate, rich, and large dataset to validate the concept and further develop the proposed 
personalized health model. However, getting such kind of dataset poses significant challenges 
especially when it comes to obtaining data from a large number of participants due to a variety 
of reasons, i.e. expensive and time-consuming. The dataset used in this dissertation was 
contributed by three individuals (2 males and 1 female) and incorporates highly precise 
longitudinal records of 10 patient-years. These participants were proven individuals with high 
knowledge of their conditions and different diabetes technologies. As shown in Tables 4 & 6, 
the dataset consists of blood glucose reading, insulin injection, ingested carbohydrate, and 
episodes of acute infection reported by the individuals. Throughout the data collection period, 
the participants have indicated that they were free of illness or other health complications except 
for the reported date of infections. As shown in Table 4, various diabetes technologies and self-
management devices were used throughout the data collection period, such as Dexcom 
continuous glucose monitor (CGM), Diabetes Diary [16], the xDrip with an app, the Spike app 
[212], insulin pens, and pumps. From the ten patient-years, the first five patient-years were 
reported to be regular years and the rest five patient-years were reported to contain at least one 
or more episodes of acute infections. The reported infection episodes were influenza (flu), mild 
and light common cold without fever. The study protocol has been reviewed by the Norwegian 
Regional Committees for Medical Health Research Ethics Northern Norway (REK) (Reference 
number: 108435). Written consents have been obtained and the participants have donated the 




Table 4: Type of datasets and diabetes technologies used for self-management, source [259], 
Table 1. 
 Self-Management 
Patient  BG Insulin administration  Diet 
Subject 1 
Self-monitoring blood 
glucose (SMBG) - Finger 
pricks recorded in Diabetes 
Diary mobile app and 
Dexcom CGM 
Insulin Pen ( Multiple boluses 
(NovoRapid) and one time basal 
(Lantus) before bed) recorded in 
Diabetes Diary mobile app 
Carbohydrate in grams recorded 
in Diabetes Diary mobile app 
Subject 2 
SMBG - Finger pricks 
recorded in Spike mobile 
app and Dexcom G4 CGM 
Insulin Pen ( Multiple boluses 
(Humalog) and one-time basal 
(Toujeo) before bed) recorded in 
Spike mobile app 
Carbohydrate in grams recorded 
in Spike mobile app 
Subject 3 
Enlite (Medtronic) CGM 
and Dexcom G4 CGM 
Medtronic MinMed G640 insulin 
pump (Basal rates profile (Fiasp) 
and multiple boluses (Fiasp)) 
Carbohydrate in grams recorded 
in pump information 
 
 
During data collection, for trustworthiness, specific and strict inclusion criteria were used to 
select the dataset included in the study to make valid conclusions. The criteria used in data 
selection include data reliability, accuracy, completeness, and longer period, i.e. at least more 
than 3 months. It is obvious that a study that completely relies on user collected data requires a 
dataset, which is reliable, complete, accurate, and collected over a longer period to produce 
credible evidence. In this regard, I only include data collected from highly proven and 
motivated individuals who have advanced knowledge and understanding of the disease 
condition and its self-management practices including several diabetes-related technologies. 
For instance, one of the most important issues is carbohydrate counting, which is prone to errors 
in most cases. In this regard, I make sure that the included participants have long experiences 
and advanced knowledge of carbohydrate counting, which is referred to as level 3 (advanced) 











Table 5: Detailed description of participant characteristics, source [259], Table 2. 
Variables  
Gender  2 males and 1 female 
Age  34  13.2 years 
Bodyweight Subject 1 (83 kg), Subject 2 (77kg), Subject 3 (70kg) 
HbA1c Subject 1 (6.0%), Subject 2 (7.3%), Subject 3 (6.2%) 
Carbohydrate counting  Level 3 (advanced) 
 
 
 Data re-sampling, imputation and preprocessing  
As shown in Table 6, the self-collected dataset utilized in this dissertation incorporates key 
parameters of blood glucose dynamics and represented as follows; continuous glucose reading 
(𝕌𝑐𝑔), blood glucose reading (𝕌𝑔), injected bolus insulin (𝕌𝑓
𝐼 ), injected basal insulin (𝕌𝑠
𝐼 ), and 
ingested carbohydrate (𝕌ℂ). Re-sampling of the raw data was carried out at a uniform rate by 
assigning the individual measurement to its nearest time-bin [69].  For instance, assume a time-
bin 𝑇𝑏, which represent a time interval between 2:00pm-3:00pm of a particular day. Hence, any 
measurements registered between 2:00pm and 3:00pm are assigned to 𝑇𝑏. In some cases, the 
total number of measurements in a specific time-bin could be more than one element and in 
these cases, either the sum or average of the elements are computed to combine the elements 
into a single element. In this regard, for a particular time-bin, elements of blood glucose 
measurements, i.e. SMBG and CGM, are averaged into a single element. However, the sum of 
elements is used to combine insulin and carbohydrate measurements into a single element in 
their respective time-bin, as shown in Table 7. Within each time-bin, the average blood glucose 
response to the total amount of carbohydrate consumption and insulin administration is 
considered.   
Generally, data smoothing was performed using a moving average filter after the data is re-
sampled as described above. The idea behind the smoothing was to capture only the essential 
features-long term variations and eliminate features with fast-time scale and short term 
variations. Selecting the optimal or appropriate window size is very challenging given the 
complementary issues of better smoothing and the cost associated with a significant delay (shift 
introduced) [18; 182]. Generally, selecting the proper window size is application dependent. In 
this regard, for an application that sought after early detection of infection incidences, it is more 
important to give more emphasis to reducing the inherent delay while selecting the optimal 
window size. 
As shown in Table 7, to compute the required insulin-to-carbohydrate ratio, it is necessary to 
compute the values of the total insulin and carbohydrate for each respective time-bin, and then 
for each time-bin, divide the computed insulin values with carbohydrate values. In this 
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dissertation, two time-bins of different lengths were considered; hourly and daily, which defines 
the scope of the data granularity investigated. For instance, an hourly time-bin signifies that a 
change in blood glucose dynamics will be tracked at the end of each hour throughout the day. 
It is obvious that increasing the granularity of the data, i.e. reducing the time-bin to an hourly 
level, can provide detailed information and helps to look at the data with finer detail. However, 
it gets tricky and challenging to compute the ratio for narrower time-bin, i.e. hourly resampling, 
due to frequent zeros and missing values. In this regard, the challenge was mitigated by 
smoothing the data before computing the ratio and using cubic spline interpolation to estimate 
the missing blood glucose values.  
 
 
Table 6: Description of self-collected user data, source [259], Table 3. 
Subject’s Record Variables 
Variable Name Description Units 
𝕌𝒄𝒈 Continuous Glucose Reading mg/dl 
𝕌𝒈 Blood Glucose Reading mg/dl 
𝕌𝒇
𝑰  Injected Insulin (Bolus) units 
𝕌𝒔
𝑰  Injected Insulin (Basal) units 


























Table 7: Re-sampled, imputed, and pre-processed data, source [259], Table 4. 
Preprocessed Variables 
Variable Name Description Units 
𝕌[𝒕−𝚫𝒕,   𝒕]
𝒄𝒈
 Mean Continuous Glucose Reading mg/dl 
𝕌[𝒕−𝚫𝒕,   𝒕]
𝒈


























Ratio of Insulin (Basal) to Carbohydrate units/grams 
 
 
 Empirical data analysis  
The empirical data analysis aimed to answer two principal questions related to the effect of 
infection episode on blood glucose dynamics; 1) To what degree does infection affect key blood 
glucose parameters, and 2) Which parameters can be regarded as optimal parameters, and can 
be used for developing the proposed personalized health model with a minimum false alarm 
rate as possible. Pre-selected parameters from the individual’s diabetes profile were analyzed 
including blood glucose levels, carbohydrate, insulin, and insulin to carbohydrate ratio. The 
investigation was carried out based on a dataset that incorporates infection and non-infection 
(regular) patient-years, and the non-infection patient-years were used as a baseline to compare 
and validate the effect of all patient controllable and uncontrollable parameters against the self-
reported period of acute infection. To better capture the difference, the data were analyzed at 
three levels of data granularity (timeframes), i.e. weekly, daily, and hourly. Within these 
timeframes, the probability distribution and temporal evolution of the pre-selected parameters 
were analyzed.  
During the weekly analysis, a raw dataset was used, and the comparison looks into the pre-
infection, infection, and post-infection week’s values only. The comparison takes into account 
the week’s daily mean blood glucose values and the sum of carbohydrate and insulin 
information along with the standard deviation between the days. The comparison was 
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interpreted based on both the inter and intra-deviations between these groups. For instance, 
inter-deviation implies the deviation of the infection week blood glucose level as compared to 
the pre-infection and post-infection week blood glucose values, while the intra-deviation 
signifies to what extent do the infection week blood glucose level deviates considering the 
infection week insulin injections and carbohydrate consumptions. The comparative results 
between the group were depicted using a statistical boxplot.  
During the daily and hourly analysis, a smoothed dataset was used, and the comparison looks 
into the entire patient-years including the period of infection episode. Throughout the patient-
year, the mean blood glucose response was analyzed in each time-bin taking into account the 
total insulin and carbohydrate values along with insulin-to-carbohydrate ratio within the 
respective time-bin. As described earlier, validation of the infection-induced change was 
performed by comparing with the non-infection patient-years. Besides, the change in data 
distribution was analyzed using a kernel density estimator [88; 89; 101]. To this end, a Gaussian 
adaptive bivariate and univariate kernel density estimator were used, and the procedure is given 
in Tables 8 & 9. To compute the optimal bandwidth, bandwidth selection approaches proposed 
by Botev et. al. [28] and Bowman et. al. [40; 187] were used for the univariate and bivariate 
estimators respectively [263]. 
 
 
Table 8: Approaches used in estimating the distribution of insulin-to-carbohydrate ratio, 
source [259], Textbox 1. 
Approach: -  One-dimensional adaptive kernel density estimation 
1: Given: Time series datasets of univariate diabetes profile parameter 𝑿 ∈  𝕯, and Adaptive Kernel 
density estimator 𝕄 − 𝒐𝒏𝒆 𝒅𝒊𝒎𝒆𝒏𝒔𝒊𝒐𝒏𝒂𝒍, 
2: Remove the reported days of infection from the time series datasets 𝕯, and form a new dataset 
𝓧 ∈ 𝓠; 
3: Compute the one-dimensional density based on the kernel density estimator 𝕄 using 𝕯 and  𝓠; 















Table 9: Approaches used in estimating the distribution of blood glucose levels and insulin-
to-carbohydrate ratio, source [259], Textbox 2. 
Approach: -  Two-dimensional adaptive kernel density estimation 
1: Given: Time series datasets of bivariate diabetes profile parameters 𝑿, 𝒀 ∈  𝕯, and Adaptive 
Kernel density estimator ℕ − 𝒕𝒘𝒐 − 𝒅𝒊𝒎𝒆𝒏𝒔𝒊𝒐𝒏𝒂𝒍, 
2: Remove the reported days of infection from the time series datasets 𝕯, and form a new dataset 
𝓧, 𝓨 ∈ 𝓠; 
3: Compute the two-dimensional density based on the kernel density estimator ℕ using  𝕯 and  𝓠; 
4: Compare the distribution from ℕ; 
 
 
 Modeling approaches 
This section aims to realize a personalized health model, which relies on health-related data 
recorded by the individual with type 1 diabetes and can monitor and screen the individual’s 
health status in a continuous manner and detect automatically when the individual becomes 
sick. The input features to the model were selected based on the empirical data analysis 
described above. The models implemented in this dissertation were MATLAB toolboxes, and 
include ddtools, prtools, and anomaly detection toolbox [66; 68; 218]. Two categories of 
approaches were evaluated and compared; one-class classifier [57; 122; 123; 164; 217] and 
unsupervised method [42; 87; 215]. The models were evaluated based on two attributes; data 
granularity (daily and hourly), and data nature (raw and smoothed data). In all evaluation 
scenarios, the frequency of detection is defined by setting the levels of data granularities; hourly 
and daily analysis.  
The dataset was labeled as a set of target and non-target data. All the patient’s data, which are 
a regular period of the year was set as a target. The period containing the self-reported infection 
episode was set as a non-target. The one-class classifier models were trained on the target and 
tested using a dataset containing both the target and non-target data. N times k-fold stratified 
cross-validation was used to evaluate the performance of the one-class classifier. To a certain 
extent, wherever necessary class mitigation procedure was also considered [146]. Regarding 
the unsupervised method, no data labeling is required, and hence the entire patient-year was 
presented at once [87; 183]. 
For performance comparison, three performance metrics were used; area under the ROC curve 
(AUC), specificity, and F1-Score [96; 97; 168; 224]. Average (standard deviation) of AUC, 
specificity, and F1-Score were reported. These metrics are widely used in assessing model 
performance for one-class and two-class tasks. 
 The area under the ROC curve (AUC) is the integration of the ROC curve over a range 
of different thresholds or summing over different misclassification costs. AUC is 
insensitive to data imbalance and is useful to compare classifiers, however, it is 
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independent of a single threshold and this poses a challenge to use AUC in a real-world 
implementation [97].  
 Specificity can be defined as the ratio of correctly classified non-target sample objects 
to the total number of non-target sample objects [192]. Hence, it represents the 
percentage of correctly classified infection state (non-target sample) to the total number 
of infection days. In my context, it is only used to illustrate the screening power of each 
model, i.e. accurately classifying the infection days (illness days) as such from the entire 
infection period.  
 F1-Score is the harmonic mean of precision and recall, with a value ranging from 0 to 
1. A model with a high (1.0) F1-Score indicates high detection performance, i.e. high 
recall and precision [224]. F1-Score is considered suitable for assessing model 
performance towards one target class and also when there are unbalanced datasets [96; 
97; 124; 168; 192]. This metric is found valuable especially for an application that 
requires considering both the false positive rate and false-negative rate. 
In addition to the performance assessment with the above-mentioned attributes, the models 
were also compared based on the required sample size to generate acceptable performance, the 
model computational time, performance associated with dimensions of input features, and 
performance associated with different degree of deviations in the input features, which could 
aid towards model selection considering real-world settings.  
 The sample size attributes describe the minimum set of training sample objects needed 
for a model to produce an acceptable description. Considering a system that relies on 
self-recorded data, this attribute sets the lower limit for an individual to join such a 
system just by fulfilling the minimum data size requirement. This is important mainly 
because it might be difficult for an individual to accumulate a large set of datasets 
initially.  
 The computation time attribute describes how long does a model take to learn and 
classify sample objects. Considering a system that handles lots of participants with a 
large dataset, the model’s response time is vital in selecting the best model for the task.  
 The model performance associated with input dimensionality compares the performance 
gained from using a small number of inputs as possible without affecting the model's 
performances. This is very important in certain cases where there is a challenge of 
acquiring all the necessary records.  
 Performance associated with different degrees of simulated deviations was also used to 
assess the model’s detection performance in response to changes that range from small 
to large deviations in the input feature. This attribute is essential for choosing the 
optimal model that can detect deviations that range from small to large values 
considering the fact that different pathogens could induce different deviations in the 
blood glucose dynamics.
 Assessment of concerns, expectations, and willingness 
This section aims to identify a set of factors that need to be addressed during system design and 
implementation, the EDMON system in general and the patient unit in particular. These factors 
are very essential for the successful development of the patient unit in terms of long-term patient 
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engagement, and the successful sharing of the self-collected data to the proposed EDMON 
system. A system like EDMON that relies on self-collected data typically requires a timely 
transfer of these data for further processing to produce precise results. As a requirement, the 
patient is expected to register accurate and precise data and be able to transfer it promptly. In 
this regard, fulfilling patient expectations and addressing their concerns could have a great 
impact on the successful mass sharing of health-related data to the proposed EDMON system 
An exploratory sequential method [75; 171; 239] was used, where we primarily designed a 
qualitative interview guide incorporating five separate themes and performed data collection 
and analysis, and then used the findings from the qualitative study to further inform and rectify 
the design of the quantitative survey questioners and data collection.  
 Goals, attitude, and expectations 
 Wearables and sensors usage   
 Data integration   
 Data sharing   
 Social media and entertainment factors   
In this regard, initially, a qualitative exploration, i.e. face-to-face interview, was conducted 
based on a detailed concept and application scenarios of the proposed EDMON system in 
general, and the patient unit, i.e. mHealth app, in particular. Then, the findings from the 
qualitative interviews were used in refining the quantitative survey questionnaires. As an effort 
to pinpoint factors that standout only for people with type 1 diabetes, a comparative analysis 
with other groups of people was carried out including other chronic patients and healthy 
individuals. Generally, this phase of the dissertation aims at providing design strategies to 
develop a system that will be acceptable by the participants.   
As described above, among other things, the quantitative survey aimed to focus on the data 
sharing theme explored in the qualitative study. In this regard, the survey explored user 
concerns, expectations, and willingness towards sharing self-collected health-related data to the 
proposed EDMON system. The survey questionnaire was distributed to various internet users 
and diabetes groups, i.e. Swiss English-speaking cohort of healthy people and both English and 
Norwegian speaking online diabetes groups. The data were collected between November 2018 
and August 2019. Further detailed information about the questionnaire can be found at 
DataverseNO [105]. Descriptive statistics of various parameters that relate to data sharing while 
using different wearables and mHealth apps are reported. The study protocol has been reviewed 
by the Norwegian Regional Committees for Medical Health Research Ethics Northern Norway 
(REK) (reference number = 2017/562/REK nord) and Norwegian centre for research data 
(NSD) (reference number = 54558 / 3 / LB). All the participants were asked to consents during 
the survey and the participants response were anonymized. 
 Methodology critique 
 Empirical data analysis and modeling 
Based on the existing body of knowledge, deviation from a normal state into an abnormal state 
can be detected via developing either a predictive or novelty detection model. In this regard, 
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this dissertation looks into the possibility of implementing a model for the proposed 
personalized health model. Regarding the prediction model-based approaches, the literature 
suggests a shortcoming of the existing state-of-the-art blood glucose prediction models, which 
often fail to accurately predict above a 30-minute prediction horizon [173; 256]. For this reason, 
this dissertation focuses on developing a personalized health model relying on novelty detection 
strategies. The number of subjects and events of infection included in the empirical data 
analysis and modeling can be another limitation. However, it should be noted that I was able to 
communicate with a lot of individuals, universities, and an online community such as do it 
yourself (DIY) community, for a possible donation of a dataset but I didn’t receive much 
positive response. Further, the special requirements that oblige to include a dataset that is 
reliable, accurate, rich, and long enough have contributed to the failure to collect more dataset, 
i.e. incorporate at least the three key diabetes parameters (blood glucose level, insulin, and diet), 
one infection episode, and is longer than three months. For instance, given the strict inclusion 
criteria, I was forced to reject the dataset received from Ohio University for its inaccuracy 
containing two separate meal registrations entry. I was able to contact the university for 
clarification on the spotted errors and per the description provided by the university, the error 
was inherent and the mistake had occurred due to the problem associated with the data 
collection tools, which allows the participants to record meals registrations in two different 
places. On top of that, the error was not only having two records of meal registrations at the 
same time of the day, but these two records also have different values of carbohydrate 
registrations. It is very challenging to get an accurate, rich, and longer dataset from a large 
number of participants. It is worth mentioning that different types of infection (pathogens) 
could have a different effect on blood glucose dynamics but I studied using mainly influenza 
(Flu) and common cold data and this might be another limitation.  
The dataset used in empirical data analysis and modeling didn’t include physical activity data 
and this might also be another limitation. Physical activity could have a significant effect on 
blood glucose dynamics and its inclusion during modeling could bring a positive effect on the 
accuracy of the infection detection model.  
 Assessment of concerns, expectations, and willingness  
This sub-study could be benefited more if the number of participants is large enough in all three 
groups to further strengthen the conclusion, and this could be a limitation. However, it should 
be noted that for instance the survey questionnaire was distributed in various diabetes forums 
and online groups and was up for almost ten months. The other possible limitation could be 
linked with the unbalanced number of participants among the group used during the 
comparison. However, it should be noted that the comparison was only used to spot outstanding 
factors for people with type 1 diabetes.  
 Hardware and software tools 
The dissertation makes uses of different hardware and software tools at various phases of the 
sub-studies. The following hardware tools were used during data collection, empirical data 
analysis, and modeling sub-phases. During the data collection phase, participants have used 
various diabetes management technologies including smartphones, CGM, finger prickers, and 
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test strips, glucose meters, insulin injection (pens, and pumps). The empirical data analysis and 
modeling phase of the dissertation were carried out on a Lenovo laptop. 
 Lenovo laptop (Intel(R) Core(TM) i7-6600U@2.81GHz, RAM 16 GB, 
Windows 10 64bits) 
 Smartphones 
 Finger prickers (lancet) and test strips  
 Insulin pens and pumps 
 CGM and glucose meters 
The following software tools were used during data collection, empirical data analysis, 
modeling, and quantitative survey sub-phases. During the data collection phase, participants 
have used various diabetes-related technologies including mobile apps (Diabetes Diary, and 
Spike apps), and the xDrip with an app. Data extraction tool such as sqlitestudio was used to 
extract data. The empirical data analysis and modeling phase of the dissertation were carried 
out using MATLAB. MATLAB toolbox, Prtools, Ddtools, and Anomaly detection toolbox 
were used during the development of the personalized health model. SPSS statistical software 
used for the quantitative survey study.  
 MATLAB® 2018 a & b (Mathworks, Inc, Natwick, MA). 
 SPSS Statistical Software.  
 Prtools is a MATLAB toolbox for pattern recognition [68].  
 Ddtools is a MATLAB toolbox for data description, outlier, and novelty detection [218]. 
 Anomaly detection toolbox is a MATLAB toolbox that provides different unsupervised 
anomaly detection models [66]. 
 Mobile apps for data collection (Diabetes Diary, and Spike apps) [16; 212].  
 Data extraction tools including sqlitestudio-3.1.1.  
 Dexcom studio 12.0.4.6. 
 EdrawMax is used for drawing figures and flow charts. 
 Chapter summary  
This chapter presented and discussed an overview of the materials used and the methodology 
followed in various sub-phases of the dissertation. To answer each research question as part of 
the main research problem, various sub-phases with distinct approaches were carried out. 
Moreover, presented a detailed description of key concepts and methodology behind 
developing the personalized health model along with the approach used to select optimal 
parameters of blood glucose dynamics indicative of infection onset amongst people with type 
1 diabetes. It further presented the approaches used in assessing user concerns, expectations, 
and willingness for successful sharing of self-collected health-related data to the proposed 
EDMON system. Finally, it presented the critics of the methodology followed at each sub-






4 EDMON - A Personalized Health Model-based Digital 
Infectious Disease Detection System: Framework 
and Challenges   
Synopsis: This chapter puts forward the proposed framework for a personalized health 
model-based digital infectious disease detection system that harness health-related data from 
people with type 1 diabetes collected on a daily basis to detect infection onset, and thereby 
utilizing this information to detecting infectious disease outbreak based on a Spatio-temporal 
cluster detection technique. The framework presents the main components of the proposed 
EDMON system along with challenges that need to be addressed during system design and 
implementation. The first half of the chapter presents the components and the latter half 
discusses the challenges. This chapter provides answers to the first research question (Q1). 
 Introduction  
Digital infectious disease detection system exploits digital health-related data and technology 
for the purpose of detecting infectious disease outbreaks [44; 170; 181]. Most of the existing 
digital infectious disease detection system relies on population-level data and doesn’t possess 
a mechanism to trace back to the individuals who are sick [44; 181; 237]. In this regard, the 
proposed personalized health model-based digital infectious disease detection system is a 
pioneer in the field utilizing self-collected health-related data to monitor and screen the 
individual’s health status in a continuous manner and detect infection onset and use this 
information to detect infectious disease outbreak among the public in a specified region of 
interest. Hence, this framework introduces a personalized health model concept to perform the 
task of individual health monitoring and detection. There are very few previous studies that 
attempt to describe system architecture for detecting infection incidences in people with 
diabetes [17; 30; 135]. However, these studies provide a system overview considering very 
limited data types, i.e. blood glucose levels and white blood cell counts.    
The most interesting characteristic of the proposed EDMON system, i.e. a personalized health 
model-based digital infectious disease detection system, is that it can alert individuals about 
any potential health changes besides the outbreak detection. In other words, a personalized 
health model designed for outbreak detection can also serve the individuals by providing 
information that is relevant for decision support during crises. Considering the nature and the 
way the surveillance data is generated, the digital infectious disease detection system can be 
grouped as either indicator or event-based system [49; 170; 260]. In this regard, the proposed 
EDMON system can be regarded as an event-based digital infectious disease detection system. 
The events in the proposed framework are micro-event and macro-event, where micro-events 
depict the detection of infection at individual levels and macro-events represent outbreaks at 
the population level. The framework presented in this chapter is part of the findings presented 
in Paper 1 [259]. 
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 The proposed framework  
The availability of self-recorded health-related data from individuals with type 1 diabetes 
provides a fertile ground for the proposed EDMON system. In this regard, the proposed 
framework relies on user collected data and incorporates a patient unit, data repository unit, 
infection detection unit, clustering unit, and information dissemination unit, as shown in Figure 
6. The patient unit is a user mobile devices terminal with a disease surveillance functionality 
and is used for collecting and transmitting data to a central server. The data repository unit 
stores the incoming user data. The infection detection unit tracks, monitor, and screen the 
individual’s health status and detect infection onset by analyzing the data in real-time or near 
real-time based on a personalized health model (a case detector). The presence of outbreaks at 
any time under the region of interest is detected by the clustering unit, which uses the result 
from the case detectors as input and identifies any possible cluster of infected individuals based 
on a Spatio-temporal analysis. The information dissemination unit uses the result from the case 
detector and clustering unit to provide real-time or near real-time health status information for 
the individual participants as well as information regarding the current status of the area under 
surveillance for the concerned bodies, i.e. ordinary citizens, patients, and public health officials. 
The rest of the dissertation chapters focus on topics related to the patient unit and infections 




Figure 6: The proposed framework of EDMON - a personalized health model-based digital 
infectious disease detection system, adapted from [58; 255; 259], Figure 14. 
 
  The Patient unit 
The patient unit, as shown in Figure 6, is consisting of sensors and data, and a mobile health 
application (mHealth app), where the sensors reading and data are integrated and stored in the 
mHealth app before being transmitted to the central server.  
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    Sensors and data 
As part of self-management, people with type 1 diabetes collect different parameters that affect 
blood glucose dynamics and this group of the patient often record the key parameters; blood 
glucose levels, insulin administration (bolus and basal), carbohydrate ingestion given in grams, 
and could also record other optional parameters such as physical activity session or exercise 
load, heart rate, stress, sleep quality, and others [3; 148].  
 Compulsory data and equipment 
The proposed EDMON system requires compulsory data and their associated pieces of 
equipment to perform the day to day operation; these compulsory data include blood glucose 
level, insulin, carbohydrate, and user’s location information and pieces of equipment needed to 
continuously record these pieces of information.  
Blood glucose levels can be measured using either finger pricks based self-monitoring blood 
glucose (SMBG) or continuous glucose monitoring (CGM). Finger pricks based glucose 
monitoring requires a lancet (finger pricker), test strips, and glucose meter [127], and various 
brands on the market can automatically transfer the result into a smartphone app. CGM 
measures the individual’s blood glucose levels in real-time, e.g. every 5 minutes, and 
continuously throughout the day and 24/7. There are various brands of CGM devices available 
on the market including Dexcom2, FreeStyle3, Guardian4, Eversense5, and others [129]. CGM 
devices incorporate a sensor, and a transmitter, which estimates the blood glucose values and 
transmits the result into a receiver, which is usually a smartphone app, pump, or other receivers.  
Insulin administration is crucial in diabetes self-management to regulate blood glucose levels. 
There are different types of insulin based on how quickly they act to lowering blood glucose 
levels; administered insulin can be fast-acting (bolus), intermediate-acting or, slow-acting 
(basal) [240; 241]. Insulin administration is carried out based on either multiple daily injections 
(MDI), or continuous subcutaneous insulin infusion (CSII) [63; 125; 241]. MDI is mostly 
carried out using insulin pens to inject insulin and there are different brands of insulin pens on 
the market including Owen Mumford Autopen6, Humalog Kwikpen7, Novo Nordisk NovoPen 
48, and, others. CSII is usually carried out using insulin pumps and there are different brands of 
insulin pumps on the market including Medtronic9, Omnipod, Accu-Chek10, Tandem Diabetes 
Care11, and others [139].  
Carbohydrate counting is necessary to estimate the amount of insulin intake during mealtime 
and further action to correct blood glucose levels [84]. Carbohydrate amount measured in grams 
is estimated for a given meal, which usually depends on the individual patient's expertise related 













to counting carbohydrate contents of each food type and drink. Ideally, this patient group is 
expected to rely on an advanced (Level 3) [84] carbohydrate counting, which uses the 
individualized insulin-to-carbohydrate ratios [63; 167; 210; 228] to estimate the insulin amount 
at a time. The level of knowledge towards carbohydrate counting varies from individual to 
individual, which determines the quality and accuracy of the registered values. Most 
importantly, since carbohydrate is registered manually, it is most likely prone to errors.     
Apart from these key parameters of the blood glucose dynamic, the proposed EDMON system 
requires the individual’s user location for the purpose of locating a cluster of sick individuals. 
The user location information can be recorded as either a static or dynamic address and can be 
in the form of longitude and latitude, postal codes, or any other reference coordinates. The 
ethical challenges raised by using the individual’s health-related data and location information 
are discussed in the next section. 
 Optional data and equipment  
Physical activity sessions, heart rate, stress, sleep quality, and other certain physiological 
parameters are also important parameters where people with type 1 diabetes could record for 
the purpose of self-managing their blood glucose levels. These optional datasets can be used to 
further improve the system detection accuracy if properly recorded on a timely basis. 
Registration of physical activity sessions or exercise load information is very important along 
with carbohydrate registration to decide the right amount of insulin intake. Physical activity 
sessions or exercise load could enhance insulin sensitivity thereby reducing the amount of 
insulin requirements [27]. There are various wearable sensors that estimate and measure 
physical activity sessions on the market including Polar12, Garmin13, Apple Watch14, Fitbit15, 
Samsung Watch16, and others [73; 103; 104; 213]. Most of the existing wearables also have the 
capability to record other parameters such as heart rate. In this regard, for example, the 
following brands incorporate heart rate sensors; Polar, Samsung Watch, Garmin, Scosche 
Rhythm, Wahoo Tickr Fit, and others. Moreover, there are also wearable that monitor sleep 
quality including Polar, Fitbit Versa, Oura Ring17, Withings Move18, and others. There are also 
wearables that estimate stress levels based on the individual heart rate variability including 
Garmin, Samsung smartwatches, Apple Watch, Fitbit, Google Wear OS smartwatches19, and 
others.  
    Mobile health (mHealth) app 
The purpose of the mobile health (mHealth) app is to integrate sensor readings and data from 
various diabetes-related technologies and wearables devices. Automatic data collection features 
are favored by people with diabetes and whenever possible, the app should support automatic 
data registrations capability and provide only manual registrations if it is a must [252]. Different 











sensors reading from blood glucose reading devices, insulin pens and pumps, physical activity 
and exercise sessions, heart rate, sleep quality, stress and other physiological parameters such 
as blood pressure, body temperature, and others along with diet and geographical location 
information should be integrated to the app [58; 255]. There exist a variety of self-management 
mHealth apps in Google Play and AppStore including the most well-known apps such as 
Diabetes Diary 20 , Spike App 21 , and mySugr 22 . Hence, the proposed app exhibit similar 
functionality with these well-known apps and further add surveillance functionality required by 
the proposed EDMON system. In this regard, the main requirements and functionality of the 
proposed mHealth app include: 
 Automatically record blood glucose levels, both SMBG and CGM.  
 Automatically record insulin units, both bolus and basal insulin in a separate record.  
 Automatically record physical activities and exercise sessions.  
 Automatically record heart rate, emotional stress, and sleep quality in a separate record. 
 Enable manual recording of certain parameters, especially for diet information, other 
medications, and illness status.  
 Automatically record user geographical location. For example, a user location can be 
estimated based on the Global Positioning System (GPS) from the phone upon data 
registration (Coucheron et al., 2019). User location can be in terms of longitude and 
latitude [85], postal code address [86], or any other local reference coordinates. 
 A timestamp for each data registration.   
 Transmit the data to a central server upon each registration. The data packet could include 
all the above compulsory parameters and the optional parameters if available along with 
the geographical location and time of registration tagged on it.  
    Communication architecture and protocols 
The proposed personalized health model-based digital infectious disease detection system, as 
shown in Figure 6, is a three-tier architecture that contains three different tiers performing 
different tasks. In this configuration, the personalized health model can be placed either in the 
patient unit or remote computing unit. Placing the personalized algorithm in the remote 
computing server requires all the required user data to be transmitted to the server and this 
configuration could be prone to degraded accuracy as a result of remote site computations 
emanating from data transmission requirements [58]. Moreover, it brings challenges in terms 
of user data security, privacy, and confidentiality issues as a result of migrating the user data 
from the smartphone to the central server. However, instead of moving the user data to the 
central server, it is possible to place the personalized health algorithm within the user 
smartphone app, where only the health status of the individual (as normal, suspicious, and 
infected) is transmitted to a centralized server for further clustering computation. However, 
unlike the remote computing unit, placing the personalized health algorithm in the user’s 
smartphone app (patient unit) needs a feasibility study given the fact that the algorithm needs 






to run frequently to identify and detect deviations from normality; thereby could require high 
power consumption and memory spaces that could affect the user’s smartphone.   
Most of the existing diabetes equipment and technologies have some form of access to the data. 
Integrating the data to the mHealth app, transmitting the data to the computing server, and 
storing the data requires to ensure complete data security, protection of user privacy, and 
confidentiality throughout the system’s data flow [107]. In this regard, it is necessary to use 
state-of-the-art communication protocols that ensure security, robustness, and privacy and 
strictly follow compliance with international regulations. 
    Challenges  
The proposed personalized health model-based digital infectious disease detection system 
highly depends on the accuracy of the data, and entirely on its collection procedure. As 
described above, one of the main challenges regarding data collection and transmission is 
related to data accuracy, reliability, data security, privacy and confidentiality, and user 
acceptance and willingness to share data.  
Data quality is the most critical factor that needs to be addressed since accurate analysis in the 
proposed EDMON system assumes high precision sets of data. An inaccurate dataset could 
hamper system accuracy and result in unpredictable performance degradation. Data accuracy 
challenges could emanate during manual data registration into the mHealth app, data integration 
into the mHealth app, and data transmissions to a remote server. Manual data registration to the 
mHealth app is prone to errors. For instance, a user can incorrectly record carbohydrate amounts 
upon registration, which could greatly hamper the accuracy of the personalized health model. 
Therefore, it is necessary to look for a mechanism that can cross-check values by requesting 
the user to validate the input especially when an out-of-range input value is recorded. In the 
same fashion, the necessity of integrating sensors reading into the mHealth app requires dealing 
with heterogeneous data formats due to multiple vendor involvements. The main challenge in 
this regard is standardization and interoperability issues that need to be addressed. Apart from 
these challenges, transmitting the data to a remote server could result in missing, corrupted, and 
delayed data that could affect the system's accuracy. In this regard, it is necessary to look for a 
method that ensures the quality of information through an advanced pre-processing and data 
quality control algorithm [58; 255; 259].  
The sensitivity of user-health data is another challenge that needs to be carefully addressed 
through the entire system’s data flow. In this regard, one of the possible approaches could be 
to de-identify and anonymize the data following international regulating body guidelines such 
as General Data Protection Regulation (GDPR) and Health Insurance Portability and 
Accountability Act (HIPPA) [83; 107]. Apart from this, it is also necessary to follow the state-
of-the-art privacy-preserving and secure data communication protocols to ensure that data 
security, privacy, and confidentiality are respected throughout the data collection and 
transmission phase. It is necessary to understand that the successful design and acceptability of 
the proposed EDMON system relies on fulfilling those requirements. Moreover, as described 
above, it is necessary to tag each user data with the user's geographical location to successfully 
locate a cluster of infected individuals on a Spatio-temporal basis. In this regard, in addition to 
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the de-identification procedure, it is necessary to look for a robust approach that can strictly 
hide user identity upon transmission in case if the data is compromised during data 
transmission.  
Finally, a new mHealth app usually faces acceptance challenges by the intended users for a 
variety of reasons [252]. These factors range from user perception of the app, lack of motivation 
and trust issues related to using the apps and sharing of the data to the proposed EDMON 
system, and ease of use associated with the app complexity. Therefore, it is necessary to 
persuade and motivate the user to continuously engage with the app by buying user trust and 
answering all their concerns, and addressing ethical and motivational challenges.  
 Computing unit 
As shown in Figure 6, the proposed computing unit performs three important tasks; storing the 
data, tracking the individual health status, and detecting a cluster of infected individuals based 
on a Spatio-temporal basis.  
    Data repository (database) unit 
The data repository stores the individual’s data transmitted from the mHealth app. The database 
should store each data in a structured format containing user key ID, geographical location, 
time of data registration, and a record containing all the compulsory and optional datasets. The 
individual’s geographical location could be either static or dynamic address depending on the 
necessity [58; 259]. The static address can be a home or work address and recorded during user 
creation and upon individual registration to the system. On the other hand, the dynamic address 
is updated in real-time during each new data registrations. This type of address is very useful 
to trace back contacts upon infectious disease outbreaks.  
    The Infection detection unit – individual level 
The proposed personalized health model monitors the individual’s health status and detect when 
the indivdual become sick, which is designated as mirco-events. This requires to tracking the 
individual’s health status through developing a personalized health model that learn from the 
historical diabetes profile and judge the current information. The modeling can be realized 
through either prediction model [173; 256] or novelty detection methods [51; 70; 153; 178], as 
shown in Figure 7. The prediction model can be implemented as either a residual [99; 100; 
254; 266] or conformal approach [112; 136; 137; 204; 211; 233-235]. Similarly, novelty 
detection can be realized through a supervised, semi-supervised, or unsupervised approaches 
[51; 70; 153; 253]. In literature, different categories of novelty detection methods have been 
reported including classification or domain-based [110; 116; 124; 150; 198; 217; 221; 242; 
253], statistical techniques based [178], clustering-based [6; 217], distance-based [51; 87], 
ensemble-based approaches [6; 51; 87; 136; 153; 169; 178; 206; 242; 265; 267], prediction-




Figure 7: Alternative methods for realizing the proposed personalized health model, source 
[259], Figure 15. 
 
The alarm management (decision making) unit processes the output from the personalized 
health model and assign a status to the individual’s health. Hence, the individual’s health status 
at any time could be among these three states; normal (0), suspicious (-1), and infected (1) 
[259]. The normal state depicts when the current readings conform to past knowledge. A 
suspicious state depicts when the current readings begin deviating but not enough to be 
designated either as a normal or infected state. An infected state depicts when the current 
reading deviates completely from past knowledge. The unit also needs to compute and inform 
the individual about the degree of deviation when detected as being sick. The output from this 
unit will notify the individuals and also be used as input to the cluster detection analysis.  
    The Clustering unit – population level 
The clustering unit accepts outputs from each individual’s alarm management unit and counts 
the number of individuals who are reported to be in an infected state. This count data can be 
used as either a standalone or in conjunction with other data sources, other similar disease 
surveillance system, to aid in outbreak detection. The following discussion assumes the 
standalone context and outlines challenges the way forward. In this regard, the proposed cluster 
detection analysis accepts the individual’s health status, location, and the time of micro-events 
detection [255] and performs a computation to detect any unexpected rise in either count or rate 
of infected individuals within a pre-specified region of interest, also known as macro-events 
[259]. As described above, the individual user’s location can be recorded as a static address 
such as home and postal code address [92] or a dynamic address like longitude and latitude 
coordinates [67] that can be estimated from the mobile phone’s GPS information upon data 
registration. The frequency of computation determines the time-step required to repeat the 
scanning procedures and can be fixed to anything between 1 hour to 24 hrs depending on the 
system design requirement [259].   
Detection of outbreaks can be realized as either spatial, temporal, or Spatio-temporal methods 
depending on the type of information utilized [261; 262]. According to the literature, the state-
of-the-art outbreak detection methods require a certain size of surveillance data from a large 
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population to draw a statistically valid conclusion [236; 237]. However, certain cases like 
biological terrorism affect a particular region and relatively small population and outbreak 
detection methods devised to detect such an incidence requires answering practical challenges 
related to data sparsity [237]. Data sparsity often arises in a system that tracks a small number 
of the population. Tracking surveillance data from a small population within a certain period 
often results in small event counts, which pose a challenge to draw a statistically valid 
conclusion in practical settings. Furthermore, implementing global detection, which considers 
the entire region as one, could end up masking local outbreaks affecting a small proportion of 
the region. By the same token, partitioning the entire region of interest into small equivalent 
areas could also end up in multiple testing problems [170; 199; 236]. In the same manner, an 
outbreak detection mechanism that exploits data from personalized surveillance of people with 
type 1 diabetes faces similar challenges, i.e. relatively small and scattered population. In this 
case, it is necessary to devise outbreak detection mechanisms, which are less sensitive to 
geography and sparse data from a small population. The output from this unit is used to notify 
the responsible individuals through the information dissemination unit.  
 The Information dissemination (visualization) unit 
As shown in Figure 6, the information dissemination unit processes the output from the cluster 
detection analysis and displays real-time information in an interactive way with the appropriate 
format to be easily understandable by the end-users. Various data presentation formats such as 
tables, graphs, and maps can be used for depicting the outbreak information [259; 262]. An 
example depicting a detected hypothetical outbreak on an interactive map is given in Figure 8. 
The real-time information can be viewed through a dedicated website or app [255]. In this 
regard, the end-users are consumers of the real-time information for quicker public health 
actions and individual participant, who wants to know his/her health status along with a degree 





Figure 8: Example depicting mapping of a detected cluster in a hypothetical outbreak. 
 Motivational and ethical challenges 
The proposed personalized health model-based digital infectious disease detection system 
completely relies on user-generated data mainly collected for other purposes and typically 
requires accurate, reliable, and precise data in a continuous fashion [259]. Getting such kind of 
data requires motivated users who engage with the patient unit for a longer period of time, and 
also willing to share the data with the proposed EDMON system. However, it is easier said than 
done and this requires considering various factors that could enhance user motivation during 
system design and implementation and also address user's concerns and expectations towards 
the system [252]. As described above, generally, a new system usually faces acceptance 
challenges by the intended users for a variety of reasons. These factors range from user 
perception of the system, lack of motivation especially related to using the mHealth apps and 
sharing of the data to the system, lack of trust related to data security, privacy, and 
confidentiality issues, and ease of use associated with system complexity [2; 7; 85; 120; 252]. 
Therefore, it is necessary to persuade and motivate the user to continuously engage with the 
system by buying user trust by answering all concerns, ethical, motivational, and other security-
related challenges.  
 Knowledge summary 
In the context of the original research question, the added knowledge is presented within the 
scope of the proposed framework of a personalized health model-based digital infectious 
disease detection system.   
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What do we know about the topic already? 
 Various systems that collect several diabetes-related health data to a remote server for 
remote diabetes management, monitoring and follow-up systems, data analysis for 
personalized feedback, and decision making have increasingly been studied and 
presented in the literature [5; 149; 163]. However, none of these consider detecting 
infection onset at an individual level.  
 Various digital infection detection systems have been studied and presented in literature 
utilizing various digital data ranging from a query search engine, work and school 
absenteeism, over the counter pharmacy drug sales, and other sources [44; 170; 232]. 
However, none of these utilizes a personalized health model to detect infectious disease 
outbreaks at the population level.    
 There are very few previous studies that attempt to describe system architecture for 
detecting infection incidences in people with diabetes [17; 30; 135]. However, these 
studies provide the system overview considering very limited data types, i.e. blood 
glucose levels and white blood cell counts.    
 
What does this chapter add to our knowledge? 
 Presented a framework that combines self-management practices in people with type 1 
diabetes and a disease surveillance system concept to fills the gaps in the existing digital 
infectious disease detection system via utilizing a personalized health model to detect 
infection onset at the individual level and thereby utilizing this information to detecting 
outbreaks at the population level. 
 The presented framework incorporates different units performing a series of tasks; 
patient unit, data repository (database) unit, infection detection unit, clustering unit, 
information visualization unit, and a wireless communication platform. 
 Highlights the main challenges in relation to system design and implementation along 
with ethical, motivational, and data sharing challenges within the scope of the proposed 
EDMON system.  
 Chapter summary  
This chapter presents and discussed the framework of the proposed personalized health model-
based digital infectious disease detection system. The realized framework identifies five 
important constituents of the proposed EDMON system, relationships, and task requirements 
of the components; a patient unit, data repository unit, infection detection unit, clustering unit, 
and information visualization unit. The patient unit is a standalone smartphone app (mHealth 
app) that integrates and stores different sensor readings, which could be through either manual 
or automatic recordings. The individual’s data-structure should contain two types of data; 
compulsory and optional data types, where the compulsory data includes blood glucose levels, 
insulin and carbohydrate registration, geographical location, and time of registration. Currently, 
most diabetes technologies enable Bluetooth connections to foster the integration of sensor 
readings. The data stored in the mobile app needs to be transmitted to a database server, where 
it is stored for further processing. However, given the sensitivity of health data, high emphasis 
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needs to be given to data security, privacy, and confidentiality. In this regard, the transmission 
and storage of data in a server need to strictly follow major international guidelines, e.g. HIPPA 
compliance. The infection detection unit access the individual’s records from the database and 
execute the personalized health model, which is trained on the individual’s historical data, to 
look for any abnormal deviations promptly. In this regard, the personalized health model can 
be formulated as blood glucose prediction or novelty detection. At any given time, the output 
from the personalized health model is the individual’s health status coded as normal (0), 
suspicious (-1), and infected (1). The clustering unit accepts the timely health status from each 
individual participant along with their respective geographical location and time of data 
registration to perform a Spatio-temporal analysis to detect a group of infected individuals 
under a region of surveillance. The status of the region or city under surveillance is visualized 
based on either a standalone smartphone app (mHealth app) or a web-based or both. Besides, 
this chapter also presents various challenges from both users and technological perspectives for 
the successful acceptance of the proposed EDMON system; 1) data accuracy related to manual 
data registration into the mHealth app, data integration into the mHealth app, and data 
transmissions to a remote server, 2) motivation related to user engagement to the patient unit 
for a longer period 3), willingness related to user perception concerning data sharing and 
willingness to share 4) data sparsity related to the statistical significance of outbreak detection 










5 Infection Characterization and Parameter Selection  
Synopsis: This chapter puts forward the empirical data analysis conducted to study the effect 
of infection on key parameters of blood glucose dynamics amongst people with type 1 diabetes. 
The idea was to investigate, characterize and select optimal parameters for developing the 
proposed personalized health model. The analysis focuses on the trend and the probability 
distribution of the key parameters. Different data granularity was considered during the 
analysis; weekly, daily and hourly timeframes. The first half of the chapter provides an 
overview of the dataset and proceeds to the trend analysis and probability distribution 
comparison. Finally, it provides a concluding remark. This chapter provides answers to the 
second research question (Q2). 
 Introduction  
As described in the background chapter, several factors disturb blood glucose dynamics [22]. 
Most of these factors induce predictable disturbances except factors such as physical and 
emotional stress, diseases, acute illness, severe wounds, infections, and others [253; 256]. In 
this regard, it is quite necessary to conduct empirical data analysis to understand the 
confounding nature of the other unpredictable factors along with the predictable ones on the 
path towards detecting infection onset and also to assess and numerically estimate the impact 
of infection on the key parameters of blood glucose dynamics. To the best of my knowledge, 
this is the first study that empirically and numerically quantifies the effect of infection episodes 
on key parameters of the blood glucose dynamics among people with type 1 diabetes exploiting 
self-recorded data. To this end, this chapter focus on characterizing the disturbance infection 
onset creates on the blood glucose dynamics amongst people with type 1 diabetes and thereby 
choosing optimal parameters for developing the proposed personalized health model. The 
association between infection and hyperglycemia has been reported in the literature [41; 47; 
152; 160]. However, the idea of using self-recorded data for the purpose of detecting outbreaks 
is a novel and recent phenomenon. In this regard, there are few literature that investigate the 
potential of using these data sources for disease surveillance purposes [17; 29-36; 38; 90; 98; 
134; 135; 209; 255]. For instance, Botsis et.al. [29; 31; 34; 38] reported elevated blood glucose 
levels and hemoglobin A1c (HbA1c) for the duration of infection as compared to the normal 
period. Generally, these studies reported the association and suggested the possibility of 
detecting infection in this patient group by exploiting self-recorded data. Despite these findings, 
none of this literature investigated the nature and degree of abnormalities triggered by infection 
onset through systematic analysis of each parameter of blood glucose dynamics. The results 
presented in this chapter are part of the findings presented in Paper 1 [259]. 
 Raw dataset 
As described in the method chapter, the raw dataset used in the empirical data analysis 
comprised of self-recorded data containing blood glucose levels, amount of insulin injection, 
amount of carbohydrate in the diet (grams), and infection episodes. In total, the length of the 
data is ten patient-years, among which the first half (five years) is regular years with no 
infection episodes, and the latter half (five years) contains a minimum of one infection episodes 
per individuals. An exemplar raw data containing influenza (flu) infections are given in Figures 
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 Data preparation and comparative analysis 
As described in the method chapter, the raw dataset was first smoothed by a moving average 
filter. Different length of window sizes was tested to choose the optimal value, and a value of 
1, 2, 3, and 4 days was evaluated. Hence, a window size of 2 days (48 hours) was chosen and 
the choice was much constrained to avoid substantial delays that could arise from using a larger 
window size. The comparative analysis considers three data granularity (timeframes); hourly, 
daily, and weekly. Comparison of the first two timeframes uses the smoothed dataset, however, 
the weekly comparison uses the raw dataset and applies only to the dataset containing infection 
episodes. Within each timeframe, the comparative analysis investigates the change in average 
blood glucose levels taking into account the impact of total carbohydrate consumption and 
insulin intake. It is better to note that, the regular patient-years were aimed at establishing a 
reference (baseline) knowledge of the individuals under normal period. The trend and 
distribution of the data were investigated to pinpoint uncharacteristic deviations as a result of 
the infection episode.  
  Data trend  
 Regular patient-years 
The analysis of the regular patient-years with the two timeframes; daily and hourly, exhibit the 
normal process of blood glucose dynamics, as can be seen from Figure 11-12, and more figures 
can be found in Appendix 2 of Paper 1 [259]. Insulin is administered in pre, during, and post-
meal scenarios taking into account the amount of carbohydrate consumption. Occasionally, 
correction insulin is also injected depending on the resultant blood glucose levels [26; 175]. 
The nature of this self-management practice is mainly manifested through the evolution of the 
insulin-to-carbohydrate ratio [63; 132]. As can be seen from the figures, values of the insulin-
to-carbohydrate ratio are relatively stable depicting the normal process of the individual’s blood 
glucose dynamics, where blood glucose regulation is mainly maintained with a balanced 
consumption of carbohydrates and insulin requirements. As per the findings, the values of the 
ratio oscillate between 0.05 and 0.2 throughout the entire patient-years. This dynamic but stable 
characteristic of the ratio signifies the impact of patient-controllable and uncontrollable 




a) A daily plot of the patient-year, source [259] Appendix 2, Figure 1. 
 
 
b) An hourly plot of the patient-year, source [259] Appendix 2, Figure 1. 
 
Figure 11: A specific regular patient-year depicting blood glucose levels, amount of 
carbohydrate consumption and insulin injections, and fluctuations of the insulin-to-
carbohydrate ratio. Figure (a) illustrates fluctuations within the daily timeframe. Figure (b) 




a) A daily plot of the patient-year, source [259] Appendix 2, Figure 3. 
 
 
b) An hourly plot of the patient-year, source [259] Appendix 2, Figure 3. 
 
Figure 12: A specific regular patient-year depicting blood glucose levels, amount of 
carbohydrate consumption and insulin injections, and fluctuations of the insulin-to-
carbohydrate ratio. Figure (a) illustrates fluctuations within the daily timeframe. Figure (b) 
illustrates fluctuations within the hourly timeframe. 
  Patient-years with Infection events 
As described above, in the patient-years with infection episodes, apart from the trend, the 
distribution of data was also compared on a daily and hourly basis. Furthermore, a pre-infection 
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week, infection week, and post-infection week comparison of parameters were carried to 
characterize and single out the impact of the infection episode effectively.  
 Daily and Hourly Analysis  
The analysis of the two timeframes; daily and hourly, reveals the infection-triggered deviations 
from the normal process of blood glucose dynamics, as can be seen from Figure 13-14 and 
more figures can be found in Appendix 3 of Paper 1 [259]. During normal circumstances, 
insulin is administered on pre, during, and post-meal scenarios following the amount of 
carbohydrate consumed and in certain cases, correction insulin is also administered depending 
on the resultant blood glucose levels. However, this normal process is violated and seems no 
longer valid throughout the infection episodes [259]. This infection triggered deviation is 
typically manifested in the values of the insulin-to-carbohydrate ratio. As can be seen from the 
figures, the values of the ratio are sky-rocketed depicting the abnormal infection triggered 
situation, where the patient is forced to inject much higher insulin irrespective of consuming 
carbohydrates. In this situation, much of the insulin intake is correction insulin that is directed 
towards regulating blood glucose levels, which are disturbed due to infection incidences. As 
per the findings, the values of the ratio were elevated above the normal values (0.05-0.2), and 
reach between 0.25 and 0.5 depending on the individual. These findings demonstrate the 
substantial impact of infection episodes on blood glucose dynamics as compared to the other 
patient controllable and uncontrollable parameters. The analysis also reveals that other infection 
episodes such as fever-free mild and light cold as reported by the individual patients have a 








b) An hourly plot of the patient-year, source [259], Figure 7. 
 
Figure 13: A particular patient-year with influenza (flu) incidence within the first week of 
December, and depicts blood glucose levels, amount of carbohydrate consumption and insulin 
injections, and fluctuations of the insulin-to-carbohydrate ratio. Figure (a) illustrates 










b) An hourly plot of the patient-year, source [259] Appendix 3, Figure 4. 
 
Figure 14: A particular patient-year with fever-free mild and light cold in the first week of 
August and mid-February respectively, and influenza (flu) incidence in mid-August. The 
figures depict blood glucose levels, amount of carbohydrate consumption and insulin injections, 
and fluctuations of the insulin-to-carbohydrate ratio. Figure (a) illustrates fluctuations within 
the daily timeframe. Figure (b) illustrates fluctuations within the hourly timeframe. 
 Comparison of Pre, Infection, and Post-infection Weeks 
Each week's daily average blood glucose values, the sum of insulin injection, and the sum of 
carbohydrate consumption were compared within the timespan of the pre-infection week, 
infection week, and, post-infection weeks. The overall comparison of the infection triggered 
deviations from the pre-infection and post-infection weeks were depicted with a statistical 
boxplot incorporating the key parameters. The analysis among other things aims to quantify the 
infection-triggered deviations compared to the normal pre-infection and post-infection weeks. 
As per the findings, it can be seen in Table 10 and Figures 15-17, the infection week’s blood 
glucose levels remain elevated even if the individual keeps injecting much more insulin with a 
smaller amount of carbohydrate consumption. These phenomena violated the normal process 
of blood glucose dynamics and illustrate the influence of infection (flu) on blood glucose 
dynamics, which could be associated with the result of the action of infection-triggered glucose 
production and insulin resistance that develops within the body [152; 159; 259]. Under normal 
circumstances, when the patient injects much higher insulin and consumes much-reduced 
carbohydrate, these phenomena push the state of the blood glucose dynamics into the 
hypoglycemia region. However, this doesn’t happen after infection onset, and this could be 
mainly due to the added effect of infection triggered glucose production and insulin resistance 





Table 10: Average and standard deviation of blood glucose levels, the sum of insulin doses 
(bolus), and the sum of carbohydrates intake within pre-infection, infection, and post-infection 
weeks, source [259], Table 5. 
Influenza (flu) incidence in the first patient-year 
Parameter Pre-infection week 
( Mean (SD)) 
Infection week 
( Mean (SD)) 
Post-infection week 
( Mean (SD)) 
BG (mg/dL) 130.74 (16.89) 141.95 (14.37)   119.16 (7.39) 
Total insulin (bolus) 23.39 (4.91) 35.30 (6.11) 21.32 (4.61) 
Carbohydrate (grams) 241.11 (57.27)   178.80 (65.69) 241.18 (37.63) 
Influenza (flu) incidence in the second patient-year 
BG (mg/dL) 143.01 (19.53) 155.36 (21.99) 126.17 (11.70) 
Total insulin (bolus) 28.07 ( 8.85) 41.07 (9.44) 25.36 (6.93) 
Carbohydrate (grams) 190.14 (43.93) 161.14 (58.43) 214.57 (34.66) 
Influenza (flu) incidence in the third patient-year 
BG (mg/dL) 136.93 (18.58) 144.12 (20.30) 134.18 (11.96) 
Total insulin (bolus) 20.08 ( 5.44) 31.50 (10.84) 22.83 (3.86) 
Carbohydrate (grams) 178.0 (45.87) 144.83 (37.63) 195.83 (42.59) 
Influenza (flu) incidence in the fourth patient-year 
BG (mg/dL) 157.74 (31.12) 161.34 (19.88) 138.57 (19.83) 
Total insulin (bolus) 24.43 (5.26) 32.14 (7.01) 29.29 (5.22) 
Carbohydrate (grams) 199.06 (53.45) 167.04 (44.94) 226.07 (18.23) 
Influenza (flu) incidence in the fifth patient-year 
BG (mg/dL) 135.21 (14.58) 139.88 (15.54) 122.87 (14.49) 
Insulin (bolus) 32.80 (4.59) 40.37 (8.31) 33.36 (7.94) 
Insulin (basal) 19.20 (1.21) 20.42 (2.06) 18.68 (1.56) 




 Blood glucose levels 
Blood glucose levels were higher for a longer period throughout the infection period in all the 
infection weeks. As described earlier, this phenomenon could be linked with the production of 
excess glucose from the liver as a result of the infection episode [152]. In this regard, the 
infection week’s average blood glucose levels were higher as compared to the pre-infection and 
post-infection weeks’ average blood glucose levels. Numerically, as shown in Figures 15 and 
Table 10, the average blood glucose levels were higher in all the infection weeks with a 
percentage of 8.57% and 19.12%, 8.63% and 23.13%, 7.26% and 7.41%, 2.28 and 16.43%, 
3.45% and 13.84% as compared to the pre-infection and post-infection weeks’ average blood 




a) Box-plot of a particular patient-year, source [259], Figure 3. 
 
 
b) Box-plot of a particular patient-year, source [259] Appendix 1, Figure 2. 
 
Figure 15: Comparison of blood glucose levels during pre-infection week, infection week, and 
post-infection week. As can be seen, the blood glucose is elevated during the infection week as 
compared to the pre and post-infection weeks. 
 
 Insulin intake 
Insulin (bolus) administered during the infection weeks was much higher as compared to the 
pre and post-infection weeks. As described earlier, the enhanced insulin intake could be directly 
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associated with the insulin resistance that develops within the body following infection onset 
mainly due to the action of the counter-regulatory hormones [152; 159]. In this regard, the 
infection weeks’ insulin injections were much higher as compared to the pre-infection and post-
infection weeks’ insulin injections. Numerically, as shown in Figures 16 and Table 10, the 
overall insulin injections were significantly higher in all the infection weeks with a percentage 
of 50.93% and 65.59%, 46.31% and 61.94%, 56.87% and 37.98%, 31.56% and 9.7%, 23.08% 
and 21.01% as compared to the pre-infection and post-infection week’s overall insulin 












b) Box-plot of a particular patient-year, source [259] Appendix 1, Figure 2. 
 
Figure 16: Comparison of insulin (bolus) injections during the pre-infection week, infection 
week, and post-infection week.  As can be seen, the amount of insulin (bolus)intake is elevated 
during the infection week as compared to the pre and post-infection weeks. 
 
 Carbohydrate consumption  
Carbohydrate (grams) consumed during the infection weeks were much lower as compared to 
the pre-infection and post-infection weeks’ consumption. This phenomenon could be linked 
either with the patient action to avoid a further crisis of hyperglycemia or lack of appetite as a 
result of the infection [152; 259]. In this regard, the infection weeks’ overall carbohydrate 
consumptions were much lower as compared to the pre-infection and post-infection weeks’ 
overall carbohydrate consumptions. Numerically, as shown in Figures 17 and Table 10, the 
overall carbohydrate consumptions were significantly lower in all the infection weeks with a 
percentage of 25.84% and 25.87%, 15.25% and 24.90%, 18.63% and 26.04%, 16.09% and 
35.34% as compared to the pre-infection and post-infection week’s overall carbohydrate 




a) Box-plot of a particular patient-year, source [259], Figure 5. 
 
 
b) Box-plot of a particular patient-year, source [259] Appendix 1, Figure 2. 
 
Figure 17: Comparison of carbohydrate consumptions (grams) during the pre-infection week, 
infection week, and post-infection week. As can be seen, the amount of Carbohydrate (grams) 
intake is significantly lower during the infection week as compared to the pre and post-infection 
weeks. 
 
 Insulin-to-carbohydrate ratio 
The ratio of the insulin-to-carbohydrate reflects the combined phenomena of insulin injections 
and carbohydrate consumptions. On an individual basis, it depicts the required insulin intake to 
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offset the action of a single gram of carbohydrate consumed. As described above, the dramatic 
shift in insulin injections and carbohydrate consumptions following infection episodes is also 
reflected in the required values of the ratio. During normal circumstances, the value usually 
fluctuates between 0.05 and 0.2, see Figure 11-12. However, as clearly demonstrated in Figure 
13-14, the values of the insulin-to-carbohydrate ratio significantly raised to a higher value to 
accompany the individual’s requirements following infection onset [259]. In this regard, the 
infection weeks’ values of insulin-to-carbohydrate ratio were much higher as compared to the 
pre-infection and post-infection weeks’ values of the ratio. Numerically, as shown in Table 10, 
the values of insulin-to-carbohydrate ratio were significantly higher in all the infection weeks 
with a percentage of 125.84%, 144.43%, 93.75%, 70.84% as compared to the pre-infection and 
post-infection week’s normal values. More figures can be found in Appendix 1 of Paper 1 [259]. 
 Data Distribution 
The individual self-management practice is usually related to the individual’s diet habits, 
physical activity or exercise sessions, medication intake, and others. To study the influence of 
infection on blood glucose dynamics along with the nature and shape of the anomalies 
generated, the individual’s data distribution was estimated using a kernel density estimator and 
compared with the distribution of the same data after removing the reported infection days. The 
distribution estimation was conducted for each patient-years with infection episode considering 
univariate (insulin-to-carbohydrate ratio) and bivariate (insulin-to-carbohydrate ratio versus 
blood glucose levels) variables. As can be seen from Figures 18, data distribution of the 
infection period generates a longer tail and sparse density, and more figures can be found in 
Appendix 1 of Paper 1 [259]. These deviations could correlate with the strength of the 
individual’s immunity, type of infection, and severity (pathogens), and hormones involved 
[152; 259].   
 
 
a) Kernel density estimation of daily total insulin (bolus)-to-carbohydrate ratio, source 




b) Kernel density estimation of daily average blood glucose levels and total insulin (bolus)-
to-carbohydrate ratio, source [259] Appendix 1, Figure 13 (a). 
 
Figure 18: Kernel density estimation of a particular patient-year. Figure (a) depicts the 
univariate kernel estimation. Figure (b) depicts the bivariate kernel estimation.  
 
 Characterizing the observed phenomenon  
This section characterizes the observed phenomenon, describes the optimal predictive 
parameters, and further tries to generalize the findings beyond people with type 1 diabetes into 
other types of diabetes. As per the findings, infection often triggers a series of shifts in the blood 
glucose dynamics and mainly with respect to blood glucose levels, insulin and carbohydrate 
intake, and the ratio of insulin-to-carbohydrate [259]. However, the literature suggests that the 
extent and degree of abnormalities associated with these infection triggered phenomena often 
correlate with the strength of the individual’s immunity, the category of the pathogens, and the 
type of hormones [238]. The underlying cause of the hyperglycemia crises upon infection onset 
is the added effect of patient uncontrollable parameters in addition to the regular patient 
controllable parameters [152], as given in Equation 1 below. The effect of the patient's 
uncontrollable parameter, i.e. counter-regulatory hormone, triggered by infection as a result of 
stress, is inhibiting insulin production and stimulating glucose production, which is the body 
mechanism to cope up with infection [159]. Hence, this patient group usually struggles to 
maintain euglycemia. However, during the regular days, hyperglycemia is mostly triggered by 
a patient controllable parameter (diet) and usually managed by controlling the key patient 
controllable parameters, e.g. limiting the amount of carbohydrate intake, injecting proper 
amount of insulin, and doing adjusted physical activity or exercise session [259]. Generally, 
this infection triggered phenomena can be characterized by an equation representing the 
relationship between blood glucose levels and other key parameters that disturb the dynamics 
along with the added effect of infection onset; 
 
66 
𝔹𝔾𝓽 = ℂℍ𝓽 + ℂℝℍ𝓽 − 𝝋𝕀ℕ𝓽 − ℙ𝔸𝓽,                                                           
Where the factor 𝝋 depicts the body’s level of insulin sensitivity, 𝔹𝔾 is the average blood 
glucose values, ℂℍ is the sum of carbohydrate intake in grams, 𝕀ℕ is the sum of insulin dose, 
ℙ𝔸 is the aggregate level of physical activity or exercises load, and ℂℝℍ is the amount of extra 
glucose generated as a result of the effect of counter-regulatory hormones, i.e. adrenalin and 
cortisol [259]. As depicted in the equation, infection triggers CRH induced glucose and 
diminishes the body’s level of insulin sensitivity (𝜑 ), thereby resulting in hyperglycemia 
despite consuming regular diets and requiring more insulin doses to compensate for the 
reduction in body’s level of sensitivity. Further, to compensate for the effect of CRHs, a 
reduction in the amount of carbohydrate consumption is expected [259]. These phenomena are 
manifested in the analysis of all the individual infection episodes. Hence, the event marker for 
infection episode can be designated as the occurrence of a dynamic shift from the typical 
operating point of blood glucose dynamics as manifested by the shift sustained on the ratio of 
the insulin-to-carbohydrate. Considering the nature of blood glucose metabolism and infection 
along with the body’s physiological reactions, these phenomena can be expected in other types 
of diabetes, however, the degrees of abnormalities can be varied in between. Based on the 
evidence presented, infection triggered deviations are manifested on the key parameters, and 
blood glucose levels, insulin doses, carbohydrate intake, and the ratio of insulin-to-
carbohydrate can be taken into account as input features for realizing a personalized health 
model to detect infection episode in an individual with type 1 diabetes [259]. Generally, the 
result proved the potential of the presented data to develop the proposed personalized health 
model-based digital infectious disease detection system. In this regard, the analysis among other 
things demonstrated the informational value and discriminative power of the data, which 
obviously can reduce false alarms that could emanate from confounding parameters such as 
emotional stress.  
 Limitation  
Considering the complexity of blood glucose dynamics, it is obvious that this study could 
benefit from a larger sample size and could further strengthen the conclusion. However, due to 
the difficulty of getting accurate and rich datasets containing infection episodes, the study was 
carried out on the presented datasets. Actually, the inclusion criteria were stiff given the fact 
that the study expects rich datasets that are accurate enough as well as are required at least to 
contain one event of infection, which makes the challenge far more difficult. Moreover, the 
study could also be far more beneficial if the dataset contains physical activity data to further 
strengthen the conclusion. However, taking into account the nature of blood glucose 
metabolism, which has more or less common dynamics among each individual, the presented 
results can conform and be generalized among these patient groups. 
 Knowledge Summary 
In the context of the original research question, the following section presents the added 
knowledge within the scope of the presented results.   
What do we know about the topic already? 
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 The association between infection onset and hyperglycemia episode has long been 
known.  
 Previously, the idea of using blood glucose levels to detect outbreaks and surveillance 
purposes has been suggested and presented in the literature. 
 However, none of these studies characterized and numerically quantifies the impact of 
infection on the key parameters of blood glucose dynamics and pinpoint optimal 
parameters with high accuracy. 
 
What does this chapter add to our knowledge? 
 To the best of my knowledge, this is the first study that empirically analyzes self-
recorded data and numerically quantifies the effect of infection episodes on key 
parameters of blood glucose dynamics among people with type 1 diabetes.  
 Infection significantly alters the operating point of the individual’s blood glucose 
dynamics. 
 Infection onset triggers elevated blood glucose levels regardless of higher insulin doses 
and lesser carbohydrate consumptions. This event marker designates the occurrence of 
a dynamic shift from the typical operating point of blood glucose dynamics as 
manifested by the shift sustained on the ratio of the insulin-to-carbohydrate following 
infection onset. 
 Discovered and presented a unique parameter, i.e. the ratio of insulin-to-carbohydrate, 
with excellent informational value and discriminative power to minimize the false 
alarm.   
 Characterization of the blood glucose dynamics reveals optimal parameters for realizing 
a personalized health model to detect infection onset in an individual with type 1 
diabetes.  
 Chapter Summary  
This chapter presented and discussed results related to the characterization of the impact of 
infection onset on the individual’s blood glucose dynamics. Infection onset brought a 
substantial shift in the typical operating point of the individual’s blood glucose dynamics. As 
per the findings, infection onset triggers elevated blood glucose levels for a prolonged duration 
regardless of the individual actions accompanied by higher insulin doses and lesser 
carbohydrate consumptions to regulate and control the hyperglycemia crisis triggered by the 
incident. The event marker designates the occurrence of a dynamic shift from the typical 
operating point of blood glucose dynamics as manifested by the shift sustained on the ratio of 
the insulin-to-carbohydrate following the infection onset. Hence, this characterization reveals 
the potential of the key parameters of blood glucose dynamics such as blood glucose level, 
carbohydrate, insulin, and the ratio of insulin-to-carbohydrate information for realizing the 
proposed personalized health model towards detecting infection onset in an individual with type 
1 diabetes. In this regard, a personalized health model that utilizes these input features can be 
developed based on either a prediction model or an anomaly and novelty detection methods. As 
far as my knowledge is concerned, this is the first study that empirically analyses self-recorded 
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data and numerically quantifies the effect of infection episodes on the key parameters of blood 
glucose dynamics among people with type 1 diabetes. In conclusion, these findings provide 
optimal parameters of blood glucose dynamics to support the effort towards realizing a 
personalized health model, and however, additional large-scale studies might be needed to 


















6 Designing a Personalized Health Model 
Synopsis: This chapter puts forward a solution for realizing the proposed personalized health 
model, which can describe the individual’s blood glucose dynamics from the self-recorded data. 
The aim was to devise a model for tracking the individual’s health status and automatic 
detection of health changes. The first half of the chapter provides an overview of the input 
features used in modeling, and the subsequent section provides the model's performance 
derived from using a bivariate input feature and an alternative solution using a univariate input 
feature. Finally, it provides a comparative analysis and concluding remark. This chapter 
provides answers to the third research question (Q3). 
 Introduction   
This chapter focuses on the approaches devised to realize the proposed personalized health 
model for effective tracking of the individual’s health status and automatic detection of 
infection onset among people with type 1 diabetes. To the best of my knowledge, this is the 
first attempt towards realizing a personalized health model to capture infection episodes among 
people with type 1 diabetes using self-recorded data. Apart from this, it is better to note that 
there was a single previous attempt to capture the stress state among type 1 diabetes under 
ambulatory settings [76]. The proposed model utilizes those optimal features suggested in 
chapter five, specifically blood glucose levels and the ratio of insulin-to-carbohydrate. As 
demonstrated in chapter five, those input features were selected based on their informational 
values and discriminative power compared to the baseline normal data [259]. As discussed in 
chapter four, the realization of the proposed personalized health model can be approached 
either using a predictive model of blood glucose dynamics or anomaly (novelty) detection 
methods [259]. In the literature, the state-of-the-art blood glucose prediction models are often 
described to be accurate in a limited setting and prediction horizon [173; 256]. The prediction 
performance of those models often degrades beyond a 30-minute prediction horizon, which 
becomes a bottleneck to effectively be used in the proposed settings, i.e. changes within hours 
and days [165; 256]. An ideal blood glucose predictor requires to incorporate a vast majority 
of input features that affect blood glucose dynamics, which is difficult to achieve in a practical 
setting [256]. In this regard, the requirement calls for a personalized health model that can 
capture the dynamics and be able to detect abnormalities within the context of limited data 
settings. Consequently, as an option to these drawbacks of prediction models, an anomaly 
(novelty) detection method was devised to realize the proposed personalized health model. This 
option can be formulated as supervised, i.e. multi-class classification, semi-supervised, i.e. one-
class classification, or unsupervised method [4; 51; 183]. Implementing the proposed model as 
supervised can be challenging and impractical given the effort required to acquire and labeling 
the normal and anomaly class [124; 217]. Practically there are several issues involved with the 
characterization and demarcation of the infection triggered anomaly class boundaries in 
comparison to the normal class [51; 258]: 
 Characterizing the effect of different pathogens: Demarcating pathogen-specific class 
boundary requires understanding the effect of each pathogen on blood glucose 
dynamics, and this calls for gathering pathogen-specific data from a large group of 
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participants. Such data collection is expensive and time-consuming if not impossible 
[258].   
 Effect of the same pathogens among different individuals: Apart from the inter-
pathogen class boundaries, there still exists variations among the intra-pathogen class 
boundary that emanates from the difference in individuals' infection resistance. This 
poses a serious challenge and further complicates the demarcation task [258].     
 Lack of available data source: Even if the above demarcation tasks are accomplished, 
there still exist challenges related to an imbalanced class problem. Gathering a balanced 
dataset containing both the normal and abnormal class from the individual participant 
require waiting for the individual to get infected on multiple occasions and this further 
poses an implementation challenge [258].     
Considering these stated challenges, the other design option is to use a semi-supervised method, 
i.e. one-class classifier, that relies on learning the regular situations and able to detecting 
nonconformities with the reference description [51; 113; 217; 219]. This strategy alleviates the 
above-stated challenges related to characterization and lack of dataset. Apart from this, another 
design option to the stated challenges could be an unsupervised method that relies on the entire 
dataset to define and find anomalies within the data [51]. In this regard, this chapter presents 
the performance of semi-supervised (one-class classifier) and unsupervised methods for the 
proposed personalized health model. These models utilize univariate (insulin-to-carbohydrate 
ratio) and bivariate (blood glucose levels versus insulin-to-carbohydrate ratio) as input features. 
The performance achieved from these models and input features is compared along with the 
model's computational time and necessary sample size to generate acceptable performance. The 
first half of the results presented in this chapter, i.e. bivariate inputs, are part of the findings 
presented in Paper 3 [258]. 
 Input features  
To better understand the input features, it is necessary to comprehend the characteristics of 
blood glucose dynamics depending on the three key parameters; insulin, carbohydrate, and 
physical activity or exercise load, that disturb blood glucose levels. Depending on these 
parameters, the state of wellness of blood glucose dynamics among an individual with type 1 
diabetes can be grouped into any of the four quadrants; carbohydrate action as quadrant 1, 
physical activity action as quadrant 2, insulin action as quadrant 3, and metabolic change due 
to infection onset as quadrant 4. 
Carbohydrate action as quadrant 1: As shown in Figure 19, this quadrant covers the normal 
region of the blood glucose dynamics, where the patient consumes more carbohydrate without 
taking required actions, i.e. administering insulin and performing balanced physical activity or 
exercise sessions, to control or regulate the blood glucose levels. Particular examples of such a 
situation is a holiday effect, where individuals ingest too much carbohydrate during the holiday 
seasons.  Datasets that lie within this region are sparser and less dense.  
Physical activity action as quadrant 2: As shown in Figure 19, this quadrant covers the normal 
region of the blood glucose dynamics, where the patient ingests more carbohydrates but favors 
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performing physical activity or exercise sessions than administering insulin to control the blood 
glucose levels. It is evident that though the patient ingests more carbohydrates, rigorous 
physical activity or exercise load could induce hypoglycemia. The sparsity of any particular 
points that fall within this region is dependent on the extent to which physical activity is used 
to replace the insulin needs. This sparsity happens since replacing insulin needs with physical 
activity or exercises session could create a very small value of insulin-to-carbohydrate ratio that 
fall outside the typical range of 0.05 to 0.2.    
Insulin action as quadrant 3: As shown in Figure 19, this quadrant also covers a normal region 
of the blood glucose dynamics, where the patient ingests less carbohydrate and administer more 
insulin to regulate the blood glucose levels. This is a very dangerous region of the dynamics, 
since taking more insulin without taking a proper meal could drive the blood glucose dynamics 
into a dangerous hypoglycemia state that could make the individuals end up being unconscious 
and sometimes death depending on the degree. The sparsity of the points that fall in this region 
is dependent on the degree of difference between carbohydrate intake and how much insulin is 
delivered for such an amount. 
Metabolic change due to infection onset as quadrant 4: As shown in Figure 19, this quadrant 
covers the abnormal region of the blood glucose dynamics, where the blood glucose levels 
remain elevated though the patient administers more insulin and ingests lower carbohydrate to 
control blood glucose levels. This is abnormal given the fact that these states of inputs should 
always be expected to put the individuals in quadrant 3 under normal circumstances, which is 
a dangerous hypoglycemia state. Yet, excessive production of glucose and insulin resistance as 
a result of infection prevented the blood glucose levels from going into a hypoglycemia state 
and, therefore, the individual’s blood glucose levels remain high. This region only contains 







Figure 19: Quadrants of wellness in an individual with type 1 diabetes, source [258], Figure 
7. 
 Description of input features 
This section describes the characteristics of the input features as per the results presented in 
chapter five.  As described above, the models’ input features were univariate input, the ratio of 
insulin-to-carbohydrate, and bivariate input, blood glucose levels vs. the ratio of insulin to 
carbohydrate. The models' performance was compared based on data type - raw and smoothed 
data, data granularities - hourly and daily timeframes, and data sample sizes - one, two, three, 
and four months. The input features were smoothed via a moving average filter of 2 days (48 
hours) window.  
 Input features - Regular patient-years versus patient-years with infection  
The patient years exhibit different characteristics depending on the presence or absence of 
infection as per the result presented in chapter five. Throughout the regular patient-years, the 
data happens to be bounded but containing a high-density region and some sparse regions with 
low density, as shown in Figures 20-21, and more figures can be found in Appendix 2 of Paper 
3 [258]. In all the figures, the x-axis representing the ratio happens to be bounded between 0.05 
and 0.2 depicting the typical behavior of the insulin-to-carbohydrate ratio during the normal 
operations, as demonstrated in chapter five. In regard to the patient-years with infection, the 
data exhibits similar characteristics compared to the regular patient-years, except that in this 
data infection days happen to be outside of the typical range of the boundary, as shown in 
Figure 22-23, and more figures can be found in Appendix 2 of Paper 3 [258]. In this regard, 
the task of modeling requires to describe those regular days and capture those novel or 




a) A daily plot of typical regular patient-year, source [258], Figure 1. 
 
 
b) An hourly plot of typical regular patient-year, source [258], Figure 2. 
 
Figure 20: A daily and hourly plot of typical smoothed regular patient-year depicting the scatter 




 A daily plot of typical regular patient-year, source [258] Appendix 2, Figure 4. 
 
 
 An hourly plot of typical regular patient-year, source [258] Appendix 2, Figure 4. 
 
Figure 21: A daily and hourly plot of typical smoothed regular patient-year depicting the scatter 




 A daily plot of typical patient-year with an event of infection influenza (flu), source 
[258], Figure 3. 
 
 
 An hourly plot of typical patient-year with an event of infection influenza (flu), source 
[258], Figure 4. 
 
Figure 22: A daily and hourly plot of typical smoothed patient-year with an event of infection 
influenza (flu), and depicting the scatter plot of average blood glucose levels vs. the ratio of 




 A daily plot of typical patient-year with an event of infection influenza (flu), source 
[258] Appendix 2, Figure 8. 
 
 
 An hourly plot of typical patient-year with an event of infection influenza (flu) source 
[258], Appendix 2, Figure 8. 
 
Figure 23: A daily and hourly plot of typical smoothed patient-year with an event of infection 
influenza (flu), and depicting the scatter plot of average blood glucose levels vs. the ratio of 
insulin to carbohydrate.  
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 Data containing simulated events of infections  
The degree of infection triggered deviations on blood glucose dynamics depends on several 
factors and is mainly related to the type of pathogens involved and the individual immunity 
[259]. Per the findings and description provided in chapter five, and considering pathogen-
specific deviations, infection states of different sizes and shapes were simulated and injected 
into the daily regular patient-years. The simulated infection states were for a duration of two-
weeks and incorporate 10%, 20%, 30%, and 40% of simultaneous deviation, i.e. higher insulin 
and lower carbohydrate by the same factor, from the aggregated insulin and carbohydrate 
profile of an individual, as shown in Figure 24. Those deviations were added to the five regular 
patient-years. The simulated infection states were used to assess and evaluate the model’s 
performance in response to the different degrees of infection-induced changes from small to 
large changes in the individual blood glucose dynamics. This directly corresponds to the fact 
that different pathogens trigger a different degree of deviation in blood glucose dynamics. 
 
Figure 24: Characteristics of the input feature, i.e. insulin to carbohydrate ratio, with simulated 
infection states of varying degree and shape (α = 0%, 10%, 20%, 30%, and 40%). 
 
 Practical experiments and results 
Two categories of approaches were evaluated and compared; one-class classifiers and 
unsupervised methods. A detailed description of the models given in Table 11 can be found in 
Appendix 1 of Paper 3 [258]. For the one-class classifiers, during training, the regular period 
of the patient year was designated as a target class, and the period incorporating the infection 
episode as a non-target class. The exact location of the anomalies (novel) days was determined 
based on the individual’s self-reported time-window of the infection episode and through the 
analysis conducted in chapter five. As demonstrated and presented in chapter five, the number 
of days with abnormal values of the insulin-to-carbohydrate ratio is regarded as non-target 
(anomalies) days. The one-class classifiers were trained using the target sample objects and 
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tested with a dataset containing both target and non-target sample objects. The unsupervised 
models were evaluated by presenting the entire dataset at once. The computational time 
required to execute each model was also estimated. The classifiers were compared based on 
their performance, required sample size to produce an acceptable description of the data, and 
computational time. Furthermore, the performance of those classifiers was compared with the 
unsupervised models.  
 
 
Table 11: Models tested for the proposed personalized health model. BD = boundary and 
domain-based, DN= density-based, RE = reconstruction-based methods.  
Models One-class classifier Unsupervised 
Support vector data description (SVDD) [217; 218; 221] √         BD 𝑋 
Incremental SVDD (IncSVDD) [218] √         BD 𝑋 
One-class support vector machine (V-SVM) [198] √         BD 𝑋 
Nearest neighbor (NN) [183; 216; 217; 220] √         BD 𝑋 
Minimum spanning tree (MST) [116] √         BD 𝑋 
Gaussian [183; 216; 218; 219] √         DN 𝑋 
Minimum covariance Gaussian (MCG) [188; 216] √         DN 𝑋 
Mixture of Gaussian (MOG) [216; 218] √         DN 𝑋 
Parzen [174; 183; 216; 219] √         DN 𝑋 
Naïve Parzen [216; 218] √         DN 𝑋 
k-nearest neighbor (KNN) [183; 216; 219] √         DN 𝑋 
Local outlier factor (LOF) [42; 218] √         DN √ 
Principal component analysis (PCA) [216-218] √         RE 𝑋 
K-means [218] √         RE 𝑋 
Self-organizing map (SOM) [217; 218] √         RE 𝑋 
Auto-encoder network (AE) [216; 217] √         RE 𝑋 
Connectivity-based outlier factor (COF) [215] 𝑋 √ 
 
 
 Model evaluation 
The model evaluation was conducted based on data type - raw and smoothed data, data 
granularities - hourly and daily timeframes, and data sample sizes - one, two, three, and four 
months. For each data granularity, the ratio of total insulin to total carbohydrate was computed 
and used as either a univariate input or used along with average blood glucose levels as bivariate 
input. For the daily case, the models were evaluated based on raw data and its smoothed version 
with a two-days moving average filter. The model’s performance was evaluated for each 
individual’s dataset and reported using three performance metrics; m runs average and standard 
deviation of the area under the receiver operating characteristic (AUC), specificity, and F1-
score. Comparison of the overall models' performance among all the individual's dataset was 
carried based on these metrics, however, for the sake of clarity, the findings are depicted in 
terms of  F1-score, given its practical implication, and the rest of the metrics values are given 
in Appendix B of this dissertation and Appendix 4 of Paper 3 [258]. 
 
79 
 One-class classifiers 
The hyper-parameters of most of the one-class classifier models, i.e. complexity parameter γ, 
were optimized based on the consistency approach [222] except for Parzen, and NN, which was 
optimized by using the leave-one-out error. Min-max was used for normalizing the dataset 
[118]. For MST, the complete MST is selected. For PCA, the fraction of variance retained from 
the training dataset was determined based on repeated experiments and set to be 0.6. Twenty 
times 5-fold & ten times 3-fold stratified cross-validation was used to evaluate the performance 
of the bivariate and univariate one-class classifiers respectively. In all the cases, a pre-specified 
threshold of outlier fraction in the training dataset was set to be 𝜀𝔱 = 0.01, where one percent of 
the most dissimilar target data could be excluded from generating the data description. As 
described earlier in this chapter, the models were evaluated based on three important data 
features; granularity (hourly and daily), data nature (raw and smoothed data), and sample 
object size (1, 2, 3, and 4 months). 
 Unsupervised method 
For comparison purposes, two unsupervised models; local outlier factor (LOF) and connectivity 
based outlier factor (COF), were also evaluated based on two important data features; 
granularity (hourly and daily), and data nature (raw and smoothed data). The whole patient-
year, i.e., a sample size of 365 days for the daily case and 365*24 hours for the hourly case was 
used during evaluation. The model’s performance was measured based on the average of twenty 
runs. Both LOF and COF require a user-supplied parameter, i.e. number of neighbors (k). In 
this dissertation, the value was determined based on a set of repeated experiments, and an 
optimal value with superior performance was selected. In this regard, k was set to be 30 days 
and 240 hrs for the daily and hourly scenario respectively. Performance evaluation was carried 
out by setting a detection threshold, and an optimal threshold was determined through repeated 
evaluation of different values.  
 One-class classifier performance 
This section presents the comparison of the models' performance with respect to the type of 
input features; data nature (raw and smoothed), data granularity (daily and hourly), and 
training sample sizes (1,2,3,4 months). The median and average performance of each model 
was computed from their respective performance on the individual’s infection states in relation 
to different sample sizes, data granularity, and nature of data, which can be seen in Appendix B 
of this dissertation and Appendix 4 of Paper 3 [258]. Whenever necessary, the overall standard 
deviation of each model was computed as a pooled standard deviation. Generally, the 
evaluations demonstrated that the models' performance improved with increasing sample size, 
and smoothing the data enabled the models to generate better descriptions with smaller sample 
sizes. Despite the stated improvement, one of the drawbacks of smoothing is related to the delay 
incurred, which could result in late detection. 
 Bivariate input feature - Contextual anomalies 
The bivariate input describes the use of both blood glucose levels and the ratio of insulin-to-
carbohydrate as input parameters in modeling the detection algorithm. As a contextual 
anomaly, the blood glucose level is regarded as a behavior, which is evaluated by considering 
within the context of the insulin-to-carbohydrate ratio. Regarding the training sample size, the 
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models generate different descriptions, which mainly depend on the data nature and 
granularity, as shown in Figure 25-27. As a rule of thumb, a sample size of 3 months for the 
daily raw data, 1 month for the daily smoothed data, and 2 months for the hourly data could be 
sufficient to start with when the individual participants join the system. However, it is better to 
note that through time there will exist more data, and further model improvement (re-training) 
can be carried out. As expected, in contrast to the raw data, the smoothed version achieved 
excellent description. Among the three categories, the boundary and domain-based method 
produced a better performance with a 1-month sample size in both data granularities, 
specifically v-SVM. For a higher sample size, the density-based method generated a better 
description with the raw daily data, the boundary and domain-based method are better with the 
smoothed daily data, and the density and reconstruction-based methods are better with the 
hourly data. In particular, on average, v-SVM, K-means, and K-NN are the three top-
performing models from their respective category demonstrating superior performance 
(excellent descriptions) as compared to the rest of the models. The performance (score) plot of 
the models can be found in Appendix 3 of Paper 3 [258], depicting the capability of each model 
in detecting the infection episode from the regular period. These models were trained on a 
random block of 120 regular days (4 months) of the patient year and tested on the entire patient-
year. 
 Daily raw dataset 
The raw data is pre-processed data without further smoothing and can contain short-term and 
fast-scale features that could affect the model's generalization. As expected, as shown in Figure 
25, the models suffer in performance degradations, where the models’ performance exhibits 
wider variations. Increasing the sample size has shown little improvement on the models’ 
descriptions, specifically after the three-month sample size. As compared to the other methods, 
the boundary and domain-based method, specifically v-SVM, performed better with a 1-month 
sample size. With a two-month sample size, all the three methods improved, and density-based 
method, particularly K-NN, and reconstruction based method, particularly K-means, performed 
better. For higher sample sizes (three and four-month), generally, the density-based method 
outperforms the other methods. In this regard, the boundary and domain-based method (i.e. 
SVDD and v-SVM), density-based method (i.e. K-NN, Parzen, and Naïve Parzen), and 
reconstruction-based method (i.e. K-means and SOM) demonstrated better performance. 
Overall, a model such as v-SVM performed better with the 1-month sample size, and SVDD, 




Figure 25: Bivariate input feature - The models’ median and average F1-score over the daily 
raw datasets, source partially from [258], Figure 8. 
 
 Daily smoothed dataset 
The smoothed dataset is a filtered version with fewer short-term and fast-scale features, and in 
this version, the models are generally expected to improve. As shown in Figure 26, as expected 
the models achieved significant improvements over the raw version of the data. Increasing the 
sample size has drastically improved the models’ description attaining enhanced performance, 
specifically can be seen from the two-month sample size and onwards. As compared to the 
other methods, the boundary and domain-based method, particularly v-SVM, achieved 
excellent descriptions with a 1-month sample size. With a two-month sample size, all the three 
methods improved, and boundary and domain-based method, particularly v-SVM, density-
based method, particularly K-NN, and reconstruction based method, particularly K-means, 
performed better. For higher sample sizes (three and four-month), all the methods achieved 
comparable descriptions. Overall, v-SVM is the best model, which generates excellent 
descriptions in all sample sizes. From each respective method, on average, models such as v-
SVM, K-NN, and K-means achieved superior descriptions for all the higher sample sizes and 




Figure 26: Bivariate input feature - The models’ median and average F1-score over the daily 
smoothed datasets, source partially from [258], Figure 8. 
 
 Hourly smoothed dataset 
The hourly dataset depicts the average change in blood glucose levels in relation to the ratio of 
insulin-to-carbohydrate within each hour of the day. Unlike the daily scenario, the hourly 
dataset incorporates more training examples per day (24 sample objects). Increasing the data 
granularity could provide finer details and early detection, however, at the cost of unwanted 
features, which might become very significant as the level gets higher. As can be seen in Figure 
27, despite smoothing the models still exhibit wider performance variations as compared to the 
daily smoothed dataset. As per the previous findings, generally, increasing the sample size and 
smoothing the data should enable the models to generalize well with little variations, however, 
the presence of unwanted features within the hourly data hampers the models’ generalization 
ability. In this dataset, in a comparison between methods, the boundary and domain-based 
method, particularly v-SVM, achieved better descriptions with a 1-month sample size. With a 
two-month sample size, all the three methods improved, and boundary and domain-based 
method (i.e. v-SVM), density-based method (i.e. Gaussian families and K-NN), and 
reconstruction based method (i.e. K-means) performed better. For higher sample sizes (three 
and four-month), generally, the density-based method is better. Overall, a model such as v-
SVM performed better with the 1-month sample size, and Gaussian, MCD Gaussian, KNN, and 
K-means performed better with higher sample sizes and the worst-performing models being 




Figure 27: Bivariate input feature - The models’ median and average F1-score over the hourly 
smoothed datasets, source partially from [258], Figure 8. 
 
 Univariate input feature - Point anomalies 
The univariate input describes the use of the ratio of insulin-to-carbohydrate as the sole input 
parameters in modeling the detection algorithms. Per the findings presented in chapter five, the 
ratio of insulin-to-carbohydrate is demonstrated to be highly informative containing high 
discriminative power compared to the other key parameters of blood glucose dynamics. In this 
regard, this input feature is expected to generate improved performance compared to the 
bivariate input feature. This alternative approach presents an advantage when there is a lack of 
access to blood glucose measurements. As a point anomaly, each point in the time-series of the 
ratio is evaluated against a reference description generated by the models to determine its 
degree of normality. As per the findings, generally, the models exhibit performance variations 
with different sample sizes, as shown in Figure 28-30, and the degree of these variations is 
mainly dependent on the data nature and granularity. Regarding the optimal sample size, there 
is no much difference with the bivariate input feature. As a rule of thumb, a sample size of 2 
months for the daily raw data, 1 month for the daily smoothed data, and 2 months for the hourly 
data could be sufficient to start with when the individual participants join the system. However, 
through time there will exist more data, and further model improvement can be carried out after 
the individual participants join the proposed system. Similar to the bivariate feature, smoothing 
allows the models to generate excellent description compared to the raw dataset. In general, 
among the three methods, the boundary and domain-based method produced a better 
performance with a 1-month sample size in both data granularities. For a higher sample size, 
all the three methods achieved comparable description with the raw and smoothed daily data, 
and the density and reconstruction-based methods are better with the hourly data. In particular, 
on average, v-SVM produced a better performance from 1-month sample size and all the models 
achieved comparable performance for the higher sample size except NN.  The performance 
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(score) plot of the models can be found in Appendix A of this dissertation, which depicts the 
capability of each model in detecting the infection episode from the regular period. These 
models were trained on a random block of 120 regular days (4 months) of the patient year and 
tested on the entire patient-year. 
 Daily raw dataset 
As described earlier in this chapter, this input dataset is without smoothing and can contain 
short and fast-scale features, which could affect the models' generalization. As compared to the 
bivariate feature, the models demonstrated better performance with the univariate input feature 
with smaller sample sizes, i.e. one and two months, and comparable performance with higher 
sample sizes (three and four months), as shown in Figure 28. Increasing the sample size has a 
better effect in improving the model's performance as compared to the bivariate input case. The 
performance improvement is mainly related to the characteristic of the insulin-to-carbohydrate 
ratio, which exhibit similar patterns of values during the regular days of the year. As compared 
to the other methods, the boundary and domain-based method, specifically v-SVM, performed 
better with 1-month sample size. With a two-month sample size, all the three methods 
demonstrated significant improvement, and all the models except NN generated comparable 
description. For higher sample sizes (three and four-month), there is no difference among all 
the three methods, and the worst model being NN. Overall, a model such as v-SVM performed 
better with the 1-month sample size, and except NN, all the other models achieved comparable 








 Daily smoothed dataset 
As described earlier in this chapter, this input dataset is a filtered (smoothed) version of the raw 
dataset, and generally, the models are expected to generate improved description compared to 
the raw version. As compared to the raw dataset, as expected, the models have achieved 
significant performance improvement, as shown in Figure 29. Further comparison with the 
bivariate input demonstrated the advantage of the univariate input, which enabled the models 
to achieve better description in all the sample sizes. In this specific dataset, increasing the 
sample size has little effect on performance improvement as the models have already achieved 
better description with lower sample sizes. As compared to the other methods, the boundary 
and domain-based method, specifically v-SVM, performed better with a 1-month sample size. 
With a two-month sample size, all the three methods improved, and boundary and domain-
based method (i.e. v-SVM and MST), density-based method (i.e. Gaussian families, LOF and 
K-NN), and reconstruction based method (i.e. K-means) performed better. For higher sample 
sizes (three and four-month), all three methods generate comparable performances, and all the 
models produced similar descriptions except NN, which produces the worst description. 
Overall, on average, models such as v-SVM and MST achieved relatively greater performance 
in all the sample sizes, while all the other models except NN achieved a comparable description 
with two and more sample sizes. Generally, as the sample size increases, all the models except 
NN achieved comparable performance.  
 
 
Figure 29: Univariate input feature - The models’ median and average F1-score over the daily 
smoothed datasets. 
 
 Hourly smoothed dataset 
As described earlier, the hourly dataset is a filtered version depicting the relationship between 
the average blood glucose levels and the ratio. However, in the univariate sense, only the user’s 
estimated carb consumption and insulin requirements within each hour of the day are 
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considered. As described earlier, increasing the data granularity could improve the possibility 
of detecting the anomalies state at an earlier stage, however, at the cost of accuracy. Therefore, 
as expected, despite presenting a large sample size and smoothing the data, as can be seen from 
Figure 30, the models exhibit high variance as compared to the daily smoothed dataset. Further 
comparison with the bivariate input demonstrated the advantage of the univariate input only 
with smaller sample sizes, and with higher sample sizes both the input produced comparable 
descriptions. As compared to the other methods, the boundary and domain-based method, 
specifically v-SVM, performed better with 1-month sample size. With a two-month sample 
size, all the three methods improved, and boundary and domain-based method (i.e. v-SVM, and 
SVDD), density-based method (i.e. Gaussian families, LOF, Parzen, Naïve Parzen, and K-NN), 
and reconstruction based method (i.e. SOM and, K-means) performed better. For higher sample 
sizes (three and four-month), all three methods generate comparable performances, and the 
models achieved somewhat comparable descriptions except NN, which generated the worst 
description in all the sample sizes. Generally, increasing the sample size has helped the models 
to capture the data distribution better. Overall, models such as v-SVM achieved relatively 
greater performance with a 1-month sample size, while models such as Gaussian families and 
K-means achieved better descriptions with higher sample sizes.  
 
 
Figure 30: Univariate input feature - The models’ median and average F1-score over the hourly 
smoothed datasets. 
 
 Models performance with a different level of deviations   
This section presents evaluations of the model’s performance with data containing simulated 
deviations of different degrees. As described earlier in this chapter, a two-week-long simulated 
infection triggered deviations was injected into the five regular patient-years. Simultaneous 
deviations of α = 10%, 20%, 30%, and 40% were added to the daily aggregated insulin and 
carbohydrate values. Univariate input was used and the models were trained with 4-month 
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sample size, and their performance was evaluated and compared on the raw and smoothed 
version of each patient-years. As shown in Figure 31, with increasing deviation α, the model’s 
detection performance improves. In a comparison of the data types, the models achieved better 
detection performance with the smoothed dataset. Detecting infection states that induce very 
small deviations, i.e. α < 10% change, requires training the models with a suitable threshold 
that could reject outliers in the training dataset that exceeds the induced deviations (i.e. α < 
10%). However, this could in turn increases the false alarm rate and make the model less 
sensitive flagging regular days as an infection state. In this regard, for an application that 
involves detecting an infection state, it is necessary to favor the inclusion of some of the less 
significant outliers in the data description to avoid frequent false alarm, however, at the expense 
of missing infection state that induces small deviations (i.e. α < 10%) on the blood glucose 
dynamics. Per the findings, with α = 10%, the density-based method performed a better 
detection task, and specifically, MOG achieved better description. In this regard, generally, the 
Gaussian family achieved better performance with the raw dataset, however, all the models 
achieved comparable descriptions except NN with the smoothed dataset. It is better to note that, 
despite the small deviation (α = 10%), smoothing the data has helped the models to achieve 
good descriptions. For α = 20%, among the three methods, the density-based method (i.e. 
Gaussian families, Parzen and naïve Parzen) and reconstruction-based method (i.e. SOM and 
K-means) achieved better description with the raw data, and regarding the smoothed data, the 
boundary and domain-based method (i.e. SVDD, and v-SVM), density-based method (i.e. 
Gaussian families, and K-NN) and reconstruction based method (i.e. SOM, and K-means) 
achieved relatively better and comparable performance. For α = 30%, the density-based method 
performed better, and specifically, Parzen and naïve Parzen achieved slightly better 
performance with the raw data, and almost all the models except the nearest neighbor achieved 
comparable performance with the smoothed dataset. For α = 40%, all the three methods 
achieved comparable performance, and all the models except NN achieved comparable 





Figure 31: Univariate input feature - median and average performance (F1-score) of the models 
over the five patient years injected with different degree of deviations.  
 
 Comparison of input features  
The performance of any model can be greatly affected by the input features selected for 
modeling [226]. In this regard, this section presents the comparative analysis of the performance 
achieved with a univariate input, i.e. insulin to carbohydrate ratio, and a bivariate input, i.e. 
blood glucose levels and insulin to carbohydrate ratio. As shown in Figure 32-34, except under 
certain circumstances, where both achieved comparable performance, the univariate models 
display superior performances. However, despite the improved performance one of the 
drawbacks of the univariate input-based models emanates from the fact that these models 
cannot differentiate points that lie within quadrants 1 and 2 or quadrants 3 and 4, as shown in 
Figure 19 [258]. In this regard, theoretically, a very large ratio that resides in quadrant 3 is 
considered as normal value as long as the individual blood glucose levels go to the 
hypoglycemia state responding to the high insulin injection and low carbohydrate intake [197; 
258], and however, the univariate models consider such a situation as abnormal by just looking 
upon the ratio values as outliers. However, it should be noted that in practical settings such 
incidence might be fatal for the individuals and might end up being unconscious and sometimes 
dead [61; 151], and therefore, such ratio values might be almost non-existent in a practical 
sense. Therefore, it can be concluded that the univariate models could do the same task as the 
bivariate models when it comes to detecting infection incidences, i.e. large ratio values, 
despiting lacking the capability to differentiate between quadrant 3 and 4. However, as 
compared to the bivariate model, the univariate model might sometimes generate a false alarm 
in rare situations that are very sparse, i.e. too small values not included in training the models. 
This rare situation is manifested in the individual’s blood glucose management practice, for 
instance, if the patient on random days prefers to replace insulin requirement with physical 
exercise/activity sessions, this instance could end up with very small insulin to carbohydrate 
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ratio and be flagged as a false alarm. In these circumstances, without the blood glucose level 
feature, it will remain difficult for these models to differentiate between the normality or 
abnormality of a small value of insulin to carbohydrate ratio. Hence, having blood glucose 




Figure 32: Daily raw dataset - performance comparison (F1-score) of models using bivariate 
input, i.e. blood glucose levels and insulin to carbohydrate ratio, and univariate input feature, 
i.e. insulin to carbohydrate ratio, based on the daily raw dataset. The error bars are given in 







Figure 33: Daily smoothed dataset - performance comparison (F1-score) of models using 
bivariate input, i.e. blood glucose levels and insulin to carbohydrate ratio, and univariate input 
feature, i.e. insulin to carbohydrate ratio, based on the daily smoothed dataset. The error bars 
are given in terms of the overall mean and standard deviation of each model across all the 




Figure 34: Hourly smoothed dataset - performance comparison (F1-score) of models using 
bivariate input, i.e. blood glucose levels and insulin to carbohydrate ratio, and univariate input 
feature, i.e. insulin to carbohydrate ratio, based on the hourly smoothed dataset. The error bars 
are given in terms of the overall mean and standard deviation of each model across all the 
patient-years and infection states.  
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 Unsupervised method performance 
For comparison purposes, this section presents the performance of two density-based 
unsupervised models, LOF and COF, as given in Figure 35-37. The performance of these 
models was compared based on the type of input features, data nature (raw and smoothed), and 
data granularity (daily and hourly). The average performance of each model was computed 
using their respective performance on the individual infection states in relation to different data 
granularity, and the nature of data can be seen in Appendix B of this dissertation and Appendix 
4 of Paper 3 [258]. The optimal threshold and number of neighbors were selected after 
performing repeated evaluations for different combinations of values. Generally, LOF has a 
slight edge over the COF in all the infection states, and this could be linked with the nature of 
the data distribution that agrees with the LOF assumption of spherical neighbor’s distribution 
[42].  
 Bivariate input feature -  Contextual anomalies 
The performance of the unsupervised models, LOF and COF, using a bivariate input, i.e. blood 
glucose levels and the insulin-to-carbohydrate ratio is given in Figure 35. The optimal 
threshold values used in the model evaluation are given in Table 12. As can be seen from the 
figure, smoothing the data enabled the models to generate better performance, and as a result, 
both the models were able to yield excellent performance with the daily dataset [258]. However, 
this is not the case for the hourly dataset, mainly related to the presence of highly detailed 
information containing unwanted short-term and fast-scale features. In general, both the models 
were able to produce a comparable performance in all the datasets, however, LOF has displayed 
better performance. The performance (score) plot of the models can be found in Appendix 3 of 
Paper 3 [258], depicting the capability of each model in detecting the infection episode from 








Figure 35: Bivariate input features - performance comparison (F1-score) of the unsupervised 
models using bivariate input, i.e. blood glucose levels and insulin to carbohydrate ratio, source 
[258], Table 8. 
 
 
Table 12: Bivariate input features - optimal values of thresholds used in performance 
evaluation. The values given as Th are the optimal threshold values used for each patient-year, 
h depicting that particular year, source [258], Table 8.  
Granularity Pre-pro. Model (Thresholdpatient-year) 
Daily 
Without filter 
LOF  (T1=2.4, T2=1.2, T3=1.45, T4=1.8) 
COF (T1=1.4, T2=1.3, T3=1.4, T4=1.4)) 
With filter 
LOF (T1=1.7, T2=1.6, T3=1.95, T4=2.2)) 
COF (T1=1.3, T2=1.3, T3=1.8, T4=1.8)) 
Hourly With filter 
LOF (T1=1.4, T2=1.3, T3=1.35, T4=1.5)) 
COF (T1=1.2, T2=1.1, T3=, T4=1.1)) 
 
 
 Univariate input feature - Point anomalies 
The performance of the unsupervised models, LOF and COF, using a univariate input, i.e. the 
insulin-to-carbohydrate ratio is given in Figure 36. The optimal threshold values used in the 
model evaluation are given in Table 13. As can be seen from the figure, like the bivariate case, 
smoothing the daily dataset significantly improved the models’ performance. As described 
above, similar to the bivariate case, smoothing the hourly dataset yields inferior performance 
to the daily scenario, due to the presence of unwanted short-term and fast-scale features as a 
result of higher data granularity. In general, both these models achieved comparable 
performance in all the infection states. Regarding the raw dataset, LOF showed a slight edge 
over the COF. For the hourly and daily smoothed dataset, both the models achieved comparable 
performance. The performance (score) plot of the models can be found in Appendix A of this 
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dissertation, depicting the capability of each model in detecting the infection state from the 




Figure 36: Univariate input features - performance comparison (F1-score) of the unsupervised 
models using univariate input, i.e. insulin to carbohydrate ratio. 
 
 
Table 13: Univariate input features - optimal values of thresholds used in performance 
evaluation. The values given as Th are the optimal threshold values used for each patient-year, 
h depicting that particular year.  
Granularity Pre-pro. Model (Thresholdpatient-year) 
Daily 
Without filter 
LOF  (T1=2.7, T2=1.5, T3=2.95, T4=2.2) 
COF (T1=1.4, T2=1.1, T3=2.3, T4=1.8)) 
With filter 
LOF (T1=1.9, T2=1.9, T3=2.8, T4=2.8)) 
COF (T1=1.6, T2=1.5, T3=2.8, T4=3.1)) 
Hourly With filter 
LOF (T=1.9, T2=1.6, T3=1.2, T4=1.7)) 
COF (T1=1.6, T2=1.3, T3=1.2, T4=1.3)) 
 
 
 Comparison of input features 
This section presents the comparison of the average performance that can be gained by utilizing 
either of the bivariate or univariate input features. To this end, the performance of the 
unsupervised models, LOF and COF, using blood glucose levels and insulin-to-carbohydrate 
ratio versus the single insulin-to-carbohydrate ratio, is given in Figure 37. Per the findings, the 
models with a univariate input feature have achieved improved performance compared to the 
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bivariate input. This improvement could be linked with the discriminative power of the ratio 
compared to blood glucose levels.  
 
 
Figure 37: Performance comparison (F1-score) of the unsupervised models using a bivariate 
input, i.e. blood glucose levels and insulin to carbohydrate ratio versus a univariate input, i.e. 
insulin to carbohydrate ratio, source partially from [258], Table 8. 
 
 Comparison of unsupervised versus one-class classifier  
This section presents the comparative performance of the one-class classifier and the 
unsupervised method. In this regard, as per the findings, compared to the semi-supervised 
method, i.e. one-class classifier, the unsupervised method fails to achieve comparable 
performance, especially with the bivariate input feature. One of the drawbacks of the 
unsupervised method is related to the fact that they require a fairly large sample size to at least 
produce comparable performance with the one-class classifiers [87]. This characteristic can be 
easily observed by looking at the performance of the unsupervised method based on the whole 
patient-year and the one-class classifier trained only with four months of the patient-year. To 
further illustrate the difference in performance, the comparison of the best performing 
unsupervised model, LOF, to its one-class classifier version, is given in Figure 38. As can be 
seen from the figure, under almost all the circumstances the one-class classifier model achieved 
superior performance. The characteristic of the data distribution, which contains a high and 
sparse density pattern, could be the reason behind the performance degradation of the 
unsupervised method [176] since these models require perfect demarcation between normal and 
abnormal values. As described in the input features, the state of blood glucose dynamics 
contains very rare events that contribute to the existence of sparse regions within the four 
quadrants. In this regard, a typical example could be a holiday season, where an individual 
happens to consume too many carbohydrates. Furthermore, the individual decision to switch to 
physical activity or exercise sessions to compensate for insulin requirements could result in a 
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similar pattern. These sparse data or rare events are a normal portion of the data, which needs 
to be treated as such by the detection methods. However, in these typical scenarios, the 
unsupervised method could end up considering these situations as abnormal resulting in a false 
alarm. In this regard, one of the main drawbacks of the unsupervised method is related to the 
fact that they determine anomalies from the data themselves and, there is no mechanism to let 
the model learn and accept certain sparse regions just like the one-class classifiers. Thus, the 
atypical nature of the underlying data distribution affects the performance of an unsupervised 
method. Yet, the one-class classifier method can handle such kind of situation if properly 
introduced with such an example during the learning phase [258]. 
 
 
Figure 38: Performance comparison (F1-score) of unsupervised and one-class classifier version 
of the local outlier factor (LOF) model using both a bivariate input, i.e. blood glucose levels 
and insulin to carbohydrate ratio, and a univariate input, i.e. insulin to carbohydrate ratio.  
 
 Computational Time 
Models computational (running) time depicts the necessary time required by a model to learn 
and classify given sample objects [217; 258]. In real-world applications, it can become a 
bottleneck for a large scale implementation, i.e. real-time mass outbreak detection. In a certain 
application, however, the learning time can be compromised considering that the model can be 
trained offline [258]. However, the testing time is very crucial in almost all applications and is 
one of the determinants of the model's success in achieving the proposed real-time task. To this 
end, the model's average running time (learning and testing time) is estimated and compared. 
To quantify and compare the required computational time by each model, different sample sizes 
of bivariate training and testing data were used, i.e. 240, 480, 720, 960, 1200, 1440, 1680, 
1920, 2160, 2400, 2640, 2880 objects. The resulting rough (average) computational time 
requirements of the models is given in Figure 39 (a & b). Per the finding, generally, models 
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that took a significant amount of training time include NN, SVDD, and SOM. During the 
detection phase, almost all the models took considerably less time except certain models such 
as LOF and Incsvdd [258].  
 
 
a) The computational time for the training phase, source [258], Figure 5. 
 
 
b) The computational time for the detection phase, source [258], Figure 6. 
 
Figure 39: Average running time required for the training and detection phase. Figure (a) 
depicts the models’ time requirement during the training phase. Figure (b) depicts the models’ 
time requirement during the detection phase. The labels in X-axis stands for a quotient of the 
sample size divided by twenty-four, i.e.10 (10*24), 20 (20*24), 30 (30*24), 40 (40*24), 50 
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(50*24), 60 (60*24), 70 (70*24), 80 (80*24), 90 (90*24), 100 (100*24), 110 (110*24), 120 
(120*24) sample objects. The models’ average computational time requirement is depicted on 
the Y-axis.  
 
 Practical significance 
The practical significance of the presented personalized health model can be viewed within the 
scope of infectious disease outbreak detection, as demonstrated in this dissertation, and 
assisting the individuals during infection episodes, i.e. decision support and learning platform 
[258]. In this regard, the ability to detecting infection onset in real-time and under free-living 
conditions can be devised to provide crucial and supportive information for decision making 
[258; 259]. The following information can be vital to manage the crises; 
 As discussed in chapter five, infection episodes induce elevated blood glucose levels 
despite administering proper insulin and consuming less carbohydrate [259]. In this 
regard, having real-time health status information can assist to provide information on 
blood glucose evolution during the course of infection, such as time in-range blood 
glucose levels [80], and glucose variability [50; 207; 251]. Such information coupled 
with insulin sensitivity change could be very important to the individual. This is mainly 
important in short term to mitigate the crises and also in the long term to learn how to 
cope with a similar situation in the future.  
 The other big challenge for the individuals during infection onset is setting right the 
ratio of insulin to carbohydrate while taking a closer look at the blood glucose levels. 
As discussed in chapter five, the reason is the presence of insulin resistance and glucose 
production as the body’s response mechanism to the infection-causing pathogens [259]. 
Thus providing information regarding the evolution of the ratio during the crises can 
help the individuals to estimate and set right the ratio during the crises. Further, this 
kind of information can enable the individual to be aware of the degree of insulin 
sensitivity change during infection episodes to better cope in the future.     
Apart from this, the other important area could be a learning platform that can be used for 
educational purposes. In this regard, it could be essential to educating individuals about the 
effect of different infection pathogens and their associated deviations triggered on the key 
parameters of blood glucose dynamics [259]. However, to use such a service in practice require 
to analyze data containing different kind of pathogens and a large population to estimate the 
degree of deviations associated with each pathogen among different individuals. The idea here 
is to devise a simulation model, where a user can enter his body mass index, age, infection type, 
days since infection begins, and other similar information to see his/her estimated range of 
blood glucose levels, and change in the ratio (insulin sensitivity). In this regard, educating 
individuals with such simulated information about what to anticipate at each phase of the 
disease progression could be very essential [258; 259].  
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 Limitation  
Taking into account the complexity of blood glucose dynamics, the development of the 
proposed personalized health model requires considering a dataset from a large number of 
participants and incorporating all the key parameters of the blood glucose dynamics. In this 
regard, this study could be benefited from incorporating physical activity data and other 
information. Furthermore, utilizing data from a large number of participants could further 
validate the conclusion. However, it was very challenging and difficult for me to get a rich and 
precise dataset to further strengthen the conclusion. Actually, my inclusion criteria were stiff 
given the fact that I only considered datasets that are complete, accurate, and long enough (more 
than 3 months) as well as are required to contain at least one infection episode, which makes 
the data collection challenge far more difficult.  
 Knowledge Summary  
In the context of the original research question, the following section presents the added 
knowledge within the scope of the presented results.   
What do we know about the topic already? 
 Semi-supervised (one-class classifier) and unsupervised methods have been used in 
various medical applications such as diagnosis and monitoring [57; 110; 164; 230].  
 There is literature that exploits data from different sources such as google search, 
school, and works absenteeism, wearables data such as resting heart rate and sleep 
quality, pharmacy drug sales, and others to forecast infectious disease outbreaks [181; 
194; 227]. However, none of this literature has used a personalized health model to 
screen the health status of an individual in near real-time and under free-living 
conditions based on their self-recorded health-related digital data for infectious disease 
outbreak detection purposes. 
 
What does this chapter add to our knowledge? 
 To the best of my knowledge, this is the first attempt towards realizing a personalized 
health model to screen health status and capture infection episodes among people with 
type 1 diabetes using self-recorded data. 
 Approaches and design alternatives for realizing a personalized health model is 
presented. This model is the core and building block of the proposed personalized digital 
infectious disease detection system. 
 A personalized health model for health status monitoring and detection of infection 
episodes among people with type 1 diabetes is realized. The experimental result 
indicates the success of the proposed approach achieving excellent performance in 
monitoring health status and detecting the infection episodes.   
 Models with two alternative input features were evaluated and reported; bivariate input, 
i.e. blood glucose levels and insulin-to-carbohydrate ratio, and univariate input, i.e. 
insulin-to-carbohydrate ratio. The point is to consider the univariate input as an 
alternative when there is a challenge in getting blood glucose measurements. The 
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experimental result demonstrated the potential of these input features in the proposed 
tasks. Among these two input alternatives, the univariate input feature achieved slightly 
better performance.  
 Two approaches for setting the frequency of monitoring are evaluated and reported. In 
this regard, the models were tested in two different data granularities, i.e. hourly and 
daily. The experimental results demonstrated the capability of these approaches 
achieving excellent performance in both data granularities. This capability allows the 
proposed system to be developed considering both frequencies of monitoring, where the 
personalized health model can run and perform computation either every hour or every 
day, or both.  
 Within the scope of the realized personalized health model, the initial data requirement 
from an individual to join the proposed system is evaluated and reported. The 
assessment mainly considers the required sample size to generate acceptable model 
performance in real-world settings. In this regard, the experimental result indicates that 
every new participant joining such a system is required to fulfill minimum pre-collected 
data requirement, and per the findings, a sample size of three-month training sample 
size for the daily raw dataset (60 sample objects), a one-month (30 sample objects) 
training sample size for the daily smoothed dataset, and a two-month training sample 
sizes for the hourly dataset (60*24 objects) can be regarded as a rule of thumb data size, 
to begin with.  Of course, the presence of more data at the beginning will be favored, 
however, this is not the case in practical settings. The point here was to establish a rule 
of thumb data size for everybody to join the proposed system without compromising 
the system’s accuracy. 
 Among the models tested, on average, models such as v-SVM, K-NN, and K-means 
achieved relatively better performance with all evaluation criteria. The unsupervised 
models underperformed compared to the one-class classifiers, and mainly due to the 
nature of the data distribution.   
 The degree and severity of infection episodes dictate its detectability through the 
developed personalized health models. In this regard, the experimental result 
demonstrated that infection episodes, which trigger large and medium deviations are 
captured with greater accuracy by the models. As per the findings, influenza (flu) 
episodes were detected with superior accuracy, and infection such as mild common cold 
without fever was also detected. However, infection such as light cold without fever 
was not detected.  
 Chapter summary  
This chapter presented and discussed results related to the development of a personalized health 
model for detecting infection episodes among people with type 1 diabetes. A group of one-class 
classifiers and unsupervised methods were tested, evaluated and performance assessed. The 
one-class classifier models were evaluated in terms of input features, i.e. bivariate and 
univariate, data granularity, i.e. daily and hourly, and required sample sizes, i.e. one, two, three, 
and four months. The unsupervised models were evaluated with all these criteria but the sample 
size. Generally, the experimental results demonstrated the potential of the proposed approaches 
in achieving the intended task. In this regard, the proposed methods especially the one-class 
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classifiers have demonstrated superior performance in detecting deviations from the norm due 
to infection onset. In comparison to each particular one-class classifier model from their 
respective groups, v-SVM, KNN, and, K-means achieved relatively better performance on 
average with all the evaluation criteria. From the unsupervised models, LOF has demonstrated 
a slight edge over COF with all the evaluation criteria. Comparing the one-class classifier with 
the unsupervised method, the experimental result demonstrated the potential of the former to 
the latter in these typical datasets. As far as my knowledge is concerned, this is the first study 
that targeted a personalized health model to detect infection episodes among people with type 
1 diabetes exploiting self-recorded data. In conclusion, these findings provide a novel approach 
to support the ongoing surveillance efforts, and however, additional large-scale studies might 




7 Concerns, Expectations, and Willingness Towards 
Sharing Self-Collected Health-Related Data 
Synopsis: This chapter puts forward findings related to user concerns, expectations, and 
willingness for long-term and successful sharing of self-collected health-related data. The 
objective was to identify factors that enhance users' participation in the sharing of self-recorded 
health-related data to the proposed system. The chapter presents results from a quantitative 
survey conducted to identify these factors and closes with a concluding remark. This chapter 
provides answers to the fourth research question (Q4). 
 Introduction  
As presented and discussed in chapter four, the fundamental requirements in the proposed 
EDMON system, are the availability of continuous, accurate, and precise self-recorded data 
from the individual participants, and the willingness to share these data with the center for 
further processing [259]. In fact, the individual participant usually self-records various 
parameters of the blood glucose dynamics as part of his/her self-management practice. In this 
regard, the idea behind the EDMON system is to use these data for secondary purposes, i.e. 
infectious disease outbreak detection. This objective especially calls for a user, who is 
motivated to continuously record accurate and precise health data and also willing to share the 
data with the intended system. However, from a practical perspective, peoples motivation to 
self-record accurate and precise data and willingness to share them vary considerably, and there 
are several factors, concerns, and barriers to realizing these requirements in practical settings 
[9; 24; 53; 60; 83; 93; 126; 189; 200; 201; 244; 245; 247; 249; 250; 252]. Data sharing concerns, 
barriers, and willingness could vary under different circumstances, however, factors such as 
lack of trust, incentives, and reciprocity, and concerns such as data ownership, access controls, 
and confidentiality are among those depicted in the literature [177; 229; 246; 247]. To be 
successful, a system like EDNON needs to consider different factors, concerns, barriers, and 
enablers during system design and implementation. Therefore, this chapter focus on assessing 
factors related to user concerns, expectations, and willingness for long-term and successful 
mass sharing of self-collected health-related data. Moreover, it also assesses the user mHealth 
apps feature preference and experience with health tracking technologies during data collection. 
The study was carried out in two steps using exploratory sequential method [75; 171; 239], 
where we primarily designed a qualitative interview guide incorporating five separate themes 
and performed data collection and analysis, and then used the findings from the qualitative 
study to further inform and rectify design of the quantitative survey questioners [105] and data 
collection. The qualitative study was developed based on a detailed concept and application 
scenarios of the proposed EDMON system, in general, and the patient unit, i.e. mHealth app, 
in particular [7; 130]. The initial qualitative exploration assesses factors within the scope of 
four main themes; sensors and wearables, data sharing, data integration, and social media and 
entertainment. Within these themes, face-to-face interviews were conducted assessing user 
knowledge, experience, and expectation [252]. The results from this qualitative exploration 
were used to develop the quantitative survey questionnaire [105]. To pinpoint factors that stand 
out for people with diabetes, the study performed a comparative analysis against other chronic 
patients, and healthy individuals [257]. In total 430 participants responded to the survey, of 
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which 61 individuals with diabetes, 82 individuals with other chronic diseases, and 285 healthy 
individuals. The respondents were from Norway (59), Switzerland (187), Germany (13), 
US/UK/Australia/Canada (77), France (26), and the other 46 respondents were from 35 
different countries over the globe [257]. As can be seen from Table 14, there doesn’t exist an 
age difference (p=.083) or gender difference (p=.133) among the study groups. The results 
presented in this chapter are part of the findings presented in Paper 5 [257].  
 
Table 14: Participants demographics, familiarity with wearable technologies, and data sharing 




 Data recording related experiences and preference  
As described in chapter four, the proposed EDMON system considers mHealth app as a patient 
unit, which is expected to integrate readings from various diabetes-related sensors and other 
wearables technologies [259]. In this regard, this section explores the participant's experience 
and regular usage of health-tracking technologies and further spotted features of mHealth apps 
that the respondents rated important. For the EDMON system to be successful, it is crucial to 
take into account the users' preferences and experiences while designing and developing the 
patient unit [2; 77; 140; 252]. 
 Experience and usage of health-tracking technologies  
This section presents and discusses the result related to the participant’s experience and regular 
usage of health tracking technologies. The respondents were presented with two questions 
assessing the individual's experiences and regular usage of health tracking technologies. The 
first question asked the respondents if they have experience with any wearable devices 
(Yes/No) and the second question presented the following options; sensors integrated into the 
smartphone, physical activity tracker, mobile health (mHealth) apps, health-specific 
measurements, and none [105], and asked if they regularly use any of these health-tracking 
technologies. As per the findings, as can be seen in Table 14 above, many people with diabetes, 
close to 97%, in one way or another have used wearable device for self-management purposes 
through collecting physical activity and other health-related data, as compared to people with 
other chronic diseases (55%), and healthy individuals (51%), χ2(423) =44.04, p=.001 [257]. 
Furthermore, as shown in Figure 40, people with diabetes tend to often regularly use health-
specific measurement devices and physical activity as compared to the other study groups. In 
this regard, the result demonstrated that most people with diabetes (87%) regularly use health-
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specific devices in combination with a physical activity tracker, and only 3% reports no use of 
sensor or wearable devices [257]. Among the other study groups including people with other 
chronic diseases and healthy individuals, smartphones integrated with sensors and mobile 
health apps are popular.  
 
Figure 40: Health-tracking technologies usage and experience among the three groups, source 
[257], Figure 2 (b). 
 
 mHealth apps and features preference  
This section presents and discusses the results related to the participant’s preferences for 
mHealth app features. As described in chapter four, the proposed EDMON system relies on a 
mHealth app for collecting the necessary data from the individual subject [259], and, in this 
regard, it is crucial to understand what kind of features this group of patients prefer. Existing 
literature outlined the importance of mHealth app features and functionalities for its rating 
among the users, and are determinant factors that could have a positive impact on the user's 
long term engagement [111; 156; 252]. Taking this into account, the respondents were asked to 
rate these features; automatic setup and easy to understand/use, customizable feedback, 
automatic data collection, non-disturbing, and tailored data analysis (1=not important to 4=very 
important) [105]. The respondent's feature preferences are given in Figure 41. As per the 
findings, non-disturbing features that require fewer interactions and features that allow 
automatic setup, and are easy to understand (use) is rated as very important by most 
respondents, i.e. main effect of feature, F(3.83,1163.75)=3.389, p=.01, η2=.011 [257]. 
Generally, people with chronic disease rated all the features as equally important, F 
(2,304)=12.09, p<.001, η2=.074. When it comes to people with diabetes, features that enable 
automatic data collection is rated as the most crucial feature, yielding a significant interaction 
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effect, F(7.66,1163.75)=2.104, p=.035, η2=.014. In this regard, the most probable reason is that 
manual registration of data is more time consuming, and full of hassle. To this end, one 
respondent said, "What is missing in most of the diabetes app is an automatic integration of 
sensors that automatically collect data and different types of wearables for automatic collection 
of data. In the short term manual input is not a big problem but in the long term, it would be a 
lot of hassle to do that. Take a lot of time. Simple is a lot better " [252]. Furthermore, automatic 
setup and understandability, customized feedback, non-disturbing, and tailored analysis and 
functionalities were also favored by people with diabetes [257].   
 
 
Figure 41: Preference of mobile health (mHealth) app features, source [257], Figure 1 (b). 
 
 Data sharing  
As discussed in chapter four, the proposed EDMON system expects the individual participant 
to continuously record accurate, and precise data and share these data with the center for further 
processing [259]. Taking into account the sensitivity of health-related data, sharing of such data 
faces significant challenges for several reasons [81; 117; 119; 126; 131; 225; 229]. To be 
successful, it is necessary to involve all the stakeholders throughout system design and 
implementation. In this regard, this section explores the participant's concerns, expectations, 
and willingness towards mass sharing of self-recorded health-related data to the intended 
system. Among the three groups, many people with diabetes reported data sharing experience 
(47%), as shown in Table 14 above, compared to people with other chronic diseases (33%), 
and healthy individuals (23%), χ2=19.6, p<.001 [257].    
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 Data sharing concerns and expectations 
This section presents and discusses results related to the participant’s concerns and expectations 
towards sharing data for the intended system. Understanding participant's concerns and 
expectations towards sharing self-collected health data are important steps for successful 
system design and development [15; 81; 117; 225; 257]. Taking this into account, the 
respondents were asked about their degree of concerns and what do they expect in return for 
sharing a given health data.  
Several concerns could arise during data sharing [15; 117; 225], and in this regard, the 
respondents were asked to rate different concerns, which are expected to arise during data 
sharing, based on a 1 to 4 scale; trust-related issues (e.g. privacy/confidentiality/ security), data 
ownership - who owns the data, data storage - where is the data stored/service availability, and 
transparency of health data usage by 3rd parties [105]. As per the findings, as shown in Figure 
42, for people with diabetes, transparency is the highly-rated concerns, followed by confidence 
related to data security and confidentiality (trust), ownership related to who owns the data 
irrespective of storage location, and storage related to where the data is stored. As can be seen 
from the figure, the group of healthy individuals is the least concerned with any of those stated 
issues, and this could be related to the type of data these groups usually collect, which is less 
health-specific [257]. All the respondents reported transparency as the most crucial concern and 




Figure 42: Participants’ concerns towards sharing health data, source [257], Figure 1 (a). 
 
Understanding what kind of services the users might expect, i.e. incentives, in return for sharing 
data and addressing those expectations during system design and implementation could have a 
positive impact on a long-lasting engagement with the proposed EDMON system [225; 257]. 
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To this end,  the users' expectations were assessed by asking the respondents to rate the 
following features based on a 1 to 4 scale; personalized feedback and notification, integrated 
view (including data analysis, aggregated results, and trends), decision support, comparing 
status with others, and don’t expect anything [105]. Per the findings, as shown in Figure 43, 
generally, 60% of the respondents (256 out of 429) rated personalized feedback as the most 
important feature, 53% of the respondents (233 out of 429) rated integrated view, 36% of the 
respondents (154 out of 429) rated decision support, and least rated feature was a status 
comparison, and only 16% of the respondents (68 out of 429) expected it in return [257]. 
Expectations among the three groups didn’t differ, smallest p >.74. In this regard, providing 
such features as personalized feedback, integrated view, decision support, and comparing status 
with peer groups for people with diabetes could motivate this group for successful sharing of 
self-collected health data to the proposed EDMON system. Interestingly, a high number of 






Figure 43: Participants' expectations in response to data sharing, source [257], Figure 2 (a). 
 
 Willingness towards anonymous sharing of data  
This section presents and discusses results related to the participant’s willingness to 
anonymously share different types of health-related data to the proposed EDMON system. 
User’s willingness to share his/her health data depends on various factors such as the 
sensitiveness of the data type to be shared, views and attitude towards data sharing, perceived 
benefits and risks of data sharing, trust issues, fear of privacy, and data breaches, and a lot of 
other factors [117; 120; 257]. As described in chapter four, the proposed EDMON system, 
requires the individual participants to share mandatory data types (such as blood glucose levels, 
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insulin, diet, medication, and geographical location) and optional data types (such as physical 
activity, other physiological parameters, and others) [259]. Hence, the point was to assess the 
users' willingness to anonymously share these and other data types to the proposed EDMON 
system. To this end, the respondents were asked about their willingness to anonymously share 
health-related data to a central server. The following options were presented based on a 
multiple-choice format; lifestyle and dietary intake, medication intake and treatment, 
physiological indicators, physical activity and exercises data, geographical location (GPS), 
signs of infection, daily mood and feelings, weight, sleep duration, social environment (e.g. 
risks of infection), and none of these [105]. Per the findings, as shown in Table 15, generally, 
people with diabetes happen to be willing to share most parameters [257]. However, they are 
reserved for certain parameters such as geographical location (GPS), and signs of infection. In 
comparison between groups (corrected for multiple comparisons), generally, the respondents 
don’t differ towards the sharing of certain parameters such as lifestyle and dietary intake, daily 
mood and feelings, sleep duration, geographical location, and social environment. In general, 
the respondents happen to be least willing (restrictive) towards sharing information about their 
geographical location (GPS). As described above, geographical location information is one of 
the mandatory data types that need to be shared with the proposed EDMON system for 
performing a clustering and outbreak detection analysis. In an ideal scenario, having fine-
grained information such as where the individual work, live, school, and recently been can 
assist in tracing back contacts if an infectious outbreak is detected [170; 199; 259; 261]. In this 
regard, the practical implication is that the proposed EDMON system needs to put a substantial 
effort to provide a proper privacy-preserving mechanism that can persuade the users or use 
simply use a high levels address such as postal code and avoid the individual’s location [39; 
259; 262].   
 
 



































































































































N 213 219 195 202 193 248 87 240 221  173    89 
Diabetes 53 41 31 46 29 43 20 43 43 30 5 
Other chronic 44 45 45 40 46 54 16 50 49 35 16 
No chronic 116 133 119 116 118 151 51 147 129 108 68 
Chi-square 43.48 9.05 5.22 24.39 5.73 8.93 6.92 8.29 15.48 2.87 7.59 





 Practical Implication 
As presented and discussed in chapter four, the proposed EDMON system requires a 
continuous recording of accurate and precise data and sharing of these data to the system. 
However, in practical settings, there are a number of challenges that arise during system design 
and implementation and require proper mitigations options to properly address them. As per 
the findings, the challenge can arise from 1) lack of motivation to stick to the EDMON app for 
continuous, accurate, and precise data recording, 2)  failure to address users concerns that arise 
in response to data sharing 3) failure to fulfill user expectations out of the system, and others 
[252; 257]. In this regard, Table 16 provides the main findings in this regard and puts forward 
mitigation options for the challenges, and also highlights promising findings that foster the 
system implementation.  
 
 
Table 16: Topics and findings related to data recording and sharing, requirements of the 
proposed EDMON system, and mitigation options for challenges that arise. 









Most people with diabetes, close to 
97%,  have reported experience with 
wearable devices and sensors. 
Accurate and precise 
data recording in 
continuous manners 
This is very relevant to accomplish the 
stated requirements; accurate and precise 
data recordings. Having well-experienced 
users is an asset.   
Regular 
usage 
Most people with diabetes (87%) 
regularly use health-specific devices 
and activity tracker, and only 3% 
reports no use of sensor or wearable 
devices. 
This is a great advantage and to some 
extent can guarantee the continuity of the 
data to the proposed EDMON system. 





Most people with diabetes prefer 
automatic data collection, automatic 
setup, understandability, customized 
feedback, non-disturbing, and tailored 
analysis.  
Designing and developing a usable 
mHealth app for long term engagement 
requires involving the users in the process 
and incorporating users' preferences. In 
this regard, adding these features to the 
EDMON patient unit app can facilitate 
long-lasting engagements.   
Data sharing  
Experience 
Almost half of the people with diabetes 
reported data sharing experience 
(47%). 
Continuous (real-time) 
sharing of recorded data 
This is a promising level of experience 
that can be further nurtured through 
properly addressing concerns, 
expectations, and also carefully looking at 
willingness and conditions for willingness 
to certain types of data. 
Concerns 
People with diabetes raised concerns 
including transparency, data security, 
confidentiality (trust), data ownership, 
and data storage location. 
Failure to resolve users' concerns in regard 
to data sharing could have a great impact 
on hampering their motivations to engage 
with the system. Hence, it is crucial to 




Personalized feedback, integrated 
view, decision support, status 
comparison. 
Providing some kind of incentives to 
better help manage their condition in 
return to data sharing could motivate the 
individuals to better stick to the system for 
a long time. Hence, it is necessary to 
include these functionalities in the 
proposed EDMON system. 
Willingness 
People with diabetes happen to be 
willing to share most parameters but 
geographical location. 
Regarding the geographical location, users 
are clearly against it. Hence, a substantial 
effort is needed to persuade the users by 
providing strong privacy, security, and 
confidentiality measures or simply rely on 
higher-level address such as postal code, 
which is less sensitive. 
 Limitation  
One of the main limitations of the study could be the number of participants. The study could 
be benefited more if the number of participants is large enough to further strengthen the 
conclusion. The other possible limitation could be linked with the unbalanced number of 
participants among the group used during the comparison. However, it should be noted that the 
survey was distributed in different social media and forms for longer periods, and the 
questionaries were also developed in three different languages to reach broader audiences.  
 Knowledge summary  
In the context of the original research question, the following section presents the added 
knowledge within the scope of the presented results.   
What do we know about the topic already? 
 There are rapid advancements in health tracking technology, and these technologies are 
being integrated into our daily life, and consequently, a large amount of data are being 
generated each day. 
 Continuous collection of quality health data (active and long term engagement) and 
willingness to share these data are mainly hampered by various factors.  
 Several pieces of literature have previously addressed the issue under different contexts 
and objectives. 
 Data sharing in particular are affected by the underlying objective. For instance, most 
people could refrain from sharing if there is an underlying commercial objective rather 
than public or patient benefits. 
 
What does this chapter add to our knowledge? 
 The result identified that the rate of adoption of health tracking devices is increasing, 
for instance, among the diabetes participants, almost 87% of the respondents reported 
regular use of health-specific devices and activity tracker, and only 3% reports no use 
of such devices. Furthermore, 97% of the respondents reported experience with some 
type of wearable devices and sensors. Besides, features such as automatic data 
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collection, easier interface, e.g. voice command, tailored and personalized feedback are 
reported to enhance usage time and long-term engagement. 
 The result indicates that user's willingness to share health-related data mainly depends 
on the type of data under consideration and related concerns such as privacy, security, 
confidentiality, transparency, and ownership. For people with diabetes, transparency 
and confidentiality of the data are found to be very critical when sharing self-
management data.  The underlying reason can be linked to fear associated with 
information leakage or data usage by 3rd parties. In this regard, for example, blood 
glucose information containing experiences of repeated lows blood glucose level 
(hypoglycemia), if discovered by a licensing authority, might end up suspending one’s 
driving license. 
 Fulfillment of user's expectations and resolving individual concerns could highly 
facilitate sharing health-related data to a central repository. In this regard, the result 
indicates that participants expect some kind of immediate benefits or incentives from 
sharing, and this includes tailored and personalized data analysis, integrated view, 
customized feedback, and others. However, comparison of status among peers in the 
society is found to be less relevant. The respondents also highlight benefits to the 
general public health as an additional facilitator.   
 The result identified that despite anonymization, respondents still refrain from sharing 
some kind of data. The respondent's willingness to share anonymous health-related data 
does differ for different data types. For example, most of the participants don’t want to 
share their geographical location for various reasons. However, on the other hand, 
participants are willing to share health-related data including medication, physiological 
parameters, weight, and others. 
 Chapter summary  
This chapter presented and discussed the individual’s concerns, expectations, and willingness 
towards successful sharing of self-collected data to the proposed EDMON system along with 
mHealth features that could enhance active usage time and engagement. The study relies on an 
exploratory sequential method, where the findings from a qualitative interview were used to 
further inform and rectify the design of the quantitative survey questioners and data collection. 
The qualitative interview guide was developed based on a detailed concept and application 
scenarios of the proposed EDMON system in general and the patient unit, i.e. mHealth app, in 
particular. The result identified that among people with diabetes, the rate of adoption of health 
tracking and fitness devices is higher. Besides, factors such as automatic data collection, easier 
interface, e.g. voice command, tailored and personalized feedback are reported to enhance 
usage time and long-term engagement. When it comes to sharing self-collected health-related 
data, the findings demonstrated that people with diabetes are willing to share certain parameters 
such as medication intake and treatments, physiological indicators, lifestyle and dietary intake, 
physical activity data, sleep duration, and weight. However, they are reserved for certain 
parameters such as geographical location (GPS), and signs of infection. In return to data 
sharing, people with diabetes expects some kinds of benefits or incentives such as tailored and 
personalized data analysis, integrated view, customized feedback, and others. There are various 
concerns people with diabetes have regarding data sharing, including transparency, confidence 
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related to data security and confidentiality (trust), ownership related to who owns the data, and 
storage related to where the data is stored. Generally, the findings presented in this chapter can 
support the effort towards enhancing user engagement and facilitate successful data sharing, 







8 Conclusion and Future Works 
Generally, there has been a consensus about the effect of infection onset in people with type 1 
diabetes, and it has been known for a long time, however, there has been little to no attempt 
towards exploiting self-recorded data from these patient group to detect infection onset on an 
individual basis; thereby assisting the effort towards detecting infectious disease outbreaks. 
Moreover, in the bodies of literature, little to no studies have previously considered infection 
onset as a major parameter while designing and modeling either prediction or anomaly detection 
services for this group of patients. These knowledge gaps have stimulated towards defining the 
main research problem (MP) as follows: What is the effect of infection incidence on key 
parameters of blood glucose dynamics amongst people with type 1 diabetes, and how can self-
recorded data from this patient group assist in detecting an infectious disease outbreak? 
 Contribution  
This section will highlight and discuss the main contributions within the scope of the original 
research problem and the objective of the dissertation.  
Contribution 1 (C1) - Paper 1 related to Q1. A general framework of a personalized health 
model-based digital infectious disease detection system for realizing a system that can collect, 
analyze, detect, and notify the concerned bodies about the ongoing outbreak. 
This contribution is linked to the first research question (Q1) and aims to provide a general 
framework for the proposed personalized health model-based-digital infection detection 
system, i.e. EDMON system. In literature, there are various implemented systems designed for 
diabetes-related service, i.e. remote monitoring [14; 109; 185; 193; 268], and disease 
surveillance purposes [8; 54; 55; 91; 227]. Therefore, the point was to integrate concepts from 
those systems and come up with a novel framework that utilizes self-recorded data from people 
with type 1 diabetes, and assist in detecting infectious disease outbreaks. The framework is one 
of a kind introducing the individualization concept for surveillance purposes in practical 
settings. In this regard, the framework put forward a personalized health model-based-digital 
infectious disease detection system that detects infection onset at an individual level and uses 
such information for detecting infectious disease outbreaks among the public by identifying a 
cluster of infected individuals based on time and geographical locations. Moreover, it also 
highlights challenges that could emanate from practical implementation. Therefore, the 
contribution is the framework itself, from where the actual system can be implemented.    
 
The entire work related to this contribution is presented and discussed in Chapter 4. 
 
Contribution 2 (C2) - Paper 1 related to Q2. A proof of concept towards using key 
parameters of blood glucose dynamics for infection detection. 
This contribution is linked to the second research question (Q2) and aims to provide a 
characterization of the effect of infection episodes on key parameters of blood glucose 
dynamics amongst people with type 1 diabetes. Among other things, the characterization 
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identifies optimal parameters for infection detection by quantifying the nature and degree of 
infection triggered deviations. The point was to select optimal parameters from the group of 
key parameters of blood glucose dynamics to realize the proposed personalized health model 
with a minimum false alarm rate as possible. In this regard, some studies in the literature have 
investigated the possibility of using self-recorded data from this patient group for outbreak 
detection and surveillance purposes, see chapter five. However, none of these studies 
investigated and characterized the effect of infection episodes on each key parameter of the 
blood glucose dynamics and pinpoint optimal parameters with high accuracy. To the best of my 
knowledge, this is the first study that empirically and numerically quantifies the effect of 
infection episodes on each key parameter of the blood glucose dynamics among people with 
type 1 diabetes exploiting self-recorded data. The study carried out a trend analysis and data 
distribution estimation to pinpoint the optimal parameters relying on a real dataset of ten 
patient-years. Therefore, the contribution is the characterization of the effect of infection 
episodes, and identification of optimal parameters for developing the proposed personalized 
health model. 
 
The entire work related to this contribution is presented and discussed in Chapter 5. 
Contribution 3 (C3) - Paper 3 related Q4. A personalized health model for detecting 
infection incidences in people with type 1 diabetes using blood glucose, insulin, and 
carbohydrate information. 
This contribution is linked to the fourth research question (Q4) and aims to provide a 
personalized health model that is capable of monitoring the individual’s health status in free-
living conditions. To the best of my knowledge, this is the first attempt towards realizing a 
personalized health model to capture infection episodes among people with type 1 diabetes 
using self-recorded data. The model accepts the user's self-recorded data continuously and 
automatically detects when the individual becomes sick. The realized model is a type of 
contextual anomaly detector exploiting blood glucose levels and insulin-to-carbohydrate ratio, 
where blood glucose is the behavior to be observed and the ratio of insulin-to-carbohydrate is 
the context. A group of one-class classifiers and unsupervised models were tested and 
evaluated. Therefore, the contribution is the personalized health model.  
 
The entire work related to this contribution is presented and discussed in the first half of 
Chapter 6. 
 
Contribution 4 (C4) - Paper 4 related Q4. An alternative personalized health model for 
detecting infection incidences in people with type 1 diabetes using only insulin and 
carbohydrate information. 
This contribution is linked to the fourth research question (Q4) and aims to provide an 
alternative approach towards realizing a personalized health model for monitoring the 
individual’s health status in free-living conditions, and automatic detection of infection onset. 
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The point was to realize a model with less number of input parameters, i.e. using only insulin-
to-carbohydrate ratio, and provide an alternative model. The realized model is a type of point 
anomaly detector exploiting the insulin-to-carbohydrate ratio, where each point of the time-
series is observed. Almost the same group of one-class classifiers and unsupervised models 
were tested and evaluated. Therefore, the contribution is the alternative personalized health 
model.  
 
The entire work related to this contribution is presented and discussed in the second half of 
Chapter 6. 
 
Contribution 5 (C5) - Paper 5 related to Q5. Assessments of user concerns, expectations, 
and willingness towards sharing self-collected health-related data.  
This contribution is linked to the fifth research question (Q5) and aims to provide a list of user 
concerns, expectations, and willingness for long-term engagement and successful sharing of 
health-related data to the proposed EDMON system. An exploratory sequential method was 
used, where we primarily designed a qualitative interview guide incorporating five separate 
themes and performed data collection and analysis, and then used the findings from the 
qualitative study to further inform and rectify the design of the quantitative survey questioners 
and data collection. In this regard, initially, a qualitative exploration, i.e. face-to-face interview, 
was conducted based on a detailed concept and application scenarios of the proposed EDMON 
system in general, and the patient unit, i.e. mHealth app, in particular. Then, the findings from 
the qualitative interviews were used as input to inform, rectify, and refine the quantitative 
survey questionnaires. The contribution is a list of user concerns, expectations, and willingness 
for long-term engagement and successful sharing of self-collected health-related data to the 
proposed EDMON system. These factors are essential and need to be taken into account during 
the design and implementation of the proposed EDMON system. 
 
The entire work related to this contribution is presented and discussed in Chapter 7. 
 Main Conclusion  
To effectively answer the main research problem, it is necessary to briefly address the different 
sub-questions as they were derived to address part of the main research problem.  
Question 1 (Q1). How is a personalized health model-based digital infectious disease 
detection system that collects self-recorded data from participants, analyses the data, detect 
deviations on an individual basis, identify a cluster of individual, and notify the status of an 
outbreak to be designed and implemented? 
To answer this in a commendable way, it was quite necessary to identify and address different 
sub-components of the proposed EDMON system and realize a framework that depicts the 
relationship and task requirements of the components. In this regard, the realized framework 
contains different units performing a series of tasks; patient unit, data repository (database) unit, 
infection detection unit, clustering unit, information visualization unit, and a wireless 
communication platform. The patient unit is a standalone smartphone app (mHealth app) that 
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integrates and stores different sensor readings, which could be through either manual or 
automatic recordings. The individual’s data-structure should at least contain information on 
blood glucose levels, insulin and carbohydrate registration, geographical location, and time of 
registration. Currently, most diabetes technologies enable Bluetooth connections to foster the 
integration of sensor readings. The data stored in the mobile app needs to be transmitted to a 
database server, where it is stored for further processing. However, given the sensitivity of 
health data, high emphasis needs to be given to data security, privacy, and confidentiality. In 
this regard, the transmission and storage of data in a server need to strictly follow major 
international guidelines, e.g. HIPPA compliance. The infection detection unit should have 
access to the individual’s records from the database and execute the personalized health model, 
which is trained on the individual’s historical data, to look for any abnormal deviations 
promptly. At any given time, the output from the personalized health model is the individual’s 
health status coded as normal (0), suspicious (-1), and infected (1). The clustering unit should 
accept the timely health status from each individual participant along with their respective 
geographical location and time of data registration to perform a Spatio-temporal analysis to 
detect a group of infected individuals under a region of surveillance. The status of the region or 
city under surveillance can be visualized based on either a standalone smartphone app (mHealth 
app) or a web-based or both. The information can be useful for the patient himself/herself, 
relatives, societies, healthcare, and public health officials.  
 
Question 2 (Q2). What is the effect of infection incidence on key parameters of blood glucose 
dynamics among people with type 1 diabetes, and which parameters can effectively be used 
for detecting infection incidences in people with type 1 diabetes? 
To answer this question, background work was conducted assessing previous similar works and 
existing knowledge about the effect of infection onset amongst people with type 1 diabetes. In 
this regard, particular emphasis was given to empirical studies that numerically assess the 
nature, and degree of infection triggered deviations on different parameters of the individual’s 
blood glucose dynamics as compared to the regular period. A knowledge gap was identified 
and empirical data analysis was conducted using data containing real infection episodes [253; 
259]. The empirical analysis demonstrated that compared to the regular period, infection onset 
triggers significant deviations from the typical norm of blood glucose dynamics. Per the 
findings, during the entire course of infection, blood glucose levels remain elevated regardless 
of higher insulin injections and consumption of lesser carbohydrates. This event marks the onset 
of infection in people with type 1 diabetes. During the regular period, blood glucose usually 
drops to the hypoglycemia region with higher insulin injections and lesser carbohydrate 
consumption. Hence, the individual diabetes profiles including blood glucose level, insulin 
injection, carbohydrate ingestion, and insulin-to-carbohydrate ratio are significantly affected 
by infection episode and can be successfully be used for developing a personalized infection 
detection model. Among these parameters, blood glucose level and the ratio of insulin-to-




Question 3 (Q3). What is the status regarding an infection detection system using self-
recorded data from people with type 1 diabetes and to what extent do the existing personalized 
decision support systems, and blood glucose alarm events applications consider infection 
incidence and its effect while developing blood glucose anomalies detection algorithms? 
As a roadmap to the realization of a personalized health model for detecting infection onset, it 
was necessary to perform a review that assesses the existence of any previously developed and 
implemented infection detection system exploiting self-recorded data from people with type 1 
diabetes, and also other existing systems such as personalized decision support system and 
blood glucose alarm event applications. The point here was to look after similar systems and 
also to evaluate how and to what extent do the existing blood glucose anomaly detection 
algorithm uses information related to infection. In this regard, there are few attempts to realize 
an infection detection system, see chapter two. However, it turns out that there doesn’t exist 
any developed and implemented infection detection system and almost all the studies don’t 
consider information related to infection episode as a parameter while developing anomalies 
detection and prediction model [253]. For instance, an anomalies detection algorithm designed 
to detect hyperglycemia episodes (high blood glucose levels) in people with type 1 diabetes 
consider only detecting the presence or absence of hyperglycemia and ignores the underlying 
cause, which in some cases might be infection onset.   
  
Question 4 (Q4). How to design and develop a personalized health model that can 
continuously monitor individual health status and automatically detect infection onset using 
self-recorded data from people with type 1 diabetes? 
To answer this question, it was necessary to look for a model that can continuously monitor the 
individual’s health status and automatically detect infection onset in this patient group while 
reducing false alarms. This can be achieved via either a blood glucose prediction approach or 
an anomaly detection approach, see chapter four. However, the choice is quite dependent on 
the state-of-the-art performance of these approaches under free-living conditions. In this regard, 
given the state-of-the-art performance of blood glucose prediction models, which rapidly 
degrades after 30 min prediction horizon, it is natural to look for other possible approaches that 
can operate in hourly and daily timeframes (data granularity). The optimal approach, in this 
case, will be to rely on semi-supervised (one-class classifiers) and unsupervised anomaly 
detection strategies. One-class classifier requires to learn the domain knowledge (reference 
description) that accurately describes what is normal to detect deviations from normality. 
However, the unsupervised approach doesn’t require training and detect deviation from 






Question 5 (Q5). What are the user concerns and expectations towards sharing self-collected 
health-related data with the proposed system? and what type of data are they willing to 
anonymously share?  
To answer this in a commendable way, it was necessary to perform either a qualitative interview 
or quantitative survey, or both to identify a list of factors based on either a prototype system or 
a detailed concept and application scenarios of the proposed EDMON system. In this regard, 
an exploratory sequential method was used, where findings from a qualitative face-to-face 
interview were used to further inform, rectify, and refine the quantitative survey questionaries. 
Per the findings, factors such as automatic data collection, easier interface, e.g. voice command, 
tailored and personalized feedback were reported to enhance usage time and long-term 
engagement. People with diabetes are found to be willing to anonymously share most of the 
parameters including medication intake and treatments, physiological indicators, lifestyle and 
dietary intake, physical activity data, sleep duration, and weight. However, they are reserved 
for certain parameters such as geographical location (GPS), and signs of infection. In return to 
data sharing, people with diabetes expects tailored and personalized data analysis, integrated 
view, feedback, and others. There are various concerns people with diabetes have in relation to 
data sharing including transparency, confidence related to data security and confidentiality 
(trust), ownership related to who owns the data, and storage related to where the data is stored. 
 Main Research Problem – MP 
MP: What is the effect of infection incidence on key parameters of blood glucose dynamics 
amongst people with type 1 diabetes, and how can self-recorded data from this patient group 
assist in detecting an infectious disease outbreak? 
Blood glucose dynamics are affected by numerous factors and infection onset is one of them. 
This dissertation has shown that infection onset amongst people with type 1 diabetes triggers a 
substantial shift in the operating point of the blood glucose dynamics, which results in 
prolonged hyperglycemia regardless of higher insulin injection and fewer carbohydrate 
consumptions, which contradicts the typical norm of blood glucose dynamics. It is important 
to note that these circumstances during the regular day usually result in severe hypoglycemia. 
Generally, per the findings, infection episode triggers substantial deviations on the key 
parameters of blood glucose dynamics; and blood glucose level, amount of insulin injection, 
amount of carbohydrate consumption, and the ratio of insulin-to-carbohydrate and can be 
regarded as optimal parameters for infection detections. In this regard, the results demonstrated 
the potential of the individual’s diabetes profile containing these self-recorded data for realizing 
a personalized health model for continuous monitoring of an individual’s health status, and 
automatic detection of infection onset in free-living conditions; thereby using such information 
for detecting infectious disease outbreaks by identifying a cluster of infected individuals based 
on time and geographical locations. In regard to the personalized health model, the experimental 
results demonstrated the potential of the models designed with bivariate input (blood glucose 
levels and insulin-to-carbohydrate ratio), and univariate input (insulin-to-carbohydrate ratio). 
The proposed personalized health model with a one-class classifier and unsupervised methods 
have shown significant detection capability.    
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The results presented have practical significance for understanding the effect of infection 
episodes amongst people with type 1 diabetes, and the nature of infection triggered deviations 
incurred on blood glucose dynamics. Given the criticality of detection time in infectious disease 
surveillance, recent efforts have been focused on analyzing different data sources, which are 
mainly aggregated data at population levels. In this regard, little to no efforts have been made 
to realize individualized surveillance based on a personalized health model exploiting self-
recorded data. In this regard, the result presented in this dissertation has practical significance 
for understanding the potential of personalized health model in outbreak detection settings. 
Actually, the advantage behind the personalized health model concept introduced in this 
dissertation lies in its usefulness beyond the surveillance purpose. In this regard, the presented 
personalized health model can also be used for other purposes such as to devise decision support 
tools and learning platforms for the patient to properly manage infection-induced crises. 
Generally, developing a personalized health model-based digital infectious disease detection 
system like EDMON, which aims for early detection, i.e. during the incubation period, requires 
considering various aspects, and the results presented in this dissertation construct evidence 
that supports the efforts towards building the next generation personalized health model-based-
digital infectious disease surveillance systems and provoke further thoughts in this challenging 
field.  
 Future Works 
This dissertation produced several topics that need to be realized in long term for the proposed 
EDMON system, along with other important additional topics to be considered for further 
improvement.  
Prototype development: This dissertation has presented and discussed the required framework 
along with user concerns, expectations, and willingness for data sharing, and the necessary 
personalized health model to realize the prototype system. During the Ph.D. period, an initial 
prototype for the backend server, and mHealth app has been developed [58]. These components 
need further improvements and currently, the integration of different sensors into the mHealth 
app is underway. Therefore, the effort to realize the prototype system is still ongoing. During 
the entire system design and development, it is necessary to involve all the stakeholders.    
Effect of different pathogens: This dissertation has presented findings from a real incidence of 
influenza and common cold without fever and demonstrated its effect on key parameters of 
blood glucose dynamics. However, a large scale study is required to further validate the findings 
with a large number of participants. Moreover, it is necessary to perform analysis and identify 
the effect of other different pathogens on blood glucose dynamics.  
Blood glucose prediction model: This dissertation has developed the infection detection unit 
with an anomaly detection method and demonstrated its applicability to the task. The choice 
was made based on the state-of-the-art performance of these two methods. However, it is 
necessary to test the prediction based method and compare the performance with the anomaly 
detection method presented. 
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Physical activity data: The models and empirical analysis presented in this dissertation exploits 
the three key parameters of blood glucose dynamics: blood glucose levels, insulin, 
carbohydrate, and insulin-to-carbohydrate ratio, and the findings demonstrated the potential of 
these parameters. However, it is necessary to investigate the added benefit of utilizing physical 
activity or exercise sessions data.  
Disease Characterization: After detection of an infectious disease outbreak comes disease 
characterization, which is an integral part of outbreak reporting. Disease characterization is a 
process by which the type of causative agent or pathogens is determined [237]. In the existing 
disease surveillance systems, characterization is often carried out mainly by investigating the 
pathogen's mode of transmission, epidemics curve (incubation period), and its symptoms 
manifestations [1; 59; 237]. However, in the context of people with type 1 diabetes, it might be 
possible to characterize the pathogens through the individual's self-recorded data. In this regard, 
there are studies that report the associations between the degree of infection-triggered 
deviations on blood glucose dynamics and the type of pathogens involved, and hence, 
thoroughly analyzing large-scale datasets incorporating a different type of infections or 
pathogens could characterize them via quantifying the deviations each pathogen induces on 
blood glucose dynamics. 
Detection time: Early detection is a crucial characteristic of any infectious disease surveillance 
system. In this regard, a surveillance system capable of detecting infectious disease outbreaks 
during the incubation period is highly sought. To this end, there is evidence suggesting that 
people with type 1 diabetes sometimes experience elevated blood glucose levels before 
symptom onset. Therefore, it might be possible to detect infection onset in this patient group 
before the individual experiences symptoms. In this regard, it is necessary to investigate and 
analyze CGM features within the context of other parameters of blood glucose dynamics, and 
along with different physiological parameters such as heart rate, body temperature, and other 
vital signs. 
Harnessing data from wearables: The ubiquitous nature of smartphones and wearables 
equipped with a variety of physiological sensors have presented a huge potential and unbounded 
possibility to realize a personalized health model-based digital infectious disease detection 
system [181; 194]. A huge amount of data is being generated each day that can be geared toward 
detecting infectious disease outbreaks. As demonstrated in this dissertation, apart from its use 
in detecting infectious disease outbreaks, this type of early warning system can also address the 
need of having real-time health status information for different groups in the population, 
including chronic patients, aging populations, people using ambient assisted living, and healthy 
individuals. In literature, there is evidence suggesting the predictive potential of different 
physiological parameters in response to infection onset including heart rate, sleep quality, body 
temperature, and other similar variables [181]. Therefore, it might be possible to realize a 
personalized health model after performing a large scale study to further assess the predictive 
potential of these and other similar physiological parameters. The advantage of this approach 
lies in the fact that it can incorporate almost every individual in the population that uses 
wearable devices for their own purposes. From a surveillance perspective, having a large 
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population under surveillance is an advantage to produce statistically significant outbreak 
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10     Appendix A - Score plot of the models using the 
univariate input feature: Ratio of Insulin to 
Carbohydrate 
The following appendix presents the performance score of the different models evaluated in the 
dissertation using univariate input – insulin-to-carbohydrate ratio. Both the one-class classifiers 
and unsupervised models were tested. For the one-class classifier models, a random block of a 
4-month sample size from each patient-year was used to train the models and evaluated with 
the whole patient-year – containing both the regular and infection days. Unsupervised models 
were tested with the whole patient-year. The smoothed version of the dataset is used and the 
models were tested with both the hourly and daily datasets.  The score plot of the models is 
given below, and, as can be seen from the figures, each model generated different scores and 
rejected varying portions of the infection episodes.   
10.1. One-class classifier Method 
10.1.1. Daily   
10.1.1.1. The First Infection Episode (Flu) 
 




Figure 2: Density-based method. 
 










10.1.1.2. The Second Infection Episode (Flu) 
 






Figure 6: Reconstruction-based method. 
 
10.1.1.3. The Third Infection Episode (Flu) 
 
























10.1.1.4. The Fourth Infection Episode (Flu) 
 
Figure 10: Boundary and domain-based. 
 
 




Figure 12: Reconstruction-based method. 
 
10.1.2. Hourly  
10.1.2.1. The First Infection Episode (Flu) 
 





Figure 14: Density-based method. 
 
 



















10.1.2.2. The Second Infection Episode (Flu) 
 
Figure 16: Boundary and domain-based. 
 
 




Figure 18: Reconstruction-based method. 
 
10.1.2.3. The Third Infection Episode (Flu) 
 





Figure 20: Density-based method. 
 
 











10.1.2.4. The Fourth Infection Episode (Flu) 
 
Figure 22: Boundary and domain-based method. 
 
 






Figure 24: Reconstruction-based method. 
 
10.2. Unsupervised method 
10.2.1. Daily  
10.2.1.1. The First Infection Episode (Flu) 
 







10.2.1.2. The Second Infection Episode (Flu) 
 
Figure 26: LOF and COF (k = 30 data points). 
 
10.2.1.3. The Third Infection Episode (Flu) 
 







10.2.1.4. The Fourth Infection Episode (Flu) 
 
Figure 28: LOF and COF (k = 30 data points). 
 
10.2.2. Hourly  
10.2.2.1. The First Infection Episode (Flu) 
 






10.2.2.2. The Second Infection Episode (Flu) 
 
Figure 30: LOF and COF(k = 240 data points). 
 9.2.2.3. The Third Infection Episode (Flu) 
 














10.2.2.4.  The Fourth Infection Episode (Flu) 
 












11    Appendix B – Models performance using the 
univariate input feature: Ratio of Insulin-to- 
Carbohydrate 
This appendix presents the evaluation of the models in each patient-year. The performance is 
depicted in terms of the area under the ROC curve (AUC), specificity, and F1-score. The table 
depicts the performance of each model in regard to different evaluation criteria; 1) model 
performance across each infection episode and thereby depicting performance variations among 
individuals, 2) sample sizes depicts model performance with limited data sample sizes, 3)  data 
granularity, i.e. daily and hourly, depicts the model's performance in response to variations in 
detail within the data, 4) data nature, i.e. raw and smoothed data (moving average window size 
= 2 days or 48 hrs), depicts the model performance improvement gained by removing short 
term and fast scale features from the data.  
11.1. One-class classifier Method  
11.1.1. Daily  
11.1.1.1. The 1st Infection Episode (Flu) 
Table 1: Univariate Input Raw Data (different sample sizes) - Average and standard deviation 







Table 2: Univariate Input Smoothed Data (different sample sizes) - Average and standard 
deviation (F1-score, AUC, specificity).  
 
 
11.1.1.2. The 2nd Infection Episode (Flu) 
Table 3: Univariate Input Raw Data (different sample sizes) - Average and standard deviation 






Table 4: Univariate Input Smoothed Data (different sample sizes) - Average and standard 
deviation (F1-score, AUC, specificity). 
 
 
11.1.1.3. The 3rd Infection Episode (Flu) 
Table 5: Univariate Input Raw Data (different sample sizes) - Average and standard deviation 






Table 6: Univariate Input Smoothed Data (different sample sizes) - Average and standard 
deviation (F1-score, AUC, specificity). 
 
 
11.1.1.4. The 4th Infection Episode (Flu) 
Table 7: Univariate Input Raw Data (different sample sizes) - Average and standard deviation 





Table 8: Univariate Input Smoothed Data (different sample sizes) - Average and standard 
deviation (F1-score, AUC, specificity). 
 
 
11.1.2. Hourly  
11.1.2.1. The 1st Infection Episode (Flu) 
Table 9: Univariate Input Smoothed Data (different sample sizes) - Average and standard 





11.1.2.2. The 2nd Infection Episode (Flu) 
Table 10: Univariate Input Smoothed Data (different sample sizes) - Average and standard 
deviation (F1-score, AUC, specificity). 
 
 
11.1.2.3. The 3rd Infection Episode (Flu) 
Table 11: Univariate Input Smoothed Data (different sample sizes) - Average and standard 




11.1.2.4.The 4th Infection Episode (Flu) 
Table 12: Univariate Input Smoothed Data (different sample sizes) - Average and standard 
deviation (F1-score, AUC, specificity). 
 
11.2.  Unsupervised Method 
Table 13: Univariate Input Raw and Smoothed Data for both the daily and hourly data 
granularity - Average and standard deviation (F1-score, AUC, specificity). The parameters kd 
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Background: Type 1 diabetes is a chronic condition of blood glucose metabolic disorder caused by a lack of insulin secretion
from pancreas cells. In people with type 1 diabetes, hyperglycemia often occurs upon infection incidences. Despite the fact that
patients increasingly gather data about themselves, there are no solid findings that uncover the effect of infection incidences on
key parameters of blood glucose dynamics to support the effort toward developing a digital infectious disease detection system.
Objective: The study aims to retrospectively analyze the effect of infection incidence and pinpoint optimal parameters that can
effectively be used as input variables for developing an infection detection algorithm and to provide a general framework regarding
how a digital infectious disease detection system can be designed and developed using self-recorded data from people with type
1 diabetes as a secondary source of information.
Methods: We retrospectively analyzed high precision self-recorded data of 10 patient-years captured within the longitudinal
records of three people with type 1 diabetes. Obtaining such a rich and large data set from a large number of participants is
extremely expensive and difficult to acquire, if not impossible. The data set incorporates blood glucose, insulin, carbohydrate,
and self-reported events of infections. We investigated the temporal evolution and probability distribution of the key blood glucose
parameters within a specified timeframe (weekly, daily, and hourly).
Results: Our analysis demonstrated that upon infection incidence, there is a dramatic shift in the operating point of the individual
blood glucose dynamics in all the timeframes (weekly, daily, and hourly), which clearly violates the usual norm of blood glucose
dynamics. During regular or normal situations, higher insulin and reduced carbohydrate intake usually results in lower blood
glucose levels. However, in all infection cases as opposed to the regular or normal days, blood glucose levels were elevated for
a prolonged period despite higher insulin and reduced carbohydrates intake. For instance, compared with the preinfection and
postinfection weeks, on average, blood glucose levels were elevated by 6.1% and 16%, insulin (bolus) was increased by 42%
and 39.3%, and carbohydrate consumption was reduced by 19% and 28.1%, respectively.
Conclusions: We presented the effect of infection incidence on key parameters of blood glucose dynamics along with the
necessary framework to exploit the information for realizing a digital infectious disease detection system. The results demonstrated
that compared with regular or normal days, infection incidence substantially alters the norm of blood glucose dynamics, which
are quite significant changes that could possibly be detected through personalized modeling, for example, prediction models and
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anomaly detection algorithms. Generally, we foresee that these findings can benefit the efforts toward building next generation
digital infectious disease detection systems and provoke further thoughts in this challenging field.
(J Med Internet Res 2020;22(8):e18911) doi: 10.2196/18911
KEYWORDS
type 1 diabetes; self-recorded health data; infection incidence; decision making; infectious disease outbreaks; public health
surveillance
Introduction
The incidence of infectious disease outbreaks can create panic
in society and is a threat to local and global health security.
Such outbreaks require immediate detection and appropriate
response during the initial phase of the incidence to reduce
fatality and save lives [1]. The timeliness of outbreak detection
defines the success of the appropriate response by the concerned
bodies. The state-of-the-art syndromic surveillance systems
have been improved compared with the traditional surveillance
system, which is generally passive and dependent on laboratory
confirmation [2]. Syndromic surveillance makes use of features
that come before diagnosis, including different activities
triggered by the onset of symptoms, such as Google search,
Twitter, school and work absenteeism, pharmacy drug sells,
and other sources as a signal of change in individual and
population health [2]. These signals are mainly acquired from
the secondary source of information, typically built for other
purposes. However, to keep up the pace with the rapidly
changing social and biological dynamics, novel outbreak
detection mechanisms are highly sought [2].
The advancement and omnipresence of smartphones, Internet
of Things (IoT) devices, wearables, and sensors have enabled
individuals to easily self-record health-related events often for
self-tracking or self-managing their disease [3,4]. The recent
movement known as quantified self and lifelogging is the result
of such technological advancement, where people collect various
kinds of health-related events and data for personal informatics
purposes, that is, self-surveillance and self-management [5-8].
To this end, people with diabetes are not an exception, where
they self-record detailed information as part of their
self-management, including blood glucose levels, diet and
insulin intake, physical activity, medication, and other
information [4,9,10]. Consequently, a huge amount of
self-recorded, personal health-related data is generated each
day that have great potential to be used as a secondary source
of information for other purposes such as digital epidemiology
[11,12]. According to recent reports, personal health data or
self-collected health-related data have provided an enormous
opportunity to enhance the possibility of detecting infection
incidence during the presymptomatic stage (improved sensitivity
and timeliness), specifically during the incubation period, where
most of the existing systems neglect from their process [13].
Type 1 diabetes is a chronic condition of blood glucose
metabolic disorder caused by lack of insulin secretion from
pancreas cells [14]. These patient groups are recommended to
maintain their blood glucose levels within a specified range
through self-management practice [14,15]. Blood glucose levels
are controlled by balancing insulin and meal intake along with
other contexts such as physical activity, medications, and others.
Blood glucose dynamics are affected by various factors that can
be categorized as common, individual, and unpredictable factors
[16]. These factors could be further categorized as
patient-controllable and patient-uncontrollable parameters [17].
Patient-controllable parameters incorporate factors on which
the patient has direct control and can roughly understand their
immediate effect on blood glucose dynamics. However,
patient-uncontrollable parameters include factors in which the
patient does not have direct control and faces a challenge to
understand their immediate effect on blood glucose levels. From
the patient perspective, usually patient-controllable parameters
induce reasonable deviations on blood glucose levels; however,
patient-uncontrollable parameters induce unreasonable blood
glucose deviations and usually differ from the usual norm of
blood glucose dynamics [18]. The total number of people living
with diabetes is increasing worldwide. According to recent
reports [14], there were 415 million people between the ages
of 20 and 79 years in 2015, and this value is projected to
increase by 54% in 2040. From this figure, 5% are believed to
have type 1 diabetes. In these patient groups, infection incidence
often results in complications and difficulties in controlling
blood glucose levels within the recommended range [19-21].
As a result, early detection of infection incidence among these
patient groups could provide a way to assist the individual and
at the same time can be used to realize a digital infectious
disease detection system.
Currently, with the advancement of technology, the need to
have a system that is able to detect infection incidence at the
presymptomatic stage is highly sought [13]. In this regard, there
are some previous investigations that have showcased the use
of self-recorded data from people with diabetes as surveillance
events (indicators) by uncovering the effect of infection
incidence on blood glucose levels and glycemic control in
real-life settings [18,22-36]. These studies reported the presence
of prolonged hyperglycemia episodes as a result of infection
incidence, thereby revealing the potential of self-recorded data
as a secondary source of information for realizing a digital
infectious disease detection system. For instance, Botsis et al
[22] conducted a proof-of-concept study based on daily glycemic
control data of 248 people with type 2 diabetes and concluded
that blood glucose levels, insulin dosage, diet (carbohydrate
consumption), physical activity, and other physiological
parameters could be used as potential event indicators of
infection incidence but calls for further investigations.
Furthermore, Botsis et al [18] also reported elevated glycated
hemoglobin (HbA1c) levels after infections regardless of tight
blood glucose control, which only settled down to normal levels
after the patient recovered. Moreover, other studies conducted
in hospital settings also reported similar results in this direction
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[37,38]. Despite reporting the potential of using self-recorded
data as a surveillance event indicator, none of these studies
demonstrated the extent to which each parameter is affected at
an individual level as a result of infection incidence. Therefore,
the purpose of this study was to retrospectively analyze the
effect of infection incidence at an individual level and pinpoint
optimal parameters that can effectively be used as input variables
for developing an infection detection algorithm, thereby
illustrating how these patient groups can assist in detecting
infectious disease outbreaks. Moreover, this study provides a
general framework regarding how a digital infectious disease
detection system can be designed using self-recorded data from
people with type 1 diabetes as a secondary source of
information. Furthermore, this sheds light on the possibility of
assisting the individual during such an incident. To this end,
we analyzed temporal trends and probability distributions of
different diabetes profile parameters (ie, blood glucose, insulin,
carbohydrate, and others) to uncover the effect of infection
incidence on the blood glucose dynamics, thereby identifying
parameters that can effectively be used as potential events
(indicators) of infection incidence. In addition, a framework is
presented depicting the necessary structure to properly exploit
self-recorded data from these patient groups to realize a real-time
digital infectious disease detection system. This paper is
structured as follows: the Methods section describes the
materials and methods used to analyze the data sets. The Results
section presents the results depicting the effect of acute infection
incidence in comparison with regular or normal situations. The
Discussion section presents the overall findings and proposes
a framework for designing and developing a real-time digital
infectious disease detection system using self-recorded data
from these patient groups. The final section of Discussion
presents our concluding remarks.
Methods
Materials
High precision self-recorded data of 10 patient years collected
from 3 real subjects (2 males and 1 female) with type 1 diabetes
were used. The patients were free from any other chronic or
other form of disease, except the self-reported acute infection
incidence throughout the entire data collection period. The data
sets consisted of blood glucose measurements (self-monitoring
of blood glucose [SMBG] and continuous glucose monitoring
[CGM]), injected insulin (basal and bolus), diet (carbohydrate
in grams), and self-reported events of acute infection. The
patients used different diabetes self-management technologies
throughout the data collection period to gather these data sets
including the Diabetes Diary app (Norwegian Centre for
E-health Research) [39], the Spike app [40], the xDrip with app,
Dexcom CGM, insulin pens, and insulin pumps, as shown in
Table 1. The data sets consist of both normal years, without any
significant acute infection incidence, and years with at least one
or more acute infection incidence. The normal (without
infection) patient years were used as a baseline to compare the
effect of all patient-controllable parameters and
patient-uncontrollable parameters against the self-reported
incidence of acute infection. The self-reported incidences of
acute infections were a case of influenza (flu) and mild and light
common cold without fever. All the experiments and analyses
were conducted using MATLAB version 2018a (Mathworks).
Table 1. Equipment used in diabetes self-management.
Self-managementPatients
DietInsulin administrationBGa
Carbohydrate in grams recorded in
the Diabetes Diary mobile app
Insulin pen (multiple bolus and one-time basal in the
morning) recorded in the Diabetes Diary mobile app
SMBGb—finger pricks recorded in the
Diabetes Diary mobile app and Dexcom
CGMc
Subject 1
Carbohydrate in grams recorded in
the Spike mobile app
Insulin pen (multiple bolus [Humalog] and one-time
basal [Toujeo] before bed) recorded in the Spike
mobile app
SMBG—finger pricks recorded in the
Spike mobile app and Dexcom G4 CGM
Subject 2
Carbohydrate in grams recorded in
pump information
Medtronic MinMed G640 insulin pump (basal rates
profile [Fiasp] and multiple bolus [Fiasp])




bSMBG: self-monitoring of blood glucose.
cCGM: continuous glucose monitoring.
Patient Characteristics
The participants were highly motivated individuals with type
1 diabetes who had advanced knowledge and understanding of
several diabetes-related technologies. Hence, the self-recorded
data can be regarded as highly precise and accurate. All the
participants had advanced knowledge of carbohydrate counting,
which can be considered as level 3 (advanced) [41]. The
long-term average HbA1c and characteristics of the participants
are given in Table 2.
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Level 3 (advanced)Carbohydrate counting
aHbA1c: glycated hemoglobin.
Data Collection and Ethics
The study protocol has been submitted to the Norwegian
Regional Committees for Medical Health Research Ethics
Northern Norway (REK) for evaluation and was found exempted
from regional ethics review because it resides outside of the
scope of medical research (reference number: 108435). Written
consent was obtained and the participants donated the data sets.
All data from the participants were anonymized.
Approaches
We retrospectively assessed and analyzed the diabetes profile
(blood glucose, insulin, carbohydrate, and
insulin-to-carbohydrate ratio) to uncover the nature, size, and
shape of the infection-induced shift in the operating region of
the blood glucose dynamics. A data size of 10 patient years
incorporating blood glucose levels (SMBG and CGM), insulin
(bolus and basal), diet (carbohydrate in grams), and self-reported
events of acute infection was used. The analysis was performed
based on specified timeframes (weekly, daily, and hourly) to
reveal the effect of acute infection development on blood
glucose dynamics. The data set incorporates 5 normal patient
years without any infection incidence and 5 patient years each
with at least one case of self-reported incidence of acute
infection. Normal patient years were used as a baseline for
comparison purposes. We analyzed the temporal evolution and
probability distribution of blood glucose levels, injected insulin,
carbohydrate intake (grams), and insulin-to-carbohydrate ratio
within the stated timeframe. For the daily and hourly timeframes,
a moving-average filter and nonparametric density estimation
techniques, the kernel density estimator, were used to analyze
the trend and data distribution before, during, and after the
infection incidence. A moving-average filter with a window
size of 2 days was employed to remove fast timescale features
through smoothing. The window size includes N−1 observations
from the previous data points and the current data point, where
N is the window size. Generally, the window size of a
moving-average filter is determined based on complementary
issues of better smoothing and the cost of significant delay
(shift) incurred [42,43]. A small window size often generates
less delay (shift) but at the cost of more short-term features and
having a larger window size will smoothen the data in a better
manner but at the cost of significant delay in the timeliness of
detecting the infection incidence. Therefore, the window size
was determined based on these complementary issues, and more
importance was given to minimize the inherent delay (shift)
incurred due to the window size. To this end, window sizes of
1, 2, 3, and 4 days were applied and tested to choose the optimal
size of the window, and as a result, a window size of 2 days
was found to be satisfactory. The preinfection, infection, and
postinfection week analyses were carried out on the raw data
set based on the week’s daily average and SD of blood glucose
levels and daily sum and SD of insulin and carbohydrate. A
statistical boxplot was used to depict the comparison during
preinfection, infection, and postinfection weeks.
Data Resampling, Imputation, and Preprocessing
The features of the self-collected data from individuals with
type 1 diabetes are shown in Table 3. The raw data were
resampled at a uniform rate by assigning each measurement
into the nearest time-bin based on its time stamp. Generally,
whenever there is more than one measurement within each
time-bin, the measurements are combined into a single
measurement by either summing or averaging the elements. For
blood glucose levels (both CGM and SMBG), the measurements
were averaged into their respective sampling time-bins.
However, regarding carbohydrate consumption and insulin
injections, the sum of the elements in their respective sampling
time-bin was computed, as shown in Table 4. In each time-bin,
the effect of total insulin and total carbohydrate on the average
blood glucose level was considered. The resampled data were
further preprocessed using a moving-average filter with a 2-day
(48-hour) window size to capture only the important
patterns—long-term variation, while filtering and smoothing
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local and short-term variations. Moreover, for narrower time-bin
resampling, for example, an hour, there are more frequent zeros
of measurement, especially for carbohydrate and insulin
measurements, which poses a significant challenge to compute
the insulin-to-carbohydrate ratio as the ratio goes to infinity
given that the carbohydrate amount is zero. Therefore, in such
cases of a narrower time-bin, the ratio was computed only after
computing the moving-average value of insulin and carbohydrate
based on a window size of 48 hours. Regarding the missing
blood glucose values during the hourly computations, a cubic
spline interpolation was used to estimate the missing values.
Table 3. Self-collected user data.
Subject’s record variablesVariable names
UnitsDescription
mg/dLContinuous glucose reading
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Table 4. Data preprocessing.
Preprocessed variablesVariable name
UnitsDescription
mg/dLAverage continuous glucose reading
mg/dLAverage self-management blood glucose reading
UnitsSum injected insulin (bolus)
UnitsSum injected insulin (basal)
GramsSum ingested carbohydrate
Units/gramsRatio of insulin (bolus) to carbohydrate
Units/gramsRatio of insulin (basal) to carbohydrate
Kernel Density Estimation
Nonparametric density estimation is an alternative to the
parametric approach, which involves specifying a model using
a number of parameters that can be estimated through the
likelihood principle [44,45]. In this study, we used kernel density
estimation techniques [46-48] to estimate the probability
distribution of the diabetes profile key parameters to uncover
the deviation incurred by the acute infection incidence. In this
regard, both univariate and bivariate kernel density estimators
are used to assess and analyze the insulin-to-carbohydrate ratio
(univariate) and blood glucose levels along with the
insulin-to-carbohydrate ratio (bivariate), respectively. An
adaptive kernel density estimator with a Gaussian kernel was
used in both cases. For the univariate kernel density estimator
[49], bandwidth selection is based on the suggestion from Botev
et al [44], which is a data-driven and plug-in bandwidth selector
that does not use normal reference rules. For the bivariate
estimator, a rule-of-thumb bandwidth selection suggested by
Bowman et al [50,51] was used to determine the appropriate
bandwidth [52]. These computations are carried out based on
the procedures given in Textboxes 1 and 2.
Textbox 1. One-dimensional adaptive kernel density estimation.
Approach: one-dimensional adaptive kernel density estimation
• Given: time series data sets of the insulin-to-carbohydrate ratio X ε D and an adaptive kernel density estimator M – one – dimensional
• Remove the reported days of infection from the time series data sets D and form a new data set X ε Q
• Compute the one dimensional density based on the kernel density estimator M using D and Q
• Compare the distribution from M
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Textbox 2. Two-dimensional adaptive kernel density estimation.
Approach: two-dimensional adaptive kernel density estimation
• Given: time series data sets of blood glucose level and the insulin-to-carbohydrate ratio X, Y ε D and an adaptive kernel density estimator N –
two - dimensional
• Remove the reported days of infection from the time series data sets D and form a new data set X, Y ε Q
• Compute the two-dimensional density based on the kernel density estimator N using D and Q
• Compare the distribution from N
Results
Overview
The analysis was conducted based on an hourly, daily, and
weekly basis to reveal the deviations incurred due to the
infection incidence. A total of 10 patient years were analyzed,
and 5 of these years were found to include at least one incidence
of acute infection lasting around 1-2 weeks. The proposed
approach is designed to smooth out short-duration variations
and include the 2 major patient-controllable factors, insulin and
diet intake. Normal patient years were used to compare the
effect of all patient-controllable parameters and
patient-uncontrollable parameters against the self-reported
incidence of acute infection. The trend analysis for both the
normal patient years and patient years with acute infections
using the proposed approach is presented below along with the
nonparametric probability distribution. The weekly mean
deviations of key diabetes parameters (blood glucose, insulin,
and diet) during the preinfection, infection, and postinfection
weeks are given in Multimedia Appendix 1.
Trend Analysis
Trend Comparison for Normal Patient Years
During normal years when patients do not have any significant
illness or infections (Multimedia Appendix 2), the
insulin-to-carbohydrate ratio follows a similar trend in all the
subjects, where the insulin-to-carbohydrate ratio lies between
0.05 and 0.2. An elaborate analytical plot of a typical patient
year without infection incidence showing the phenomena is
depicted in Figures 1 and 2. A detailed analytical plot of the 5
patient years depicting the same phenomena can be found in
Multimedia Appendix 2. The insulin-to-carbohydrate ratio
conveys interesting information about the usual operating point
of the patient, depicting the necessary amount of insulin (bolus)
required for every gram of carbohydrate consumed to maintain
the blood glucose levels within a healthy range (typically
recommended to be between 70 and 180 mg/dL). As can be
seen from the yearlong trend analysis of the regular or normal
patient years (Multimedia Appendix 2), despite the presence of
various factors that are known to disturb blood glucose
dynamics, both patient-controllable parameters and
patient-uncontrollable parameters except infection incidence,
the insulin-to-carbohydrate ratio remains to be relatively stable.
Figure 1. The first patient year, where there is no incidence of acute infections. The figure depicts the daily variation of average blood glucose levels,
total insulin (bolus), total carbohydrate, and total insulin-to-total carbohydrate ratio. The operating point of the patient’s insulin-to-carbohydrate ratio
through these regular or normal days is between 0.05-0.2.
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Figure 2. The first patient year, where there is no incidence of acute infections. The figure depicts variation of average blood glucose levels, total
insulin (bolus), total carbohydrate, and total insulin-to-carbohydrate ratio during each hours of the day. The operating point of the patient’s
insulin-to-carbohydrate ratio through these regular or normal hours is between 0.05-0.2.
Trend Comparison of Patient Years With Acute Infection
The trend analysis of the key diabetes parameters, blood glucose,
insulin, and carbohydrate, during acute infection suggests that
there is a dramatic shift in the evolution of blood glucose,
insulin, and carbohydrate (for detailed information, see
Multimedia Appendices 1 and 3). Infection incidence brought
about a dramatic increase in blood glucose levels, insulin intake,
and reduction in carbohydrate consumption. The detailed
analysis and the shift incurred on a weekly, daily, and hourly
basis are presented in the following section.
Weekly Analysis
The weekly analysis of the patient years was conducted by
analyzing the deviation incurred on the key parameters of the
blood glucose dynamics during the infection week in comparison
with before and after the infection incidence. The raw data were
used to estimate the deviations incurred due to infection
incidence. The mean and SD of blood glucose levels, total
insulin (bolus), and total carbohydrate were computed and used
for comparison of the infection-induced deviations. As shown
in Figures 3-5 and Table 5, in all the infection cases, the weekly
analysis demonstrated that blood glucose levels were elevated
despite higher insulin injection and reduced carbohydrate
consumption. In all of these cases, it is clear that the incidence
of infection has brought unreasonable deviation, with respect
to the patient-controllable parameters, in the operation of the
overall blood glucose dynamics as compared with the usual
norm of the blood glucose dynamics. The presence of elevated
blood glucose levels in the infection week, regardless of the
high amount of insulin injections and lower carbohydrate
consumption, clearly violated the norm of the blood glucose
dynamics, where during normal situations the blood glucose
levels are expected to drop with high insulin and reduced
carbohydrate consumption. The fact that the blood glucose
remains elevated during the infection incidence despite higher
insulin injections and low carbohydrate consumption is highly
associated with the infection phenomenon, which enhances the
production of glucose and increased insulin resistance within
the body to deliver more energy for the body to fight the
pathogens. A more detailed description of the weekly analysis
can be found in Multimedia Appendix 1.
J Med Internet Res 2020 | vol. 22 | iss. 8 | e18911 | p. 8https://www.jmir.org/2020/8/e18911
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 3. Analysis of blood glucose levels during the preinfection week, infection week, and postinfection week based on the first case of infection
(flu). The asterisk shows the mean value, and the red line depicts the median value for the week.
Figure 4. Analysis of total insulin (bolus) intake during preinfection week, infection week, and postinfection week based on the first case of infection
(flu). The asterisk shows the mean value, and the red line depicts the median value for the week.
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Figure 5. Analysis of total carbohydrate (grams) intake during preinfection week, infection week, and postinfection week based on the first case of
infection (flu). The asterisk shows the mean value, and the red line depicts the median value for the week.
Table 5. Mean and standard deviation of blood glucose levels, total insulin (bolus), and total carbohydrate during the preinfection week, infection
week, and postinfection week.
Postinfection week, mean (SD)Infection week, mean (SD)Preinfection week, mean (SD)Parameters
The first case of infection (flu)
119.16 (7.39)141.95 (14.37)130.74 (16.89)BGa (mg/dL)
21.32 (4.61)35.30 (6.11)23.39 (4.91)Total insulin (bolus)
241.18 (37.63)178.80 (65.69)241.11 (57.27)Carbohydrate (grams)
The second case of infection (flu)
126.17 (11.70)155.36 (21.99)143.01 (19.53)BG (mg/dL)
25.36 (6.93)41.07 (9.44)28.07 (8.85)Total insulin (bolus)
214.57 (34.66)161.14 (58.43)190.14 (43.93)Carbohydrate (grams)
The third case of infection (flu)
134.18 (11.96)144.12 (20.30)136.93 (18.58)BG (mg/dL)
22.83 (3.86)31.50 (10.84)20.08 (5.44)Total insulin (bolus)
195.83 (42.59)144.83 (37.63)178.0 (45.87)Carbohydrate (grams)
The fourth case of infection (flu)
138.57 (19.83)161.34 (19.88)157.74 (31.12)BG (mg/dL)
29.29 (5.22)32.14 (7.01)24.43 (5.26)Total insulin (bolus)
226.07 (18.23)167.04 (44.94)199.06 (53.45)Carbohydrate (grams)
The fifth case of infection (flu)
122.87 (14.49)139.88 (15.54)135.21 (14.58)BG (mg/dL)
33.36 (7.94)40.37 (8.31)32.80 (4.59)Insulin (bolus)
18.68 (1.56)20.42 (2.06)19.20 (1.21)Insulin (basal)
52.46 (8.47)61.21 (8.26)52.33 (5.14)Total insulin
aBG: blood glucose.
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In all these infection incidences, the individual blood glucose
levels remain elevated for a prolonged period of time despite
low carbohydrate consumption and increased insulin injections
as compared with the regular or normal days. Blood glucose
levels were elevated during the infection week as compared
with the preinfection and postinfection weeks.
• During the first case of infection, the overall mean
percentage increase in the infection week’s blood glucose
levels was 8.57% over the preinfection week and 19.12%
over the postinfection week, as shown in Table 5.
• During the second case of infection, the overall mean
percentage increase in the infection week’s blood glucose
levels was 8.63% over the preinfection week and 23.13%
over the postinfection week, as shown in Table 5.
• During the third case of infection, the overall mean
percentage increase in the infection week’s blood glucose
levels was 7.26% over the preinfection week and 7.41%
over the postinfection week, as shown in Table 5.
• During the fourth case of infection, the overall mean
percentage increase in the infection week’s blood glucose
levels was 2.28% over the preinfection week and 16.43%
over the postinfection week, as shown in Table 5.
• During the fifth case of infection, the overall mean
percentage increase in the infection week’s blood glucose
levels was 3.45% over the preinfection week and 13.84%
over the postinfection week, as shown in Table 5.
Insulin Intake
The comparison of infection week insulin injections with
preinfection and postinfection weeks revealed that there was a
dramatic increase in the amount of insulin intake during the
infection period.
• During the first case of infection, the overall mean
percentage increase in the infection week’s insulin (bolus)
injection was 50.93% over the preinfection week and
65.59% over the postinfection week, as shown in Table 5.
• During the second case of infection, the overall mean
percentage increase in the infection week’s insulin (bolus)
injection was 46.31% over the preinfection week and
61.94% over the postinfection week, as shown in Table 5.
• During the third case of infection, the overall mean
percentage increase in the infection week’s insulin (bolus)
injection was 56.87% over the preinfection week and
37.98% over the postinfection week, as shown in Table 5.
• During the fourth case of infection, the overall mean
percentage increase in the infection week’s insulin (bolus)
injection was 31.56% over the preinfection week and 9.7%
over the postinfection week, as shown in Table 5.
• During the fifth case of infection, the overall mean
percentage increase in the infection week’s insulin (bolus)
injection was 23.08% over the preinfection week and
21.01% over the postinfection week, as shown in Table 5.
Carbohydrate Consumption
Comparison of the amount of carbohydrate consumption during
the infection week with the preinfection and postinfection weeks
revealed that there was a significant reduction during the
infection period.
• During the first case of infection, the overall mean
percentage reduction in the infection week’s carbohydrate
consumption was 25.84% below the preinfection week and
25.87% below the postinfection week, as shown in Table
5.
• During the second case of infection, the overall mean
percentage reduction in the infection week’s carbohydrate
consumption was 15.25% below the preinfection week and
24.90% below the postinfection week, as shown in Table
5.
• During the third case of infection, the overall mean
percentage increase in the infection week’s carbohydrate
consumption was 18.63% below the preinfection week and
26.04% below the postinfection week, as shown in Table
5.
• During the fourth case of infection, the overall mean
percentage increase in the infection week’s carbohydrate
consumption was 16.09% below the preinfection week and
35.34% below the postinfection week, as shown in Table
5.
Insulin-to-Carbohydrate Ratio
The insulin-to-carbohydrate ratio defines the amount of insulin
a patient needs to take for every gram of carbohydrate
consumed. The value of the insulin-to-carbohydrate ratio usually
lies between 0.05 and 0.2 on normal occasions. However, it has
dramatically increased upon the incidence of infection.
• During the first case of infection, the overall mean
percentage increase in the infection week’s
insulin-to-carbohydrate ratio was around 125.84% above
the normal operating point of the patient, as shown in Table
5.
• During the second case of infection, the overall mean
percentage increase in the infection week’s
insulin-to-carbohydrate ratio was approximately 144.43%
above the normal operating point of the patient, as shown
in Table 5.
• During the first case of infection, the overall mean
percentage increase in the infection week’s
insulin-to-carbohydrate ratio was around 93.75% above the
normal operating point of the patient, as shown in Table 5.
• During the fourth case of infection, the overall mean
percentage increase in the infection week’s
insulin-to-carbohydrate ratio was approximately 70.84%
above the normal operating point of the patient, as shown
in Table 5.
Daily and Hourly Analysis
Hourly and daily analyses were conducted by analyzing the
deviations incurred on the key diabetes parameters, blood
glucose levels, insulin, carbohydrate, and the
insulin-to-carbohydrate ratio as a result of infection incidence
in contrast to the whole patient year. The comparison was carried
out based on the smoothed version of the data, that is, 2 days
window moving-average filter. Similar to the weekly analysis,
the infection-induced shift of the blood glucose dynamics, that
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is, higher glucose production and increased insulin resistance,
is clearly shown in both the daily and hourly analyses. As can
be seen in Figures 6-11, the insulin-to-carbohydrate ratio of the
patient has drastically shifted to a higher value to account for
the effect of increased glucose production and insulin resistance
(see Multimedia Appendix 3 for a detailed plot of the hourly
analysis in all the infection cases). In all of these cases, the
insulin-to-carbohydrate ratio increases from the usual values of
0.05 to 0.2 during the normal period to higher values reaching
0.6, depending on the degree of severity of the infection
incidence, type of pathogens involved, and the individual
immunity.
Figure 6. Daily analysis of the first infection case (flu). The figure depicts variation of average blood glucose levels, total insulin (bolus), total
carbohydrate, and total insulin-to-total carbohydrate ratio. The operating point of the patient’s insulin-to-carbohydrate ratio had dramatically shifted
and raised above the regular or normal days and reach a top around 0.5 upon midinfection week.
Figure 7. Hourly analysis of the first infection case (flu). The figure depicts variation of average blood glucose levels, total insulin (bolus), total
carbohydrate, and total insulin-to-total carbohydrate ratio. The operating point of the patient’s insulin-to-carbohydrate ratio had dramatically shifted
and raised above the regular or normal days and reach a top around 0.5 upon midinfection week.
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Figure 8. Daily analysis of the second infection case (flu). The figure depicts variation of average blood glucose levels, total insulin (bolus), total
carbohydrate, and total insulin-to-total carbohydrate ratio. The operating point of the patient’s insulin-to-carbohydrate ratio had dramatically shifted
and raised above the regular or normal days and reach a top around 0.45 upon midinfection week.
Figure 9. Daily analysis of the third infection case (flu). The figure depicts variation of average blood glucose levels, total insulin (bolus), total
carbohydrate, and total insulin-to-total carbohydrate ratio. The operating point of the patient’s insulin-to-carbohydrate ratio had dramatically shifted
and raised above the regular or normal days and topped around 0.4 upon midinfection week.
J Med Internet Res 2020 | vol. 22 | iss. 8 | e18911 | p. 13https://www.jmir.org/2020/8/e18911
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Figure 10. Daily analysis of the fourth infection case (mild common cold without fever, light common cold without fever, and flu). The figure depicts
variation of average blood glucose levels, total insulin (bolus), total carbohydrate, and total insulin-to-total carbohydrate ratio. The operating point of
the patient’s insulin-to-carbohydrate ratio had dramatically shifted and raised above the regular or normal days and reach a top around 0.28 upon
midinfection week. A light common cold without fever seems to not significantly affect the operating point.
Figure 11. Daily analysis of the fifth infection case (flu). The figure depicts variation of average blood glucose levels, total insulin including both bolus
and basal insulin, daily average rate of change of CGM and, absolute value of rate of change of CGM (computed based on CGM direction from the
pump information), percentage of basal and bolus per total insulin units. As can be seen, as a result of the ongoing infection incidence, there is clear
and dramatic rise in the amount of insulin, while blood glucose levels remain elevated.
Kernel Density Estimation–Probability Distribution
Kernel density was estimated to study and characterize the
nature, shape, and degree of severity of the deviations incurred
due to infection incidence by analyzing the probability
distribution of the individual key parameters of the blood
glucose dynamics. A univariate and bivariate kernel density
estimation based on the insulin-to-carbohydrate ratio and blood
glucose levels was carried out on the yearlong data, as shown
in Figures 12 and 13 (a detailed plot for all the infection cases,
both hourly and daily, can be found in Multimedia Appendix
1). As can be seen from the figures, the infection incidence has
brought a significant change in the probability distribution.
However, the nature, shape, and degree of outlierness depend
on the type of pathogen involved, severity of infection, and
individual immunity.
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Figure 12. Univariate kernel density estimation of a patient year using the daily insulin-to-carbohydrate ratio. As can be seen from the tail of the
distribution, during regular or normal days (the green shaded region), the yearly distribution of the patient’s insulin-to-carbohydrate ratio lies within
the values of 0.005 and 0.2. However, during infection incidence (the red shaded region), there is a clear deviation in the tail of the distribution, where
the values reaches around 0.58.
Figure 13. Bivariate kernel density estimation of a patient year using both the daily average blood glucose levels and insulin-to-carbohydrate ratio. As
can be seen from the bivariate distribution, during regular or normal days (the top light green figure), the distributions are concentrated around the high
density regions. However, during infection incidence (the lower figure), there is a clear bump far from the high density regions.
Discussion
Principal Findings
Presently, in relation to people’s mobility and travel, there is a
growing concern regarding an infectious disease outbreak. Such
an incident can be a menace to our global health security, which
calls for early detection and immediate response. Thus, there is
a growing need for new approaches and technologies to upgrade
the existing surveillance system for early detection of emerging
infectious diseases [1]. Existing disease surveillance systems
detect the incidence of outbreaks long after the incidence of the
first symptoms. Therefore, the purpose of this study was to
demonstrate how people with type 1 diabetes can assist in
outbreak detection and further to shed light upon the possibility
of assisting the individual during such an incident.
The advancement and omnipresence of smartphones, IoT
devices, wearables, and sensors have enabled individuals to
easily self-record health-related events often for self-tracking
or self-managing their disease [5,6,53]. People with diabetes
self-record detailed information including blood glucose levels,
diet and insulin intake, physical activity, medication, and other
parameters. The presence of such large self-recorded health data
presents an opportunity to be used as a secondary source of
information for other purposes such as digital epidemiology
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and decision support applications. According to recent reports,
the use of personal health information or self-collected data
could mitigate the possibility of detecting infection incidence
during the presymptomatic stage (improved sensitivity and
timeliness), specifically during the incubation period, of which
most of the current systems neglect from their process [13]. Our
findings demonstrated that upon infection incidence, there is a
dramatic shift in the operating point of the individual’s blood
glucose dynamics, which clearly violates the usual norm of
blood glucose dynamics. During regular or normal days, blood
glucose levels usually decrease when there is a significant
increase in insulin injection and reduction in carbohydrate
consumption. However, in all of the infection cases we analyzed,
compared with the preinfection and postinfection weeks, the
following were noticed:
• Blood glucose levels were elevated by an average of 6.1%
and 16% over the preinfection and postinfection weeks,
respectively.
• Insulin injection (bolus) increased by 42% and 39.3% over
preinfection and postinfection weeks, respectively.
• Carbohydrate consumption was reduced by 19% and 28.1%
compared with preinfection and postinfection weeks,
respectively.
• The insulin-to-carbohydrate ratio increased by 108.7% on
average in all cases.
In general, all of these findings confirm that during infection
incidence, blood glucose levels are elevated despite injecting
higher amounts of insulin and reduced carbohydrate
consumption. The identified changes are quite significant
anomalies compared with the regular or normal days and could
potentially be detected with a dedicated personalized
(individualized) computational health model. Various algorithms
that span from prediction models to anomaly detection
algorithms can be investigated to detect such infection-induced
changes in blood glucose dynamics. Apart from the potential
use of these findings in personalized digital infectious disease
detection systems, it could also be used for decision support in
self-management during infection and illness. As presented
earlier, during the course of infection, individuals with diabetes
usually struggle with severe hyperglycemia. Managing blood
glucose levels during infection incidence is not an easy task,
given the fact that it is caused by a mixed effect of both
patient-controllable and patient-uncontrollable parameters. The
patient can only estimate the disturbance caused by the amount
of carbohydrate consumption, insulin injection, and physical
activity load, which is not the case during infection incidence.
Apart from these known major factors, that is,
patient-controllable parameters, there is an underlying and
unknown disturbance caused by the patient’s uncontrollable
parameters, such as counterregulatory hormones (CRHs), as a
result of infection incidence. This unknown disturbance mainly
increases glucose production from the liver and reduces insulin
sensitivity. To this end, people with type 1 diabetes face a very
difficult challenge to estimate the necessary amount of insulin
for a given amount of carbohydrate consumption. In this regard,
providing real-time decision support could reduce the burden
during such a crisis. One possible approach could be
characterizing the effect of different pathogens on blood glucose
dynamics, mainly on insulin resistance and its sensitivity change
over the course of infection. However, a large set of
infection-related self-recorded data need to be analyzed for
investigating how each pathogen affects the key parameters of
blood glucose dynamics during the entire course of infection.
This requires collecting and analyzing infection-related data,
and estimating the overall changes each pathogen could bring
on insulin sensitivity during the course of infection. To this end,
the presented result reflects a promising result that can be geared
toward decision support during infection or illness. For example,
the change in insulin–to-carbohydrate ratio can be used to
provide general information related to each pathogen on what
to expect, such as the percentage of insulin resistance during
the first days, in the middle, and at the final days of the infection.
Infection-Induced Shift of Operating Point in Blood
Glucose Dynamics
During infection incidence, people with diabetes usually struggle
with severe hyperglycemia and critical hypoglycemia if not
properly managed. However, during regular or normal days,
the patient can manage the incidence of hyperglycemia, which
is mostly diet-induced, by properly controlling the
patient-controllable parameters, for example, amount of
carbohydrate consumption, insulin injection, and performing
balanced physical activity or exercise. Yet, during infection
incidence, it turns out to be very difficult to manage the
hyperglycemia incidence due to the fact that it is caused by a
mixed effect of both patient-controllable and
patient-uncontrollable parameters. The patient’s uncontrollable
parameters define the action of hormonal effects such as CRH
induced by either physiological stress or emotional stress. The
hormonal effect is two-sided, which is a higher glucose
production from the liver and inhibiting insulin production and
reducing sensitivity [54,55]. A detailed study conducted by
Waldhausl et al [56] demonstrated the significant effect of stress
hormones on the production of glucose and insulin resistance.
The study was conducted by infusing different stress hormones
to investigate the effect of exposure to these hormones on blood
glucose response [55]. The extent and degree of hyperglycemia
events and insulin resistance during infection incidence directly
correlate with the type of pathogen, the type of hormone
involved and the severity of the infection [37,38,55]. Generally,
the phenomenal effect of infection incidence on blood glucose
dynamics in people with diabetes can be simply described using
the following relationships:
Where φ is an insulin sensitivity factor, BG is the blood glucose
level, CH is the amount of carbohydrate consumption, IN is the
amount of insulin injection, PA is the amount of physical activity
session or exercise load, and CRH is the effect of CRHs. The
equation depicts the phenomena that occur during infection
incidence, where blood glucose levels are raised by the action
of both patient-controllable parameters (CH) and
patient-uncontrollable parameters (CRHs, such as cortisol and
adrenalin). Thus, consumption of any regular diet in an
individual can induce severe hyperglycemia due to the added
effect of glucose production from the liver as a result of the
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CRH effect [55]. For this reason, the patient is expected to
reduce the amount of carbohydrate intake to a certain extent to
optimally manage the hyperglycemia crises and at the same
time avoiding any critical hypoglycemia incidences (for more
information, see Multimedia Appendix 1). By the same token,
blood glucose levels can be lowered to euglycemia by the
patient-controllable parameters (insulin [IN] and physical
activity session or exercise load [PA]). However, due to the
change in insulin sensitivity, the action of insulin is reduced (φ
is affected by infection incidence), and the patient is expected
to deliver more insulin injections to counterbalance the effect
of insulin resistance [57]. According to our results, all these
scenarios are reflected in the individual’s blood glucose dynamic
infected with flu (influenza), where a dynamic shift occurred
from the usual operating point of the blood glucose dynamics.
There are elevated blood glucose levels, despite injecting a
higher amount of insulin and consuming less carbohydrate than
the regular or normal days. These characteristics are clearly
demonstrated on the shift incurred on the individual’s
insulin–to-carbohydrate ratio as compared with the regular or
normal days. Therefore, blood glucose, amount of injected
insulin, diet intake, and insulin-to-carbohydrate ratio and other
supporting physiological parameters such as body temperature
and blood pressure can be exploited to develop a personalized
health model for detecting infection incidence among people
with type 1 diabetes. Given the similarity, this result can also
be translated to other types of diabetes, such as people with type
2 diabetes. It is worth mentioning that apart from infection
incidence, other factors such as emotional stress could also
result in similar variable episodes of elevated blood glucose
levels [17]. This can obviously impact the detection performance
of the model. However, our results based on yearlong patients’
data demonstrated that the use of carbohydrate consumption,
insulin injections, and insulin-to-carbohydrate ratio along with
the blood glucose could solve this confounding nature.
Moreover, acute emotional stress, other than the chronic ones,
might have less influence on one’s meal appetite compared with
infection incidence to skew the insulin-to-carbohydrate ratio
[17].
Relevance of the Data
The informational values of the data, availability of the data,
and cost of the data are the 3 key metrics necessary to evaluate
the relevance of new surveillance data for a digital infectious
disease detection system [58]. The informational value of the
data assesses how informative the data are to facilitate the
detection or characterization of infectious disease outbreaks. In
this regard, the surveillance data must clearly indicate the
absence or presence of infections either on an individual or
population level or both in a timely manner. Furthermore, the
rate of false alarms derived from the data is an important factor
that dictates the acceptability of the surveillance data, which is
in turn governed by the signal-to-noise ratio defining the signal’s
strength depicting the infection period as compared to the regular
or normal period (baseline data) [58]. In this regard, our results
demonstrated that the infection-induced signal exhibits high
discriminative power from the baseline (normal or regular)
patterns. The availability of surveillance data is another crucial
indicator for screening potential types of data, which needs to
be addressed [58]. In this regard, given the widespread and
ubiquitous nature of mobile apps, and different sensors, people
with type 1 diabetes collect far more data than ever. For
example, many people with type 1 diabetes use continuous
glucose monitors and insulin pumps, which are predicted to
grow further in terms of both quality and quantity of data in the
coming years. The most crucial challenge in this direction
includes issues related to security, privacy, and confidentiality
of user data if there is a necessity to collect user data into a
central server than deploying the detection algorithm on the
user’s own mobile device. The cost of data delineates the
associated cost in relation to acquiring the data in question,
including the cost incurred for realizing the data collection
system [58]. In this regard, the individual’s self-recorded data
are solely collected for their own use and used as a secondary
source of information for disease surveillance purposes.
Providing tailored and valuable feedback to the individual
patient might further motivate them to participate on a large
scale (for further details, see the section Ethical and Motivational
Challenges).
Framework of a Personalized Digital Infectious Disease
Detection System
Epidemic intelligence encompasses activities directed toward
early detections, verification, and assessment of potential public
health threats to notify and recommend necessary measures for
the concerned bodies regarding the ongoing situation [56]. Early
detection systems such as Google Flu Trends and other existing
systems have certain limitations because they do not have the
mechanisms to identify or track individual cases through
diagnosis or screening based on a personalized health model.
This limitation has a major impact and certainly introduces bias
in disease outbreak prediction. Currently, a personalized health
model, which resembles the way clinicians and epidemiologists
classify an individual as normal, suspected, or confirmed case,
for screening and case detection doesn’t exist [58]. Having a
personalized health model can provide information for both
individual health-related decision support purposes and at the
same time can be used for tracking infectious disease outbreaks
among the public. The results of this study demonstrated that
commencement of infection in people with type 1 diabetes
significantly alters the individual blood glucose dynamics, and
such a change can potentially be detected through modeling of
the individual blood glucose dynamics. Moreover, incorporating
various physiological parameters, for example, heart rate and
body temperature, to a personalized health model will further
enable the capture of infection incidence as early as possible,
that is, incubation period. Therefore, the development of a
personalized health model–based digital infectious disease
detection system is vital for the success of next-generation public
health surveillance systems. The data sources and signal
exploited, outbreak detection algorithms employed, clustering
approaches, and visualization techniques used to play a central
role in any digital infectious disease detection systems by
determining its accuracy (sensitivity) and timeliness (lead time)
[56]. On the basis of the kind of data sources and signals
exploited, infectious disease surveillance systems can be
generally grouped into an indicator-based and event-based
system [56,59,60]. Event-based systems mainly rely on
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unstructured data collected through formal or informal sources
and is characterized by quick detection, reporting, and
assessments of public health events, including clusters of disease
[56,60]. On the other hand, indicator-based systems mainly use
structured data, which are collected following a standard case
definition and is characterized by routine reporting of disease
cases [56,60]. The proposed system [26,61], as shown in Figure
14, is categorized under event-based digital infectious disease
detection systems, where the events are grouped under
microevents and macroevents [56]. Under the umbrella of these
events and the proposed system in general, a framework of
several components such as infection detection algorithms (how
to develop an algorithm to detect infection incidence at the
individual level); clustering algorithms (how to group the
infected individuals to form a cluster); visualization techniques
(how to report and display the detected outbreak incidence) and
further ethical and motivation challenges are briefly discussed
below.
Figure 14. The Proposed System Architecture.
Microevent: Individual-Level Detection of Infection
Incidence
The detection of microevents as the name suggests is carried
out at an individual level by tracking the individual’s diabetes
profile including blood glucose levels, amount of insulin
injections, carbohydrate consumption, physical activity or
exercise sessions, and others. The presence of elevated blood
glucose levels despite injecting higher amounts of insulin and
consumption of less carbohydrates is regarded as a marker of
an event of infection incidence and hence can be defined as a
microevent for the event-based digital infectious disease
detection system. Detecting the incidence of these kinds of
deviation from the usual norm of blood glucose dynamics
requires a proper personalized health model, which can learn
from past history of the patient and judge whether the
information conforms with the usual trend. Hence, the proposed
personalized health model for detecting these types of
microevents incorporates 3 components: a data source,
personalized infection detection algorithm, and alarm
management module, as shown in Figure 15. As can be seen
from the figure, the personalized infection detection algorithm
can be modeled using either a prediction model–based approach
or a novelty or anomaly detection–based approach.
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Figure 15. The proposed personalized infection detection algorithms for detecting microevents (incidences of infections) in people with type 1 diabetes.
These approaches are alternative means of achieving the same objective, which is detecting infection incidences.
Data Sources and Input
The patient unit is a mobile health app, as shown in Figure 14,
which integrates data from different sensors and wearables that
record key diabetes parameters, such as blood glucose levels,
insulin dosage, diet, physical activity, and other optional
physiological parameters including body temperature, heart
rate, blood pressure, and others [26,61]. The app is also expected
to record the geographical location of the individual along with
the time of data registration. For example, one way of estimating
user location can be carried out based on global positioning
system (GPS) information from the mobile phone during data
registration [61]. The geographical location of the user can be
the geographical coordinates of longitude and latitude [62],
postal code address [63], or any local reference coordinates.
Personalized Infection Detection Algorithm
Detection of microevents can be carried out using individual
self-recorded historical data based on a personalized health
model, that is, either a prediction model [64,65] or novelty
detection algorithms [66-68], as shown in Figure 15. The
prediction model–based algorithm requires learning the
individual blood glucose dynamics for accurate prediction, and
for the purpose of detecting the microevents, it can be
implemented as either a residual-based [69-72] or a conformal
prediction–based approach [73-80]. In a similar fashion, novelty
detection–based algorithms can be other alternatives for
detecting novel microevents relying on either supervised,
semisupervised, and unsupervised approaches [4,66,67,81].
Different categories of novelty detection approaches could be
exploited for detecting infection-induced deviations in blood
glucose dynamics, including approaches based on statistical
techniques [68], prediction, density [82-85], distance [67,86],
classification or domain [4,62,63,87-92], clustering [62,93],
and ensemble [67,68,80-82,85,86,92-95].
Alarm Management (Decision Making)
The alarm management module accepts the score computed by
the personalized infection detection algorithm as input and
evaluates the degree of severity of the infection incidence. The
severity is evaluated based on the degree of abnormalities of
the anomalies score, and a label could be assigned to the
individual patient status as normal (0), suspicious (−1), and
infected (1). For example, a rule-based fuzzy logic with
membership functions of infected, normal, and suspicious can
be used to assign the label indicating the severity of the infection
incidence using the anomaly score. The output from the alarm
management will be directly fed to the cluster detection analysis,
which is used to detect a group of patients based on geography
(space) and time so as to revel if there is any ongoing infectious
disease outbreak.
Macroevents: Population-Level Infectious Disease
Outbreak Detection
Cluster Detection Mechanism
Cluster detection is defined as the process of identifying a group
of infected individuals with similar spatial, temporal, or
spatio-temporal attributes [96]. A spatial cluster analysis only
considers a patient’s geographical location, and a temporal
cluster analysis considers only the time aspect of the events.
However, a spatio-temporal cluster analysis is conducted to
look for aberrant patterns and detect a cluster of infected people
within a specified geographical region and predefined timeframe
[96,97]. The analysis of space time clusters is carried out based
on a couple of steps: geocoding and identification, which
transforms the patient address into meaningful coordinates and
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detecting the clusters based on the transformed location and
time. A space time cluster analysis is the most favored approach
when it comes to early detection of an infectious disease
outbreak. A space time cluster analysis can be designed by
performing a spatial analysis first and then superimposing the
temporal aspect [97]. Regarding the proposed system, the input
to the space time cluster detection analysis consists of the
individual patient status from alarm management, user location,
and time of data registration [26]. The status of the individual
patient at any time can be normal (0), infected (1), or suspicious
(−1), which comes from alarm management. The user’s
geographical location can be geographical coordinates of
longitude and latitude [98], postal code address [99], or any
local reference coordinates. Estimation of user location can be
carried out using GPS information from the user’s mobile phone,
which can be accessed during each data registration. The time
aspects depend on the requirement of detection frequency and
can be set to either an hourly or daily window. One optimal
approach could be tracking the individual during each hour of
the day for any statistically significant deviations and performing
a concluding analysis at the end of each day based on the daily
analysis. Various algorithms have been implemented in the
literature, including the density-based clustering algorithm,
Bayesian spatial scan statistics, K-NN with Haversian distance
(K-nearness), cumulative summation, space time scan statistics,
space time permutation scan statistic, and space scan statistics
[96,97,100], which can be further tested and adopted. The most
important challenge is the sparsity of the data set considering
the small proportion of people with type 1 diabetes that can be
under surveillance over a large region. Therefore, it is necessary
to adopt these cluster detection techniques to overcome data
sparsity and produce acceptable detection accuracy. In the
proposed system, the detected clusters, if there is any, can be
displayed and viewed based on real-time and interactive data
visualization tools.
Data Visualization
Data visualization is a mechanism by which detected clusters
of disease outbreaks, if there is any, are presented to the
responsible bodies for quicker public health actions and
responses. Generally, such a visualization tool could report
outbreaks of epidemic cases for investigation and follow-up,
and it could also report the duration of the epidemic (timing),
degree of severity of the epidemic, and the region under threat.
In the literature, there are various implemented visualization
tools and visual displays with regard to disease outbreak
detection systems, including ArcGIS, Google map API, TwiInfo,
OpenStreetMap, and JFreeChart, and display mechanisms such
as maps, time series, graphs, and color indicators [96]. These
visualization tools and display mechanisms can be further tested
and adopted in the proposed system. The real-time health status
of an individual from the ongoing tracking could be accessible
to the end user and can be displayed in a stand-alone software
app based on smartphones, tablets, and computers or a dedicated
website [26]. Generally, both the data providers (participants)
and the general population could benefit from the system in the
sense that they can take actions needed to avoid being infected.
Moreover, the individual patient could also receive analysis and
feedback from the system to learn the situation, such as the
degree and severity of deviation of different parameters,
including blood glucose, insulin, diet, and
insulin-to-carbohydrate ratio, along with their trend as compared
with the noninfection period.
Ethical and Motivational Challenges
The implementation of a digital infectious disease detection
system based on self-recorded data poses serious challenges
that require special attention, such as user privacy and security,
data confidentiality, user acceptance, and motivations [26,101],
especially during data collection, transmission, and data storage
[102,103]. Personal health–related data are sensitive, and the
data collection, transmission, and data storage procedure need
to follow the standards and regulations provided by the major
governing bodies, such as General Data Protection Regulation
(GDPR) and Health Insurance Portability and Accountability
Act (HIPAA) [104,105]. This includes privacy-preserving
mechanisms such as pseudonymization and anonymization to
meet the necessary data compliance requirement along with
user informed consent [102,103]. According to GDPR, the
deidentification procedure is one of the recommended
anonymization standards to preserve data confidentiality
[104,105]. Moreover, from the technology perspective, it is
necessary to look for a robust mechanism to ensure that user
privacy and security are respected during data collection,
transmission, and storage, as this is highly critical for successful
acceptance of the proposed system [26,106]. One such
alternative is to look for the possibility of deploying the infection
detection algorithm (app logic) on the user (client) mobile device
terminal to avoid transmission of patient data to a central server,
where only the timely computed infection status of the patient
will be sent to the central server for further cluster detection
processing. However, this choice requires further feasibility
studies to determine the cost, especially in terms of power
constraints related to the mobile device terminal, since the
detection algorithms need to continuously run in the background
to compute the individual’s infection status, at the most each
hour of the day [26]. In addition, users might also lack
willingness to adopt a new technology or system for various
reasons ranging from lack of trust, lack of motivation, lack of
perceived usefulness, and ease of use [26,101]. However, these
challenges can be mitigated by properly buying user trust by
developing state-of-the-art technology for preserving privacy,
security, and confidentiality of the user and addressing factors
that enhance user motivation, including usability knowledge,
simplicity and ease of use, reduced time and frequency of
interaction with the system, incentives, and others [101].
Conclusions
The relationship between infection incidents and elevated blood
glucose levels has been known for a long time. People with type
1 diabetes often experience prolonged episodes of elevated
blood glucose levels as a result of infection incidence. Despite
the fact that patients increasingly gather data about themselves,
there are no solid findings on how to use such self-recorded
data as a secondary source of information for other purposes,
such as self-management–related decision support during
infection incidence and digital infectious disease detection
systems. We presented the effect of infection incidence on key
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parameters of the blood glucose dynamics along with the
necessary framework to exploit the information for realizing a
digital infectious disease detection system and further shed light
on the possibility of assisting individuals during infection-related
blood glucose management crises. The results demonstrated
that despite tight blood glucose control, blood glucose level is
still elevated during infection incidence. The analysis shows
that infection incidences have a significant impact on blood
glucose dynamics as compared with the other
patient-uncontrollable factors. All of these findings indicate
that blood glucose levels were elevated despite a higher amount
of insulin injection and reduced carbohydrate consumption,
which are quite significant changes that could possibly be
detected through personalized modeling that spans from
prediction models to anomaly detection algorithms. However,
further large-scale studies are required to strengthen the findings.
Moreover, future research should investigate the possibility of
improving detection time and disease characterization. Early
detection, that is, during the incubation period, is a critical
component of any outbreak detection system and therefore needs
to be improved by analyzing how various features of CGM can
be used in context with other parameters, such as diet, insulin,
and physical activity data. For instance, different individuals
with type 1 diabetes often reported the experiences of an
elevated episode of blood glucose levels before the onset of the
first symptoms. Disease characterization involves determining
the type and nature of pathogens that cause the infection, which
is an important component of outbreak reporting. The extent
and degree of the impact of infection incidence on blood glucose
dynamics are highly correlated with the disease pathogens
involved. In this regard, carefully analyzing a large-scale
self-recorded data set containing several infection incidences
(different pathogens) could characterize them based on their
effect on blood glucose dynamics. Generally, we foresee that
these findings can benefit the efforts toward building
next-generation digital infectious disease surveillance systems
and provoke further thoughts in this challenging field.
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Appendix 1: Comparative Analysis of Parameters of Blood Glucose 
Dynamics with and without Infection Incidences  










(mg/dl) 130.74 (16.89) 141.95 (14.37)   119.16 (7.39)
23.39 (4.91) 35.30 (6.11) 21.32 (4.61)
(grams) 241.11 (57.27)   178.80 (65.69) 241.18 (37.63) 
 
(mg/dl)   134.24 (32.67) 147.38 (36.89)     129.77 (39.13)
    0.99 (1.87) 1.51 (2.32) 0.89 (1.77)
(grams) 10.16 (16.50)    7.32 (13.76)   10.20 (15.84) 
(mg/dl) 143.01 (19.53) 155.36 (21.99) 126.17 (11.70)
28.07 ( 8.85) 41.07 (9.44) 25.36 (6.93)
(grams) 190.14 (43.93) 161.14 (58.43) 214.57 (34.66) 
 
(mg/dl) 147.51 (40.75) 162.32 (39.49) 130.85 (36.49)
1.14 (1.92) 1.68 (2.48) 0.98 (1.94)
(grams) 8.3517 (14.68) 6.88 (14.25) 8.39 (14.56) 
 
(mg/dl) 136.93 (18.58) 144.12 (20.30) 134.18 (11.96)
20.08 ( 5.44) 31.50 (10.84) 22.83 (3.86)
2 
 
(grams) 178.0 (45.87) 144.83 (37.63) 195.83 (42.59) 
 
(mg/dl) 143.30 (40.51) 149.84 (32.90) 139.77 (39.61)
1.00 (1.77) 1.50 (2.17) 0.93 (1.62)
(grams) 7.71 (14.31) 6.48 (12.82) 7.28 (13.42) 
 
(mg/dl) 157.74 (31.12) 161.34 (19.88) 138.57 (19.83)
24.43 (5.26) 32.14 (7.01) 29.29 (5.22)
(grams) 199.06 (53.45) 167.04 (44.94) 226.07 (18.23) 
 
(mg/dl) 151.57 (51.15) 157.68 (52.43) 142.16 (47.79)
0.96 (2.60) 1.39 (2.97) 1.19 (3.24)
(grams) 8.38 (20.25) 6.78 (18.52) 9.78 (22.57) 
 
(mg/dl) 135.21 (14.58) 139.88 (15.54) 122.87 (14.49)
32.80 (4.59) 40.37 (8.31) 33.36 (7.94)
19.20 (1.21) 20.42 (2.06) 18.68 (1.56) 
 52.33 (5.14) 61.21 (8.26) 52.46 (8.47) 
 
(mg/dl) 134.23 (34.16) 144.09 (44.25) 122.12 (35.99)
1.36 (2.58) 1.76 (2.82) 1.45 (2.63)
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Appendix 2: Analytical plot of the Normal/Regular Patient Years 



































Appendix 3: Analytical plot of the Patient Years with acute 
infection 
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Background: Diabetes mellitus is a chronic metabolic disorder that results in abnormal blood glucose (BG) regulations. The
BG level is preferably maintained close to normality through self-management practices, which involves actively tracking BG
levels and taking proper actions including adjusting diet and insulin medications. BG anomalies could be defined as any undesirable
reading because of either a precisely known reason (normal cause variation) or an unknown reason (special cause variation) to
the patient. Recently, machine-learning applications have been widely introduced within diabetes research in general and BG
anomaly detection in particular. However, irrespective of their expanding and increasing popularity, there is a lack of up-to-date
reviews that materialize the current trends in modeling options and strategies for BG anomaly classification and detection in
people with diabetes.
Objective: This review aimed to identify, assess, and analyze the state-of-the-art machine-learning strategies and their hybrid
systems focusing on BG anomaly classification and detection including glycemic variability (GV), hyperglycemia, and hypoglycemia
in type 1 diabetes within the context of personalized decision support systems and BG alarm events applications, which are
important constituents for optimal diabetes self-management.
Methods: A rigorous literature search was conducted between September 1 and October 1, 2017, and October 15 and November
5, 2018, through various Web-based databases. Peer-reviewed journals and articles were considered. Information from the selected
literature was extracted based on predefined categories, which were based on previous research and further elaborated through
brainstorming.
Results: The initial results were vetted using the title, abstract, and keywords and retrieved 496 papers. After a thorough
assessment and screening, 47 articles remained, which were critically analyzed. The interrater agreement was measured using a
Cohen kappa test, and disagreements were resolved through discussion. The state-of-the-art classes of machine learning have
been developed and tested up to the task and achieved promising performance including artificial neural network, support vector
machine, decision tree, genetic algorithm, Gaussian process regression, Bayesian neural network, deep belief network, and others.
Conclusions: Despite the complexity of BG dynamics, there are many attempts to capture hypoglycemia and hyperglycemia
incidences and the extent of an individual’s GV using different approaches. Recently, the advancement of diabetes technologies
and continuous accumulation of self-collected health data have paved the way for popularity of machine learning in these tasks.
According to the review, most of the identified studies used a theoretical threshold, which suffers from inter- and intrapatient
variation. Therefore, future studies should consider the difference among patients and also track its temporal change over time.
Moreover, studies should also give more emphasis on the types of inputs used and their associated time lag. Generally, we foresee
that these developments might encourage researchers to further develop and test these systems on a large-scale basis.
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Introduction
Background
Diabetes mellitus is a chronic metabolic disorder that results in
abnormal blood glucose (BG) regulation. The BG level is
maintained close to normality through self-management
practices, which involves actively tracking BG levels and taking
proper actions including diet and insulin medications. The
estimated number of people with diabetes aged between 20 and
79 years was 415 million (uncertainty interval: 340-536 million)
in 2015 and is expected to reach 642 million (uncertainty
interval: 521-829 million) by 2040 [1]. The global economic
burden of diabetes in adults aged between 20 and 79 years was
estimated to be US $1.31 trillion (95% CI 1.28-1.36) in 2015
[2]. The total number of deaths attributed to diabetes is estimated
to be 5 million in people with diabetes aged between 20 and 79
years [1]. People with diabetes have a higher risk of getting
infections as compared with the normal population, which
potentially increases their morbidity and mortality [3]. The
greater and frequent risk of infections is mainly correlated with
a hyperglycemia environment [3,4]. Moreover, studies suggest
a hypoglycemia episode could result in a higher hospitalization
and mortality rate [5].
The individual’s BG dynamic is affected by various factors,
which are mainly categorized as common, individual, and
unpredictable factors [6]. The common factors include amount
of food intake, insulin intake, previous level of BG, pregnancy,
drug and vitamin intake, smoking, and alcohol intake. The
individual factors include dawn phenomena, physical exercise
load, and menstruation. The unpredictable factors include stress,
concomitant diseases, and infections [6]. Swings in BG
dynamics, that is, hypoglycemia and hyperglycemia, could be
generally categorized under a normal cause variation and special
cause variation. The normal cause variation is regarded as
caused by those common and individual factors, whereas the
special cause variation is caused by those unpredictable factors.
The underlying reason of the special cause variations is difficult
to understand and remains a challenge for the patient during the
incidences. For instance, during stress and infections, the patient
usually struggles with hyperglycemia and injects frequent insulin
to lower his or her BG levels.
BG anomalies could be defined as any undesirable reading
because of either a precisely known reason (normal cause
variation) or an unknown reason (special cause variation) to the
patient [7]. Even if the advancement in self-management
applications and diabetes monitoring technologies has made
things easier, the challenge of BG anomalies remains to be
managed by the patient themselves. There are some
technological developments in the direction of personalized
decision systems and BG event alarms to provide an alert and
decision support to the patient in the time of these challenges.
Techniques such as classification and detection of glycemic
variability (GV), hypoglycemia, and hyperglycemia, in
particular, and BG anomalies, in general, are central to the
development of these diabetes technologies. The ubiquitous
nature and widespread use of mobile health (mHealth) apps,
sensors and wearables, and other point-of-care (POC) devices
for self-monitoring and management purposes have made
possible the generation of automated and continuous
diabetes-related data, which brought an opportunity for the
introduction of machine learning and its application for
intelligent and improved systems, which is capable of solving
complex tasks within a dynamic knowledge and dynamic
environment. In this regard, there are some reviews conducted
toward the applications of artificial intelligence in
diabetes-related tasks. For instance, Contreras et al [8] conducted
literature reviews on the applications of artificial intelligence
in the context of critical diabetes management issues such as
BG prediction and strategies for BG control, adverse glycemic
events detection, bolus calculators and advisory system, patient
personalization (tailored features), and others [8]. Moreover,
Rigla et al [9] also conducted a review to provide a general
overview and popularity of artificial intelligence applications
to diabetes problems. Generally, both Contreras et al [8] and
Rigla et al [9] tried to demonstrate the potential of artificial
intelligence with regard to all groups of people with diabetes
focusing on general self-management issues. As far as our
knowledge is concerned, there are almost no reviews conducted
toward techniques of BG anomaly classification and detection
focusing on various approaches, in general, and
machine-learning applications, in particular. However, there
were some reviews conducted to evaluate the significant effect
of pattern management based on self-monitoring BG (SMBG)
with regard to clinical practices [10]. Therefore, we suggest that
there is a lack of reviews focusing on BG anomaly classification
and detection. The objective of this review was to identify,
assess, and analyze the state-of-the-art machine-learning
strategies in BG anomaly classification and detection including
GV, hyperglycemia, and hypoglycemia in people with type 1
diabetes. Moreover, it has presented the current modeling
options of machine-learning applications and their hybrid
systems. The review covers machine-learning approaches
pertinent to personalized decision support systems and BG alarm
events applications in type 1 diabetes.
Machine Learning Tasks in Type 1 Diabetes
Machine-learning approaches (tasks) are generally categorized
as regression, prediction, classification, detection, and clustering,
which are grouped either in supervised, semisupervised,
unsupervised, or reinforcement learning based on the type of
learning employed. Generally, reinforcement learning is out of
the scope of this review, where we mainly focus on the other 3
categories. Machine learning–based data mining tasks could be
categorized as descriptive or unsupervised (ie, clustering,
association, and summarization), semisupervised (ie,
classification and detection), and predictive or supervised
learning (ie, classification and regression) [11]. In this regard,
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the most widely used machine learning–based data mining tasks
in the literature are BG anomalies detection, BG prediction,
modeling of BG dynamics, and decision making or education,
as shown in Figure 1. In this review, we will focus on the typical
applications of classification and detection tasks in diabetes
research, specifically in BG anomaly detection within the
context of a personalized decision support system and BG alarm
events applications. The review considers various classes of
machine learning algorithms: artificial neural network (ANN),
decision trees (DTs), support vector machine (SVM),
evolutionary algorithms (EAs), and others.
An ANN is a biologically inspired computational model
consisting of a set of interconnected neurons and a scaled
connection between them that is called weights [12]. On the
basis of network topology, an ANN is mainly categorized as a
feedforward ANN (single-layer perceptron (SLP), multi-layer
perceptron (MLP), and radial basis function [RBF]) and
feedback ANN (recurrent neural network [RNN], Elman net,
Kohonen’s self-organizing map (SOM), and Hopfield networks)
[12]. The SVM works based on the theory of structural risk
minimization principle [13]. Learning in the SVM occurs
through finding an optimal hyperplane that can maximize the
margin between the classes. The SVM has been widely exploited
in numerous applications such as regression and prediction,
pattern identification and recognition, categorization, and
classification [13]. An EA is a biologically inspired approach
to problem solving [14]. The 2 most used variants of EA are
genetic programming (GP) and genetic algorithm (GA). Random
forest (RF) or DTs are a kind of an ensemble approach of
learning for different classification and regression applications,
which mainly learns by constructing a multitude of DTs
generating the mode of the class or mean of prediction. The
hidden Markov model (HMM) is a variant of the statistical
Markov model, where the system being modeled is assumed to
follow a Markov property with unobserved states [15]. There
are various versions of HMMs; however, in this review, we
considered only those trained with a framework close to machine
learning families. Hybridization is the process of combining 2
or more different approaches in parallel or serious connection,
either at the preprocessing stage, feature extraction, or learning
stage, when looking for an improved performance [16].
Figure 1. Most widely used machine learning–based data mining tasks based on self-recorded data in people with type 1 diabetes. The yellow shaded
ellipse depicts the scope of this review.
Blood Glucose Anomaly Classification and Detection
Hawkins defined anomalies as “observations that deviate much
from the other observations so as to arouse suspicions that it
could be generated by a different process” [7,17,18]. There are
terms that are often used interchangeably with anomalies, such
as outliers, deviations, exceptions, rare instances, and
irregularities. The problem of identifying and capturing
anomalies in data can be supervised, semisupervised, and
unsupervised tasks [19,20]. These strategies can roughly be
categorized as classifier- or model-based (detection) approach.
The semisupervised is better when anomalous instances are not
easily available, whereas supervised techniques are more
suitable when there are sufficient labeled instances of both
normal and anomalous instances. The unsupervised approach
does not require any reference data labels, where normal
behaviors have to be determined dynamically, and the detections
are mainly performed with regard to the entire datasets. The
model-based strategies can be considered as a diagnosis of the
system’s behavior during abnormal situations through modeling
and adequately characterizing the system’s behavior during
normal situations [19,21]. It uses a system’s model to either
estimate or predict the underlying system (process) dynamics
to capture anomalies in the data. The most important design
requirement in using a model includes discovering and
characterizing what is to be considered a normal pattern of
behaviors [22]. Unlike the classifier-based strategies, the
model-based strategies do not require rigorous knowledge of
the underlying expected anomalies, that is, to fully understand
and characterize the shape and nature of the expected anomalies
[22]. By simply defining what is the expected normal pattern
the system should exhibit, the model-based anomaly detection
is capable of detecting abnormal behavior, which is not
considered as the normal behavior of the system. Defining and
discovering what is normal is a challenging task especially for
dynamic and complex systems, for example, BG dynamics.
However, this is often tackled in a dynamic and complex system
by relying on either a machine learning model trained on a large
enough dataset or using an explicit mathematical model, for
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example, physiological model of BG dynamics, of the system
if it exists already.
BG readings are time series data, and anomalies in BG levels
could be regarded as any undesirable readings, as shown in
Figure 1, because of either a predictable cause (normal cause
variation) or an unpredictable cause (special cause variation).
A normal cause variation could be defined as any hypoglycemia
or hyperglycemia incidences with the underlying cause known
to the patient herself or himself and also referred as predictable
(patient controllable) factors such as insulin injection, diet
intake, physical activity, and others. However, special cause
variation refers to any hypoglycemia or hyperglycemia
incidences with the underlying cause unknown to the patient
and also called unpredictable (patient uncontrollable) factors
such as stress, infections, insulin set failure, and others. The
classifier, semisupervised (model)– and unsupervised-based
approach could be used to solve the challenge of capturing BG
anomalies caused by both the predictable factors (normal cause
variation) and unpredictable cause (special cause variation).
However, regarding the unpredictable factors (special cause
variation), the classifier-based approach remains to be very
challenging with limited feasibility as the classifier-based
strategies require a thorough understanding and characterization
of the nature, size, and shape of the anomalies, along with its
inter- and intravariability among the patients. With the same
token, the unsupervised approach could face the same challenge
as it does not have any mechanisms for differentiating the one
with special cause from the normal cause variations. However,
the model-based (semisupervised) approach happens to be more
appropriate given that it only requires to characterize what is
considered to be normal so as to detect what is believed to be
abnormal. For example, infection (stress)–related hyperglycemia
and a diet-induced hyperglycemia are treated differently
according to the model-based (semisupervised) anomaly
detection strategies. In this regard, diet-induced hyperglycemia
is treated as normal, as the model could describe the underlying
cause (certain meal), but infection-related hyperglycemia is
considered as an anomaly because the model cannot describe
the underlying cause based on patient controllable variables
(eg, meals and insulin).
GV measures the degree or the rate at which the patient’s BG
fluctuates between high and low levels [23]. GV is useful to
provide all-inclusive information on one’s self-management
practices concerning postprandial spikes in BG, as well as
episodes of hypoglycemic and hyperglycemic events [23,24],
which are the main factors that contribute for a higher risk of
cardiovascular events in people with diabetes. The evaluation
of GV helps to comprehend and assess the effect of the patient’s
timely actions on the hypoglycemia and hyperglycemia
incidence by associating out-of-target BG levels with
patient-specific factors, such as insulin dosage, other medication,
meals, activity, stress, and illness [23]. However, there is no
gold standard approach for assessing GV, and despite its
importance, it remains to be challenging.
Blood Glucose Prediction
BG prediction is about forecasting an individual’s future BG
levels using current and past information and is also an
important constituent of BG anomaly classification and detection
approaches. It mainly aims to provide crucial alarms for patients
in advance with sufficient lead time so as to avoid further
complications from hypoglycemia or hyperglycemia incidences.
According to Oviedo et al [25], BG prediction models could be
categorized into 3 main groups: physiological models,
data-driven models, and hybrid models [25]. These categories
are solely demarcated based on the necessity of extensive
knowledge of the underlying BG dynamics: black box approach
(data-driven model), intermediate knowledge (hybrid model),
and extensive knowledge (physiological model). The data-driven
model, which is mainly referred to as black box model, uses
the patient’s continuous glucose monitoring (CGM), insulin,
dietary, and other relevant information to develop a prediction
model, for example, machine learning and time series
approaches. There are a variety of data-driven models developed
and tested in the literature including machine learning (neural
network, support vector regression, jump neural network, RNN,
and others) and time series models (autoregressive [AR] with
exogenous input, AR moving average with exogenous input,
AR moving average, and others) [25]. Hybrid models make use
of the advantages from the data-driven and physiological models
[25]. Most of the hybrid models rely on the physiological model
to compute meal and insulin information as input for the
data-driven models [25]. Physiological models mainly rely on
3 sets of mathematical (differential) equations to describe the
underlying dynamics: BG dynamics, insulin dynamics, and meal
absorption dynamics. Physiological models are roughly grouped
into lumped and comprehensive models based on the way the
model treats each organ and tissue so as to develop the
differential equations [26]. There are a variety of physiological
models developed in the literature such as Berger, Hovorka,
Cobelli, Lehmann and Deutsch model, and others [26].
Generally, there are plenty of models implemented in the
literature on the prediction of BG levels [25,26]. However, BG
prediction is not under the scope of this review, and we mainly
focus on the data-driven BG pattern classification and anomaly
detection approaches under the umbrella of machine learning.
Methods
Search Strategy
The objective of this review was to identify, assess, and analyze
the state-of-the-art machine learning strategies and their hybrid
system focusing on BG anomaly classification and detection
including GV, hyperglycemia, and hypoglycemia in people with
type 1 diabetes. The review covers machine learning approaches
pertinent to personalized decision support systems and BG alarm
events applications. Therefore, for the purpose of the study, a
rigorous literature search was conducted between September 1
and October 1, 2017, through various Web-based databases
including Google scholar, IEEE Xplore, DBLP Computer
Science Bibliography, ScienceDirect, PubMed or Medline,
Journal of Diabetes Science and Technology, and Diabetes
Technology & Therapeutics. Additional search was also
conducted between October 15 and November 5, 2018, on those
databases to refine and update the records. Furthermore, the
reference list of the selected articles was used to extract
additional articles to get a complete overview of the field.
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Peer-reviewed journals and articles published between 2000
and 2018 were considered. The inclusion and exclusion criteria
were setup through rigorous discussion and brainstorming
among the authors. Different combinations of terms such as
diabetes, intelligent system, hybrid system, machine learning,
BG event indicators (hypo- and hyperglycemia prediction), BG
event alarm, BG personalized decision system, clinical,
closed-loop system, hyperglycemia, hypoglycemia, GV, and
personalized profile were used during the search. The terms
were combined using AND/OR for a better search strategy.
Relevant articles were first identified by reviewing the title,
keywords, and abstracts for a preliminary filter with our
selection criteria, and then we reviewed full text articles that
seemed relevant. Information from the selected literature was
extracted based on some predefined categories, which were
based on previous research, and further elaborated through
brainstorming.
Inclusion and Exclusion Criteria
To be included in the review, the studies should have developed,
implemented, tested, and discussed machine learning and any
of its hybrid approaches in type 1 diabetes focusing on one or
more of the following application areas:
• BG anomaly detection
• Hypoglycemia prediction, classification, or detection
• Hyperglycemia prediction, classification, or detection
• Glycemic or BG variability classification or detection
Therefore, the studies that reside outside of these stated scopes
were excluded from the review including all articles written in
other languages but English.
Data Categorization and Data Collection
Information was extracted from the selected studies based on
predefined parameters (variables) and categories. The categories
were defined based on rigorous brainstorming and discussion
among the authors. These categories were demarcated solely to
collect the relevant data and to assess, analyze, and evaluate the
model’s characteristics and its experimental setup.
Application Scenario
This category defines the type of applications where the machine
learning algorithm is being exploited. It can be hypoglycemia
and hyperglycemia prediction, classification and detection, or
GV classification and detection.
Type of Input
This category was defined to assess, analyze, and evaluate the
type of inputs used to develop the algorithm. This includes the
key diabetes parameters and other physiological parameters
relevant for BG anomaly classification and detections: BG,
heart rate variability, and others.
Data Format, Type, Size, and Data Source
This category was defined to assess, analyze, and evaluate the
type of data format used as input to the algorithm. This depends
on the basis of the type of diabetes technologies, mobile apps,
and POC devices used for data collection and algorithm
development. It includes different data formats such as from
CGM devices, mHealth apps (ie, diabetes diary), heart rate
monitoring devices, and others.
Input Preprocessing
This category defines the kind of preprocessing algorithm the
system implements so as to avoid missing, sparse, and corrupted
input data.
Class of Machine Learning
This category defines the class of machine learning algorithm
used to train and test the BG anomaly classification and
detection algorithm. It includes different classes of machine
learning algorithm: ANN, SVM, Bayesian network, DT, and
others.
Training or Learning Method and Algorithm
This category defines the class of learning algorithms used to
train the model. It includes different training algorithms such
as the backpropagation algorithm, kernel, optimization
techniques, and others.
Performance Metrics or Evaluation Criteria
This category defines the type of evaluation metrics used to
assess the accuracy of the classification and detection algorithm
implemented. It includes different performance metrics such as
specificity, sensitivity, receiver operating characteristic (ROC)
curves, and others.
Literature Evaluation
The included literature was analyzed and evaluated based on
the above defined categories and variables to uncover the
state-of-the-art machine learning applications in hyperglycemia
or hypoglycemia prediction, classification and detection, and
GV classification and detection. It also tries to pinpoint their
characteristics along with the experimental setup used to
implement and test the algorithms. The first evaluation and
analysis was carried out based on the type of input used to
develop the algorithms to uncover the state-of-the-art inputs
used in these circumstances. The second evaluation and analysis
was carried out based on the various classes of machine learning
used to develop these algorithms to uncover the rate of adoption
and their suitability to the task. The third evaluation and analysis
was carried out based on the performance metrics used to
evaluate the performance of these algorithms.
Results
Relevant Literature
The initial hit was vetted using the title, abstract, and keywords
and retrieved a total of 496 papers (DBLP Computer Science
(20), Diabetes Technology & Therapeutics (23), Google Scholar
(160), IEEE (215), Journal of Diabetes Science and Technology
(22), PubMed Medlin (27), and ScienceDirect (29); see Figure
2). After removing duplicates from the list, 410 records
remained. Then, we did an independent assessment of the
articles and screening based on the inclusion and exclusion
criteria, which eliminated another 215 papers, leaving 195
relevant papers. After a full-text assessment, 47 articles were
left (hyperglycemia=5, glycemic variabilities=3, and
hypoglycemia=39), which were critically analyzed as shown in
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Figures 2 and 3. The interrater agreement was measured using
a Cohen kappa test, and disagreements were resolved through
discussion.
Figure 2. Flow diagram of the review process.
Figure 3. The number of articles published per year of publication.
Evaluation and Analysis of the Literature
The literature, as described previously, was evaluated based on
the type of machine learning used to develop the algorithm, the
type of input used to train the system, and the performance
metrics used to evaluate the algorithm performance based on
the tables in Multimedia Appendices 1 and 2.
Data Characteristics and Input Parameters
Input Parameters
Selecting the proper types of input parameters is one of the
crucial design strategies for successful classification and
detection algorithm development. In this regard, the outer bigger
ring, the middle ring, and the inner ring in Multimedia Appendix
1 depict the types of input used in hypoglycemia, hyperglycemia,
and GV classification and detection algorithm, respectively.
According to hypoglycemia classification and detection
algorithm, BG, heart rate, and QT interval are the most used
types of input parameters (25/39, 64%). BG alone is the second
most used type of input parameter (4/39, 10%). BG and insulin
are the third most used types of input parameters along with
BG, insulin, diet, physical activity, and others (3/39, 8%). BG
and diet alone, along with BG, insulin, and diet, and BG, heart
rate, skin impedance, and BG, insulin, diet, heart rate, galvanic
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response, skin impedance are the fifth most used types of input
parameters (1/39, 3%). According to hyperglycemia
classification and detection algorithm, BG alone, and BG and
insulin represent the most used types of input parameters (2/5,
40%). BG, heart rate, and QT interval represent the second most
used types of input parameters (1/5, 20%). According to GV
classification and detection algorithm, BG alone (3/6, 50%),
and BG and insulin (3/6, 50%) are equally ranked as the most
used types of input parameters, as shown in Figure 4.
Figure 4. Reported input features, machine learning class, and accuracy. ANN: artificial neural network; BBNN: block-based neural network; BG:
blood glucose; BNN: Bayesian Neural Network; DBN: deep belief network; DT: decision tree; ELM: extreme learning machine; GA: genetic algorithm;
GP: genetic programming; HMM: hidden Markov model; NAR: nonlinear autoregressive network; NARX: nonlinear autoregressive network with
exogenous inputs; NBC: Naive Bayes classifier; RNN: recurrent neural network; SVM: support vector machine; VTWNN: variable translation wavelet
neural network.
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Different kinds of data sources ranging from BG monitors,
physical activity, electrocardiogram (ECG), and heart rate
sensors have been used in the reviewed articles for
hyperglycemia, hypoglycemia, and GV classification and
detection algorithms. The reviewed articles relied on different
kinds of data formats including SMBG (finger sticks), CGM,
and ECG signals, as shown in Table 1. Generally, ECG signal
is the most used type of data format (51%), followed by CGM
(39%) and SMBG (10%). Specifically, hypoglycemia
classification and detection involve (CGM (n=11), ECG (n=24),
and SMBG (n=5)). Regarding, hyperglycemia classification
and detection (CGM (n=5) and ECG (n=1)) and GV
classification and detection (CGM (n=3)).
Table 1. Types of data formats used in the studies (N=49).
Count, n (%)Data type/format
19 (39)Continuous glucose monitoring
5 (10)Self-monitoring blood glucose
25 (51)Electrocardiogram signal
With regard to BG monitoring, different devices and brands
have been exploited for developing hypo-/hyperglycemia and
GV classification and detection algorithms, as shown in Table
2. Generally, Yellow Spring Instruments is the most used device
(50%) followed by Guardian Real Time (MinMed CGM; 28%).
GlycoMark (7%) is the third most used device followed by
HemoCue Glucose 201 (5%) and Self-Monitored BG (5%).
Specifically, the most used devices for hypoglycemia
classification and detection are Guardian Real Time (MinMed,
CGM; n=7), Yellow Spring Instruments (n=21), HemoCue
Glucose 201 (n=2), Dexcom CGM system (n=1), Self-Monitored
BG (SMBG; n=2), Medtronic Enlite CGM sensors (n=1),
Medtronic insulin pump (n=4), SensorWear armband (physical
activity; n=2), and Basis Peak fitness band (n=1). and Basis
Peak fitness band (n=1). As for hyperglycemia classification
and detection, Guardian Real Time (MinMed CGM; n=2) and
Medtronic insulin pump (n=3) had been used. With regard to
GV classification and detection, GlycoMark (n=3), Guardian
Real Time (MinMed CGM; n=3), and Medtronic insulin pump
(n=3) had been used.
Table 2. Types of devices used for the monitoring of blood glucose levels (N=42).
Count, n (%)Devices
12 (28)Guardian Real Time (MinMed, CGMa)
2 (5)HemoCue Glucose 201 (HemoCue)
21 (50)Yellow Spring Instruments
1 (3)Dexcom CGM system
1 (3)Medtronic Enlite CGM sensors
3 (7)GlycoMark
2 (5)Self-Monitored Blood Glucose-unknown device
aCGM: continuous glucose monitoring.
Various brands of physiological monitoring (heart rate and ECG
signals) devices have been exploited in the reviewed articles.
Generally, as shown in Table 3, Compumedics system is the
most used system (52%) followed by a customized device such
as a battery-powered chest belt–worn device (22%). HypoMon
is the third most used device (13%) followed by Basis Peak
fitness band (9%) and a self-designed portable apparatus (4%).
Specifically, for hypoglycemia classification and detection
purposes, various devices have been used such as HypoMon
(n=3), Basis Peak (n=2), Compumedics system (n=11), a
battery-powered chest belt–worn (n=5), and self-designed
portable apparatus (n=1). With regard to hyperglycemia
classification and detection, only 1 article has used the
Compumedics system (n=1), which indicates that heart rate and
ECG signals have a limited use in this case.
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Table 3. Types of devices used for the monitoring of physiological parameters (heart rate and electrocardiogram signals; N=23).
Count, n (%)Devices
3 (13)HypoMon
2 (9)Basis peak fitness band
12 (52)Compumedics system
5 (22)A battery-powered chest belt–worn (customized)
1 (4)Self-designed portable apparatus (customized)
Data Preprocessing
Data preprocessing is an important stage of any machine
learning strategy. In this regard, there were various kinds of
data preprocessing strategies used in the reviewed articles. The
reviewed articles had relied on both BG and other physiological
(heart rate, ECG, skin impedance, and others) data, which of
course involves different preprocessing strategies depending
on the data type under consideration. Regarding the BG data,
various preprocessing approaches had been used including
differencing (derivative) BG values [27,28], CGM data
reconstruction, or smoothing using different methods such as
spline interpolation [29-33], a rough feature elimination, such
as fast separability and correlation analysis algorithm [28,29],
representing BG temporal change information [34], feature
selection and feature ranking [35], filtering using Pearson’s
correlation coefficient (PCC) and the t test, and the wrapper
approach using greedy backward elimination [33]. The other
physiological parameters (heart rate, ECG, skin impedance, and
others) had been preprocessed using different methods such as
normalization [36-38], feature extraction and selection [39,40],
feature extraction using fast Fourier transform (FFT) [41],
unsupervised restricted Boltzmann machine–based feature
representation [42], filtering techniques such as Infinite impulse
response high pass filter [41,43], correlation analysis [44-46],
and transformation of frequency domain into time domain (FFT)
[47].
Class of Machine Learning
Hypoglycemia Classification and Detection
Different classes of machine learning techniques have been
adopted in hypoglycemia prediction, classification, and detection
algorithms to predict, classify, and detect the incoming
hypoglycemia incident in people with type 1 diabetes, as shown
in Figure 4. Conventional feedforward ANN is the most adopted
class of machine learning, which is used in 26% (17/65) of the
studies , as shown in Multimedia Appendix 1. Hybridization of
machine learning techniques with other approaches such as time
series, fuzzy logic, and others are the second most adopted
approach (12/65, 18%). The SVM ranked the third most adopted
class of machine learning (9/65, 14%). DT ranked the fourth
most adopted technique (4/65, 6%). GA, time delay ANN and
time sensitive ANN, block-based neural network (BBNN), and
adaptive neural fuzzy inference system (ANFIS) are the fifth
most used classes of machine learning (3/65, 5%). Nonlinear
autoregressive network with exogenous inputs (NARX) and
nonlinear autoregressive network (NAR) along with Gaussian
process regression, combinational neural logic network , and
Bayesian neural network (BNN) ranked as the sixth most used
classes of machine learning (2/65, 3%). Deep belief network
(DBN), radial basis function neural network (RBFNN), and
variable translation wavelet neural network (VTWNN) are the
seventh most used classes of machine learning (1/65, 2%).
Hyperglycemia Classification and Detection
Hyperglycemia classification, prediction, and detection has been
practiced less when compared with hypoglycemia, which might
be linked because of its less severe short-term complications as
opposed to hypoglycemia incidences. However, irrespective of
this limitation, different types of machine learning techniques
have been adopted, as shown in Figure 4. For example, ANN
is the most used machine learning technique in 34% (3/9) of
the studies (feedforward (1/9) and feedback RNN (2/9)), as
shown in Multimedia Appendix 1 along with EA (3/9,34%)
(GA (1/9) and GP (2/9)). The HMM (2/9, 22%) is the third most
used followed by a hybrid approach (1/9, 11%).
Glycemic Variability Classification and Detection
GV detection is a recent development, which has great
importance in quantifying factors associated with
hypo-/hyperglycemia incidence. In this regard, there is some
research and development involving machine learning
techniques, as shown in Figure 4. For example, feedforward
ANN is the most used class of machine learning (3/8, 37%), as
shown in Multimedia Appendix 1. Naive Bayes classifier (NBC)
and SVM are the second most adopted techniques of machine
learning (2/8, 25%). DT is the third most used class of machine
learning (1/8, 13%).
Performance Metrics
The performance metrics used in the evaluation of
hypoglycemia, hyperglycemia, and GV classification and
detection algorithms are depicted in the outer ring, the middle
ring, and inner ring, respectively, as shown in Multimedia
Appendix 1. According to hypoglycemia classification and
detection, sensitivity, and specificity are the most used
performance metrics (37/58, 64%). Accuracy and precision are
the second most used performance metrics (9/58, 15%). Root
mean square error and mean square error are the third most used
performance metrics (4/58, 7%). Geometric mean is the fourth
most used performance metric (3/58, 5%). Correlation
coefficient is the fifth most used performance metric (2/58, 3%).
Time lag (TL), recall, and ROC curve are the sixth most used
performance metrics (1/58, 2%). According to hyperglycemia
classification and detection, accuracy and precision, root mean
square error and mean square error, time lag (TL), correlation
coefficient, recall, and false positive rate are the most used
performance metrics (2/15, 13%). ROC curve, geometric mean,
sensitivity, and specificity are the third most used performance
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metrics (1/15, 7%). According to GV classification and
detection, accuracy, and precision are the most used performance
metrics (3/5, 60%). Sensitivity and specificity are the second
most used performance metrics (2/5, 40%).
Discussion
Principal Findings
The objective of this review was to identify, assess, and analyze
the state-of-the-art machine applications in BG pattern
classifications and anomaly detection: hyperglycemia,
hypoglycemia, and GV classification and detection. According
to the reviewed literature, the anomaly classification and
detection approach could be roughly categorized as either a
classifier-based or a model-based approach [19,21]. The
classifier-based approach mainly relies on using either a
specified threshold or some kinds of rules to classify the BG
levels as either normal or abnormal. The difference is that unlike
the model-based approach, the classifier-based approach requires
rigorous and deeper knowledge regarding the nature, size, and
shape of the underlying anomalies under consideration so as to
develop the necessary threshold or rule to capture them.
However, the model-based approach only requires to demarcate
the boundary of what is known to be normal so as to capture
what is believed to be abnormal [21]. The model-based approach
does not require rigorous knowledge of the underlying expected
anomalies, that is, to fully understand and characterize the shape
and nature of the expected anomalies [22]. By simply defining
what is the expected normal pattern that the system should
exhibit, a model-based approach is capable of detecting
abnormal behavior, which is not considered as the normal
behavior of the system. Defining and discovering what is normal
is a challenging task especially for dynamic and complex
systems, for example, BG dynamics. However, this is often
tackled in a dynamic and complex system by either relying on
a machine learning model trained on large enough datasets or
using an explicit mathematical model of the system such as a
physiological or compartmental BG dynamics model [21].
Various classes of machine learning algorithms have been
adopted for the task. Regarding hypoglycemia classification
and detection, feedforward ANN, hybrid systems, SVM, DT,
GA, ANFIS, NARX, NAR, Gaussian process regression, DBN,
and BNN have been developed and tested. These techniques
have explored various kinds of input parameters notably BG,
heart rate, QT interval, insulin, diet, physical activity, galvanic
response, and skin impedance. Concerning hyperglycemia
classification and detection, RNN, GP, HMM, feedforward
ANN, GA, and hybrid systems have been developed and tested,
exploring various types of input parameters including BG,
insulin, heart rate, and QT interval. GV detection is a recent
development, which has great importance in quantifying factors
associated with hypoglycemia and hyperglycemia incidence.
In this regard, there is some research and development involving
machine learning techniques. For example, feedforward ANN,
NBC, SVM, and DT have been tested up to the task using BG
and insulin delivery profiles.
Generally, all of the studies have relied on either indirect
indicator variables such as heart rate, QT interval, and others
or a subset of input parameters that affects BG dynamics. The
patient’s contextual information, for example, meals, physical
activity, insulin, and sleep, have a significant effect on BG
dynamics, and a proper anomaly classification and detection
algorithm should consider the effects of these parameters. In
this regard, however, the individual patient is expected to record
meal, insulin, and physical activity data. One of the main
limitations is meal modeling, where most of the algorithm
depends on the individual estimation of carbohydrate, which is
prone to errors and further aggravates the degradation to
detection performance. With regard to physical activity, there
are various wearables and sensors that can record the
individual’s physical activity load and durations. However,
there is the lack of a uniform approach among the studies with
certain limitations on the way these signals are employed in the
classification and detection algorithms. For example, there are
some studies that consider levels of activity as low, moderate,
and high and others consider descriptive features by
summarizing the number, intensity, steps, exercise durations,
and others to better quantify the effect of physical activities.
Moreover, recording insulin dosage has its inherent limitations,
which might affect the detection performance. For example,
blockage of insulin flow from the insulin pump because of the
infusion set failure and error incurred during manual
registrations might pose a significant challenge in the
performance of the detection system. Furthermore, CGM is
becoming one of the most important components in these
classification and detection algorithms. However, even if CGM
advancement has enabled patients to have continuous estimation
of their subcutaneous glucose levels, it has limitations when
used in a personalized detection system (an alarm). In this
regard, recent studies have showed that autocorrelation of the
CGM reading vanishes after 30 min, making the detection
performance to degrade afterward. These findings suggest that
any classification and detection algorithms aiming for a better
lead time should consider other patient’s contextual information
and various features of the CGM itself. There are some studies
that develop a model by assessing several features of the CGM
signal so as to compensate for its inaccuracy. Moreover, CGM
is found to be inaccurate during hypoglycemia episodes, that
is, insulin-induced hypoglycemia versus spontaneous
hypoglycemia. In this regard, insulin-induced hypoglycemia is
found to be difficult to detect as compared with spontaneous
hypoglycemia. Fast occurring hypoglycemia is difficult to detect
because of the blood-interstitial delay, which makes them
important features to be detected by a given model. Furthermore,
CGM calibration frequency and timing also affects the
performance of the classification and detection algorithm.
The reviewed studies are limited to and could be roughly
categorized by age groups (children, young, adult, and old),
time of the day (diurnal vs nocturnal) and configurations (online
vs offline). For example, most of the studies consider nocturnal
hypoglycemia detection, considering the fact that most of
hypoglycemia crises occurred during nighttime and also the
crises during this time have a bad consequence as compared
with the diurnal period. Moreover, it is a fact that nocturnal
detection is simpler as compared with the diurnal considering
the dynamics of the patients. However, irrespective of these
challenges, there are also studies that consider the diurnal period.
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However, there are limited studies that attempt to develop an
algorithm that could detect anomalies in both of those contexts.
With regard to the age group, most surveys reported that age
group has a great effect on BG dynamics, which is typically
related with the dynamics and active lifestyle adopted by each
group. Therefore, it is deemed a necessary approach to consider
a personalized algorithm for each age group. With regard to the
configuration, there are fewer attempts of online (real-time)
algorithms, where almost all of the algorithms were tested and
implemented in the offline mode. In this regard, the most crucial
issues concerning machine learning strategies could be the
necessity of frequent retraining when subjected to a real-time
and dynamic task.
In addition, the most important component in classification and
detection algorithms is the threshold used to differentiate the
normal from the abnormal. In this regard, almost most of the
studies have used a static threshold based on suggestions either
from the literature or physicians and other concerned bodies
such as the American Diabetes Association. However, the
critical issues in this approach are that the threshold might vary
from patient to patient and also some patients might not feel
any symptoms at the specified threshold (when using indirect
indicators such as heart rate, QT interval, and others). However,
there are some studies that employed a fuzzy logic–based
approach by having a continuous decision space.
In principle, any future BG anomaly classification and detection
algorithm should be expected to detect any upcoming anomalies
as soon as possible (lead time—giving more response time),
avoid any false alarm at any cost, perform in real-time (in an
online fashion), adapt with the dynamics of BG evolution (learn
continuously), automatically tune its parameters without user
intervention, be able to perform throughout the day in a free
living condition (diurnal and nocturnal periods), and incorporate
as many input variables to better capture the dynamics. In this
regard, for example, the most crucial issues concerning a
real-time (online) machine learning algorithm could be the
necessity of frequent retraining when subject to a real-time and
dynamic task. Moreover, developing a model that considers a
real-time and adaption-to-free-living condition needs to
incorporate a wide range of parameters that affect BG dynamics.
Furthermore, it should properly consider and address the
inherent technological limitation that affects the performance
of the detection algorithm. Almost all of the studies need a
proper clinical validation to be integrated into a smartphone
and CGM for a real-time application. This can be better
described by looking at the number of samples used and their
validation strategies (see Multimedia Appendix 2). Therefore,
future studies should give more emphasis on clinical validation
by taking a sufficient number of subjects in the development
and testing phase so as to better quantify the inter- and
intravariability among patients. In addition, the most crucial
concept of justifying and reporting the underlying cause, as
because of either patient controllable or patient uncontrollable
parameters, for the detected anomalies is not addressed in any
of the reviewed literature. For example, the underlying cause
of hyperglycemia incidences could be patient controllable
parameters such as diet or patient uncontrollable parameters
such as stress and infections. Therefore, in this regard, a proper
hyperglycemia classification and detection system might be
expected to be able to identify and report the underlying cause,
which has a greater significance to the patient especially during
infection crises.
Summary of Existing Efforts: Machine Learning
Techniques
Artificial Neural Network
There are various types of ANNs used in solving BG
classification and anomaly detection tasks: hypoglycemia,
hyperglycemia, and GV classification and detection. Regarding
hypoglycemia classification and detection, for instance, Eljil et
al [48], had proposed a special type of ANN known as the
time-sensitive ANN and compared the result with a time delay
neural network, NARX, distributed time delay neural network,
and NAR. San et al [37,49] proposed an evolvable BBNN and
compared the result with feedforward ANNs and multiple
regression. Moreover, San et al [42] proposed a DBN and
compared the result with a wavelet neural network, a
feedforward ANN, and multiple regression models. Some of
the studies have also investigated the advantage of having a
separate feature extraction and classification unit. In this regard,
for example, both Laione et al [47] and Nguyen et al [41,50]
have proposed an ANN using FFT for data extraction. Nguyen
et al [41] have further trained the network through a 2-step
process that combines the advantage of GA and the Levenberg
Marquardt algorithm. Chan et al and Yan et al [51,52] also
proposed a neural network–based rule discovery system that
consisted of a neural network–based classification unit and
rule-based extraction unit. There are some studies that optimized
the ANN parameters through a particle swarm optimization
technique. For example, Ling et al [53], Phyo et al [36,54,55],
and San et al [56] proposed a new hybrid rough neural network,
a VTWNN, a normalized RBFNN, and a combinational neural
logic network with the neural logic AND, OR, and NOT gates,
respectively, where the design parameters of the network were
optimized through a hybrid particle swarm optimization with
wavelet mutation operation. Moreover, Nguyen et al [43,57]
also proposed an ANN that is optimized through a standard
particle swarm optimization strategy. Furthermore, some studies
have investigated extreme learning machines (ELMs). For
instance, Ling et al [58] and San et al [59] proposed a
feedforward ANN trained through an ELM and compared the
result with a feedforward ANN optimized through particle
swarm optimization, multiple regression–based fuzzy inference
system, fuzzy inference system, and linear multiple regression.
Mo et al [60] have also used ELMs and regularized the ELMs
on CGM data. In addition, Nguyen et al [61-63] and Ngo et al
[64] had proposed an optimal BNN algorithm using feedforward
ANN architecture. There are some studies that tried to integrate
a physiological model with ANN. For instance, Bertachi et al
[65] integrated the physiological model of an individual diabetes
patient with an ANN to predict nocturnal hypoglycemia events.
Regarding, hyperglycemia classification and detection, there is
only 1 study by Nguyen et al [38] that uses a feedforward
multilayer ANN trained using different training algorithms, that
is, gradient descent, gradient descent with momentum, scaled
conjugate gradient, and resilient back propagation. Regarding
J Med Internet Res 2019 | vol. 21 | iss. 5 | e11030 | p. 11https://www.jmir.org/2019/5/e11030/
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
GV classification and detection, the reviewed studies had been
performed either for detection purposes or for automated metrics
purposes. For the detection purpose, for example, Wiley et al
[33] proposed Naive Bayes (NB), multilayer perceptron (MLP)
ANN, and SVM models to detect excessive GV on CGM data
and compared the accuracy of the result with the other 2 diabetes
experts. Concerning the automated metrics, Marling et al [66]
had developed an NBC (probabilistic reasoning), an MLP ANN,
and a logistic model tree (DT built using logistic regression),
which could be used to monitor CGM data. Moreover, Marling
et al [32] also proposed an MLP ANN and support vector
regression to develop a consensus perceived GV metric.
Support Vector Machines, Kernel Function, and
Gaussian Process Regression
SVM, kernel function (KF), and Gaussian process regression
have been exploited for hypoglycemia classification and
detection purposes in the reviewed literature. For example,
Georga et al [67] developed a support vector regression for
hypoglycemia prediction and compared the performance with
a feedforward MLP ANN and Gaussian process regression.
Georga et al [68] also proposed support vector regression and
Gaussian process regression for BG prediction so as to indicate
the daily incidences of hyperglycemia and hypoglycemia to the
patients as well as provision of decision support to physicians
in making the decision about treatment and risk of
complications. Moreover, Jensen et al [29,30] developed an
automatic pattern recognition system so as to detect
hypoglycemia incidences retrospectively using CGM data and
thereby to foster a thorough evaluation of past events and
discussion with their caregivers. Jensen et al [28,69] also
proposed a real-time pattern classification model by using
several features from the CGM data so as to detect
hypoglycemia incidences in real-time. Furthermore, Marling et
al [70] proposed a hypoglycemia detection algorithm that
incorporates noninvasive sensor data from fitness bands and
also compared different kernels for the task: linear, Gaussian,
and quadratic kernels. Nuryani et al [71] also proposed a
swarm-based SVM algorithm using the repolarization
variabilities as input so as to detect hypoglycemia incidences.
Genetic Programming and Genetic Algorithm
There is little visibility of GP and GA usage in their nonhybrid
form for BG classification and anomaly detection tasks:
hypoglycemia, hyperglycemia, and GV classification and
detection. However, there are some studies that use these
techniques in their hybrid form. For example, Ling et al
[44,72,73] developed a hypoglycemia detection algorithm using
a GA-based multiple regression coupled with a fuzzy inference
system. The study exploited the GA so as to optimize the fuzzy
rules, membership function of the fuzzy inference system, and
also model parameters of the regression.
Random Forest
RF and DT have been mostly used in the context of
hypoglycemia classification and detection tasks. For example,
Eljil et al [27] proposed DTs using different techniques, namely,
C4.5, J4.8, REPTree, bagging, and the cost-sensitive version
of J4.8. Jung et al [74] also proposed DTs using new predictor
variables using CGM data. Moreover, Jung et al [34] proposed
a DT- and SVM-based prediction model using self-monitored
BG. Zhang et al [35] also proposed a new approach using the
classification tree to predict the occurrences of acute
hypoglycemia during intravenous insulin infusion before the
actual hypoglycemic events take place.
Hidden Markov Model
Generally, HMM is used to model an environment that could
better describe the evolution of the individual BG dynamics. In
this regard, there are some studies that use HMM to develop
model-based BG anomaly classification and detection
algorithms. For example, Zhu et al [15,75] studied an approach
for automatic detection of anomalies in individual BG data,
using a model trained with historical data containing daily
normal measurements. The trained Markovian world tries to
analyze the incoming BG data and flags if it deviates from what
is known by the model.
Hybrid and Ensemble Models
Hybridization approaches have been extensively used when
looking for performance improvement by exploiting the
advantage from 2 or more different approaches [16]. In this
regard, there are some attempts in the reviewed articles which
tried merging different approaches for enhanced performance
in hypoglycemia classification and detection. For example,
hybridization of an ANN with other techniques is demonstrated
in some of these studies. Chan et al [76] developed a hybrid
system that consisted of an ANN and a GA and also compared
the performance with MLP ANN and classical statistical
algorithms. Ghevondian et al [77] proposed a novel hybrid
system of a fuzzy neural network ANN estimator to predict the
BG profile and hypoglycemia incidences. San et al [78]
proposed a hybrid system using an ANFIS and compared the
performance with the wavelet neural network, feedforward
ANN, and multiple regression. There is also some literature that
tries to hybridize the SVM with other techniques. For example,
Nuryani et al [39,79] proposed a hybrid fuzzy SVM and
investigated the applicability of 3 KFs: radial basis, exponential
radial basis, and polynomial function for the task. Moreover,
Nuryani et al [40,80] also further developed a novel strategy
using a hybrid particle swarm-based fuzzy SVM technique.
Fuzzy reasoning models are also tested in some of the studies.
For example, Ling et al [81] developed a hybrid particle
swarm-optimization–based fuzzy reasoning model, where the
fuzzy rules and the fuzzy-membership functions are optimized
through a hybrid particle swarm optimization with wavelet
mutation. The model is also compared with feedforward ANN
and multiple-regression models. Mathews et al [46] developed
a hybrid model using a fuzzy inference system with multiple
regression, where the fuzzy rules are optimized through a GA.
The study also compares the performance of the developed
system with an ANN whose parameters are optimized through
particle swarm optimization. In addition, San et al [82] proposed
a hybrid system based on rough sets concepts and neural
computing. The study has compared various hybrid approaches
trained through hybrid particle swarm optimization with wavelet
mutation including the rough BBNN, BBNN, rough feedforward
ANN, wavelet neural network, SVM with an RBF, and
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conventional feedforward ANN. Ling et al [45] also proposed
an alarm system based on the hybrid neural logic network with
multiple regression. Lai et al [83] developed a fuzzy inference
system for hypoglycemia detection, where the system parameters
are optimized through an intelligent optimizer.
Owing to the complexity of BG dynamics, it remains difficult
to achieve an accurate result in every circumstance. One model
can have better accuracy in some circumstances and the other
model can achieve better accuracy where the first model fails
to achieve a comparable result. Therefore, it is natural to look
for possibilities to exploit the strengths from these different
models to achieve better accuracy in most of the circumstances,
which lead to ensemble approaches [16]. An ensemble approach
is generally favored when one is interested to merge 2 or more
different models for improved performance. In this regard, there
are some studies that try to combine 2 different models looking
for performance improvement in the overall system. In this
regard, Daskalaki et al [84] proposed an early warning system,
for both hyperglycemia and hypoglycemia, using RNN and AR
with output correction module models. Moreover, the study
investigated the performance improvement from the combined
use of both RNN and AR with an output correction module.
Moreover, Botwey et al [31] proposed combining an AR model
with output correction and an RNN based on different data
fusion schemes including the Dempster-Shafer evidential theory,
GAs, and GP.
Conclusions
Despite the complexity of BG dynamics, there are many
attempts to capture hypoglycemia and hyperglycemia incidences
and the extent of an individual GV using different approaches.
Recently, because of the ubiquitous nature of self-management
mHealth apps, sensors and wearables have paved the way for
the continuous accumulation of self-collected health data, which
in turn contributed for the widespread research of machine
learning applications in these tasks. In the reviewed articles,
generally, the anomaly classification and detection approaches
could be categorized as either model (process)–based or
classifier (rule)–based approaches. Hypoglycemia classification
and detection has been given more attention than hyperglycemia
and GV detection, which might be because of its serious
complication and the comparable complexity involved. The
state-of-the-art indicates that various classes of machine learning
have been developed and tested in these tasks. Regarding
hypoglycemia classification and detection, feedforward ANNs,
hybrid systems, SVM, DT, GA, adaptive neural fuzzy inference
system, NARX, and NAR, Gaussian process regression, DBN,
and BNN have been developed and tested. These techniques
have explored various kinds of input parameters, notably BG,
heart rate, QT interval, insulin, diet, physical activity, galvanic
response, and skin impedance. Concerning hyperglycemia
classification and detection, RNN, GP, HMM, feedforward
ANN, GA, and hybrid systems have been developed and tested,
exploring various types of input parameters including BG,
insulin, heart rate, and QT interval. GV detection is a recent
development, which has great importance in quantifying factors
associated with hypoglycemia and hyperglycemia incidence.
In this regard, there is some research and development involving
machine learning techniques, for example, the feedforward
ANN, NBC, and SVM.
Most of these studies have used a theoretical threshold suggested
either by the literature or physicians and various concerned
bodies such as the American Diabetes Association. However,
the problem here is that some patients might feel no symptoms
at the specified threshold, and it may vary from patient to
patient. Therefore, a model should consider such differences
among the patients (intra- and intervariability) and also track
its temporal change over time. Moreover, the studies should
give more emphasis on the TL and various types of inputs used.
Furthermore, researchers should give proper emphasis to
develop anomaly classification and detection models, which
are capable of justifying and reporting the underlying cause, as
either due to patient controllable or patient uncontrollable
parameters. Generally, we foresee that these developments might
encourage researchers to further develop and test these systems
on a large-scale basis.
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Multimedia Appendix 1: Analysis of reported parameters, data characteristics, machine 
learning class, and performance metrics  
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Figure 5: Types of input variables used in the studies. The outer ring, middle ring and inner rings depicts the type of 
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Figure 6: Classes of machine learning used in hypoglycaemia classification and detection. 
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Figure 8: Classes of machine learning used in glycaemic variability classification and detection. 
Performance metrics 
 
Figure 9: Depicts the type of performance metrics used in the studies. The outer ring, middle ring and inner rings 
depicts the type of performance metrics used in hypoglycaemia, hyperglycaemias and glycaemic variability 





































Multimedia Appendix 2: Detail on reported accuracy, inputs and 
performance metrics used, and machine learning categorization. 
Table 1: Data extracted from the literatures included in the study. 
Ref. Subject Type of input Data Format/Data source Input Pre-
processing 
Class of Machine Learning Performance 
Metrics 
[1] 16 Real (14.6±1.5 years 
of age) 
BG, rate of change of heart rate, Corrected QT 
interval of electrocardiogram signal, Rate of change 
of corrected QT interval 
Department of Health, Government of Western 
Australia, Yellow Spring Instrument for BG 
 
N/A 
Hybrid-(feed-forward neural network and genetic 
algorithm) 
Sensitivity and specificity 
[2] & 
[3] 
16 Real (14.6±1.5 years 
of age) 
BG, rate of change of heart rate, Corrected QT 
interval of electrocardiogram signal, Rate of change 
of corrected QT interval 
HypoMon (Hypoglycemia Monitor from AIMedics Pty, 
Ltd.) to measure the required physiological parameters, 
Yellow Spring Instrument to measure BG. 
N/A 
Hybrid-(feed-forward neural network, rule discovery, and 
genetic algorithm) 
Sensitivity and specificity 
[4] 10 Real (2 male & 8 
female, 11-70 years of 
age) 
BG (past and present), Rate of change of BG American Hospital in Dubai-Medtronic CGM & 
Insulin Pump 
Differencing BG Values Decision trees Accuracy, sensitivity and 
specificity 
[5] 
10 Real (2 male & 8 
female, 11-70 years of 
age) 
Subcutaneous glucose measurements, insulin, and 
carbohydrate intake 
American Hospital in Dubai-Medtronic CGM & 
Insulin Pump N/A 
Artificial Neural Networks (ANN), Time- Sensitive ANN 
(TS-ANN), Time Delay Neural Network (TDNN), 
Nonlinear Autoregressive Network with exogenous inputs 
(NARX), Distributed Time Delay Neural Network 
(DTDNN), and Nonlinear Autoregressive Network (NAR).) 
Root mean squared error, 
sensitivity, specificity, 
and Accuracy 
[6] 15 Real (3 women and 
12 men whose ages 
ranged from 19 to 65 
years (average, 40.3 – 
13.5 years)) 
Glucose profile, meals, insulin intake, and physical 
activities (exercise), sleep 
Guardian  Real-time CGM system (Medtronic 
Minimed Inc., Northridge, CA), SenseWear  armband 
(BodyMedia  Inc., Pittsburgh, PA) physical activity 
monitor 
N/A Support vector for regression (SVR), feed-forward 
multilayer perceptron (MLP) and Gaussian processes (GP) 
regression  
Sensitivity, precision, and 
time lag 
[7] 15 Real Glucose, rate of meal glucose appearance, plasma 
insulin concentration, meal-derived glucose inserted 
in plasma, energy expenditure, hour of day 
Guardian  Real-time CGM system (Medtronic 
Minimed Inc., Northridge, CA), SenseWear  armband 
(BodyMedia  Inc., Pittsburgh, PA) physical activity 
monitor 
N/A Support vector regression (SVR) or Gaussian processes 
(GP) regression 
Standard deviation of the 
RMSE and correlation 
coefficient, sensitivity 
[8] 12 real (6 normal & 6 
T1DM)-6 males & 6 
females aged 26 ± 3 
years) 
Measured BGLs, skin impedances, heart rates N/A Normalization A novel fuzzy neural network estimator algorithm (FNNE)-
a parallel combination of fuzzy inference mechanism (FIM) 
and a multi-layered neural network  




10 Real (all male, age 
44 ± 15 years) 
Current CGM reading, first derivative of the current 
CGM reading and the reading before, Time since last 
insulin injection, Linear regression, Skewness, 
Kurtosis of the CGM readings in multiple intervals,  
CGM device (Guardian RT®, Minimed Inc., USA), 
emoCue Glucose 201+ glucose analyzer (HemoCue®, 
Ängleholm, Sweden) 
Reconstruction of CGM data 
using spline interpolation  and 
a rough feature elimination, 
using fast SEPCOR algorithm. 




10 Real (all male, age 
44 ± 15 years) 
Current CGM reading, first derivative of the current 
CGM reading and the reading before, Time since last 
insulin injection, Linear regression, Skewness, 
Kurtosis of the CGM readings in multiple intervals, 
CGM device (Guardian RT®, Minimed Inc., USA), 
emoCue Glucose 201+ glucose analyzer (HemoCue®, 
Ängleholm, Sweden) 
Reconstruction of CGM data 
using spline interpolation  and 
a rough feature elimination, 
using fast SEPCOR algorithm. 
Support vector machine Sensitivity, and 
specificity 
[13] 21 Real BG, Meal, Rate of decrease from a peak and absolute 
level of the BG at the decision point 
Diagnostic (professional) CGM devices N/A Decision trees Accuracy, sensitivity, and specificity 
[14] 1 Real (Male) Glucose levels right before meals (G1), Glucose 
levels after more than 5 hours (G2), Time interval (T), 
Average Fasting glucose level (AG1), The rate of 
decrease in [Glu], Ratio of current level to average 
Self-Monitored Blood Glucose (SMBG) Extraction and representing 
temporal change information,  Decision tree and SVM Accuracy 
[15] 8 Real (five male, three 
female aged 35 +_ 13.5 
years (mean +-SD)) 
ECG Signal information Portable apparatus was developed to record the EEG-
To record the EEG signal, a digitalization module was 
developed that was linked to a palmtop PC, 
Amplitude Normalization and 
Transformation (FFT). 







BG, heart rate (HR), corrected QT interval of the 
ECG signal, change of HR, and the change of 
corrected QT interval 
skin surface biosensor electrodes for the measurement 
of physiological parameters, Yellow Spring Instruments 
(YSI) used for collection of reference BG 
Normalization  and linear 
correction analysis.. 
Genetic algorithm (GA)-based multiple regression with 
fuzzy inference system (FIS) 
Sensitivity and specificity 
[19] 16 Real (children-
14.6±1.5 years) 
BG, heart rate and the corrected QT interval of the 
electrocardiogram (ECG) signal 
skin surface biosensor electrodes for the measurement 
of physiological parameters, Yellow Spring Instruments 
(YSI) used for collection of reference BG 
Normalization  
Hybrid particle-swarm-optimization-based fuzzy-reasoning 
model,  Feed-Forward Neural Network (FFNN) 
Sensitivity and specificity 
[20] 15 Real (children-
14.6±1.5 years) 
BG, heart rate and the corrected QT interval of the 
electrocardiogram (ECG) signal 
skin surface biosensor electrodes for the measurement 
of physiological parameters, Yellow Spring Instruments 
(YSI) used for collection of reference BG 
Normalization  and 
Partitioning of the input. 
Hybrid rough set based neural network (RNN) Sensitivity and specificity 
[21] 15 Real (children-
14.6±1.5 years) 
BG, electrocardiogram signal (heart rate (HR) & 
corrected QT interval (QTc), change of heart rate ( 
HR) and corrected QT interval ( QTc)) 
skin surface biosensor electrodes for the measurement 
of physiological parameters, Yellow Spring Instruments 
(YSI) used for collection of reference BG 
Correlation analysis Multiple regression (MR)-based combinational neural logic 
approach - Combinational neural logic network (NLN-
feedforward neural network (FFNN) & rule based logic) 
Sensitivity and specificity 
[22] 16 Real (children-
14.6±1.5 years) 
BG, heartrate (HR), corrected QT interval of ECG 
(QTc),change of heartrate (ΔHR), and change of 
corrected QT interval of ECG(ΔQTc), 
skin surface biosensor electrodes for the measurement 
of physiological parameters, Yellow Spring Instruments 
(YSI) used for collection of reference BG 
Normalization Single-hidden Layer Feedforward neural Network (SLFN) 
with L hidden nodes (Extreme learning machine(ELM)-
based neural network) 
Sensitivity and specificity 
[23] 1 Real (middle-aged 
male) 
BG, Insulin, meals, heart rate (HR), galvanic skin 
response (GSR), and skin and air temperatures (ST 
and AT). 
Medtronic insulin pump & Dexcom CGM system, 
smart phone (reported meals, sleep & exercise), Fitness 
band, Basis Peak (heart rate (HR), galvanic skin 
response (GSR), & skin and air temperatures (ST & 
AT)) 
Feature extraction and 
selection- using greedy feature 
selection 
Support vector machines (SVM) Sensitivity, specificity, 
precision and recall 
[24] 5 real BG, heart rate(HR),corrected QT interval, change of  
HR and change  of  corrected QT interval N/A Linear correction analysis 
Multiple regression with fuzzy inference system(FIS), 
Neural network. Parameters optimized through genetic 
algorithm (GA), particle-swarm optimization respectively. 
Sensitivity and specificity 
[25] N/A Blood Glucose (CGM) 
N/A N/A 
Single-hidden Layer Feedforward neural Network (SLFN) 
with L hidden nodes (extreme learning machines (ELM) and 
regularized ELM (RELM)) 
Root mean square error 
(RMSE), sensitivity, 
specificity, ROC   
[26] 21 Real (children, 
14.4±1.6 years) 
BG, heart rate, corrected QT interval of the 
ECG signal and skin impedance 
HypoMon, blood glucose (BG) levels were collected as 
reference using Yellow Spring Instruments 




16 Real (children, 
14.4±1.6 years) 
BG, heart rate, corrected QT interval of the 
ECG signal and skin impedance HypoMon, actual blood glucose (BG) levels were 
collected as reference using Yellow Spring Instruments 
Normalization Feed-forward multi-layer neural network (Bayesian neural 
network-Bayesian learning) 
Sensitivity and specificity 
[30] & 
[31] 
5 real (adolescent 
patients between the 
ages of 12 and 18 year 
old) 
BG, EEG responses-the centroid theta frequency and 
the centroid alpha frequency from each channel 
Compumedics system, electromyogram (EMG) signals, 
electrooculogram (EOG) signals, BGLs were acquired 
using Yellow Spring Instruments 
Filtering (IIR highpass filter 
and A notch filter at 50Hz) 
Feed-forward multi-layer neural network (standard particle 
swarm optimization strategy is applied to optimize the 
parameters) 
Sensitivity and 
specificity, ROC Curve 
[32] 5 real (adolescent 
patients between the 
ages of 12 and 18 year 
old) 
BG, EEG responses-the centroid theta frequency and 
the centroid alpha frequency from each channel 
Compumedics system, electromyogram (EMG) signals, 
electrooculogram (EOG) signals, BGLs were acquired 
using Yellow Spring Instruments 
Filtering (IIR highpass filter), 
Feature extraction (Fast 
Fourier Transform (FFT)) 
Feed-forward multi-layer neural network (genetic algorithm 
and Levenberg Marquardt algorithm) 
Sensitivity and 
specificity, ROC Curve 
[33] 5 real BG, Repolarization variabilities- QTeVI, TpTeVI, 
ToTeVI and RTpVI 
Compumedics system, BGLs were acquired using 
Yellow Spring Instruments N/A 
Swarm-based Support vector machine (SVM) (Radial basis 
function (RBF)-standard particle swarm optimization 
strategy is applied to optimize the parameters) 
Sensitivity, specificity, 
and geometric mean 
[34] & 
[35] 
5 real (with age of 
16±0.7 years) 
BG, heart rate, corrected QT (QT c) interval and 
corrected TpTe (TpTec) interval 
Compumedics system, BGLs were acquired using 
Yellow Spring Instruments 
Feature extraction Fuzzy Support Vector Machine - kernel functions (radial 
basis function (RBF), exponential radial basis function 





5 real BG, HR, RTpc, QTc, TpTec, ToTec and QTpc Princess Margaret Hospital in Perth, Australia, with 
approval from Women’s and Children’s Health Service, 
Normalization and feature 
extraction 
Hybrid particle swarm - based fuzzy support vector machine 
(SFisSvm) technique- kernel functions (radial basis function Sensitivity, specificity and geometric mean 
Department of Health, Government of Western 
Australia 
(RBF), exponential radial basis function (ERBF) and 
polynomial function)-hybrid particle swarm optimization 
[38] 15 Real (children) BG, heart rate (HR), corrected QT (QTc), change in 
the heart rate (ΔHR) and change in the QTc interval 
(ΔQTc) 
Compumedics system, BGLs were acquired using 
Yellow Spring Instruments Normalization 
Hybrid particle swarm optimization based normalized radial 
basis function neural network (NRBFNN)- hybrid particle 
swarm optimization with wavelet mutation (HPSOWM) 
Sensitivity and specificity 
[39] & 
[40] 
15 Real (children) BG, heart rate (HR) and corrected QT interval (QTc) Compumedics system, BGLs were acquired using 
Yellow Spring Instruments 
Normalization 
 
Variable translation wavelet neural network (VTWNN)- 
hybrid particle swarm optimization with wavelet mutation 
(HPSOWM) 
Sensitivity and specificity 
[41] & 
[42] 
15 Real (children) BG, heart rate (HR) and the corrected QT interval 
(QTc) 
Compumedics system, BGLs were acquired using 
Yellow Spring Instruments 
Normalization 
 
Evolvable block based neural network (BBNN)- hybrid 
particle swarm optimization with wavelet mutation 
(HPSOWM) 
Sensitivity, specificity, 
ROC Curve, and 
geometric mean value 
[43] 15 Real (children) BG, heart rate (HR) and corrected QT (QTc) Compumedics system, BGLs were acquired using 
Yellow Spring Instruments N/A 
Adaptive neural fuzzy inference system (ANFIS)- hybrid 
particle swarm optimization with wavelet mutation 
(HPSOWM) 
Sensitivity and specificity 
[44] 15 Real (children with 
ages 14.6 ± 1.5 years) 
BG, heart rate (HR) and the corrected QT 
interval (QTc) N/A N/A 
Combinational neural logic network (NLN) - hybrid particle 
swarm optimization with wavelet mutation (HPSOWM) 
Sensitivity and specificity 
[45] 15 Real (children with 
ages 14.6 ± 1.5 years 
BG, HR, QTc,  change in HR and   change in QTc Compumedics system, BGLs were acquired using 
Yellow Spring Instruments 
Rough Set based Pre-
processing 
Hybrid rough-block-based neural network (R-BBNN)- 
hybrid particle swarm optimization with wavelet mutation 
(HPSOWM) 
Sensitivity and specificity 
[46] 15 Real (children with 
ages 14.6 ± 1.5 years 
BG, heart rate (HR) and corrected QT (QTc) Compumedics system, BGLs were acquired using 
Yellow Spring Instruments 
Feature representation using 
unsupervised restricted 
Boltzmann machines (RBM)  
Deep belief network (DBN) block based neural network 
(BBNN)- greedy layer-wise manner training-
backpropagation of error derivatives. 
Sensitivity and specificity 
[47] 16 Real (children with 
ages 14.6 ± 1.5 years 
BG, HR, QTc,  Change in HR and   Change in QTc 
N/A N/A 
ELM trained feed-forward neural network (ELM-FFNN)-
single hidden layer feedforward neural network (FFNN)- 
Extreme Learning Machine (ELM) 
 
Sensitivity and specificity 
[48] N/A BG levels, Slope of changes in BG levels, dose 
response to IV insulin, Insulin titration promptness, 
Cumulated, administered insulin 
MIMIC II (Multiparameter Intelligent Monitoring in 
Intensive Care database II) from the ICUs at Beth Israel 
Deaconess Medical Center, Boston, MA. 
Feature selection and ranking   
Decision tress (Classification tree-C5.0) Sensitivity and specificity 
[49] 16 Real (children with 
ages 14.6 ± 1.5 years 
BG, heartrate (HR), corrected QT interval of the 
electrocardiogram (ECG) signal (QTc), change of 
HR, and change of QTc 
Princess Hospital for Children in Perth, Western 
Australia, Australia. The actual BG levels were 
collected as reference using the Yellow Spring 
Instruments 
N/A 
Fuzzy inference system (FIS)- multi-objective optimization 
approach- wavelet mutated differential evolution optimizers 
Sensitivity and specificity 
[50] 23 real (17 to 70 years 
of age) 
Glucose and insulin Medtronic insulin pumps (Medtronic MiniMed Inc., 
Northridge, CA, USA) combined with a real-time CGM 
system under normal daily living conditions Smoothening and Filtering 
Adaptive data-driven models (autoregressive with output 
correction – cARX, & a recurrent neural network – RNN)-
Data fusion techniques (Dempster-Shafer Evidential Theory 
(DST),Genetic Algorithms (GA), & Genetic Programming 
(GP)- teacher-forced, real-time, recurrent learning 
algorithm 
RMSE, time lag (TL), 
correlation coefficient, 
and receiver operating 
characteristic (ROC) 
curve 
[51] 23 real (17 to 70 years 
of age) 
Glucose and insulin Medtronic insulin pumps (Medtronic MiniMed Inc., 
Northridge, CA, USA) combined with a real-time CGM 
system under normal daily living conditions N/A 
Hybrid-autoregressive with an output correction 
module/recurrent neural network (cARN)-based EWS, 
recurrent neural network (RNN)- teacher-forced, real-time, 
recurrent learning algorithm 
Root mean square error, 






Hidden Markov model (HMM)- Baum-Welch algorithm 
that belongs to the family of Expectation Maximization 
algorithms, Forward-Backward algorithm 
Precision, false positives 
rates, Recall 
[53] 10 real (adolescent) BG, HR, PR, QTC, RTC, TPTEC, time domain 
(Mean RR interval (MeanRR), standard deviation of 
the RR interval index (SDNN), root mean square of 
successive RR interval differences(RMSSD), 
Percentage of consecutive RR intervals that differ by 
more than 50 ms (pNN50), HRV triangular index 
(HRVi), Baseline width of the RR interval histogram 
evaluated through triangular interpolation (TINN)) & 
frequency domain, Total spectral power (TotalPw), 
Ratio between LF and HF components (LF/HF))  
During the study period, ECG signals were 
continuously recorded by a medical device called 
Compumedics with the sampling rate of 512 Hz, while 
actual blood glucose was collected as reference using 





Normalization & interpolation Multilayer feed-forward neural network- Levenberg-
Marquardt (LM) algorithm-error back propagation learning 
method 
Sensitivity & specificity, 





Hidden Markov model (HMM)- Baum-Welch algorithm 
that belongs to the family of Expectation Maximization 
algorithms, Forward-Backward algorithm 
Precision, false positives 
rates, recall 
[55] 11 patients (9 female 
and 2 male patients 
ranged in age from 26 
to 67 years) 
Mean amplitude of glycemic excursion (MAGE), i) 
excursion frequency. ,ii) distance traveled and along 
with physicians’ variability classification for that day 
Medtronic Paradigm® insulin pumps with Real-Time 
continuous glucose monitors. GlycoMark™. The CGM 
data were extracted from the Medtronic CareLink® 
database into clinical diabetes research database. 
N/A 
Naive Bayes classifier (probabilistic reasoning), a multilayer 
perceptron (ANN), and a logistic model tree (decision tree 
built using logistic regression) 
Accuracy (classifier vs. 
physician glycemic 
variability classifications 
of daily CGM charts) 
[56] 19 patients (14 female 
and 5 male patients, 
ranging in age from 17 
to 71 (mean 47) years) 
MAGE, Excursion Frequency (EF), Distance 
Traveled (DT), SD, Area Under the Curve, Central 
Image Moments, Eccentricity, Discrete Fourier 
Transform, Roundness Ratio, Bending Energy, 
Direction Codes, Maximum Slope 
Medtronic Paradigm® insulin pumps with Real-Time 
continuous glucose monitors. GlycoMark™. The CGM 
data were extracted from the Medtronic CareLink® 
database into our clinical diabetes research database. 
Smoothing and feature 
selection (greedy forward 
selection and greedy backward 
elimination)  
Multilayer perceptrons (MPs) and support vector machines 
for regression (SVR)- Gaussian kernel, Back propagation Accuracy, sensitivity, and specificity 
[57] 11 patients (9 female 
and 2 male patients 
ranged in age from 26 
to 67 years) 
Minimum Input-Direction Codes, Excursion 
Frequency, Standard Deviation, and Distance 
Traveled 
Medtronic Paradigm® insulin pumps with Real-Time 
continuous glucose monitors. GlycoMark™. The CGM 
data were extracted from the Medtronic CareLink® 
database into clinical diabetes research database. 
Smoothing using cubic splines 
& feature selection (Pearson’s 
Correlation Coefficient & t-
test, wrapper approach using 
greedy backward elimination) 
Naive Bayes (NB), Multilayer Perceptron (MP), and 
Support Vector Machine (SVM)- Gaussian kernel, Back 
propagation, grid search optimization Accuracy, sensitivity, and specificity 
[58] 6 real patients (Two 
male, and four female) 
SMBG (finger sticks), CGM, Insulin, Physical 
activity, Diet, illness and other life events 
OhioT1DM Dataset (Medtronic 530G insulin 
pumps, Medtronic Enlite CGM sensors, Reported life-
event data via a custom smartphone app and provided 
physiological data from a Basis Peak fitness band.) 
N/A Artificial Neural Network (ANN) Accuracy, sensitivity, and specificity 
[59] 8 real patients (12 and 
18 years age) 
Frequency features of occipital lobe (Centroid 
frequency and spectral entropy) 
Yellow Spring Instruments  for BG and  Compumedics 
System for EEG Fast Fourier Transform Bayesian regularized neural network Sensitivity and specificity 
 
Table 2: Reported accuracy from the literatures. 
Ref. 
Reported System performance  
(Accuracy, Sensitivity, Specificity & Time horizon) Comment 
[1] Neural network trained with Genetic algorithm (NN-GA) (Sensitivity (75.57%), 
Specificity (57.68%)) 
Compared with Neural network trained with a Levenberg Marquardt (LM) algorithm, Statistical 
Regression (SR), Fuzzy Regression (FR), Genetic Programming (GP), and Genetic Programming based 
Fuzzy Regression (GP-FR) for detecting hypoglycemia incidences. 
[2] & 
[3] 
GA-NN based  Rule discovery  ( Specificity (79.11%)  and Sensitivity (52.01%)) Compared with Fuzzy regression (FR), Genetic programming (GP), fuzzy regression based Genetic 
programming (FR-GP), neural network trained with back propagation ( NN-BP) and Neural network 
trained genetic algorithm (NN-GA) for hypoglycemia detection. 
[4] Decision tree - 30 min Hypoglycemia prediction-(Sensitivity (86.47%), Specificity 
(96.22), Accuracy (95.97%)) 
Compared various decision tree approach J4.8, REPTree, Bagging, J4.8 and cost sensitive version of 
J4.8 using CGM data. 
[5] Time-Sensitive ANN (TS-ANN) - 30 min hypoglycemia prediction-(average 
specificity (98.2%), average accuracy (97.6%) and average sensitivity (80.19%) with a 
maximum value reaching 93%). 
Hypoglycemia were detected by BG prediction using neural network NARX (Nonlinear Autoregressive 
network with Exogenous Inputs) trained with Bayesian Regularization back propagation training 
Algorithm. 
[6] Support vector for regression - Free-living conditions (Nocturnal hypoglycemic – 
Sensitivity (30-min - 94% & 60-min -  94%) with time lags of 5.43 min and 4.57 min, 
respectively. Diurnal – without physical activities sensitivity (30-min - 92% and 60-min 
Compared Support vector for regression, Multilayer perceptron, and Gaussian processes for prediction 
of nocturnal and diurnal hypoglycemic events. The study also investigated the effect of Physical 
activity information.  
-96%), with both time lags being less than 5 min. Diurnal – with physical activities 
decreases the sensitivity by 8% and 3%, respectively. Both nocturnal and diurnal 
predictions show a high (> 90%) precision. 
[7] SVR - (30min- Average prediction Accuracy Hypo (87%) & Hyper (96%), 60min- 
Hypo (83%) & Hyper (94%)). GP  (30min- Average prediction Accuracy Hypo (88%) 
& Hyper (95%), 60min- Hypo (85%) & Hyper (88%)) 
Compared support vector regression (SVR) and Gaussian process (GP). 
[8] Fuzzy neural network estimator algorithm (FNNE) predicted the onset of 
hypoglycemia episodes with a mean error of 0.071 (p < 0.03)  
The FNNE algorithm was developed as a parallel combination of fuzzy inference mechanism (FIM) 
and a multi-layered neural network architecture. 
[9] & 
[10]  
Support vector regression (SVR) - with an event-based sensitivity of 100%, the 
algorithm produced only one false hypoglycemia detection. The sample-based 
sensitivity and specificity levels were 78% and 96%, respectively 




SVR with CGM- sample based Sensitivity 81%,  and Specificity 93% Compared CGM with and without SVR algorithm for hypoglycemia detection. 
[13] Classification and Regression Tree (CART) - Average accuracy (79.8%), average 
sensitivity (80.05%), overall specificity (79.9%)- The model was able to detect almost 
80% of hypoglycemic events 15 min in advance 
Investigated Classification and Regression Tree (CART) for hypoglycemia detection. 
[14] Decision tree (Accuracy (65.2%)) & Linear SVM (Accuracy (68.4%)) Investigated DT and SVM for hypoglycemia prediction. 




Genetic algorithm based multiple regression with fuzzy inference - Sensitivity (75%) 
and specificity (over 50%) 
Genetic algorithm is used to optimize regression and fuzzy rules. Compared various order multiple 
Regression Fuzzy Inference System and Linear multiple regression with various number of inputs. 
[19] Hybrid particle-swarm-optimization-based fuzzy-reasoning - Advanced hypoglycemic 
episodes (sensitivity (85.71%) & specificity (79.84%)) and hypoglycemic episodes 
(sensitivity (80.00%) & specificity (55.14%)) 
Investigated the applicability of PSO to optimize fuzzy rules and membership function of FRM. 
Compared with neural network and a regression method.  
[20] Hybrid rough set based neural network (RNN) - sensitivity (76.74%) and specificity 
(52.73%) whereas conventional FWNN with no rough approximation gives sensitivity 
(69.77%) and specificity (49.09%)  
Hybrid particle swarm optimization with wavelet mutation (HPSOWM) is used to optimize RNN. 
Compared the result with a feedforward neural network (FWNN). 
[21] Combinational neural logic network with multiple regression - Sensitivity (79.07%) 
and Specificity (53.64%) 
Hybrid particle swarm optimization with wavelet mutation (HPSOWM) is used to optimize the model 
parameters. Compared the result with neural logic network (NLN), wavelet neural network (WNN), 
feedforward neural network (FFNN), and multiple regression (MR) 
[22] Extreme learning machine (ELM)-based neural network -Sensitivity (78.00%)  and 
Specificity (60.00%)  
Compared the result with Particle swarm optimization based neural network (PSO-NN), Second order 
multiple regression fuzzy inference system (MR- FIS), Fuzzy inference system (FIS) and Linear 
multiple regression (LMR). 
[24] Fuzzy inference system with multiple regression - Sensitivity (80%) and Specificity 
(72.5%) 
The fuzzy membership functions and rules are optimized using genetic algorithm. Compared the result 
with particle swarm optimization neural network. 
[25] Extreme learning machines (ELM)-the mean Specificity (95.4%) and the standard 
deviation (1.13) 
Proposed and compared extreme learning machines (ELM) and regularized ELM (RELM) to predict 
hypoglycemia incidences using CGM readings.  
[26] Feedforward multi-layer neural network - Sensitivity (95.16%) and specificity 
(41.42%) 





Bayesian neural network - Sensitivity (83.46%) and specificity (63.88%) Investigated the applicability of Bayesian neural network to detect hypoglycemia from real time 
physiological parameters.  
[30] & 
[31] 
Particle Swarm Optimization-based Neural Network - Sensitivity (82%) and 
Specificity (63%) Neural network parameters are optimized through PSO.  
[32] Neural network - Sensitivity (75%) and specificity (60%) Investigated the possibility of combining Genetic Algorithm and Levenberg-Marquardt for neural 
network training in hypoglycemia detection algorithm.  
[33] Swarm-based support vector machine (SVM) - Sensitivity (82.14% ) and Specificity 
(60.19%)  
Investigated SVM-RBF for hypoglycemia detections and optimized the parameters through PSO.  
[34] & 
[35] 
Fuzzy Support Vector Machine (FSVM-RBF) - (Sensitivity (74.19%), Specificity 
(58.54%), Accuracy (63.20%)) 
Compared FSVM and SVM along with three different kernel functions (radial basis function (RBF), 
exponential radial basis function (ERBF) and polynomial function) for the classification purpose.  
[36] & 
[37] 
Hybrid particle swarm - based fuzzy support vector machine (SFisSvm) - Sensitivity 
(75.19%), Specificity (83.71%) and Geometric mean (79.33%)  
The FIS and SVM parameters are optimized using a hybrid particle swarm optimization with wavelet 
mutation algorithm. The swarm based SVM uses RBF kernel (SSvmR), sigmoid kernel (SSvmS) and 
linear kernel function (SSvmL). 
[38] Normalized radial basis function neural network (NRBFNN) - Sensitivity (76.74% ) 
and Specificity (51.82%) 
The parameters of NRBFNN are optimized through hybrid particle swarm optimization with wavelet 
mutation (HPSOWM). Compared the result with radial basis function network, feedforward neural 
network, and multi regression. 
[39] & 
[40] 
Optimized variable translation wavelet neural network (VTWNN) - Sensitivity (79.07 
%) and Specificity (50.00 %) 
The parameters of VTWNN are optimized using a hybrid particle swarm optimization with wavelet 
mutation. Compared the result with wavelet neural network (WNN), feedforward neural 
network(FWNN2) and multi regression(MR) 
[41] & 
[42] 
Block Based Neural Network  (BBNN) - Sensitivity (76.74%) and specificity (50.91%) The BBNN parameters are optimized through a hybrid particle swarm optimization with wavelet 
mutation. Compared the result with feedforward neural networks and multiple regression. 
[43] Adaptive neural fuzzy inference system (ANFIS) – Sensitivity (79.09%) and specificity 
(51.82%) 
The membership function and network parameters are optimized using swarm optimization with 
wavelet mutation (HPSOWM). Compared the result with fuzzy inference system (FIS), wavelet neural 
network (WNN), feedforward neural network (FWNN) and multiple regression (MR) 
[44] Combinational neural logic network (NLN) - Sensitivity (76.74%) and specificity 
(54.55%) 
The NLN parameters are trained by hybrid particle swarm optimization with wavelet mutation 
(HPSOWM). Compared the result with neural logic network (NLN), wavelet neural network (WNN), 
feedforward neural network (FFNN) and multi regression (MR). 
[45] Hybrid rough-block-based neural network (R-BBNN) - Sensitivity (83.72%) and 
specificity (51.91%) 
The R-BBNN parameters are optimized through a hybrid particle swarm optimization with wavelet 
mutation. Compared the result with BBNN, rough feedforward neural network (R-FWNN), wavelet 
neural network (WNN), SVM with a radial basis function and conventional feedforward neural network 
(FWNN). 
[46] Deep belief network (DBN) – Sensitivity (80.00%)  and specificity (50.00%) Compared the result with Block based neural network (BBNN), wavelet neural network (WNN), 
feedforward neural network (FFNN), and multiple regression (MR) models. 
[47] Extreme learning machine based feed-forward neural network (ELM-FFNN) - 
Sensitivity (78%) and specificity (60%) 
Compared the result with multiple regression fuzzy inference system (MRFIS), Feed-forward neural 
network trained with particle swarm optimization (FFNN-PSO), Fuzzy inference system, and Linear 
multiple regression. 
[48] Classification tree - Predicted 82.12% of acute hypoglycemic events (specificity: 
89.87%; positive predictive value: 88.72%; accuracy: 86.00%) and 76.99% of severe 
acute hypoglycemic events (80.53%, 74.31%, and 78.76% respectively). 
Investigated towards predicting hypoglycemia incidence during intravenous (IV) insulin infusion for 
ICU patients. 
[49] Fuzzy inference system (FIS) - Sensitivity (75%) and Specificity (55%) FIS parameters are tuned by an intelligent optimizer with two wavelet-mutated differential evolutions 
(WM-DE) engines. Compared the result with Neural network based rule discovery, linear multiple 
regression, evolved multiple regressions, feed-forward neural network (FFNN), and evolved fuzzy 
inference system. 
[50] Hypoglycemia (EWS (correct alarms=100%, detection time=16.7min, daily false 
alarms=0.08), EWS-DST (CA=100,DT=18.4min, DFA=1.0), EWS-
GA(CA=100,DT=13min, DFA=0.17), EWS-GP(CA=100,DT=12.3min,DFA=0.17)), 
Hyperglycemia (EWS (CA=100,DT=14.7,DFA=0.8), EWS-DST 
(CA=100,DT=11.6min,DFA=0.73), EWS-GA (CA=100,DT=12.1min,DFA=0.73),  
EWS-GP(CA=100,DT=12min, DFA=0.33)) 
Investigated into advanced data fusion schemes for merging output of different hypo/hyperglycemia 
predictors such as Dempster-Schafer Evidential Theory and Evolutionary Methods (Genetic 
Algorithms, Genetic Programming). Compared the results with cARX and RNN models, and a linear 
fusion of the two. 
[51] ARX-based system - hypoglycemic (hyperglycemic) event prediction (accuracy of 
100.0% (100.0%), detection time of 10.0 (8.0) min, and daily false alarms of 0.7 (0.5)). 
cARX-based system - Accuracy 100.0% (100.0%), DT 17.5 (14.8) min, & DFA 1.5 (1.3) 
and, RNN-based system Accuracy 100.0% (92.0%), DT 8.4 (7.0) min, and DFA 0.1 
(0.2). The hybrid cARN-based EWS - 100.0% (100.0%) prediction accuracy, detection 
16.7 (14.7) min in advance, and 0.8 (0.8) daily false alarms. 
Investigated the performance improvement using a hybrid autoregressive with an output correction 
module/recurrent neural network (cARN). Compared performance of ARX, cARX, and RNN models. 
 
[53] Feed forward multi-layer neural network - Sensitivity (70.59%), specificity (65.38%) 
and geometric mean (67.94%) 
Compared the ANN model with Linear Discriminant Analysis (LDA) and K-Nearest Neighbors (KNN) 
on hyperglycemia detection. 
[52, 54] Hidden Markov model (HMM) - The simulation result show that the proposed model is 
capable of detecting anomalies (i.e., no false positives) from the CGM readings based 
on historical data (in the presence of reasonable changes in the patient’s daily routine).  
Investigated the applicability of Hidden Markov model (HMM) in anomalies detection from the change 
in the patient’s daily lifestyle.  
[55] Naïve Bayes classifier - matched the physicians’ classifications 85% of the time that they 
were internally consistent and in agreement with each other. 
Investigated into the applicability of characterizing blood glucose variability using new metrics with 
CGM data using Naïve Bayes classifier. 
[56] SVR models - When applied to 262 different CGM plots as a screen for excessive GV 
(accuracy (90.1%), sensitivity (97.0%), and specificity (74.1%).   
Investigated the applicability of developing a perceived glycemic variability metric using SVM model. 
Compared the result with mean amplitude of glycemic excursion, standard deviation, distance travelled, 
and excursion frequency. 
[57] Multilayer Perceptron (MP)- (Accuracy 93.8%, Sensitivity 86.6%, Specificity 96.6%), 
Support Vector Machine (SVM)- (Accuracy 91.4%, Sensitivity 80.0%, Specificity 
96.0%), Naive Bayes (NB) - (Accuracy 91.9%, Sensitivity 88.3%, Specificity 93.3%). 
Investigated on an automatic glycemic variability detection and compared Naive Bayes (NB), 
Multilayer Perceptron (MP), and Support Vector Machine (SVM) models using CGM data. 
[58] Artificial Neural network – Average Accuracy (90%), Average sensitivity (72.23%) and 
Average specificity (92%) 
Developed Artificial Neural Network integrated with physiological model for both blood glucose 
prediction and classification of hypoglycemia and further compared the result with existing models. 
[59] Bayesian regularized neural network - Sensitivity (73%) and specificity (60%) Investigated and tested a feed-forward neural network trained with Bayesian regularization algorithm.  
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Background: Semisupervised and unsupervised anomaly detection methods have been widely used in various applications to
detect anomalous objects from a given data set. Specifically, these methods are popular in the medical domain because of their
suitability for applications where there is a lack of a sufficient data set for the other classes. Infection incidence often brings
prolonged hyperglycemia and frequent insulin injections in people with type 1 diabetes, which are significant anomalies. Despite
these potentials, there have been very few studies that focused on detecting infection incidences in individuals with type 1 diabetes
using a dedicated personalized health model.
Objective: This study aims to develop a personalized health model that can automatically detect the incidence of infection in
people with type 1 diabetes using blood glucose levels and insulin-to-carbohydrate ratio as input variables. The model is expected
to detect deviations from the norm because of infection incidences considering elevated blood glucose levels coupled with unusual
changes in the insulin-to-carbohydrate ratio.
Methods: Three groups of one-class classifiers were trained on target data sets (regular days) and tested on a data set containing
both the target and the nontarget (infection days). For comparison, two unsupervised models were also tested. The data set consists
of high-precision self-recorded data collected from three real subjects with type 1 diabetes incorporating blood glucose, insulin,
diet, and events of infection. The models were evaluated on two groups of data: raw and filtered data and compared based on
their performance, computational time, and number of samples required.
Results: The one-class classifiers achieved excellent performance. In comparison, the unsupervised models suffered from
performance degradation mainly because of the atypical nature of the data. Among the one-class classifiers, the boundary and
domain-based method produced a better description of the data. Regarding the computational time, nearest neighbor, support
vector data description, and self-organizing map took considerable training time, which typically increased as the sample size
increased, and only local outlier factor and connectivity-based outlier factor took considerable testing time.
Conclusions: We demonstrated the applicability of one-class classifiers and unsupervised models for the detection of infection
incidence in people with type 1 diabetes. In this patient group, detecting infection can provide an opportunity to devise tailored
services and also to detect potential public health threats. The proposed approaches achieved excellent performance; in particular,
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the boundary and domain-based method performed better. Among the respective groups, particular models such as one-class
support vector machine, K-nearest neighbor, and K-means achieved excellent performance in all the sample sizes and infection
cases. Overall, we foresee that the results could encourage researchers to examine beyond the presented features into other
additional features of the self-recorded data, for example, continuous glucose monitoring features and physical activity data, on
a large scale.
(J Med Internet Res 2020;22(8):e18912) doi: 10.2196/18912
KEYWORDS
type 1 diabetes; self-recorded health data; infection detection; decision support techniques; outbreak detection system; syndromic
surveillance
Introduction
Anomaly or novelty detection problem involves identifying the
anomalous or novel instances, which exhibit different
characteristics, from the rest of the data set and has been widely
used in various applications including machine fault and sensor
failure detection, prevention of credit card or identity fraud,
health and medical diagnostics and monitoring, cyber-intrusion
detection, and others [1-7]. The term anomaly was precisely
coined by Hawkins [8] as “observations that deviate much from
the other observations so as to arouse suspicions that it could
be generated by a different process.” Anomalousness is usually
described as point, contextual, and collective, depending on
how the degree of anomaly is computed [1,7,9]. On the basis
of the necessity of having labeled data instances for the
respective class, the anomaly detection problem can be
approached as supervised, semisupervised, and unsupervised
[3,7,9-11]. Supervised anomaly detection, for example,
multiclass classification, requires labeled data instances for both
the target and the nontarget (anomaly) classes. This
characteristic makes it impractical for tasks where there is
difficulty in either finding enough samples for the anomaly
class, that is, poorly sampled and unbalanced data, or
demarcating boundaries of the anomaly class [7,10,12].
Moreover, anomalies could also evolve over time, and what is
known today might not be valid through time, making the
characterization of anomalies class more challenging. In this
case, semisupervised anomaly detection, that is, one-class
classification, is preferred given that it only requires
characterizing what is believed to be normal (target data
instances) to detect the abnormal (nontarget data instances) [7].
Under certain circumstances, for example, medical domain,
obtaining and demarcating the anomalous (nontarget) data
instances can become very difficult, expensive, and time
consuming, if not impossible [7,13]. For instance, assume a
health diagnostic and monitoring system that detects health
changes in an individual by tracking the individual’s
physiological parameters, where the current health status is
examined based on a set of parameters, and raises a notification
alarm when the individual health deteriorates [12]. In such a
system, it becomes feasible to rely on a method that can be
trained using only the regular or normal day measurements
(target days) so as to detect deviation from normality [12,14].
This is because demarcating the exact boundaries between
normal and abnormal health conditions is very challenging given
that each pathogen has a different effect on the individual
physiology. The one-class classifiers–based anomaly detection
methods can be roughly grouped into 3 main groups: boundary
and domain-based, density-based, and reconstruction-based
methods based on how their internal function is defined and the
approach used for minimization [3,10,12,13,15,16]. These
models take into account different characteristics of the data
set, and depending on the data set under consideration, these
models could achieve different generalization performance,
overfitting, and bias [12]. Unlike supervised and semisupervised
anomaly detection methods, unsupervised methods do not
require labeled instances to detect the anomaly (nontarget)
instances because they rely on the entire data set to determine
the anomalies and can be another possible alternative to
semisupervised anomaly detection methods [7,10,12]. One of
the drawbacks of unsupervised methods is that they require
significant amount of data to achieve comparable performance.
Both semisupervised and unsupervised methods have been used
in various applications to detect anomalous instances [1,7,10,16].
In particular, these methods have been popular in the medical
domain owing to their suitability for such applications, where
there is lack of a sufficient data set for the other classes [13].
Accordingly, considering the difficulty and expense of obtaining
enough sample data sets for the infection days from people with
type 1 diabetes, a one-class classifier and unsupervised models
are proposed for detecting infection incidence in people with
type 1 diabetes.
Type 1 diabetes, also known as insulin-dependent diabetes, is
a chronic disease of blood glucose regulation (hemostasis), and
is caused by the lack of insulin secretion from pancreatic cells
[17,18]. In people with type 1 diabetes, the incidence of infection
often results in hyperglycemia and frequent insulin injection
[19-26]. Infection-induced anomalies are characterized by
violation of the norm of blood glucose dynamics, where blood
glucose remains elevated despite taking a higher amount of
insulin injection with less carbohydrate consumption [19].
Despite these potentials, there have been very few studies that
focused on detecting infection incidence in individuals with
type 1 diabetes using a dedicated personalized health model.
Therefore, the objective of this study was to develop an
algorithm, that is, a personalized health model that can
automatically detect the incidence of infection in people with
type 1 diabetes using blood glucose levels and
insulin-to-carbohydrate ratio as input variables. For this, a
one-class classifier and unsupervised models are proposed. The
model is expected to detect any deviations from the norm
because of infection incidences considering elevated blood
glucose level (hyperglycemia incidences) coupled with unusual
changes in the insulin-to-carbohydrate ratio, that is, frequent
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insulin injections and unusual reduction in the amount of
carbohydrate intake [19]. Three groups of one-class classifiers
and two unsupervised density-based models were explored. A
detailed theoretical description of the proposed models is given
in Multimedia Appendix 1 [1,7-16,27-37]. The anomaly
detection problem studied in this paper can be regarded as a
contextual anomaly, where the ratio of insulin-to-carbohydrate
is the context and the average blood glucose level is the
behavioral attribute. This is mainly because of the fact that
elevated blood glucose levels do not always signify being
anomalies without looking at the context of the ratio of
insulin-to-carbohydrate in this case. Throughout the paper, the
term object is used to describe a feature vector incorporating
the number of parameters under consideration. For example, an
object X can define a specific event of an individual blood
glucose dynamics at a specified time index k and is represented
by a feature vector Xk=(xk,1, xk,2), where xk,1 represents the ratio
of total insulin-to-total carbohydrate and xk,2 represents the
average blood glucose level in a specific time-bin (interval)
around k.
Methods
A group of one-class classifiers and unsupervised models were
tested and compared. The one-class classifier incorporates 3
groups: boundary and domain-based, density-based, and
reconstruction-based methods. The boundary and domain-based
method contains support vector data description (SVDD) [27],
one-class support vector machine (V-SVM) [28], incremental
support vector machine [29], nearest neighbor (NN) [12], and
minimum spanning tree (MST) [15]. Density-based method
includes normal Gaussian [32], minimum covariance Gaussian
[38], mixture of Gaussian (MOG) [32], Parzen [39], naïve
Parzen [32], K-nearest neighbor (KNN) [12,30], and local outlier
factor (LOF) [31]. The reconstruction-based method includes
principal component analysis (PCA) [12,32], K-means [32],
self-organizing maps (SOM) [12,32], and auto-encoder networks
[12]. In addition, the unsupervised models were also tested,
including the LOF [31,33] and the connectivity-based outlier
factor (COF) [33,34]. The input variables, average blood glucose
levels and ratio of total insulin (bolus) to total carbohydrate,
used in training and testing of the models were selected in
accordance with the description provided by Woldaregay et al
[19], and the ratio was calculated by dividing the total insulin
with the total carbohydrate within a specified time-bin. The data
set consists of high-precision self-recorded data collected from
3 real subjects (2 males and 1 female; average age 34 [SD 13.2]
years) with type 1 diabetes. It incorporates blood glucose levels,
insulin, carbohydrate information, and self-reported infections
cases of influenza (flu) and, mild and light common cold without
fever, as shown in Table 1. Exemplar data depicting the model’s
input features for 2 specific patient years with and without
infection are shown in Figures 1-4, and a more detailed
description of the input features for 10-patient years with and
without infection incidences can be found in Multimedia
Appendix 2 [12,19]. The data were resampled and imputed in
accordance with the description provided by Woldaregay et al
[19], and the preprocessed data were smoothed using a moving
average filter of 2 days’ (48 hours) window size to remove
short-term and small-scale features [19,40,41]. Feature scaling
was carried out using min-max scaling [42] to normalize the
data between 0 and 1, which is important to ensure that larger
parameters do not dominate the smaller ones. The data sets are
labeled as target and nontarget data sets, where the target data
sets include all the self-recorded normal period of the year and
the nontarget data set includes only the self-reported infection
periods when the individual was sick. Accordingly, the one-class
classifiers were trained using only the target data sets containing
the regular or normal period of the year and tested using both
the target and the nontarget (infection period) data sets. For the
unsupervised models, all the data sets containing both the target
and the nontarget data sets were presented during testing. The
hyperparameters of most of the one-class classifiers were
optimized using a consistency approach [43]. Models such as
naïve Parzen and Parzen were optimized using the leave-one-out
method. For MST, the entire MST was used. For PCA, the
fraction of variance retained from the training data set was set
to be 0.67. The models were evaluated based on different
characteristics including data nature (with and without filter),
data granularity (hourly and daily), data sample size, and
required computational time. All the experiments were
conducted using MATLAB 2018b (Mathworks, Inc). Most of
the models were implemented using ddtools, prtools, and
anomaly detection toolbox, which are MATLAB toolboxes
[32,33,35].
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Table 1. Equipments used in the self-management of diabetes.
Self-managementPatients
HbA1c
b (%)Body weight (kg)DietInsulin administrationBGa
6.083Carbohydrate in grams record-
ed in the Diabetes Diary mobile
app; level 3 (advanced carb
counting)
Insulin Pen (multiple bolus and 1-
time basal in the morning) recorded
in the Diabetes Diary mobile app
Finger pricks recorded in
the Diabetes Diary mobile
app and Dexcom CGMc
Subject 1
7.377Carbohydrate in grams record-
ed in the Spike mobile app;
level 3 (advanced carb count-
ing)
Insulin Pen (multiple bolus [Huma-
log] and 1-time basal [Toujeo] before
bed) recorded in the Spike mobile app
Finger pricks recorded in
the Spike mobile app and
Dexcom G4 CGMc
Subject 2
6.270Carbohydrate in grams record-
ed in pump information; level
3 (advanced carb counting)
Medtronic MinMed G640 insulin







cCGM: continuous glucose monitoring.
Figure 1. Daily scatter plot of average blood glucose levels versus total insulin (bolus) to total carbohydrate ratio for a specific regular or normal patient
year without any infection incidences.
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Figure 2. Hourly scatter plot of average blood glucose levels versus total insulin (bolus) to total carbohydrate ratio for a specific regular or normal
patient year without any infection incidences.
Figure 3. Daily scatter plot of average blood glucose levels versus total insulin (bolus) to total carbohydrate ratio for a specific patient year with an
infection incidence (flu).
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Figure 4. Hourly scatter plot of average blood glucose levels versus total insulin (bolus) to total carbohydrate ratio for a specific patient year with an
infection incidence (flu).
Model Evaluation
The performance of the one-class classifiers was evaluated using
20 times 5-fold stratified cross-validation. For both daily and
hourly cases, the user-specified outlier fraction threshold ß was
set to 0.01 such that 1% of the training target data are allowed
to be classified as outlier or get rejected [12]. Class imbalance
was mitigated by oversampling of the nontarget data sets through
random sampling [44]. Performance was measured using the
area under the receiver operating characteristic (ROC) curve
(AUC), specificity, and F1-score [45-48]. The AUC, specificity,
and F1-score were reported as the average (SD) of twenty times
five-fold stratified cross-validation rounds. AUC is the result
of integration (summation) of the ROC curve over a range of
possible classification thresholds [49]. It is regarded as robust
(insensitive) when it comes to the presence of data imbalance;
however, it is impractical for real-world implementation because
it is independent of a single threshold [48]. Specificity measures
the ratio of correctly classified negative samples from the total
number of available negative samples [50]. Thus, it depicts the
proportion of infection days (nontarget samples) that are
correctly classified as such to the total number of infection days
(period). It is only used to examine how the model performs in
regard to the nontarget class (infection days). F1-score is the
harmonic mean of precision and recall, where the value ranges
from 0 to 1, and high F1 scores depict high classification
performance [45]. F1-score is considered appropriate when
evaluating model performance with regard to one target class
and in the presence of unbalanced data sets [10,46-48]. The
models were further compared based on various criteria, which
can contribute to the implementation of the models in real-world
settings, including computation time, sample size, number of
user-defined parameters, and sensitivity to outliers in the training
data sets:
• Computation time: this characteristic defines the amount
of time taken to train and test the model. Regarding personal
use, response time is crucial for acceptance of the services
by a wide range of users. Furthermore, with regard to the
outbreak detection settings, this is an important parameter
given that a system that uses data from many participants
needs to have an acceptable response time. However, in
real-world applications, the training phase can be performed
in an offline mode, which makes the testing response time
very crucial.
• Sample size: this characteristic specifies the minimum
amount of training data required to generate an acceptable
performance. This is an important factor given that the
system relies on self-recorded data; it is difficult to
accumulate a large set of data for an individual initially.
• Number of user-defined parameters: this characteristic
defines the complexity of the model. It is simpler and less
data are required to estimate a model with fewer parameters.
This is an important factor because it is easier for an
individual to implement the simple model compared with
the complex model.
• Sensitivity to outliers in the training data sets: this
characteristic defines how the model estimation is affected
by outliers in the training set. This is a crucial characteristic
because the model training depends on self-reported data,
which are highly dependent on the accuracy of the user data
registration. It is possible that the user might forget to report
some infection incidence and hence might be considered
as target data sets and be used as a training data set.
Furthermore, errors incurred during manual registration of
data can also affect model generalization.
Data Collection and Ethical Declaration
The study protocol has been submitted to the Norwegian
Regional Committees for Medical Health Research Ethics
Northern Norway for evaluation and was found exempted from
regional ethics review because it is outside the scope of medical
research (reference number: 108435). Written consent was
obtained, and the participants donated the data sets. All data
from the participants were anonymized.
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The models were evaluated based on two different versions of
the same data set: raw and filtered. The input variables to the
models were the average blood glucose levels and the ratio of
total insulin (bolus)-to-total carbohydrate. The necessary
computational time for both training and testing of the models
was also estimated. A comparison of the classifiers was carried
out taking into account their performance, necessary sample
size for producing acceptable performance, and computational
time. These models were further compared based on their
theoretical guarantee provided for robustness to outliers in the
target data set and based on their complexity. In addition, these
classifiers were compared with the unsupervised version of
some selected models.
Model Evaluation
Model training and evaluations were carried out on an individual
basis taking into account different characteristics of the data,
specified time window or resolution (hourly and daily), and
nature of the data (raw data and its smoothed version). For daily
evaluation, we compared the performance of the models on raw
data and its smoothed version with a 2-day moving average
filter. For hourly evaluation, we compared the performance of
the model on a smoothed version of the data set. The purpose
of the comparison was to study the performance gain achieved
by removing short-time noises from the data set through
smoothing. The average and SD of AUC, specificity, and
F1-score are computed and reported for each model. The top
performing models from each category are highlighted in italics
within each tables.
Semisupervised Models
The regular or normal days were labeled as the target class data
set and the infection period as the nontarget class data set. Three
groups of one-class classifiers were trained on the target class
and tested on a data set containing both the target and the
nontarget classes. In addition to the data characteristics stated
above, resolution and data nature, the one-class classifier
performance was also assessed taking into account the required
sample object size to produce acceptable data description. In
this direction, we consider four groups of sample size: 1 month,
2 months, 3 months, and 4 months data sets. In the model
evaluation, the data set containing the infection period was
presented during testing. The evaluation was carried out based
on 20 times 5-fold stratified cross-validation. The performance
of the model was reported as the average and SD of AUC,
specificity, and F1-score of the rounds. A score plot of each
model for both the hourly and the daily scenarios using the
smoothed version of the data can be found in Multimedia
Appendix 3, where the models were trained on random 120
regular or normal days of the patient year and tested over the
whole year.
Daily
As can be seen in Tables 2 and 3 below (see also Multimedia
Appendix 4), the performance of the models generally improves
as the size of the sample increases. The models performed well
with respect to the raw data sets; however, the performance
significantly improved with the smoothed version of the data.
The results indicate that the sample size greatly affects the model
performance and that there is a larger variation in performance
when the training data set is small. Generally, it can be seen
that the models generalize well with the 3-month data set (90
sample objects) and further improve after 3 months. In general,
on average, with both the raw and smoothed data sets, the
boundary and domain-based method performed better with a
small sample size. As the sample size increased, all the three
groups produced comparable descriptions of the data. From
each respective category, models such as V-SVM, K-NN, and
K-means performed well across all the sample sizes.
First Case of Infection (Flu)
The boundary and domain-based method achieved a better
description of the data with a small sample size when compared
with the other two groups. However, as the sample size
increased, all the three groups achieved relatively comparable
descriptions of the data. Specific models such as V-SVM, K-NN,
and K-means performed better from their respective group.
Regarding the raw data, as seen in Table 2, all the models failed
to generalize from the 1-month data set as compared with the
large sample objects, that is, 3 months, which was expected:
1. From the boundary and domain-based method, V-SVM
performed better in all the sample sizes and achieved
comparable performance even with 60 objects and improved
significantly afterward. SVDD produced a comparable
description with higher sample sizes, that is, 3 months and
later.
2. From the density-based method, K-NN performed better
in all the sample sizes and achieved better performance
even with 60 objects. Naïve Parzen produced comparable
performance with higher sample sizes, that is, 3 months
and later.
3. From the reconstruction-based method, K-means achieved
better performance for all sample sizes.
Smoothing the data, as shown in Table 3, improved the model
performance even with 30 sample objects:
1. From the boundary and domain-based method, V-SVM
achieved better performance in all sample sizes.
2. From the density-based method, K-NN achieved better
performance for all sample sizes, minimum covariance
determinant (MCD) Gaussian produced a comparable
description with 30 and 60 sample objects, and naïve Parzen
achieved comparable description of the data with 4-month
sample objects.
3. Regarding the reconstruction-based method, PCA achieved
good performance with 30 and 60 sample objects, whereas
K-means performed better with larger sample objects.
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Table 2. Average (SD) of area under the receiver operating characteristic curve, specificity, F1-score for the raw data set (without smoothing), and
different sample size. Fraction=0.01.















































































































































































































aAUC: area under the receiver operating characteristic curve.
bSVDD: support vector data description.
cIncSVDD: incremental support vector data description.
dV-SVM: one-class support vector machine.
eItalicized values indicates the top performing models.
fNN: nearest neighbor.
gMST: minimum spanning tree.
hMOG: mixture of Gaussian.
iMCD: minimum covariance determinant.
jK-NN: K-nearest neighbor.
kLOF: local outlier factor.
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lPCA: principal component analysis.
mSOM: self-organizing maps.
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Table 3. Average of area under the receiver operating characteristic curve, specificity, and F1-score for smoothed version of the data with a 2-day
moving average filter and different sample size. Fraction=0.01.



























































































































































































aAUC: area under the receiver operating characteristic curve.
bSVDD: support vector data description.
cIncSVDD: incremental support vector data description.
dV-SVM: one-class support vector machine.
eItalicized values indicates the top performing models.
fNN: nearest neighbor.
gMST: minimum spanning tree.
hMOG: mixture of Gaussian.
iMCD: minimum covariance determinant.
jK-NN: K-nearest neighbor.
kLOF: local outlier factor.
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lPCA: principal component analysis.
mSOM: self-organizing maps.
Second Case of Infection (Flu)
The boundary and domain-based method achieved better
performance with a small sample size compared with the density
and reconstruction-based methods. However, as the sample size
increased, all the three groups achieved comparable
performance. The detailed numerical values of comparison are
given in Multimedia Appendix 4. Specific models such as
V-SVM, K-NN, and K-means performed better from their
respective group. Regarding the raw data, all the models failed
to generalize from the 1-month data set as compared with the
higher sample objects, that is, 3 months (Multimedia Appendix
4):
1. From the boundary and domain-based method, SVDD,
MST, and incremental support vector data description
(incSVDD) performed better with a larger sample object,
and V-SVM achieved better description with 30 sample
objects.
2. From the density-based method, all the models exhibited
similar performance. Naïve Parzen and K-NN, with only
60 sample objects, achieved comparable performance with
the higher sample objects.
3. From the reconstruction-based method, K-means achieved
better performance for all sample sizes.
Smoothing the data significantly improved the performance of
the model even with 30 objects, compared with the raw data
(Multimedia Appendix 4):
1. From the boundary and domain-based method, the V-SVM
achieved higher performance in all the sample sizes.
2. From the density-based method, LOF achieved better
description with small sample objects, and K-NN produced
better description with all the sample sizes. Gaussian
families achieved improved and comparable performance
with increased sample objects. Among them, K-NN with
only 60 objects achieved comparable performance with
larger sample objects.
3. Regarding the reconstruction-based method, K-means and
SOM achieved better performance, whereas K-means
performed better in all the sample sizes.
Third Case of Infection (Flu)
The boundary and domain-based method achieved better
performance with a small sample size compared with the density
and reconstruction-based methods. However, as the sample size
increased, all the three groups produced comparable
descriptions. The detailed numerical values of comparison are
given in Multimedia Appendix 4. Specific models such as
V-SVM, MST, LOF, and PCA performed better from their
respective group. Regarding the raw data, surprisingly, in
contrast to the previous two infection cases, all the models
achieved higher generalization from the 1-month data set
(Multimedia Appendix 4):
1. From the boundary and domain-based method, SVDD,
V-SVM, MST, and incSVDD performed better in all the
cases, with MST achieving better performance.
2. From the density-based method, normal and MCD Gaussian
achieved better description of the data with 1-month sample
objects. K-NN and LOF performed better with sample sizes
larger than 1-month sample objects, and LOF outperformed
all sample sizes. The LOF with only 60 objects achieved
comparable performance with the higher sample objects.
3. From the reconstruction-based method, PCA produced
better description for all sample sizes, whereas K-means
and SOM achieved comparable performance with sample
size larger than 1-month sample objects.
Smoothing the data allowed the models to generalize well and
significantly improved the performance of the model even with
30 objects, compared with the raw data (Multimedia Appendix
4):
1. From the boundary and domain-based method, the V-SVM
and MST achieved higher performance in all the sample
sizes, whereas V-SVM outperformed all the models.
2. From the density-based method, the Gaussian families,
LOF, and K-NN achieved better performance, whereas LOF
achieved better performance in all sample sizes.
3. Regarding the reconstruction-based method, K-means and
PCA achieved better performance, whereas PCA performed
better in all the sample sizes.
Fourth Case of Infection (Flu)
The boundary and domain-based method achieved better
performance with small sample sizes compared with the density
and reconstruction-based methods. All the three groups
improved with increasing sample size. The detailed numerical
values of comparison are given in Multimedia Appendix 4.
Specific models such as V-SVM, LOF, and K-means performed
better from their respective group. Regarding the raw data,
surprisingly, in contrast to all the previous three infection cases,
all the models achieved higher generalization from the 1-month
data set (Multimedia Appendix 4):
1. From the boundary and domain-based method, SVDD,
V-SVM, and incSVDD performed better for all the sample
sizes.
2. From the density-based method, MCD Gaussian performed
better with a 1-month sample size, and all the models
produced comparable descriptions as the sample size
increased, whereas the LOF performed better for all the
sample sizes.
3. From the reconstruction-based method, PCA performed
relatively better for all the sample sizes, and K-means and
SOM achieved comparable performance with a larger
sample size.
Smoothing the data significantly improved the model
performance even with 30 objects compared with the raw data
(Multimedia Appendix 4):
1. From the boundary and domain-based method, the V-SVM
achieved higher performance in all the sample sizes. As the
sample size increased, the incSVDD and MST achieved
comparable performance.
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2. From the density-based method, K-NN and LOF produced
better descriptions with a 1-month sample size. K-NN
performed better in almost all sample sizes.
3. From the reconstruction-based method, K-means achieved
better performance for all sample sizes.
Hourly
As can be seen in Table 4 (see also Multimedia Appendix 4),
the performance of the model generally improved as more
training sample data were presented. The models produced
comparable performance even with the 1-month data set
compared with the daily scenario. This is mainly because of the
presence of more samples per day (24 samples per day), which
enables the models to reach a better generalization. Generally,
the results indicate that the models generalize well after 2
months. Both the boundary and domain-based method and
reconstruction-based method achieved better performance even
with a 1-month sample size. However, the density-based method
suffers from large variation with 1-month training samples. In
general, the boundary and domain-based method performed
better in all the infection cases compared with the other two
methods. In addition, specific models such as V-SVM, K-NN,
and K-means performed well from their respective groups.
First Case of Infection (Flu)
The boundary and domain-based method achieved better
performance compared with the density and
reconstruction-based methods. As can be seen in Table 4, the
boundary and domain-based method achieved better
generalization from the 1-month data set. Specific models such
as V-SVM, K-NN, and K-means performed better from their
respective group:
1. From the boundary and domain-based method, V-SVM
achieved better description in all sample sizes, whereas
SVDD, incSVDD, and V-SVM achieved comparable
performance with a larger sample size.
2. From the density-based method, Gaussian families and
naïve Parzen performed better at large sample sizes, whereas
K-NN and LOF achieved better performance in all the
sample sizes. K-NN outperformed all the models.
3. From the reconstruction-based method, K-means performed
better in all the sample sizes, and all the other models
performed better with larger sample sizes.
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Table 4. Average (SD) of area under the receiver operating characteristic curve, specificity, F1-score for the smoothed version of the data with a 48-hour
moving average filter and different sample size. Fraction=0.01.









































































































































































aAUC: area under the receiver operating characteristic curve.
bSVDD: support vector data description.
cIncSVDD: incremental support vector data description.
dV-SVM: one-class support vector machine.
eItalicized values indicates the top performing models.
fNN: nearest neighbor.
gMST: minimum spanning tree.
hMOG: mixture of Gaussian.
iMCD: minimum covariance determinant.
jK-NN: K-nearest neighbor.
kLOF: local outlier factor.
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lPCA: principal component analysis.
mSOM: self-organizing maps.
Second Case of Infection (Flu)
The boundary and domain-based method and
reconstruction-based method achieved better performance for
all sample sizes compared with the density-based method.
Specifically, the boundary and domain-based method achieved
better generalization from the 1-month data set. The detailed
numerical values of comparison are given in Multimedia
Appendix 4. Specific models such as V-SVM, K-NN, and
K-means performed better from their respective group:
1. From the boundary and domain-based method, V-SVM
achieved better description for all the sample sizes, and
SVDD, NN, and incSVDD improved with larger training
sample size; however, V-SVM outperformed all the models
for all the sample sizes.
2. From the density-based method, normal and MCD Gaussian
performed better with the 1- and 2-month sample sizes, and
models such as K-NN performed better on all the sample
sizes, whereas naïve Parzen outperformed all the models
with the 3- and 4-month data sets.
3. From the reconstruction-based method, K-means produced
better description for all the sample sizes and the
auto-encoder and SOM performed better with larger sample
sizes.
Third Case of Infection (Flu)
Generally, in comparison, all the groups performed better at
large training sample sizes; however, the boundary and
domain-based method achieved better performance with small
training sample sizes. It achieved comparable generalization
from the 1-month data set. The detailed numerical values of
comparison are given in Multimedia Appendix 4. Specific
models such as V-SVM, families that utilize nearest neighbor
distance (K-NN and LOF), and PCA performed better from
their respective group:
1. From the boundary and domain-based method, SVDD, NN,
MST, incSVDD, and V-SVM achieved better performance
at larger training sample sizes, whereas V-SVM
outperformed all the models for all the sample sizes.
2. From the density-based method, the Gaussian families,
K-NN, LOF, and naïve Parzen achieved better performance
at larger training sample sizes, whereas K-NN and LOF
outperformed all the models for all the sample sizes.
3. From the reconstruction-based method, K-means, PCA,
auto-encoder, and SOM achieved better performance at
larger training sample sizes, whereas PCA performed better
for all sample sizes.
Fourth Case of Infection (Flu)
Generally, in comparison, all the group performed better at large
training sample size; however, the boundary and domain-based
method achieved better performance with small training sample
sizes, for example, 1-month data set. It achieved comparable
generalization from the 1-month data set. The detailed numerical
values of comparison are given in Multimedia Appendix 4.
Specific models such as V-SVM, Gaussian families (Gaussian,
MOG, and MCD Gaussian), and PCA performed better from
their respective groups:
1. From the boundary and domain-based method, NN,
incSVDD, and V-SVM achieved better performance at
larger training sample sizes, whereas V-SVM outperformed
all the models for all the sample sizes.
2. From the density-based method, Gaussian families, K-NN,
LOF, and naïve Parzen achieved better performance at
larger training sample sizes, whereas Gaussian families
outperformed all the models for all the sample sizes.
3. From the reconstruction-based method, K-means, SOM,
auto-encoder, and PCA achieved better performance at
larger training sample sizes, whereas PCA performed better
for all sample sizes.
Average Performance Across all the Infection Cases
The average performances of the models across all the infection
cases for different sample sizes, levels of data granularity
(hourly and daily), and nature of data (raw and smoothed) are
shown in Tables 5-7. In general, the boundary and domain-based
method performed better than the other two groups in both daily
and hourly smoothed data sets; however, all the groups achieved
comparable performance with respect to the daily raw data set.
Specific models such as V-SVM, K-NN, and K-means
performed better in all these circumstances.
Daily Raw Data Set
Regarding the daily raw data set, as shown in Table 5, specific
models such as V-SVM, MCD Gaussian, K-NN, and K-means
produced relatively better descriptions of the 1-month data. For
the 2-month sample size, models such as incSVDD, K-NN,
LOF, and K-means achieved better performance. For the
3-month sample size, SVDD, incSVDD, V-SVM, Gaussian,
MCD Gaussian, K-NN, LOF, and K-means produced
comparable descriptions. As expected, SVDD and most of the
density-based method improved with larger training sizes. For
the 4-month sample size, almost all the models produced much
improved performance. In the group comparison, all three
groups produced comparable descriptions in all the sample sizes.
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Table 5. Average performance of each model across all the infection cases for the daily raw data set (without smoothing) and different sample sizes.
Fraction=0.01.


























































































































































































































































aAUC: area under the receiver operating characteristic curve.
bSVDD: support vector data description.
cItalicized values indicates the top performing models.
dIncSVDD: incremental support vector data description.
eV-SVM: one-class support vector machine.
fNN: nearest neighbor.
gMST: minimum spanning tree.
hMOG: mixture of Gaussian.
iMCD: minimum covariance determinant.
jK-NN: K-nearest neighbor.
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kLOF: local outlier factor.
lPCA: principal component analysis.
mSOM: self-organizing maps.
Daily Smoothed Data Set
Regarding the daily smoothed data set, as shown in Table 6,
almost all models achieved excellent performance and much
improved data description compared with the daily raw data
set. As shown in Table 6, specific models such as V-SVM,
K-NN, and K-means produced excellent descriptions of the data
for all the sample sizes; however, V-SVM achieved superior
performance compared with these models. In the group
comparison, the boundary and domain-based method produced
excellent description of the data for all sample sizes.
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Table 6. Average performance of each model across all the infection cases for the daily smoothed data set (with filter) and different sample size.
Fraction=0.01.



























































































































































































































































































































aAUC: area under the receiver operating characteristic curve.
bSVDD: support vector data description.
cIncSVDD: incremental support vector data description.
dV-SVM: one-class support vector machine.
eItalicized values indicates the top performing models.
fNN: nearest neighbor.
gMST: minimum spanning tree.
hMOG: mixture of Gaussian.
iMCD: minimum covariance determinant.
jK-NN: K-nearest neighbor.
kLOF: local outlier factor.
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lPCA: principal component analysis.
mSOM: self-organizing maps.
Hourly Smoothed Data Set
Regarding the hourly smoothed data set, as shown in Table 7,
almost all the models failed to produce acceptable data
description from the 1-month sample size except V-SVM, which
achieved the best description. The high variability between the
performance of the models with the 1-month hourly data set
could be associated with the high data granularity, and, in fact,
the models require more data sets to capture the high variability
among the data objects. Models such as V-SVM, MCD
Gaussian, and K-means achieved superior performance from
their respective groups. In general, V-SVM outperformed in all
the sample sizes. The density and reconstruction-based models
improved with larger sample size. In the group comparison, the
boundary and domain-based method produced better description
in all the sample sizes, and the density and reconstruction-based
method achieved equivalent performance with larger sample
sizes.
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Table 7. Average performance of each model across all the infection cases for the hourly data set with smoothing and different sample size. Fraction=0.01.



















































































































































































































































































































aAUC: area under the receiver operating characteristic curve.
bSVDD: support vector data description.
cIncSVDD: incremental support vector data description.
dItalicized values indicates the top performing models.
eV-SVM: one-class support vector machine.
fNN: nearest neighbor.
gMST: minimum spanning tree.
hMOG: mixture of Gaussian.
iMCD: minimum covariance determinant.
jK-NN: K-nearest neighbor.
kLOF: local outlier factor.
lPCA: principal component analysis.
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Two density-based unsupervised models were tested and
evaluated on the same set of data as used in the one-class
classifiers: LOF and COF. The average AUC, specificity, and
F1-score were computed after 20 runs. The best performing
thresholds for all the infection cases along with the optimal
value of k (number of neighbors) are given in Table 8. As can
be seen from the table, both the LOF and the COF achieved
better performance on the smoothed data set as compared with
its raw version. In all the infection cases, LOF performed better
than COF. This is mainly because of the characteristics of the
data sets, which fulfill the LOF spherical assumption of neighbor
distribution. Considering the average F1-score across all the
infection cases, LOF achieved 74.7% on the raw daily data,
91.1% on the smoothed daily data, and 72.7% on the hourly
data, whereas COF achieved 71.9% on the raw daily data, 85.8%
on the smoothed daily data, and 68.9% on the hourly data.
However, compared with the one-class classifier, it suffers from
performance degradation mainly because the data are not
distributed uniformly, where some regions may contain high
density and others might be sparse. However, the region of
sparse density does not always signify anomalies (infection
incidence). For example, an individual patient on certain days
might prefer to take little insulin compared with most of the
days and perform heavy physical activity to replace their insulin
needs. This scenario could generate an outlier, a small ratio of
insulin-to-carbohydrate, which will be considered and detected
as outliers by unsupervised models. A detailed score plot of
each model for the different infection cases can be found in
Multimedia Appendix 3.
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Table 8. Average area under the receiver operating characteristic curve, specificity, and F1-score for both with and without smoothed versions of the
data. The parameters kd and kh represent the optimal number of nearest neighbors for the daily and hourly cases, respectively.
Frequencies, density-based methods
4th case of infection
(kd=30, kh=240)
3rd case of infection (kd=30,
kh=240)
2nd case of infection (kd=30,
kh=240)









































aAUC: area under the receiver operating characteristic curve.
bLOF: local outlier factor.
cTk: threshold for the kth month.
dCOF: connectivity-based outlier factor.
Computational Time
Computational time is the amount of time a particular model
needs to learn and execute a given task [12]. It can be regarded
as one of the best performance indicators for real-time systems.
For a real-time application, an optimal model is the one that
achieves superior detection performance with small training
and testing time. Depending on the application, sometimes
models can be trained offline, which makes the training time
less important [12]. In this regard, the computational times of
all the models were estimated and compared with each other.
The computational time was measured for different sample sizes
of the training and testing data sets. The sample size of the
training and testing data includes 240, 480, 720, 960, 1200,
1440, 1680, 1920, 2160, 2400, 2640, and 2880 sample objects
(data points) each. The required computational time for both
training and testing each model is depicted in Figures 5 and 6.
The figures demonstrate a rough estimation of the computational
time, where each model learns the data set and classifies the
sample objects. During the training phase, NN, SVDD, and
SOM took considerable time. For a training sample size of 2880
objects, NN requires 296 times, SVDD requires 206 times, and
SOM requires 42 times the time taken by K-NN on the same
sample size. Generally, as the number of sample objects
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increases, these models require much more time. However,
K-means, Gaussian families, LOF, MST, K-NN, V-SVM, PCA,
auto-encoder, and incSVDD took less time. These models took
almost constant time even when the number of samples
increased. During the testing phase, only the LOF took
considerable time compared with the other models, as can be
seen in Figure 6.
Figure 5. Plot of models’ average computational time for the training phase. The x-axis depicts the sample size, and each label stands for total sample
size divided by 24. The y-axis depicts the computational time required by each model. Gauss: Gaussian; IncSVDD: incremental support vector data
description; K-NN: K-nearest neighbor; LOF: local outlier factor; MCD: minimum covariance determinant; MOG: mixture of Gaussian; MST: minimum
spanning tree; NN: nearest neighbor; NParzen: naïve Parzen; PCA: principal component analysis; SOM: self-organizing maps; SVDD: support vector
data description; V-SVM: one-class support vector machine.
Figure 6. Plot of models’ average computational time for the testing phase. The x-axis depicts the sample size, and each label stands for total sample
size divided by 24. The y-axis depicts the computational time required by each model. Gauss: Gaussian; IncSVDD: incremental support vector data
description; K-NN: K-nearest neighbor; LOF: local outlier factor; MCD Gauss: Gaussian: SOM: self-organizing maps; MOG: mixture of Gaussian;
MST: minimum spanning tree; NN: nearest neighbor; NParzen: naïve Parzen; PCA: principal component analysis; SVDD: support vector data description;
V-SVM: one-class support vector machine.
Discussion
Principal Findings
Anomaly or novelty detection problem has been widely used
in various applications including machine fault and sensor
failure detection, prevention of credit card or identity fraud,
health and medical diagnostics and monitoring, cyber-intrusion
detection, and others [1-3]. In applications related to health and
medical diagnostics and monitoring, the anomaly detection
problem has been used to detect and identify the abnormal health
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state of an individual, for example, detecting abnormal patterns
of heartbeat recorded using an electrocardiogram [1,51-54]. The
omnipresence of various physiological sensors has facilitated
circumstances for individuals to easily self-record health-related
events and data for the purpose of self-informatics and
management [55]. Currently, people are generating huge
amounts of data on a daily basis that can contribute to both
individual and public health purposes [54]. To this end, people
with diabetes are not an exception, generating rich data in both
quality and quantity, which is expected to further improve with
advances in diabetes technologies. These data can provide
valuable information if processed with the right tools and
methodology, and in this regard, particular instance includes
detecting novel or anomalous data points for various purposes.
The availability of labeled data constrains the choice of methods
in the anomaly detection problem [3,9-11]. Supervised anomaly
detection methods are impractical for applications such as
detecting infection incidences in people with type 1 diabetes
for a number of reasons [10,12]. Blood glucose dynamics are
affected by various other factors apart from infection incidences
[19,56,57], and characterization of infection-induced anomalies
(abnormal class) from the normal class [13] is a challenging
task because of the following reasons:
1. There are no well-defined boundaries regarding how
different pathogens affect various key parameters of blood
glucose dynamics, including blood glucose levels, insulin
injections, carbohydrate ingestions, physical activity or
exercise load, and others. This results in poor boundary
demarcation between the normal and abnormal classes.
2. Class boundaries defined for a single pathogen might not
work for the other pathogens because the effect of different
pathogens on the blood glucose dynamics could be different.
3. It is expensive and time consuming to collect
infection-related data to explore and characterize
pathogen-specific class boundaries. This results in
ill-defined class boundaries even for an infection related to
a single pathogen.
4. The degree of effect of the same pathogens on the blood
glucose dynamics could differ between different individuals
because of the difference in individual immunity, which
further complicates the characterization task.
5. Lack of sufficient sample size for both the abnormal and
the normal classes results in poor training and testing data
sample size or imbalanced class problems.
Given these challenges, the best possible approach is to identify
methods that can learn from the normal health state of an
individual and classify abnormalities relying on the boundaries
learnt from the normal health state, which is a one-class
classifier approach. This definitely reduces the challenge
because it only requires the characterization of what is believed
to be a normal health state. For instance, assume a health
diagnostic and monitoring system that detects health changes
in an individual by tracking the individual’s physiological
parameters, where the current health status is examined based
on set of parameters, and raises a notification alarm when the
individual health deteriorates [12]. In such a system, it becomes
feasible to rely on a method that can be trained using only the
regular or normal day measurements (target days) so as to detect
deviation from normality [12,14]. Another possible alternative
approach is to identify a method that does not require any
characterization and labeling of classes, which is unsupervised
methods [7]. Accordingly, considering the previously mentioned
challenges, one-class classifiers and unsupervised models were
proposed for detecting infection incidence in people with type
1 diabetes. The objective was to develop a personalized health
model that can automatically detect the incidence of infection
in people with type 1 diabetes using blood glucose levels and
insulin-to-carbohydrate ratio as input variables. The model is
expected to detect any deviations from the norm as a result of
infection incidences considering blood glucose level
(hyperglycemia incidences) coupled with unusual changes in
the insulin-to-carbohydrate ratio, that is, frequent insulin
injections and unusual reduction in the amount of carbohydrate
intake [19]. A personalized health model based on one-class
classifiers and unsupervised methods was tested using blood
glucose levels and the insulin-to-carbohydrate ratio as a bivariate
input. The result demonstrated the potential of the proposed
approach, which achieved excellent performance in describing
the data set, that is, detecting infection days from the regular or
normal days, and, in particular, the boundary and domain-based
method performed better. Among the respective group, particular
models such as V-SVM, K-NN, and K-means achieved excellent
performance in all the sample sizes and infection cases.
However, the unsupervised approaches suffer performance
degradation compared with the one-class classifier mainly
because of the atypical nature of the data, which are not
distributed uniformly, where some regions may contain high
density and others might be sparse (Multimedia Appendix 2).
There are rare events (sparse region) of blood glucose dynamics
that are a normal response; however, the unsupervised methods
can still detect and flag false alarms including the following:
1. Carbohydrate action: a situation in which the ratio of
insulin-to-carbohydrate is small and the blood glucose levels
are high (hyperglycemia), Carb Action-Quadrant 1 in
Figure 7. This is a normal response to blood glucose
dynamics as consumption of more carbohydrates and less
insulin intake can derive blood glucose dynamics into the
hyperglycemia region (high blood glucose levels) if there
is no physical activity session. A typical example of this
particular situation is holiday seasons, where people
consume too many carbohydrates.
2. Physical activity action: despite a small ratio of
insulin-to-carbohydrate, the blood glucose levels still drop
to low levels (hypoglycemia), PA Action-Quadrant 2 in
Figure 7. Normally, a small ratio of insulin-to-carbohydrate
signifies that the patient consumed more carbohydrates and
injected less insulin, which normally derives the blood
glucose dynamics into the hyperglycemia region. However,
despite taking more carbohydrates and less insulin, a
rigorous physical exercise can still derive the blood glucose
dynamics into the hypoglycemia region. Therefore, this is
a normal response of blood glucose dynamics as the action
of physical activity or exercise can derive the patient into
hypoglycemic regions even if the patient consumes more
carbohydrates. For example, an individual patient on certain
days might prefer to take little insulin as compared with
most of the days and perform heavy physical activity to
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replace their insulin needs. This scenario could generate an
outlier, a small ratio of insulin-to-carbohydrate, which will
be considered and detected as anomalies by the
unsupervised models. However, this could be mitigated by
incorporating physical activity data as an input variable.
3. Insulin action: the ratio of insulin-to-carbohydrate is large,
that is, high insulin intake and low carbohydrate
consumption, and blood glucose levels are low
(hypoglycemia), Insulin Action-Quadrant 3 in Figure 7.
This is a normal response to blood glucose dynamics as
administration of high insulin with little carbohydrate
consumption can derive the blood glucose dynamics into
the hypoglycemic region.
Figure 7. Quadrants of wellness in people with type 1 diabetes. The figure depicts the 4 possible scenarios of different parameters: carbohydrate action,
insulin action, physical activity action, and abnormality because of metabolic change such as infection and stress. BG: blood glucose; PA: physical
activity.
The drawback of unsupervised methods is that they do not have
any mechanism to handle rare events even if the events are
normal. This is mainly because unsupervised methods define
an anomaly on the basis of the entire data set. However, the
one-class classifier can learn and handle such scenarios
appropriately if presented during the training phase. This is
mainly because one-class classifiers produce a reference
description based on the available normal (target) data set,
including the rare events. With regard to the one-class classifiers,
the boundary and domain-based method achieved a better
description of the data set compared with the density and
reconstruction-based methods, mainly because of the ability of
such models to handle the atypical nature of the data [12].
Detectability of the infection incidence is directly related to the
extent and degree of the effect it induces on the blood glucose
dynamics. The type of pathogen, individual’s immunity, and
hormones involved could play a role in determining the degree
of severity in this regard [19,24,58-62]. To this end, the results
demonstrated that the models were capable of detecting all the
infection incidences that can significantly alter the blood glucose
dynamics, such as influenza. Moreover, infection incidence that
had a moderate effect on the blood glucose dynamics, such as
mild common cold without fever, was also detected. However,
as expected, infection incidences that had almost little effect on
the blood glucose dynamics, such as light common cold without
fever, as reported by the individual patient, were not detected.
Regarding the computational time, NN, SVDD, and SOM took
considerable training time, which typically increased as the
number of sample objects increased. Moreover, compared with
the other models, only LOF and COF took considerable testing
time.
Comparative Analysis of the Methods
Selecting the proper model for implementation in a real-world
setting requires considering different characteristics of the
model. This includes typical model characteristics such as
performance in limited training sample size, robustness to
outliers in the training data, required training and testing time,
and complexity of the model (in terms of the number of model
parameters).
Performance and Sample Size
The sample size, N, is the number of sample objects used during
the training phase and highly affects the generalization power
of the model [12,13]. Models trained with small sample sizes
often fail to produce satisfactory descriptions mainly associated
with the presence of large variance in the sample objects
[3,12,13,63]. To this end, the results indicate that most of the
models fail to make good descriptions with a 1-month (30
objects) data set, mainly with the daily raw data set, as shown
in Figure 8. The figure depicts the average performance of each
model across all the infection cases over the 1- and 4-month
sample sizes. Specifically, MST, Gaussian families, SOM, and
auto-encoders require a considerable amount of training sample
objects to better describe the data. There is some exception, for
instance V-SVM, which produces a satisfactory description of
the 1-month data sets in all the infection cases and data
granularity. Models such as NN and PCA produced the worst
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description in most cases. As the number of training sample
objects increased, all the models improved and produced a
comparable description of the data. As a rule of thumb, for the
daily scenario, a 3-month training sample (90 sample objects)
produces a good description of the data, which can be considered
for real-world applications. Moreover, if smoothing is
considered, a 1-month sample size produces better description
than the 4-month sample size without smoothing, as shown in
Figure 8. However, for the hourly scenario, a 1-month training
sample object produces a comparable description and anything
more than this size will be enough.
Figure 8. Average performance (F1-score) of each model across all the infection cases. AE: auto-encoder; Gauss: Gaussian; IncSVDD: incremental
support vector data description; K-NN: K-nearest neighbor; LOF: local outlier factor; MCD: minimum covariance determinant; MOG: mixture of
Gaussian; MST: minimum spanning tree; NN: nearest neighbor; NP: naïve Parzen; PCA: principal component analysis; SOM: self-organizing maps;
SVDD: support vector data description; V-SVM: one-class support vector machine.
Computational Time
For real-time applications, the time a model takes to learn and
classify the sample object is essential in model selection. Table
9 depicts the rough estimation of average training and testing
time required by different classifiers, both the one-class
classifiers and the unsupervised models, based on 2880 training
and testing sample objects each. Most of the models, as shown
in Figures 5 and 6 and Table 9, require reasonable training and
testing time, except NN, SVDD, and SOM, which took a
considerably longer time. However, it is possible that in some
cases models can be trained offline, which makes the training
time less important. With regard to the testing time, most of the
models executed the classification task in a reasonable time
except COF and one class classifier version of LOF, which
consume considerable time to classify the 2880 objects. The
computational time in these particular models grows
exponentially as the sample size increases, which makes them
resource demanding in a big data setting.
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Table 9. Rough estimation of average training and testing time required by the different classifiers.





















aSVDD: support vector data description.
bIncSVDD: incremental support vector data description.
cMOG: mixture of Gaussian.
dMCD: minimum covariance determinant.
eSOM: self-organizing maps.
fK-NN: K-nearest neighbor.
gLOF: local outlier factor.
hNN: nearest neighbor.
iMST: minimum spanning tree.
jPCA: principal component analysis.
kV-SVM: one-class support vector machine.
lLOF: local outlier factor.
mN/A: not applicable.
nCOF: connectivity-based outlier factor.
Robustness to Outliers in the Training Data Set
The presence of outliers in the training data set could
significantly affect the model’s generalization ability. Outlier
objects are samples that exhibit different characteristics
compared with the rest of the objects in the data set [8,63]. For
instance, an individual might forget a previous infection incident
and could label these days as a regular or normal period during
self-reporting, which could end up being used as target data sets
for training. Another important example could be error recorded
during data registration, that is, carbohydrate, blood glucose
levels, and insulin registration. Such errors could occur during
the manual registration of carbohydrates, associated with
infusion set failures and other similar situations. In this scenario,
an individual could record lower or higher values incorrectly
affecting the input features, for example, ratio of
insulin-to-carbohydrate and blood glucose levels, resulting in
an outlier that could greatly affect the model’s generalization
ability. In this type of situation, a model’s sensitivity to outliers
in the training data is crucial to curb the influence of outliers
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on the accuracy of the description generated. To some extent,
a user-specified empirical rejection rate is incorporated in the
models to reduce the effect of outliers in the training data by
rejecting the most dissimilar objects from the description
generated. For example, a rejection rate of 1% on training data
sets implies that 1% of outliers in the training data set are
rejected. Nevertheless, the sensitivity of models to outliers in
the training data sets differs greatly between models. Among
the models, NN is regarded as the most sensitive model to
outliers in the training data set [12]. The presence of outliers in
the training data changes the shape of the description generated
by the model, forcing a larger portion of the feature space to be
accepted as the target class [10,12]. Furthermore, models that
rely on an estimation of the covariance matrix, for example,
Gaussian families, also suffer from the presence of outliers in
the training data sets [12,36]. However, when equipped with
regularization, Gaussian models can withstand such outliers.
Local density estimators such as Parzen can withstand outliers,
considering the fact that only the local density is affected [12].
Models that rely on prototype estimation, such as SOM and
K-means, are highly affected by the presence of outliers in the
training data set, which could force the estimated prototype to
be placed near or at the nontarget data set [2,12,13].
Nevertheless, boundary and domain-based method such as
SVDD and V-SVM and reconstruction-based method such as
auto-encoders are more or less insensitive to outliers and can
generate acceptable solutions [3,12,64].
Model Parameters and Associated Complexity
The parameters of a model can be either free or user defined.
These two parameters, free and user defined, provide insight
into how flexible the model is, how sensitive the model is to
overtraining, and how easy the model is to configure (simplicity)
[12,16]. Considering the number of these parameters, there exist
large variations among the models. For instance, NN does not
possess any free parameters; therefore, its performance
completely relies on the training data set [12]. This constraint
has limitations, mainly because training data that contain outliers
could ruin the model’s performance [12,15,16]. A model that
possess large number of free and user defined parameters is too
flexible and complex [12]. Regarding the user-defined
parameters, also known as hyper-parameters, a model equipped
with small number of parameters and preferably with intuitive
meaning are easy to configure. Setting up the user defined
parameters incorrectly can degrade the model’s performance
and selecting the proper values (optimization) becomes complex
and vague as the number of model parameters become too large.
One of the simplest models is Parzen density and NN, which
do not require the user to specify any parameters [3,12,13].
Some models, such as support vector families, require the user
to specify parameters that have intuitive meaning, for example,
the ratio of training objects to be rejected by the description
[12,65]. There are also models that are complex enough given
that the user is expected to specify many parameters, which are
not intuitive and require careful choice. Examples of such
models include SOM and auto-encoders, where the user is
expected to supply the number of neuron, hidden units, and
learning rate [10,12,37,66].
Practical Illustration and Area of Applications
For a real-world application, apart from the performance of the
model, it is important to consider two important aspects of the
data set, the time window of detection (data granularity) and
the required sample size. The time window or data granularity,
that is, hourly and daily, defines the frequency (continuity) of
computation one needs to conduct throughout the day to screen
the health status of the individual with type 1 diabetes. In an
hourly time window, one is expected to carry out the
computation at the end of each hour throughout the day.
However, in the daily time window, one needs to carry out one
aggregate computation at the end of the day. Decreasing the
time window (increasing the granularity of the data) enhances
early detections; however, at the coast of accuracy, for example,
more unwanted features (noise) in the data. The results
demonstrated that almost all the models produced fairly
comparable detection performances in both time windows.
Moreover, the required sample size determines the necessary
amount of data an individual with type 1 diabetes needs to
collect in advance before joining such an infection detection
system. Models that could generalize well with small sample
sizes could be preferred in a real-world application to enable
more people to join the system with ease. Generally, the results
demonstrated that the models require at least a sample size of
3-month data for the daily case and 2-month data for hourly
case to perform better. Automating the detection of infection
incidences among people with type 1 diabetes can deliver a
means to provide personalized decision support and learning
platforms for the individuals and, at the same time, can be used
to detect infectious disease outbreaks on a large scale through
spatio-temporal cluster detection [19,67,68]. Detailed
descriptions of these instances are given below:
1. A personalized decision support system and learning
platform relies on an individual’s self-recorded data to
provide relevant information in relation to decision making
to assist the individuals during crises [19,67,68]. Moreover,
it can also provide a learning platform concerning the extent
to which infection incidence affects the key parameters of
the blood glucose dynamics. Information regarding what
to expect at each stage of the course of infection could be
very important to the individuals [19]. During infection
incidences, various kinds of information could be vital for
an individual to properly manage blood glucose levels,
including time in range (blood glucose), to what extent is
the evolution of blood glucose affected during the course
of infection, to what extent does insulin sensitivity change,
and how much does the insulin-to-carbohydrate ratio shift,
that is, changes in insulin requirements for each gram of
carbohydrate intake.
2. A population-based early outbreak detection system relies
on self-recorded information from an individual with type
1 diabetes to detect individuals’ infection cases and, thereby,
detect a group of infected individuals on a spatio-temporal
basis. Such a system should collect individuals’self-recoded
data to a central server, analyze individuals’data on a timely
basis, identify and locate a cluster of people based on space
and time, and notify the responsible bodies if there is an
ongoing outbreak [19,67-71].
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Anomaly or novelty detection problem has been widely used
in various applications including machine fault and sensor
failure detection, prevention of credit card or identity fraud,
health and medical diagnostics and monitoring, cyber-intrusion
detection, and others. In this study, we demonstrated the
applicability of one-class classifiers and unsupervised anomaly
detection methods for the purpose of detecting infection
incidences in people with type 1 diabetes. In general, the
proposed methods produced excellent performance in describing
the data set, and particularly the boundary and domain-based
method performed better. In contrast to the specific models,
V-SVM, K-NN, and K-means achieved better generalization in
describing the data set in all infection cases. Detecting the
incidence of infection in people with type 1 diabetes can provide
an opportunity to devise tailored services, that is, personalized
decision support and a learning platform for the individuals,
and can simultaneously be used for detecting potential public
health threats, that is, infectious disease outbreaks, on a
large-scale basis through a spatio-temporal cluster detection.
Generally, we foresee that the results presented could encourage
researchers to further examine the presented features along with
other additional features of self-recorded data, for example,
various CGM features and physical activity data, on a large-scale
basis.
Acknowledgments
The work presented in this paper is part of the project Electronic Disease Surveillance Monitoring Network (EDMON) system,
which is funded by the University of Tromsø–The Arctic University of Norway and National Library of Medicine Mechanistic
machine learning (grant number: LM012734) and is the PhD program of the first author, AW. The authors would like to extend
their sincere gratitude to all the participants of the study.
Authors' Contributions
The first author, AW, conceived the study, designed and performed the experiments, and wrote the manuscript. IK, EÅ, JI, DA,




Theoretical background of the methods.
[DOCX File , 73 KB-Multimedia Appendix 1]
Multimedia Appendix 2
Detailed description of the models input features.
[DOCX File , 12076 KB-Multimedia Appendix 2]
Multimedia Appendix 3
Score plot of the models for each patient year.
[DOCX File , 12308 KB-Multimedia Appendix 3]
Multimedia Appendix 4
Model evaluations – performance of the models for each patient year.
[DOCX File , 62 KB-Multimedia Appendix 4]
References
1. Dunning T, Friedman E. In: Loukides M, editor. Practical Machine Learning: A New Look at Anomaly Detection. New
York, USA: O'Reilly Media Inc; 2014.
2. Agrawal S, Agrawal J. Survey on anomaly detection using data mining techniques. Procedia Comput Sci 2015;60:708-713
[FREE Full text] [doi: 10.1016/j.procs.2015.08.220]
3. Pimentel MA, Clifton DA, Clifton L, Tarassenko L. A review of novelty detection. Sig Process 2014 Jun;99:215-249 [FREE
Full text] [doi: 10.1016/j.sigpro.2013.12.026]
4. Cohen G, Hilario M, Sax H, Hugonnet S, Pellegrini C, Geissbuhler A. An application of one-class support vector machine
to nosocomial infection detection. Stud Health Technol Inform 2004;107(Pt 1):716-720. [Medline: 15360906]
5. Cohen G, Sax H, Geissbuhler A. Novelty detection using one-class Parzen density estimator. An application to surveillance
of nosocomial infections. Stud Health Technol Inform 2008;136:21-26. [Medline: 18487702]
J Med Internet Res 2020 | vol. 22 | iss. 8 | e18912 | p. 28https://www.jmir.org/2020/8/e18912
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
6. Cohen G, Hilario M, Sax H, Hugonnet S, Geissbuhler A. Learning from imbalanced data in surveillance of nosocomial
infection. Artif Intell Med 2006 May;37(1):7-18. [doi: 10.1016/j.artmed.2005.03.002] [Medline: 16233974]
7. Chandola V, Banerjee A, Kumar V. Anomaly detection: a survey. ACM Comput Surv 2009 Jul;41(3):1-58 [FREE Full
text] [doi: 10.1145/1541880.1541882]
8. Hawkins DM. Identification of Outliers. Netherlands: Springer; 1980.
9. Mehrotra KG, Mohan CK, Huang H. In: Subrahmanian VS, editor. Anomaly Detection Principles and Algorithms. Cham,
Switzerland: Springer International Publishing; 2017.
10. Khan SS, Madden MG. One-class classification: taxonomy of study and review of techniques. Knowl Eng Rev 2014 Jan
24;29(3):345-374 [FREE Full text] [doi: 10.1017/s026988891300043x]
11. Ding X, Li Y, Belatreche A, Maguire LP. An experimental evaluation of novelty detection methods. Neurocomputing 2014
Jul;135:313-327 [FREE Full text] [doi: 10.1016/j.neucom.2013.12.002]
12. Tax DM. One-Class Classification: Concept Learning in the Absence of Counter-Examples. South Holand: Technische
Universiteit Delft; 2002.
13. Irigoien I, Sierra B, Arenas C. Towards application of one-class classification methods to medical data. ScientificWorldJournal
2014;2014:730712 [FREE Full text] [doi: 10.1155/2014/730712] [Medline: 24778600]
14. Japkowicz N. Concept Learning in the Absence of Counterexamples: an Autoassociation-Based Approach to Classification.
Semantic Scholar. 1999. URL: https://www.semanticscholar.org/paper/
Concept-learning-in-the-absence-of-counterexamples%3A-Japkowicz-Hanson/03ed0a73d1f7a7b16505d6cb9c8bfbeeef7b19bb
[accessed 2020-07-23]
15. Juszczak P, Tax DM, Pe¸kalska E, Duin RP. Minimum spanning tree based one-class classifier. Neurocomputing 2009
Mar;72(7-9):1859-1869 [FREE Full text] [doi: 10.1016/j.neucom.2008.05.003]
16. Mazhelis O. One-class classifiers: a review and analysis of suitability in the context of mobile-masquerader detection. S
Afr Comput J 2006;2006(36):29-48 [FREE Full text]
17. Clark M. What is diabetes? In: Ogden J, editor. Understanding Diabetes. New Jersey, United States: John Wiley & Sons,
Ltd; Jan 20, 2004.
18. Ogurtsova K, da Rocha FJ, Huang Y, Linnenkamp U, Guariguata L, Cho N, et al. IDF diabetes atlas: global estimates for
the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017 Jun;128:40-50. [doi:
10.1016/j.diabres.2017.03.024] [Medline: 28437734]
19. Woldaregay A, Årsand E, Albers D, Launonen I, Hartvigsen G. Towards detecting infection incidences in people with type
1 diabetes using self-recorded data: a novel framework for a digital infectious disease detection mechanism. JMIR preprints
2020:- preprint [FREE Full text] [doi: 10.2196/preprints.18911]
20. Marcovecchio ML, Chiarelli F. The effects of acute and chronic stress on diabetes control. Sci Signal 2012 Oct 23;5(247):pt10.
[doi: 10.1126/scisignal.2003508] [Medline: 23092890]
21. Rayfield EJ, Ault MJ, Keusch GT, Brothers MJ, Nechemias C, Smith H. Infection and diabetes: the case for glucose control.
Am J Med 1982 Mar;72(3):439-450. [doi: 10.1016/0002-9343(82)90511-3] [Medline: 7036735]
22. Botsis T, Lai AM, Hripcsak G, Palmas W, Starren JB, Hartvigsen G. Proof of concept for the role of glycemic control in
the early detection of infections in diabetics. Health Informatics J 2012 Mar;18(1):26-35. [doi: 10.1177/1460458211428427]
[Medline: 22447875]
23. Botsis T, Hejlesen O, Bellika JG, Hartvigsen G. Blood Glucose Levels as an Indicator for the Early Detection of Infections
In Type-1 Diabetics. Faculty & Staff Insider - University of Washington. 2007. URL: http://faculty.washington.edu/lober/
www.isdsjournal.org/htdocs/articles/2025.pdf [accessed 2020-07-23]
24. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995 Jan;98(1):75-84.
[doi: 10.1016/S0002-9343(99)80083-7] [Medline: 7825623]
25. Bosarge PL, Kerby JD. Stress-induced hyperglycemia: is it harmful following trauma? Adv Surg 2013;47:287-297. [doi:
10.1016/j.yasu.2013.03.002] [Medline: 24298857]
26. Kajbaf F, Mojtahedzadeh M, Abdollahi M. Mechanisms underlying stress-induced hyperglycemia in critically ill patients.
Therapy 2007 Jan;4(1):97-106 [FREE Full text] [doi: 10.2217/14750708.4.1.97]
27. Tax DM, Duin RP. Support vector data description. Mach Learn 2004 Jan;54(1):45-66 [FREE Full text] [doi:
10.1023/b:mach.0000008084.60811.49]
28. Schölkopf B, Williamson RC, Smola AJ, Shawe-Taylor J, Platt JC. Support Vector Method for Novelty Detection. NIPS
Proceedings. 1999. URL: https://papers.nips.cc/paper/1723-support-vector-method-for-novelty-detection.pdf [accessed
2020-07-23]
29. Tax DM, Duin RP. Support vector domain description. Pattern Recognit Lett 1999 Nov;20(11-13):1191-1199 [FREE Full
text] [doi: 10.1016/s0167-8655(99)00087-2]
30. Ridder DD, Tax DM, Duin, RP. An Experimental Comparison of One-Class Classification Methods. In: Proceedings of
the 4th Annual Conference of the Advanced School for Computing and Imaging. 1998 Presented at: Annual Conference
of the Advacned School for Computing and Imaging; September 29-October 4, 1998; Delft, Netherlands URL: https://www.
researchgate.net/publication/
282673032_An_experimental_comparison_of_classification_algorithm_performances_for_highly_imbalanced_datasets
J Med Internet Res 2020 | vol. 22 | iss. 8 | e18912 | p. 29https://www.jmir.org/2020/8/e18912
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
31. Breunig MM, Kriegel H, Ng RT, Sander J. LOF: identifying density-based local outliers. SIGMOD Rec 2000 Jun
1;29(2):93-104 [FREE Full text] [doi: 10.1145/335191.335388]
32. Tax D. Software. DDTools. Delft: Delft University of Technology; 2015. URL: https://www.tudelft.nl/ewi/over-de-faculteit/
afdelingen/intelligent-systems/pattern-recognition-bioinformatics/pattern-recognition-bioinformatics/data-and-software/
dd-tools [accessed 2019-02-10]
33. A Collection of Algorithms for Anomaly/Outlier Detection. Anomaly Detection Toolbox. 2016. URL: http://dsmi-lab-ntust.
github.io/AnomalyDetectionToolbox/ [accessed 2019-03-25]
34. Tang J, Chen Z, Fu AW, Cheung DW. Enhancing effectiveness of outlier detections for low density patterns. In: Advances
in Knowledge Discovery and Data Mining. New York, USA: Springer; 2002.
35. Duin R, Juszczak P, Paclik P, Pekalska E, De Ridder D, Tax DM. Software. Delft University of Technology. 2007. URL:
http://prtools.tudelft.nl/Guide/37Pages/software.html [accessed 2019-02-25]
36. Goldstein M, Uchida S. A comparative evaluation of unsupervised anomaly detection algorithms for multivariate data.
PLoS One 2016;11(4):e0152173 [FREE Full text] [doi: 10.1371/journal.pone.0152173] [Medline: 27093601]
37. Swersky L, Marques H, Sander J, Campello RJ, Zimek A. On the Evaluation of Outlier Detection and One-Class Classification
Methods. In: IEEE International Conference on Data Science and Advanced Analytics (DSAA). 2016 Presented at: DSAA'16;
October 17-19, 2016; Montreal, QC, Canada URL: https://doi.org/10.1109/DSAA.2016.8 [doi: 10.1109/dsaa.2016.8]
38. Rousseeuw PJ, Driessen KV. A fast algorithm for the minimum covariance determinant estimator. Technometrics 1999
Aug;41(3):212-223 [FREE Full text] [doi: 10.1080/00401706.1999.10485670]
39. Parzen E. On estimation of a probability density function and mode. Ann Math Statist 1962 Sep;33(3):1065-1076 [FREE
Full text] [doi: 10.1214/aoms/1177704472]
40. Rasoulzadeh V, Erkus EC, Yogurt TA, Ulusoy I, Zergeroğlu SA. A comparative stationarity analysis of EEG signals. Ann
Oper Res 2016 Apr 26;258(1):133-157 [FREE Full text] [doi: 10.1007/s10479-016-2187-3]
41. Azami H, Mohammadi K, Bozorgtabar B. An improved signal segmentation using moving average and Savitzky-Golay
filter. J Signal Inf Process 2012;03(01):39-44. [doi: 10.4236/jsip.2012.31006]
42. Kandanaarachchi S, Muñoz MA, Hyndman RJ, Smith-Miles K. On normalization and algorithm selection for unsupervised
outlier detection. Data Min Knowl Disc 2019 Nov 21;34(2):309-354 [FREE Full text] [doi: 10.1007/s10618-019-00661-z]
43. Tax DM, Muller KA. A Consistency-based Model Selection for One-Class Classification. In: Proceedings of the 17th
International Conference on Pattern Recognition. 2004 Presented at: ICPR'04; August 26, 2004; Cambridge, UK. [doi:
10.1109/icpr.2004.1334542]
44. Maldonado S, Montecinos C. Robust classification of imbalanced data using one-class and two-class SVM-based
multiclassifiers. Intell Data Anal 2014 Jan 1;18(1):95-112. [doi: 10.3233/ida-130630]
45. Tharwat A. Classification assessment methods. Appl Comput Inf 2018 Aug:- epub ahead of print [FREE Full text] [doi:
10.1016/j.aci.2018.08.003]
46. Nguyen GH, Bouzerdoum A, Phung SL. Learning pattern classification tasks with imbalanced data sets. Pattern Recog
2009:- [FREE Full text] [doi: 10.5772/7544]
47. Hajizadeh S, Li Z, Dollevoet RP, Tax DM. Evaluating classification performance with only positive and unlabeled samples.
In: Fränti P, Brown G, Loog M, Escolano F, Pelillo M, editors. Structural, Syntactic, and Statistical Pattern Recognition:
Joint IAPR International Workshop. Berlin, Heidelberg: Springer; 2014.
48. Hajizadeh S, Núñez A, Tax DM. Semi-supervised rail defect detection from imbalanced image data. IFAC-PapersOnLine
2016;49(3):78-83 [FREE Full text] [doi: 10.1016/j.ifacol.2016.07.014]
49. Bradley AP. The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recog
1997 Jul;30(7):1145-1159 [FREE Full text] [doi: 10.1016/s0031-3203(96)00142-2]
50. McNamara LA, Martin S. Principles of epidemiology and public health. In: Long SS, Prober CG, Fischer M, editors.
Principles and Practice of Pediatric Infectious Diseases. Fifth Edition. New York, USA: Elsevier; 2018.
51. Zhu Y. Automatic detection of anomalies in blood glucose using a machine learning approach. J Commun Netw 2011
Apr;13(2):125-131 [FREE Full text] [doi: 10.1109/jcn.2011.6157411]
52. Zhu Y. Automatic Detection of Anomalies in Blood Glucose Using a Machine Learning Approach. In: International
Conference on Information Reuse & Integration. 2010 Presented at: IER'10; August 4-6, 2010; Las Vegas, NV, USA URL:
https://ieeexplore.ieee.org/document/5558959 [doi: 10.1109/jcn.2011.6157411]
53. Spinosa EJ, Carvalho AC. Support vector machines for novel class detection in Bioinformatics. Genet Mol Res 2005 Sep
30;4(3):608-615. [Medline: 16342046]
54. Lotze TH. Anomaly Detection in Time Series: Theoretical and Practical Improvements for Disease Outbreak Detection.
Digital Repository at the University of Maryland. 2009. URL: https://drum.lib.umd.edu/handle/1903/9857 [accessed
2020-07-23]
55. Tsui F, Espino JU, Dato VM, Gesteland PH, Hutman J, Wagner MM. Technical description of RODS: a real-time public
health surveillance system. J Am Med Inform Assoc 2003;10(5):399-408 [FREE Full text] [doi: 10.1197/jamia.M1345]
[Medline: 12807803]
J Med Internet Res 2020 | vol. 22 | iss. 8 | e18912 | p. 30https://www.jmir.org/2020/8/e18912
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
56. Woldaregay AZ, Årsand E, Botsis T, Albers D, Mamykina L, Hartvigsen G. Data-driven blood glucose pattern classification
and anomalies detection: machine-learning applications in type 1 diabetes. J Med Internet Res 2019 May 1;21(5):e11030
[FREE Full text] [doi: 10.2196/11030] [Medline: 31042157]
57. Oviedo S, Vehí J, Calm R, Armengol J. A review of personalized blood glucose prediction strategies for T1DM patients.
Int J Numer Method Biomed Eng 2017 Jun;33(6):---. [doi: 10.1002/cnm.2833] [Medline: 27644067]
58. Yki-Järvinen H, Sammalkorpi K, Koivisto VA, Nikkilä EA. Severity, duration, and mechanisms of insulin resistance during
acute infections. J Clin Endocrinol Metab 1989 Aug;69(2):317-323. [doi: 10.1210/jcem-69-2-317] [Medline: 2666428]
59. Rayfield EJ, Curnow RT, George DT, Beisel WR. Impaired carbohydrate metabolism during a mild viral illness. N Engl
J Med 1973 Sep 20;289(12):618-621. [doi: 10.1056/NEJM197309202891207] [Medline: 4198822]
60. McGuinness OP. Defective glucose homeostasis during infection. Annu Rev Nutr 2005;25:9-35. [doi:
10.1146/annurev.nutr.24.012003.132159] [Medline: 16011457]
61. Brealey D, Singer M. Hyperglycemia in critical illness: a review. J Diabetes Sci Technol 2009 Nov 1;3(6):1250-1260
[FREE Full text] [doi: 10.1177/193229680900300604] [Medline: 20144378]
62. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001
Dec;15(4):533-551. [doi: 10.1053/beem.2001.0168] [Medline: 11800522]
63. Tax DM, Duin RP. Characterizing One-Class Datasets. CiteSeerX. 2005. URL: http://citeseerx.ist.psu.edu/viewdoc/
download?doi=10.1.1.460.8322&rep=rep1&type=pdf [accessed 2019-07-10]
64. Wang D, Yeung DS, Tsang EC. Structured one-class classification. IEEE Trans Syst Man Cybern B Cybern 2006
Dec;36(6):1283-1295. [doi: 10.1109/tsmcb.2006.876189] [Medline: 17186805]
65. Janssens JH. Outlier Selection and One-Class Classification. Netherlands: Embedded Systems Institute, Tilburg University;
2013.
66. Wang B, Mao Z. One-class classifiers ensemble based anomaly detection scheme for process control systems. T I Meas
Control 2017 Sep 21;40(12):3466-3476 [FREE Full text] [doi: 10.1177/0142331217724508]
67. Samerski S. Individuals on alert: digital epidemiology and the individualization of surveillance. Life Sci Soc Policy 2018
Jun 14;14(1):13 [FREE Full text] [doi: 10.1186/s40504-018-0076-z] [Medline: 29900518]
68. Radin JM, Wineinger NE, Topol EJ, Steinhubl SR. Harnessing wearable device data to improve state-level real-time
surveillance of influenza-like illness in the USA: a population-based study. Lancet Digit Health 2020 Feb;2(2):e85-e93
[FREE Full text] [doi: 10.1016/s2589-7500(19)30222-5]
69. Woldaregay A, Årsand E, Giordanengo A, Albers D, Mamykina L, Botsis T, et al. EDMON-A Wireless Communication
Platform for a Real-time Infectious Disease Outbreak Detection System Using Self-recorded Data From People With Type
1 Diabetes. In: The 15th Scandinavian Conference on Health Informatics. 2017 Presented at: SHI'17; August 29, 2017;
Kristiansand, Norway URL: https://ep.liu.se/konferensartikel.aspx?series=ecp&issue=145&Article_No=3
70. Coucheron S, Woldaregay AZ, Årsand E, Botsis T, Hartvigsen G. EDMON - A System Architecture for Real-Time Infection
Monitoring and Outbreak Detection Based on Self-Recorded Data from People with Type 1 Diabetes: System Design and
Prototype Implementation. In: The 17th Scandinavian Conference on Health Informatics. 2019 Presented at: CHI'19;
November 12-13, 2019; Oslo, Norway URL: https://ep.liu.se/ecp/161/007/ecp19161007.pdf
71. Yeng PK, Woldaregay AZ, Solvoll T, Hartvigsen G. Cluster detection mechanisms for syndromic surveillance systems:
systematic review and framework development. JMIR Public Health Surveill 2020 May 26;6(2):e11512 [FREE Full text]
[doi: 10.2196/11512] [Medline: 32357126]
Abbreviations
AUC: area under the receiver operating characteristic curve
COF: connectivity-based outlier factor
IncSVDD: incremental support vector data description
K-NN: K-nearest neighbor
LOF: local outlier factor
MCD: minimum covariance determinant
MOG: mixture of Gaussian
MST: minimum spanning tree
NN: nearest neighbor
PCA: principal component analysis
SOM: self-organizing maps
SVDD: support vector data description
ROC: receiver operating characteristic curve
V-SVM: one-class support vector machine
J Med Internet Res 2020 | vol. 22 | iss. 8 | e18912 | p. 31https://www.jmir.org/2020/8/e18912
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Edited by G Eysenbach; submitted 26.03.20; peer-reviewed by S Sarbadhikari, M Nomali; comments to author 13.04.20; revised
version received 06.06.20; accepted 11.06.20; published 12.08.20
Please cite as:
Woldaregay AZ, Launonen IK, Albers D, Igual J, Årsand E, Hartvigsen G
A Novel Approach for Continuous Health Status Monitoring and Automatic Detection of Infection Incidences in People With Type 1
Diabetes Using Machine Learning Algorithms (Part 2): A Personalized Digital Infectious Disease Detection Mechanism




©Ashenafi Zebene Woldaregay, Ilkka Kalervo Launonen, David Albers, Jorge Igual, Eirik Årsand, Gunnar Hartvigsen. Originally
published in the Journal of Medical Internet Research (http://www.jmir.org), 12.08.2020. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of
Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on
http://www.jmir.org/, as well as this copyright and license information must be included.
J Med Internet Res 2020 | vol. 22 | iss. 8 | e18912 | p. 32https://www.jmir.org/2020/8/e18912
(page number not for citation purposes)
Woldaregay et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Appendix 1: Theoretical Background of the Methods  
Background  
 Notion of Object  
𝒳𝑘 = (𝓍1,1, 𝓍1,2) 𝓍1,1 𝓍1,2
 One-class Classifier  




    𝑡𝑎𝑟𝑔𝑒𝑡                  𝛪(𝒹(𝓍) ≤ 𝛽)




     𝑡𝑎𝑟𝑔𝑒𝑡                𝛪(𝒫(𝓍) ≥ 𝛽)
 𝑛𝑜𝑛 − 𝑡𝑎𝑟𝑔𝑒𝑡       𝛪(𝒫(𝓍) < 𝛽)
𝜓(𝓍) Ι
 Boundary and Domain-Based Method 
𝛼𝑖
𝑳 = 𝜺𝑺𝑽𝑫𝑫 = ∑ 𝛼𝑖(𝒙𝑖 . 𝒙𝑗) −𝑖 ∑ 𝛼𝑖𝛼𝑗(𝒙𝑖 . 𝒙𝑗)𝑖,𝑗                     
∑ 𝛼𝑖𝑖 = 1 0 ≤ 𝛼𝑖 ≤ 𝕔 𝕔
𝑥
𝝍(𝒙) = { 
𝑡𝑎𝑟𝑔𝑒𝑡,                𝑖𝑓 ‖𝑥 − а‖2 ≤ ℝ2
𝑛𝑜𝑛 − 𝑡𝑎𝑟𝑔𝑒𝑡,               𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒             
а ∑ 𝛼𝑖x𝑖𝑖
ℝ = (𝑥𝑘 . 𝑥𝑘) − 2 ∑ 𝛼𝑖𝑖 (𝑥𝑖 . 𝑥𝑘) + ∑ 𝛼𝑖𝛼𝑗𝑖,𝑗 (𝑥𝑖 . 𝑥𝑗)







 ∑ 𝛼𝑖𝛼𝑗𝐾(𝑥𝑖 , 𝑥𝑗)𝑖,𝑗
0 ≤ 𝛼𝑖 ≤
1
𝑁𝜈
, ∑ 𝛼𝑖 = 1,𝑖
𝜈 ℂ 𝑥
 
            𝝍(𝒙) = {
      𝑡𝑎𝑟𝑔𝑒𝑡,                     𝑖𝑓 ∑ 𝛼𝑖𝐾(𝑥𝑖 , 𝑥) − 𝜁 ≥ 0,𝑖
𝑛𝑜𝑛 − 𝑡𝑎𝑟𝑔𝑒𝑡,                          𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒             








    𝑡𝑎𝑟𝑔𝑒𝑡                          𝑖𝑓   𝝆𝑵𝑵(𝑥) ≤ 𝛽
𝑛𝑜𝑛 − 𝑡𝑎𝑟𝑔𝑒𝑡               𝑖𝑓   𝝆𝑵𝑵(𝑥) > 𝛽
 Density-Based Method 
𝑥 𝑋
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𝑀𝑎ℎ𝑎
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𝝆𝑴𝑶𝑮(𝑥) = ∑ 𝑷𝒊𝑒𝑥𝑝 (−(𝑥 − 𝜇𝑖)
𝑇)𝜮𝒊
−𝟏𝐾
𝑖=1 (𝑥 − 𝜇𝑖))
𝑃𝑖 Σ𝑖
β as: 
                            𝝍(𝒙) = { 
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𝑀𝑂𝐺
(𝑥) ≥ 𝛽
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     𝑡𝑎𝑟𝑔𝑒𝑡                          𝑖𝑓   𝜀𝑟𝑒𝑐𝑜𝑛𝑠𝑡𝑟𝑢𝑐𝑡𝑖𝑜𝑛 ≤ 𝛽
𝑛𝑜𝑛 − 𝑡𝑎𝑟𝑔𝑒𝑡                𝑖𝑓   𝜀𝑟𝑒𝑐𝑜𝑛𝑠𝑡𝑟𝑢𝑐𝑡𝑖𝑜𝑛 > 𝛽




𝜀𝑖𝑚 = ∑ (𝑚𝑖𝑛𝑖‖𝑥𝑘 − 𝜇𝑖‖
2)𝑘
𝜀𝑟𝑒𝑐𝑜𝑛𝑠𝑡𝑟𝑢𝑐𝑡𝑖𝑜𝑛 = 𝑚𝑖𝑛𝑖‖𝑥 − 𝜇𝑖‖
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Appendix 2 - Detailed Description of the Models Input Features 




1.2. Atypical Data 
1.3.  Description of Input Features 
1.3.1. Description of Input Features During the Normal Patient Years 
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Appendix 3-Score Plot of the Models for Each Patient Year 
A. Semi-supervised (One-class classifiers) 
1. Daily  
1.1. The First Case of Infection (flu) 




1.1.2. Density-Based Method 
 





1.2. The Second Case of Infection (flu) 
1.2.1. Boundary and Domain-Based Method 
 
 





1.2.3. Reconstruction-Based Method 
 
 
1.3. The Third Case of Infection (flu) 




1.3.2. Density-Based Method 
 





1.4. The Fourth Case of Infection (flu) 
1.4.1. Boundary and Domain-Based Method 
 





1.4.3. Reconstruction-Based Method 
 
 
2. Hourly  
2.1. The First Case of Infection (flu) 




2.1.2. Density-Based Method 
 









2.2. The Second Case of Infection (flu) 
2.2.1. Boundary and Domain-Based Method 
 




2.2.3. Reconstruction-Based Method 
 
2.3. The Third Case of Infection (flu) 





2.3.2. Density-Based Method 
 







2.4. The Fourth Case of Infection (flu) 
2.4.1. Boundary and Domain-Based Method 
 




2.4.3. Reconstruction-Based Method 
 
 
B. Unsupervised Approach 
1. Daily  





1.2. The Second Case of Infection (flu) 
 





1.4. The Fourth Case of Infection (flu) 
 
 
2. Hourly  





2.2. The Second Case of Infection (flu) 
 










Appendix 4 - Model Evaluations – Performance of the Models for 
Each Patient Year 
I. Daily  






























1. The First Case of Infection (Flu) 
𝝊 𝑺𝑽𝑴
 

























Woldaregay, A. Z. Automatic Detection of Infection State in Individuals with Type 1 Diabetes 
Under Free-Living Conditions Using Using Self-Recorded Insulin and Carbohydrate 
Information (Part 3). EARLY DRAFT MANUSCRIPT. This Manuscript contains 













Woldaregay, A. Z., Henriksen, A., Issom, D. Z., Pfuhl, G., Sato, K., Richard, A., Lovis, C., 
Arsand, E., Rochat, J., & Hartvigsen, G. (2020). User Expectations and Willingness to 
Share Self-Collected Health Data. Stud Health Technol Inform, 270, 894-898. 
doi:10.3233/SHTI200290 
 
User Expectations and Willingness to Share 
Self-Collected Health Data 
Ashenafi Zebene WOLDAREGAY a,*, André HENRIKSEN a,1,*, David-Zacharie 
ISSOM b, Gerit PFUHL a, Keiichi SATO c, Aude RICHARD b, Christian LOVIS b, 
Eirik ÅRSAND d, Jessica ROCHAT b, and Gunnar HARTVIGSEN a  
a UiT The Arctic University of Norway, Tromsø, Norway. 
b University of Geneva, Geneva, Switzerland. 
c Illinois Institute of Technology, Illinois, USA. 
d Norwegian Centre for E-health Research, Tromsø, Norway. 
Abstract. The rapid improvement in mobile health technologies revolutionized what 
and how people can self-record and manage data. This massive amount of 
information accumulated by these technologies has potentially many applications 
beyond personal need, i.e. for public health. A challenge with collecting this data is 
to motivate people to share this data for the benefit of all. The purpose of this study 
is to survey and examine factors that may motivate sharing this data. We asked 447 
participants four questions related to health data sharing and motivation. Participants 
with a chronic disease were concerned about data sharing but also willing to share 
health data if personalized feedback is provided. Functionality, ease of use, and 
privacy are regarded as crucial features of health apps. 
Keywords. Public health, mHealth, motivation, health surveys, health data sharing. 
1. Introduction 
The ubiquitous nature of smartphones, wearables, and sensors have revolutionized the 
way people collect health-related data. An increasing number of people collects large 
amounts of data for disease-management, fitness, and self-surveillance. In a recent study, 
more than 60% of American participants tracked various health parameters, including 
diet, weight, and physical exercise, where 21% relied on fitness tracker technology [1]. 
People with chronic diseases use different technologies, e.g. mHealth apps and 
continuous glucose monitors for diabetes management, collecting and processing health 
data for their self-management. This data can potentially be used as a secondary source 
of information for public health, including tracking of disease trends, behavioural patterns 
over time, chronic diseases status, research, and policy work [2, 3, 4, 5]. The impact of 
these self-collected data highly depends on people's willingness to share their data for 
the intended purpose. Considering the potential of these data to inform about individual 
and population health, understanding the users' expectations and willingness towards 
mass data sharing is an important area of research. Various factors could affect people's 
motivations to engage in mass data sharing, e.g. lack of trust, which is mainly  
1 Corresponding author, E-mail: andre.henriksen@uit.no  ; * Authors contributed equally 
Digital Personalized Health and Medicine
L.B. Pape-Haugaard et al. (Eds.)
© 2020 European Federation for Medical Informatics (EFMI) and IOS Press.
This article is published online with Open Access by IOS Press and distributed under the terms
of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
doi:10.3233/SHTI200290
894
subject to data security, privacy, and confidentiality issues [6]. When sharing such data, 
expectation and willingness often differ in different patient groups, as well as in healthy 
people [7, 8], e.g. people with type 1 diabetes have a high need to record health data 
several times per day. Here, we examine factors related to people's knowledge and 
expectations toward raising motivation for sharing of health-related data and comparing 
these factors across different groups. 
2. Method 
We created an online survey with questions related to motivational factors around 
mHealth apps and data sharing. Questions were derived from 16 in-person interviews [6]. 
The survey was conducted among English-speaking internet users in a Swiss cohort of 
healthy people and also in English and Norwegian online diabetes groups. We collected 
data between 11/2018 and 08/2019. The questions related to data sharing are: 1) How 
concerned are participants about sharing health data, 2) what do participants expect in 
return when sharing health data, 3) which data types are participants willing to share 
anonymously for research, and 4) how important are different criteria in order to agree 
to install an application that collects and shares data from their wearable device. Options 
were on a 4-point Likert scale from "not important at all" to "very important" (including 
"I don't know"), or multiple-choice. We stratified responses into three groups: 1) People 
with diabetes (PWD), 2) people with other chronic disease and 3) people without a 
chronic disease. Details about the questionnaire are available at DataverseNO [9]. We 
report descriptive statistics on age, gender, experience using wearable devices and 
mobile health apps and wearables for sharing health or activity data. 
3. Results 
Four hundred forty-seven (447) participants finished the survey, of which eight did not 
answer whether they have a disease, and nine selected "Do not want to answer". 
Further analyses are based on the remaining N=430. Sixty-one (61) participants had 
diabetes, 82 participants had another chronic disease, and 285 had no chronic disease. 
The majority of participants came from Switzerland (187), Norway (59), 
US/UK/Australia/Canada (77), France (26), and Germany (13). Remaining 46 came 
from 35 countries covering all continents. Table 1 gives their demographics, familiarity 
with mHealth apps, and sharing experience. There was no age (p=.083) or gender 
(p=.133) difference between the groups. However, 97% in the diabetes group use a 
wearable device for collecting activity or other health data, compared to only 51% in 
the "no disease" group, and 55% in the "other chronic disease" 	
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p=.001. Many PWD has experience in sharing data, less so people without a chronic 
	







A.Z. Woldaregay et al. / User Expectations and Willingness to Share Self-Collected Health Data 895
 
Table 1. Demographics and familiarity with mHealth apps. Na= no answer. 
 With diabetes With other chronic diseases Without chronic disease 
Age: <30 y; 30-50y; >50y 15; 17; 27 (Na: 2) 9; 32; 40 (Na: 1) 34; 96; 146 (Na: 6) 
Gender: female; male; other 35; 25; 1 59; 20; 3 177; 99; 3 
Wearable device: yes; no 59; 2 44; 36 143; 137 
Sharing experience: yes; no 24; 27 (Na: 10) 22; 45 (Na: 14) 47; 160; (Na: 11) 
3.1. Technologies use for health tracking 
87% of those with diabetes use a health-specific device, in addition to often using a 
Physical Activity (PA) tracker. 3% use no sensor or wearable device. Among those 
with other- or no chronic diseases, the use of sensors integrated in the smartphone and 
PA trackers are most common. 25-30% use mobile health apps. Generally, participants 
preferred to discuss health issues with health providers. PWD would discuss it with 
others PWD (17%), but rarely with their family (6%). This is in contrast to persons with 
other- or no chronic disease, where 19% and 20%, respectively, would discuss health 
issues with their family and friends, see Figure 2b. This difference with whom to share 
was statistically significant, 2=34.67, p<.001. 
3.2. Concerns about data sharing 
Regarding what people are most concerned about sharing health data, persons with no 
chronic disease are in general least concerned, and all three groups rate storage as least 
and transparency as most concerning. Figure 1a shows how each group rate concerns 
about confidence and trust, data ownership, storage location/availability, and 
transparency of third party usage. Figure 1b shows how important certain features are 
for each group in order to agree to install an application that collects and share health 
data from their wearable device. 
 
Figure 1. a: Concerns about different aspects of data sharing. b: Importance of features, answer option 1 to 4. 
3.3. Participants expectations for sharing health data 
Regarding what participants expected in return for sharing their health data, personalized 
feedback was chosen by 60% of participants, integrated view (i.e. aggregated results), 
was chosen by 53%, decision support by 36%, and least chosen (16%) was comparing 
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status with others. There was no difference between the groups in their expectations, 
smallest p > .74, but comparing with others was rated as least important (Figure 2a). 
Figure 2. a: Expectations for sharing data. b: Group distribution of health tracking technology. 
3.4. Willingness to anonymously share given data types in a research project 
Groups do not differ in sharing lifestyle/dietary information, signs of infection, daily 
mood, geographical location, sleep duration, social environment (corrected for multiple 
comparisons). Participants are least willing to share their geographical location. Persons 
with chronic disease are more willing to share medication intake, physiological 
indicators and their weight. An overview is given in Table 2.  













































































































N 213 219 195 202 193 248 87 240 221 173 89 
Diabetes 53 41 31 46 29 43 20 43 43 30 5 
Other chr. 44 45 45 40 46 54 16 50 49 35 16 
No chr. 116 133 119 116 118 151 51 147 129 108 68 
2 43.48 9.05 5.22 24.39 5.73 8.93 6.92 8.29 15.48 2.87 7.59 
p-value <.001 .011 .074 <.001 .057 .012 .031 .016 <.001 .238 .023 
3.5. Features' importance in mHealth app 
Regarding which features of a health-app is important to participants (1=not important 
to 4=very important), non-disturbed tracking and automatic setup is rated by most as 
important, i.e. the main effect of feature, F(3.2= .011. All 
features were more important to people with a chronic disease, F(2, 304)=12.09, p<.001, 
2=.074. PWD rate automatic data collection as most important, yielding a significant 
interaction effect, F(7.66, 1163.75)=2.104, p=.035, 2=.014. 
4. Discussion 
Mass sharing of health data could provide vital information for individual health 
management and public health. Continuous collection of quality health-related data and 
willingness to share these are limited by the user's motivation and expectations. The rate 
of acceptance of health tracking devices among clinicians is increasing [10], but 
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retention is decreasing [11]. Compared to PWD who use wearable sensors, participants 
with no- and other chronic disease reported higher adoption of sensors integrated in the 
smartphone and PA trackers. Automatic data collection, easier interface, e.g. voice 
command, tailored and personalized feedback is likely to increase usage and long-term 
engagement in such devices. 
Concern about health data sharing is dependent on the type of data, and related 
concerns on issues such as privacy, security, confidentiality, transparency, and 
ownership. Participants with no chronic disease are less concerned compared to people 
with a chronic disease. Indeed, potential consequences of data leakage like repeated low 
blood glucose level (hypoglycemia) might result in the suspension of one's driving 
license or disqualification of health insurance enrollment in some countries. Some 
privacy and security shall be kept, i.e. many participants do not want to share their 
geographical location. 
This study on how to motivate health data sharing is a collaboration between several 
projects where different systems for health data collection are under development. 
Results from the present study, and upcoming publications on related topics, will be used 
to direct the implementations of these systems for maximum acceptance. Future works 
include data collection, data quality and accuracy analysis, and detecting health patterns 
at the population level and in people with specific chronic diseases. Fulfilment of 
participant's expectations and resolving individual concerns could motivate sharing 
health-related data. Results indicate that participants expect some kind of immediate 
benefits from sharing their data, including tailored and personalized data analysis, 
integrated view, feedback and others. Comparison of status among peers was found to 
be less relevant. 
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